data_2mlx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mlx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' HG22 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 HG23 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HE3' HG23 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.679 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.679 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 50' ' ' PRO . 8.1 p30 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG23 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.6 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG12 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.554 ' H ' HD13 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HH ' ' HA2' ' B' ' 299' ' ' GLY . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.647 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.621 HG21 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.691 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.573 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.49 HG23 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.488 ' HG3' HG23 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.408 HG13 ' HG3' ' B' ' 241' ' ' GLU . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.597 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.466 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.573 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.406 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.529 ' HA ' HG23 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.691 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.621 HG13 HG21 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.411 HG23 HD11 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . 0.43 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.587 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.654 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.609 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.41 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.687 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.407 ' HA ' HE21 ' A' ' 340' ' ' GLN . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 337' ' ' PHE . 27.7 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.41 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.502 ' HA ' HG13 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.546 HG23 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.417 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' SER . . . . . 0.506 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.506 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.425 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' B' ' 291' ' ' LEU . 56.4 t30 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.486 HD13 HD12 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.417 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.462 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.673 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' THR . . . . . 0.541 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.597 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 . . . . . 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . 0.586 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . 0.587 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 397' ' ' ASN . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 296' ' ' THR . . . . . 0.652 HG23 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . 0.652 ' H ' HG23 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . 0.434 ' HA2' ' HH ' ' A' ' 112' ' ' TYR . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.546 HD13 HG23 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 78' ' ' ALA . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.491 HG13 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.491 HG12 HG13 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.739 HD11 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD2' HD13 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.583 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.514 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.739 ' HB3' HD11 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.514 ' HE3' ' HA2' ' A' ' 68' ' ' GLY . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.401 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.431 HD13 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.722 ' H ' ' HB1' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.481 HG21 HG22 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.656 HG21 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.653 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.653 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.546 ' HB2' HG21 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.722 ' HB1' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.41 HG22 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.513 ' HB ' HD11 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB3' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.447 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB3' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.451 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.456 ' HB2' ' HG1' ' A' ' 169' ' ' THR . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.481 HG22 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.454 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.431 ' HG2' HD13 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.563 ' HA ' ' HZ1' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.563 ' HZ1' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.452 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.547 HD13 HG11 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.499 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 411' ' ' VAL . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.427 ' HG3' HD22 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.502 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.633 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.437 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.411 ' HB2' HG22 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' B' ' 298' ' ' HIS . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.427 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.428 ' HA ' HD11 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.539 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.464 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . 0.473 ' HE2' HG22 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.402 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.47 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.464 ' HA ' ' HZ3' ' B' ' 294' ' ' LYS . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.47 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.448 HG13 HD23 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.539 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.532 HG23 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.401 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' THR . . . . . 0.477 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.566 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.577 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . 0.473 HG22 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.57 ' H ' HD21 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . 0.464 ' HZ3' ' HA ' ' A' ' 397' ' ' ASN . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . 0.545 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . 0.453 ' HE1' ' HB2' ' A' ' 351' ' ' LEU . 22.9 m-70 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . 0.423 ' HZ1' ' HB3' ' B' ' 303' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HG12 HG13 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' HG21 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG23 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HE3' HG23 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.685 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.413 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.437 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HB3' HD12 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.491 HG22 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.613 ' HE2' HD13 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.613 HD13 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.589 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.493 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.449 HG11 HG23 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 240' ' ' VAL . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.514 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.489 HG21 HG22 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.414 HG22 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.686 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.642 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.446 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.589 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.441 HD21 HG13 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.588 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.491 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.626 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.626 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.404 ' HG3' HD12 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.489 ' HA ' HE21 ' A' ' 340' ' ' GLN . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.489 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.0 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.576 HG13 HD11 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.403 HD12 ' HB1' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.623 ' HE3' ' HB3' ' B' ' 287' ' ' PRO . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.411 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.613 HD21 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.427 ' HE3' HD22 ' B' ' 291' ' ' LEU . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.576 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.46 HD22 HG23 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.518 ' HE2' HG23 ' A' ' 172' ' ' VAL . 55.5 t80 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.502 ' HB3' HG12 ' A' ' 186' ' ' VAL . 10.0 tp10 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . 0.675 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . 0.613 ' H ' HD21 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.403 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.495 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . 0.495 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.553 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG23 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.411 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.564 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG22 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.564 ' HE3' ' HA2' ' A' ' 68' ' ' GLY . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.47 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.424 HG22 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 143' ' ' THR . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.471 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.406 ' HB3' ' HD3' ' A' ' 163' ' ' ARG . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.819 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.551 HG11 HG23 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.476 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.708 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.49 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.607 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.607 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.551 HG23 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.48 HG22 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.408 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.49 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.435 HD12 HG22 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.708 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.819 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.471 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.552 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.57 HD13 HD21 ' B' ' 277' ' ' LEU . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . 0.443 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.442 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.565 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.423 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.413 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.404 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 310' ' ' GLU . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.475 ' HA2' ' HD1' ' B' ' 298' ' ' HIS . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.448 HD13 HD23 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.432 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.478 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.458 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HA ' HG23 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.473 ' HB2' ' HB1' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.565 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.542 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 . . . . . 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 266' ' ' LEU . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . 0.652 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.437 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . 0.475 ' HD1' ' HA2' ' A' ' 348' ' ' GLY . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.593 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 24' ' ' ILE . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.533 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.515 HD12 HG22 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 76' ' ' ILE . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.677 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.677 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.603 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.511 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.576 ' HE2' HD12 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.43 HG23 HD21 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.449 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.779 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.477 ' HG3' ' HZ3' ' A' ' 154' ' ' LYS . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.578 ' HB3' HG11 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.649 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.493 HG21 HG22 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.557 ' HG3' HG21 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.551 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.578 HG11 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.41 HD12 HD13 ' A' ' 166' ' ' ILE . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.508 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.493 HG22 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.779 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.4 ' O ' HG22 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.415 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HD2' HD13 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.433 ' HB3' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.538 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.538 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.403 ' HB2' HG22 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.549 ' HA ' ' HB1' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.428 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.442 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.48 HD13 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.619 HD13 HD21 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . 0.41 ' HE2' HG22 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.603 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.603 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.493 ' HG2' HD21 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.596 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.531 ' HB2' HG23 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . 0.461 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' THR . . . . . 0.519 HG23 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.551 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.496 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.469 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.469 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . 0.442 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.491 HD12 HD22 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.461 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.668 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.512 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.455 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.501 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 166' ' ' ILE . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.6 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 240' ' ' VAL . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.6 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 207' ' ' ALA . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.528 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.461 HG13 HD21 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . 0.436 ' HB3' HD23 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.427 HG13 HD22 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.461 HD21 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.404 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . 0.479 HD21 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.553 ' HB1' HD22 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.585 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.426 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . 0.44 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.42 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . 0.568 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.435 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 337' ' ' PHE . 24.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.508 HD13 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.575 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.509 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.651 ' HB2' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.474 ' HH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.447 HD13 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.474 ' HB2' ' HH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HA ' HG23 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . 0.437 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . 0.716 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' B' ' 281' ' ' PHE . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.716 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . 0.509 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . 0.447 ' NH1' HD13 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.477 ' HB2' HD22 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.493 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . 0.46 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 296' ' ' THR . . . . . 0.58 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.1 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.444 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.442 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.556 ' HB3' HD13 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.577 ' HE2' HD12 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.577 HD12 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.52 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.566 HG11 HG23 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.452 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 166' ' ' ILE . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.48 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.613 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.613 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.566 HG23 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.52 ' HB1' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.48 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.429 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.542 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 351' ' ' LEU . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 115' ' ' VAL . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.499 ' HA ' HD11 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.589 ' HA ' HE21 ' A' ' 340' ' ' GLN . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.5 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 343' ' ' ARG . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.509 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.509 HD11 HD13 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.628 HG23 HD12 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 398' ' ' MET . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.713 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.713 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.54 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.453 ' HE3' ' HB3' ' A' ' 370' ' ' LEU . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.49 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' THR . . . . . 0.451 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.445 ' HB1' ' HE3' ' A' ' 194' ' ' MET . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.56 ' HB2' ' HE2' ' B' ' 281' ' ' PHE . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . 0.56 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.407 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.565 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.565 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . 0.495 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HG3' HG12 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.619 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.564 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.605 HG21 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 66.7 m-20 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HG21 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.48 ' HA ' HG23 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.481 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.488 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.564 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' HD11 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.556 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 ' HB ' HD12 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG23 ' CD2' ' A' ' 424' ' ' PHE . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.415 ' HA ' ' ND2' ' A' ' 425' ' ' ASN . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.483 HG11 HG23 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.618 HG23 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.512 HD13 HG22 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.402 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 165' ' ' THR . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.599 ' HB1' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.599 HH21 ' HB1' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.483 HG23 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.486 ' HE1' ' HB3' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.45 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.486 ' HB3' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.433 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.439 HD12 HG22 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.618 ' HD3' HG23 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.76 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.466 ' SD ' HD11 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.466 HD12 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.556 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.445 HD13 HG11 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.406 ' O ' HG22 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.65 HD11 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.764 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.764 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.41 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . 0.484 HD12 ' HB1' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . 0.65 ' HG3' HD11 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . 0.427 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . 0.563 ' HA ' ' HB1' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.455 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.603 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.603 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.448 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.446 ' O ' HG21 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.448 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.486 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.411 HD22 HD13 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.569 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.445 HG22 HG21 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.547 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 136' ' ' ASP . 42.9 m-80 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.472 ' CE1' HD23 ' A' ' 226' ' ' LEU . 34.1 t80 . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 120.46 0.172 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.466 HD11 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . 0.454 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . 0.454 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . 0.45 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.486 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . 0.485 ' HE1' HD12 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.411 HD13 HD22 ' A' ' 403' ' ' LEU . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG13 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' HG21 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.501 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HG21 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.487 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.501 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.697 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.594 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.547 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD13 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.57 ' HA ' HD23 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.722 ' H ' ' HB1' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.447 HG13 HG23 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.493 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.659 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.659 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.556 ' HB2' HG21 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.722 ' HB1' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.433 HG22 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.612 ' HZ1' ' HB2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.444 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.603 ' HA ' HG23 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.424 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.659 HG22 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . 0.409 ' HZ1' ' HA ' ' A' ' 259' ' ' GLU . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.409 ' HA ' ' HZ1' ' A' ' 254' ' ' LYS . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . 0.461 ' HB3' HD21 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.494 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 427' ' ' LEU . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.428 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . 0.478 HH11 ' HG3' ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.474 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . 0.547 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.47 ' HB2' HD22 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.43 HG21 HG23 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.426 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.488 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.426 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.407 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.428 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . 0.492 ' HZ1' HD12 ' A' ' 385' ' ' ILE . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . 0.625 ' HB3' ' HE1' ' A' ' 398' ' ' MET . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . 0.476 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.516 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.516 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.492 HD12 ' HZ1' ' A' ' 368' ' ' LYS . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.686 HD13 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' MET . . . . . 0.509 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.428 ' O ' HG21 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' MET . . . . . 0.625 ' HE1' ' HB3' ' A' ' 370' ' ' LEU . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' HG23 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.492 HD23 HD13 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HG3' ' CE ' ' A' ' 287' ' ' LYS . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.47 HD22 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 274' ' ' MET . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.402 HD23 ' HB1' ' A' ' 281' ' ' ALA . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.502 ' CZ ' HD23 ' A' ' 226' ' ' LEU . 18.9 t80 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . 0.47 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.576 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 290' ' ' TRP . 30.7 t30 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . 0.508 ' HG3' ' HB1' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.686 ' HZ3' HD13 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 296' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . 0.586 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.685 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . 0.685 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.568 HD13 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 HG23 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HE3' HG23 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.423 HG13 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NH1' HG13 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HA ' HG21 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB3' HG23 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 76' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HD2' HD13 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.446 ' HB3' HD13 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 117' ' ' LEU . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.672 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.442 ' HA ' ' HB1' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.643 HG21 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.444 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.491 ' HG1' ' HB2' ' A' ' 234' ' ' ALA . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.428 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.471 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' MET . . . . . 0.541 ' HB2' HG23 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.66 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.442 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.447 HG22 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.457 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.476 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.491 ' HB2' ' HG1' ' A' ' 169' ' ' THR . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.648 ' HG3' HD21 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' VAL . . . . . 0.54 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' MET . . . . . 0.54 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLU . . . . . 0.554 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.483 HD22 ' HB2' ' B' ' 291' ' ' LEU . 91.7 m-20 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HZ2' ' HB3' ' B' ' 295' ' ' ALA . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.551 HD11 HG23 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ASN . . . . . 0.403 HD22 HD22 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.543 ' HG3' HG23 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.474 ' HB2' HG22 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.543 HG23 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LEU . . . . . 0.464 ' HA ' HG13 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ILE . . . . . 0.429 HD13 HD12 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ILE . . . . . 0.536 ' HA ' ' HE2' ' A' ' 374' ' ' MET . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.548 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.54 HD21 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.629 HD12 HD12 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.748 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG2' HD13 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.47 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' LEU . . . . . 0.579 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' ALA . . . . . 0.411 ' H ' HD11 ' A' ' 226' ' ' LEU . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' THR . . . . . 0.541 HG23 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 . . . . . 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' LYS . . . . . 0.535 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' PRO . . . . . 0.407 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' GLY . . . . . 0.499 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' ASP . . . . . 0.554 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' MET . . . . . 0.504 ' HE2' ' HA ' ' A' ' 374' ' ' MET . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 289' ' ' ARG . . . . . 0.54 ' NH2' HD21 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 290' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 291' ' ' LEU . . . . . 0.483 ' HB2' HD22 ' A' ' 284' ' ' ASN . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' HZ2' ' A' ' 287' ' ' LYS . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' ILE . . . . . 0.629 HD12 HD12 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG12 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' O ' HG22 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.639 HD12 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG23 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HE3' HG23 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.679 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.679 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 50' ' ' PRO . 8.1 p30 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG23 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.639 ' HA ' HD12 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.6 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HG2' HG12 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.554 ' H ' HD13 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HH ' ' HA2' ' B' ' 299' ' ' GLY . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.414 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.533 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.647 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.621 HG21 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.691 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.573 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.49 HG23 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.488 ' HG3' HG23 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.408 HG13 ' HG3' ' B' ' 241' ' ' GLU . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.429 HD21 HD13 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.597 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.466 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.404 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.573 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.406 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.404 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.469 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.673 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.529 ' HA ' HG23 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.691 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.621 HG13 HG21 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.533 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.411 HG23 HD11 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.43 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.587 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.654 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.471 HD13 HG11 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.609 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.467 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.41 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.687 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.428 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.407 ' HA ' HE21 ' A' ' 340' ' ' GLN . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 337' ' ' PHE . 27.7 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.41 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.502 ' HA ' HG13 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.502 HG13 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.546 HG23 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.417 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . 0.506 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . 0.617 ' HB3' ' HA ' ' B' ' 274' ' ' GLN . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.416 ' HA ' ' OG1' ' B' ' 269' ' ' THR . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.506 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.425 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' B' ' 291' ' ' LEU . 56.4 t30 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.486 HD13 HD12 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.417 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.432 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.432 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.456 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.462 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.45 -65.67 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.984 0.914 . . . . 15.0 109.019 179.432 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -84.7 -79.99 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 0.0 109.643 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -178.21 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.104 0.962 . . . . 0.0 108.986 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -76.76 110.39 11.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.06 0.544 . . . . 0.0 109.609 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.4 t -91.84 105.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 91.9 m -114.15 98.58 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 100.5 3.81 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.62 51.08 3.27 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.289 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.14 -99.36 1.92 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.289 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.4 -47.51 0.3 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 58.58 39.06 25.16 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.832 1.253 . . . . 0.0 112.629 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -80.31 10.91 3.97 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.996 0.519 . . . . 0.0 112.261 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 34.4 p -54.09 -69.27 0.13 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.372 1.469 . . . . 0.0 111.953 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.673 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 -119.08 87.15 2.68 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.541 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.597 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 -148.02 122.78 9.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -167.93 19.78 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.439 1.096 . . . . 0.0 109.339 165.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.432 ' O ' ' HD3' ' B' ' 248' ' ' ARG . 33.9 mm-40 -95.28 -44.63 7.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.623 0.769 . . . . 0.0 111.596 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.55 72.31 0.24 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 123.187 0.305 . . . . 0.0 113.809 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -144.38 47.77 1.38 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 108.598 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 78.9 m 77.23 -55.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.253 1.821 . . . . 0.0 113.087 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.444 ' HB3' ' HD2' ' B' ' 248' ' ' ARG . 55.4 tp -61.78 -40.59 95.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 0.0 113.414 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' B' ' 247' ' ' LEU . 7.0 mpt_? -88.09 -24.22 23.48 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.628 0.371 . . . . 0.0 111.635 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -73.07 -20.87 60.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.863 0.465 . . . . 0.0 110.552 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -37.85 84.65 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.68 . . . . 0.0 109.277 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.61 -31.75 72.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.326 0.651 . . . . 0.0 111.531 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -72.65 -38.02 67.81 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.007 0.523 . . . . 0.0 110.305 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.29 3.01 48.42 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.384 0.674 . . . . 0.0 111.71 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -75.04 99.05 3.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.57 0.748 . . . . 0.0 109.651 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 145.13 -58.13 0.52 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 49.8 t80 60.1 -76.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.628 1.571 . . . . 0.0 113.377 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.81 120.34 24.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.114 0.566 . . . . 0.0 109.565 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.543 HD21 HG21 ' B' ' 259' ' ' VAL . 0.0 OUTLIER -154.53 135.91 14.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.831 173.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . 0.543 HG21 HD21 ' B' ' 258' ' ' LEU . 23.8 m 41.83 89.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 126.661 1.985 . . . . 0.0 114.908 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 42.6 p -91.87 -89.28 0.18 Allowed 'General case' 0 CA--C 1.553 1.066 0 O-C-N 121.872 -0.517 . . . . 0.0 110.182 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.9 t70 60.59 163.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.855 1.262 . . . . 0.0 112.061 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.18 90.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 110.335 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.52 -84.04 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.15 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 82.6 p -175.16 40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.183 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 83.6 mt 69.37 97.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.852 1.661 . . . . 0.0 111.017 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.44 75.61 10.23 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.895 175.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -140.73 13.19 2.3 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.544 167.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.8 148.69 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.102 1.361 . . . . 0.0 109.386 -172.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 380' ' ' ASP . 21.7 p -63.68 -42.48 98.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.877 0.471 . . . . 0.0 111.739 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.35 150.65 23.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.453 0.644 . . . . 0.0 111.364 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -99.78 21.31 12.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.0 -175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -48.7 -52.05 25.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.959 1.304 . . . . 0.0 110.952 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -153.32 89.33 1.34 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 160.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . 0.653 ' HG2' ' HG3' ' B' ' 275' ' ' LYS . 1.3 pm0 -69.73 -38.91 77.02 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.653 ' HG3' ' HG2' ' B' ' 274' ' ' GLN . 63.8 mttm -114.13 116.28 44.72 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.586 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . 0.587 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.425 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.46 ' HB2' HD22 ' A' ' 397' ' ' ASN . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.652 HG23 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.652 ' H ' HG23 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . 0.434 ' HA2' ' HH ' ' A' ' 112' ' ' TYR . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.546 HD13 HG23 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.85 122.38 16.7 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.09 74.16 0.73 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.406 2.737 . . . . 0.0 112.994 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.91 74.78 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.89 130.26 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -169.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 45.6 p -86.75 129.69 34.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 11.8 p -73.7 80.2 1.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.923 0.868 . . . . 0.0 109.675 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 24.0 p -126.28 96.25 36.95 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.483 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.977 2.451 . . . . 12.529999999999999 111.654 -178.277 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 78' ' ' ALA . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 HG13 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.579 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.491 HG12 HG13 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.739 HD11 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD2' HD13 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.583 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.514 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.739 ' HB3' HD11 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.514 ' HE3' ' HA2' ' A' ' 68' ' ' GLY . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 1' ' ' MET . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.476 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.535 HG23 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.401 ' CG1' ' HA ' ' A' ' 424' ' ' PHE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD13 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.722 ' H ' ' HB1' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.481 HG21 HG22 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.656 HG21 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HB3' ' HZ2' ' B' ' 242' ' ' TRP . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.653 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.653 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.546 ' HB2' HG21 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.595 ' HA ' HD13 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.41 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.722 ' HB1' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.41 HG22 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.513 ' HB ' HD11 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB3' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' B' ' 227' ' ' GLY . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' B' ' 231' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB3' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.451 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.456 ' HB2' ' HG1' ' A' ' 169' ' ' THR . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.481 HG22 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.454 ' HB2' ' HB1' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.431 ' HG2' HD13 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.563 ' HA ' ' HZ1' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.563 ' HZ1' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.452 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.547 HD13 HG11 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.499 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.532 HD11 HG23 ' A' ' 411' ' ' VAL . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.535 HG12 HG23 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.427 ' HG3' HD22 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.502 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.43 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.416 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.503 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.633 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.437 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.471 ' HG3' HD12 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.411 ' HB2' HG22 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.543 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.545 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.453 ' HB2' ' HE1' ' B' ' 298' ' ' HIS . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.427 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.428 ' HA ' HD11 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.539 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.464 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.473 ' HE2' HG22 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.402 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.47 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.464 ' HA ' ' HZ3' ' B' ' 294' ' ' LYS . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.47 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.448 HG13 HD23 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.62 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.539 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.532 HG23 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.583 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.401 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -96.79 26.19 4.72 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.764 1.225 . . . . 15.0 108.191 175.006 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 67.13 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.213 1.405 . . . . 0.0 110.503 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.98 130.46 6.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.48 102.58 0.72 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.87 106.88 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 29.1 m -66.72 91.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.469 0.708 . . . . 0.0 110.536 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.3 mt -120.11 175.11 6.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.379 1.072 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 222' ' ' HIS . . . 92.42 -59.11 2.64 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.01 -63.48 4.21 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.43 92.67 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.683 0.284 . . . . 0.0 112.875 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.13 57.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.554 0.742 . . . . 0.0 111.931 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 225' ' ' ASN . 13.3 mptt -92.9 -61.47 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.537 0.735 . . . . 0.0 110.114 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -89.78 63.31 6.07 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.788 0.804 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 65.26 133.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.538 1.535 . . . . 0.0 113.049 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.477 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.566 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.53 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 53.56 26.43 5.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.498 ' HZ2' ' HB3' ' A' ' 184' ' ' ASP . 98.8 m95 -87.79 74.7 9.04 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -68.37 114.3 6.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.414 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.49 -13.41 71.04 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.489 0.493 . . . . 0.0 113.593 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt 57.73 35.01 25.14 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.325 1.45 . . . . 0.0 111.172 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.533 HG22 ' HB2' ' B' ' 248' ' ' ARG . 5.9 t -82.16 173.56 12.01 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.42 -4.73 23.94 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.561 ' HA ' ' HB2' ' B' ' 252' ' ' GLN . 12.7 mpt_? -64.89 -46.46 81.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.841 0.456 . . . . 0.0 110.211 166.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.05 -15.55 61.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.377 0.671 . . . . 0.0 111.877 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -101.28 -75.82 0.58 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.593 0.757 . . . . 0.0 111.06 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.579 ' HA ' ' H ' ' B' ' 257' ' ' GLN . . . -81.63 -25.92 35.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.956 0.902 . . . . 0.0 113.412 -169.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . 0.561 ' HB2' ' HA ' ' B' ' 248' ' ' ARG . 26.0 mm-40 -103.55 4.0 35.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.77 0.428 . . . . 0.0 111.288 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.45 3.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.663 0.785 . . . . 0.0 111.492 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -148.29 16.35 1.04 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.635 0.774 . . . . 0.0 110.862 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 129.69 162.09 10.72 Favored Glycine 0 C--O 1.244 0.726 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -70.32 91.38 0.74 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.703 0.801 . . . . 0.0 111.801 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . 0.579 ' H ' ' HA ' ' B' ' 251' ' ' ALA . 90.0 mt-30 74.38 -68.78 0.2 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.927 1.691 . . . . 0.0 111.443 170.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 7.7 tt -145.18 116.02 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.77 135.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.393 0.677 . . . . 0.0 109.242 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -154.83 78.05 1.04 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.002 0.521 . . . . 0.0 110.517 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 56.72 74.33 0.41 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.347 1.059 . . . . 0.0 111.882 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -67.7 -28.01 67.31 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.795 0.438 . . . . 0.0 110.851 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.82 -43.3 72.28 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.1 m 73.48 -64.2 0.4 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.475 1.51 . . . . 0.0 111.355 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.8 tt -63.91 98.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.9 -65.8 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.077 1.751 . . . . 0.0 111.476 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 23.1 m 77.31 -28.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.746 1.619 . . . . 0.0 112.643 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' B' ' 287' ' ' PRO . 21.5 t 64.48 117.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 125.863 1.665 . . . . 0.0 112.027 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 81.7 p -74.41 151.95 39.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.132 0.573 . . . . 0.0 110.735 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -96.94 4.01 51.78 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.984 0.514 . . . . 0.0 111.609 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.414 ' HA ' ' HA3' ' B' ' 279' ' ' GLY . . . -94.04 -86.43 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.761 0.425 . . . . 0.0 110.929 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -140.12 -51.32 0.49 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.884 0.874 . . . . 0.0 109.307 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -173.87 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.576 1.55 . . . . 0.0 107.463 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -79.3 121.76 25.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.553 1.141 . . . . 0.0 108.648 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -72.38 -51.51 7.55 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.624 ' HG ' HD11 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.624 HD11 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.577 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.473 HG22 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.57 ' H ' HD21 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.464 ' HZ3' ' HA ' ' A' ' 397' ' ' ASN . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.545 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.453 ' HE1' ' HB2' ' A' ' 351' ' ' LEU . 22.9 m-70 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.423 ' HZ1' ' HB3' ' B' ' 303' ' ' LYS . 0.1 OUTLIER -146.1 93.72 5.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -91.33 -173.03 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.421 2.747 . . . . 0.0 111.78 172.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.94 101.85 1.46 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.38 129.79 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 0.0 111.262 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.3 m -151.7 152.25 32.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.7 1.2 . . . . 0.0 108.16 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 17.1 p -67.08 84.83 0.13 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.879 0.872 . . . . 0.0 110.735 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 27.5 m -75.04 -41.71 4.13 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.301 1.04 . . . . 0.0 112.675 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.389 2.671 0 C-N-CA 122.059 1.839 . . . . 12.529999999999999 111.961 172.64 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HG12 HG13 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.491 ' O ' HG21 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.646 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG23 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HE3' HG23 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.587 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.685 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.413 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.437 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' ARG . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.538 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HB3' HD12 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.491 HG22 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.613 ' HE2' HD13 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.613 HD13 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.589 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.642 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.493 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.449 HG11 HG23 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 240' ' ' VAL . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.686 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.502 HG12 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.514 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.489 HG21 HG22 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.511 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.414 HG22 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.686 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.642 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.44 HG22 HD13 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.446 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.589 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.441 HD21 HG13 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.588 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.576 HD11 HG13 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.491 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.462 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.626 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.626 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.432 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.404 ' HG3' HD12 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.489 ' HA ' HE21 ' A' ' 340' ' ' GLN . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.489 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.0 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.435 HG23 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.576 HG13 HD11 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.533 ' HA ' HG13 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.533 HG13 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.403 HD12 ' HB1' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.407 ' HA ' ' HB1' ' B' ' 305' ' ' ALA . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.49 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.623 ' HE3' ' HB3' ' B' ' 287' ' ' PRO . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.411 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.613 HD21 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.427 ' HE3' HD22 ' B' ' 291' ' ' LEU . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.431 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.403 ' HB1' HD12 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.576 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.46 HD22 HG23 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.76 -37.51 20.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 C-N-CA 123.894 0.878 . . . . 15.0 109.126 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.64 -0.134 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 66.67 -78.82 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.258 1.423 . . . . 0.0 112.204 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -91.24 68.39 5.95 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.98 144.34 25.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.456 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.16 176.83 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.28 1.032 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.7 p -77.93 176.49 9.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.944 0.497 . . . . 0.0 111.263 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.1 130.75 17.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -129.56 179.3 16.85 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -166.63 173.99 42.03 Favored Glycine 0 N--CA 1.469 0.873 0 CA-C-O 119.987 -0.34 . . . . 0.0 112.3 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.3 2.26 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 68.21 18.44 9.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.343 1.457 . . . . 0.0 113.039 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -164.38 77.84 0.35 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.196 0.598 . . . . 0.0 109.899 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 80.8 p 49.45 -158.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.753 1.221 . . . . 0.0 113.218 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.518 ' HE2' HG23 ' A' ' 172' ' ' VAL . 55.5 t80 -130.19 -88.2 0.5 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.502 ' HB3' HG12 ' A' ' 186' ' ' VAL . 10.0 tp10 -157.95 158.02 34.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 2.9 m95 161.09 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 128.145 2.578 . . . . 0.0 109.147 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -158.93 16.09 0.18 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.656 0.782 . . . . 0.0 111.816 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.99 74.83 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.601 -0.272 . . . . 0.0 112.641 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -104.16 88.42 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.792 . . . . 0.0 109.841 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -176.56 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 36.9 tp -74.92 -39.75 61.24 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.148 0.431 . . . . 0.0 111.016 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -93.24 6.45 48.01 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.723 0.809 . . . . 0.0 111.523 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.31 -45.2 72.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.917 1.287 . . . . 0.0 112.571 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -57.77 -27.41 63.04 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.037 0.836 . . . . 0.0 112.554 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.09 -55.9 18.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.745 0.418 . . . . 0.0 110.756 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -6.21 59.34 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.138 0.575 . . . . 0.0 111.915 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.34 -43.41 13.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.094 0.557 . . . . 0.0 109.864 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -58.82 5.29 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -73.73 87.35 0.64 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.18 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -58.23 175.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.386 1.074 . . . . 0.0 112.277 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -65.52 87.58 0.08 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.847 0.832 . . . . 0.0 111.407 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.76 -52.34 2.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.168 1.387 . . . . 0.0 107.436 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.6 141.11 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.896 1.278 . . . . 0.0 108.271 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 54.1 m -71.22 133.76 46.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.865 0.466 . . . . 0.0 110.765 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.56 114.11 7.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.576 0.75 . . . . 0.0 109.4 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -106.02 2.08 27.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.719 0.808 . . . . 0.0 110.772 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -89.44 -17.36 28.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.823 0.849 . . . . 0.0 112.142 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 21.7 t 66.24 19.88 11.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.853 1.261 . . . . 0.0 110.412 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 92.8 mt 57.59 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.366 1.29 0 C-N-CA 124.773 1.229 . . . . 0.0 109.742 -166.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -132.67 -63.21 0.79 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.9 p -178.8 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.403 1.481 . . . . 0.0 107.014 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.97 162.44 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.706 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 24.2 m -69.19 102.3 1.65 Allowed 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.21 147.08 50.23 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.941 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -111.06 -17.75 13.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.256 1.022 . . . . 0.0 110.585 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -66.37 -54.59 22.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.337 0.655 . . . . 0.0 111.09 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 76.33 -29.74 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.236 1.414 . . . . 0.0 112.191 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -98.6 101.77 13.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -105.6 140.95 21.68 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 122.969 0.508 . . . . 0.0 109.974 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.675 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.613 ' H ' HD21 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.403 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.534 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.495 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.495 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.58 115.44 55.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -22.13 95.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.393 2.878 1 C-N-CA 126.42 4.747 . . . . 0.0 115.446 -164.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 363' ' ' ASP . . . -70.35 79.79 0.54 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.718 0.77 . . . . 0.0 111.293 -174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.5 160.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.707 1.203 . . . . 0.0 109.723 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.5 m -65.35 99.65 0.42 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 23.8 p -122.84 159.05 28.95 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.642 1.177 . . . . 0.0 108.641 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 6.7 t -87.63 102.66 3.63 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 122.925 0.49 . . . . 0.0 110.27 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.385 2.459 0 C-N-CA 122.994 2.463 . . . . 12.529999999999999 110.973 -176.278 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD12 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.648 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.553 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG23 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.411 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.564 ' HA2' ' HE3' ' A' ' 71' ' ' MET . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG22 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.564 ' HE3' ' HA2' ' A' ' 68' ' ' GLY . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.47 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.673 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.625 ' HA ' HD12 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.424 HG22 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HA ' HG22 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.489 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 147' ' ' GLN . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 143' ' ' THR . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.471 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.435 ' HB2' ' HG2' ' B' ' 243' ' ' GLN . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.819 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.551 HG11 HG23 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.476 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.708 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.415 HG11 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.49 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.415 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.607 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.607 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.551 HG23 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.48 HG22 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.408 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.49 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.435 HD12 HG22 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.708 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.819 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.471 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.552 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.546 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.57 HD13 HD21 ' B' ' 277' ' ' LEU . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.443 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.442 ' HA ' ' HE1' ' A' ' 274' ' ' MET . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.565 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.523 HD13 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.423 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 290' ' ' ALA . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.417 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.413 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.779 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.486 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.404 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.422 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' A' ' 310' ' ' GLU . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.475 ' HA2' ' HD1' ' B' ' 298' ' ' HIS . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.448 HD13 HD23 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.548 ' HA ' HD12 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.43 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.432 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.478 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.458 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.463 ' HA ' HG23 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.473 ' HB2' ' HB1' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.565 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.523 ' HB2' HG23 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.88 99.68 7.67 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.8 0.84 . . . . 15.0 108.815 177.485 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -77.73 149.37 34.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.808 0.843 . . . . 0.0 108.941 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 65.77 -71.66 0.08 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.473 1.109 . . . . 0.0 110.584 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 37.6 t70 68.97 168.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.029 1.331 . . . . 0.0 111.821 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.78 157.12 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 24.5 m -59.04 89.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.701 0.8 . . . . 0.0 109.594 171.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 40.3 tp -75.04 88.91 2.41 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.868 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.47 114.18 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.346 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -84.64 -2.76 88.66 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 122.81 0.243 . . . . 0.0 113.061 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.85 -160.79 20.33 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 123.406 0.527 . . . . 0.0 111.845 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.21 165.09 25.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.358 0.663 . . . . 0.0 110.885 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -138.98 96.38 3.11 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 20.7 m 66.56 161.71 0.16 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.497 1.119 . . . . 0.0 111.07 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.459 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 -163.61 -55.69 0.04 OUTLIER 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.734 -0.604 . . . . 0.0 110.593 170.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.459 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.542 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 -80.4 135.8 36.24 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -149.64 177.0 10.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.312 1.445 . . . . 0.0 108.274 168.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.435 ' HG2' ' HB2' ' A' ' 151' ' ' TRP . 52.8 mt-30 -86.68 156.08 20.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.586 0.754 . . . . 0.0 109.912 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -57.31 -73.53 0.44 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.814 . . . . 0.0 113.048 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 66.96 83.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.474 1.11 . . . . 0.0 112.782 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 17.3 m 66.27 -68.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 160.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.578 ' H ' HD21 ' B' ' 247' ' ' LEU . 2.1 pt? -111.99 2.14 16.75 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.533 ' HG2' ' HG3' ' B' ' 249' ' ' GLU . 62.6 ttm-85 -62.51 -82.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -167.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.533 ' HG3' ' HG2' ' B' ' 248' ' ' ARG . 43.5 mt-10 -101.84 -81.79 0.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.87 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -101.81 -77.42 0.55 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.99 -78.12 0.59 Allowed 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.85 -76.73 0.45 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -114.23 -85.24 0.6 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' B' ' 250' ' ' GLN . 99.2 mtt180 59.04 17.88 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.893 1.277 . . . . 0.0 113.453 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.33 -73.02 0.14 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.88 -174.16 0.15 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.254 1.422 . . . . 0.0 111.328 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -82.33 73.55 9.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.692 0.758 . . . . 0.0 109.727 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.76 134.34 41.06 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -65.4 92.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.21 1.005 . . . . 0.0 110.06 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 35.3 t -129.3 124.54 34.62 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.5 1.12 . . . . 0.0 108.844 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.83 -77.75 0.21 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.156 0.583 . . . . 0.0 110.512 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -111.0 -73.32 0.68 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.614 0.766 . . . . 0.0 109.908 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.19 -49.65 3.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.53 0.732 . . . . 0.0 110.106 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.6 m 75.78 -49.3 0.61 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.951 1.701 . . . . 0.0 112.678 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 78.9 mt 59.94 -158.73 0.31 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.166 0.987 . . . . 0.0 111.054 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 8.8 t30 76.21 -60.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.238 1.415 . . . . 0.0 111.246 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.6 t -65.95 86.96 0.1 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.677 0.791 . . . . 0.0 110.018 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.89 133.21 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.825 1.25 . . . . 0.0 108.219 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 15.3 t -94.49 45.25 1.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 122.353 1.073 . . . . 0.0 110.559 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' B' ' 271' ' ' ALA . 20.8 tt0 -72.33 -164.05 0.13 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.095 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.552 ' H ' ' HG2' ' B' ' 270' ' ' GLU . . . -48.28 -31.34 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.264 1.026 . . . . 0.0 113.539 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -86.87 29.8 0.79 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.094 0.957 . . . . 0.0 112.119 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 8.66 2.28 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.445 0.698 . . . . 0.0 112.432 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -65.24 -1.94 2.66 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.214 1.006 . . . . 0.0 112.227 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER -58.02 119.76 37.12 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.57 HD21 HD13 ' A' ' 266' ' ' LEU . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . 0.652 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.437 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.475 ' HD1' ' HA2' ' A' ' 348' ' ' GLY . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -78.85 -57.07 0.82 Allowed Pre-proline 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.32 135.99 4.63 Favored 'Trans proline' 0 C--N 1.402 3.358 0 C-N-CA 122.131 1.888 . . . . 0.0 112.14 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.48 121.46 17.82 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.8 m -151.36 144.35 24.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.831 1.252 . . . . 0.0 108.54 -171.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -77.08 83.35 3.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.345 0.593 . . . . 0.0 109.539 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 9.1 t -148.85 135.0 9.97 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.046 0.938 . . . . 0.0 109.711 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--N 1.377 2.052 0 C-N-CA 122.506 2.137 . . . . 12.529999999999999 112.211 179.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.593 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.515 HG22 HD12 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 24' ' ' ILE . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.694 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.533 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.405 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.598 HG21 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.515 HD12 HG22 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 76' ' ' ILE . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.677 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.677 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.603 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.511 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.576 ' HE2' HD12 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.576 HD12 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.43 HG23 HD21 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.449 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 140' ' ' MET . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.779 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.477 ' HG3' ' HZ3' ' A' ' 154' ' ' LYS . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.578 ' HB3' HG11 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.649 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.493 HG21 HG22 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.519 ' HA3' HG23 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.557 ' HG3' HG21 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.551 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.578 HG11 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.498 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.41 HD12 HD13 ' A' ' 166' ' ' ILE . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.508 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.493 HG22 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 151' ' ' TRP . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.779 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.4 ' O ' HG22 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.459 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.511 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.506 ' HB2' HD22 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.619 HD21 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.415 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.48 ' HD2' HD13 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.433 ' HB3' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.538 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.406 HD13 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.538 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.403 ' HB2' HG22 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.549 ' HA ' ' HB1' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.428 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.442 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.48 HD13 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.619 HD13 HD21 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.686 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.41 ' HE2' HG22 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.603 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.603 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.493 ' HG2' HD21 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.596 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.502 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.531 ' HB2' HG23 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . 0.461 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.12 -35.8 64.15 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 C-N-CA 123.288 0.635 . . . . 15.0 109.569 176.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 66.23 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.68 1.192 . . . . 0.0 111.227 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.77 98.66 1.1 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.504 0.721 . . . . 0.0 109.058 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -131.44 125.54 32.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.206 1.002 . . . . 0.0 109.501 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.53 101.07 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.3 m -86.79 140.89 29.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.397 0.679 . . . . 0.0 109.76 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 77.1 mt -73.86 92.7 2.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 109.922 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.57 100.53 2.55 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.866 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 128.41 -154.2 19.89 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.81 0.243 . . . . 0.0 112.978 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.85 14.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.0 120.06 21.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.626 0.771 . . . . 0.0 108.932 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' B' ' 231' ' ' LYS . 6.8 tmtm? 69.28 -12.12 0.44 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.091 1.356 . . . . 0.0 111.174 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.8 p 57.77 -89.61 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.586 1.554 . . . . 0.0 110.112 -155.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 175.15 -130.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.519 HG23 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.551 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -83.13 92.33 7.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -115.12 84.69 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.808 0.843 . . . . 0.0 109.133 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -97.66 -42.22 7.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.134 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.32 79.84 0.76 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.774 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . 0.489 ' HB2' ' HG3' ' B' ' 248' ' ' ARG . 74.6 mmtt -88.9 125.98 35.18 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 66.0 p -67.29 -2.05 5.46 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . 0.541 ' H ' HD21 ' B' ' 247' ' ' LEU . 2.0 pt? -111.85 -11.18 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -174.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.489 ' HG3' ' HB2' ' B' ' 245' ' ' LYS . 75.0 mtm180 -59.11 -60.98 2.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.727 0.775 . . . . 0.0 111.95 -169.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.76 -21.81 61.69 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.558 -1.655 . . . . 0.0 111.714 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -76.22 -48.38 20.56 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.138 0.495 . . . . 0.0 110.447 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.485 ' HA ' ' HA3' ' B' ' 255' ' ' GLY . . . -64.64 -39.72 94.19 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.748 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -70.09 -32.61 70.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.381 0.672 . . . . 0.0 110.806 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.5 -66.87 0.55 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.356 0.662 . . . . 0.0 111.942 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -148.74 5.92 0.7 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 111.787 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 251' ' ' ALA . . . -83.98 -15.98 68.64 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.475 0.484 . . . . 0.0 112.784 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 55.7 t80 69.93 88.23 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 109.589 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -98.26 120.65 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.81 143.96 55.56 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.92 123.73 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 123.112 0.565 . . . . 0.0 110.115 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 25.5 t -63.2 -39.78 95.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.603 0.761 . . . . 0.0 110.598 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -162.77 129.18 3.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.929 0.892 . . . . 0.0 109.197 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -86.51 -11.57 51.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 0.0 110.885 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -64.07 -63.16 1.23 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.896 0.878 . . . . 0.0 110.394 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.8 m 51.3 71.34 0.45 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 111.909 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 29.0 tp 66.85 10.97 8.0 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 124.772 1.229 . . . . 0.0 111.296 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.32 37.04 28.47 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.595 1.158 . . . . 0.0 110.805 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -68.28 96.3 0.65 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.96 -40.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.812 0.845 . . . . 0.0 109.979 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 19.1 p -95.82 -10.14 29.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.306 0.642 . . . . 0.0 110.884 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -144.78 89.19 1.96 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.121 0.968 . . . . 0.0 108.645 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.52 -5.06 14.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.495 1.118 . . . . 0.0 110.985 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.63 -26.73 62.68 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.397 0.679 . . . . 0.0 110.156 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 66.45 33.6 6.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.057 1.343 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -144.48 107.22 4.45 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -149.25 135.61 10.32 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.447 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.496 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.41 HG22 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.469 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.469 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.442 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -149.23 -40.36 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -47.78 -30.8 13.67 Favored 'Trans proline' 0 C--N 1.404 3.454 0 C-N-CA 122.295 1.996 . . . . 0.0 113.666 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.48 82.42 7.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.39 167.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.159 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.4 t -107.5 156.87 18.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.275 0.63 . . . . 0.0 109.494 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.44 -15.72 39.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.922 0.489 . . . . 0.0 111.28 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.1 t -97.32 127.35 38.54 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.07 0.548 . . . . 0.0 110.379 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.308 2.672 . . . . 12.529999999999999 111.902 176.379 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.653 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.491 HD12 HD22 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.461 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.668 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.42 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.444 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.512 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.455 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . 0.482 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.501 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.57 HG22 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 166' ' ' ILE . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.6 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 240' ' ' VAL . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.6 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.472 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 207' ' ' ALA . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.528 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.482 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.461 HG13 HD21 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.436 ' HB3' HD23 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.427 HG13 HD22 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.461 HD21 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.404 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.459 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.479 HD21 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.531 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.553 ' HB1' HD22 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.585 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.426 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . 0.44 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.42 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . 0.568 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.435 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.42 ' HB2' HG22 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 337' ' ' PHE . 24.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.41 ' O ' HG21 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.45 ' O ' HG22 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.461 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.508 HD13 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.575 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.509 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.651 ' HB2' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.474 ' HH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.447 HD13 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.474 ' HB2' ' HH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.441 ' HA ' HG23 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.553 HD22 ' HB1' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.98 71.99 10.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.342 -1.299 . . . . 15.0 108.608 -174.057 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.43 172.88 8.42 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.604 0.762 . . . . 0.0 111.228 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.55 64.85 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.874 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -128.15 104.99 8.07 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.778 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.48 123.01 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.742 0.817 . . . . 0.0 109.624 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 14.9 p -68.79 135.23 50.87 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.085 0.554 . . . . 0.0 109.959 170.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.04 135.05 16.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -159.5 -140.9 3.0 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 172.66 141.12 3.34 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.694 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -76.27 118.12 5.22 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.45 1.03 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.512 0.725 . . . . 0.0 111.583 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -85.26 117.92 24.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.39 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 75.0 p -119.42 -168.29 1.55 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.431 1.092 . . . . 0.0 110.31 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -58.92 102.29 0.12 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.467 0.707 . . . . 0.0 109.844 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -80.61 -10.27 59.74 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -119.05 -171.63 2.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 109.931 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.87 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.337 1.455 . . . . 0.0 111.7 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.58 -17.94 60.71 Favored Glycine 0 C--N 1.352 1.435 0 O-C-N 123.643 0.59 . . . . 0.0 114.314 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -70.43 78.29 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.173 0.989 . . . . 0.0 109.786 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.5 p -110.64 108.23 18.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.628 0.771 . . . . 0.0 111.371 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.98 -16.66 59.95 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.203 0.601 . . . . 0.0 110.862 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -50.25 -33.84 21.08 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.715 1.206 . . . . 0.0 110.774 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.43 -51.23 69.59 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.729 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.451 ' HA ' ' HB3' ' B' ' 253' ' ' ALA . 1.0 OUTLIER -71.54 -18.0 62.28 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.65 -45.75 64.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.206 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.96 -20.03 39.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.025 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . . . -89.06 16.85 6.46 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.453 0.701 . . . . 0.0 111.301 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.46 48.52 8.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 113.273 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -61.49 102.63 0.45 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.256 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.8 t80 73.37 96.86 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.138 1.375 . . . . 0.0 109.818 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -116.31 -163.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.973 0.909 . . . . 0.0 111.917 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.97 165.82 1.17 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.777 1.231 . . . . 0.0 112.814 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.1 m 61.97 7.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 126.683 1.993 . . . . 0.0 112.678 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 78.7 p -149.34 -7.46 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 109.566 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -62.47 -44.04 97.36 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.469 1.108 . . . . 0.0 111.45 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.69 59.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.798 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.96 -32.67 74.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.064 0.546 . . . . 0.0 111.024 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t 59.91 28.92 18.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.43 1.092 . . . . 0.0 111.609 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.7 tt 66.1 86.48 0.13 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.059 1.344 . . . . 0.0 108.505 -167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -92.92 -48.94 6.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.713 0.805 . . . . 0.0 109.826 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 47.0 t 62.91 14.42 7.45 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.303 1.041 . . . . 0.0 112.087 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.6 m 48.57 13.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 126.769 2.028 . . . . 0.0 114.211 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' B' ' 273' ' ' GLN . 39.2 p -124.66 53.79 1.44 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.951 1.301 . . . . 0.0 107.978 -176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 64.59 -86.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.878 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.88 -64.82 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -138.34 -21.77 1.04 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.468 0.707 . . . . 0.0 111.276 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . 0.561 ' HB2' ' HB ' ' B' ' 269' ' ' THR . 17.9 tm0? 66.2 172.94 0.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.502 1.521 . . . . 0.0 110.494 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.81 95.75 0.38 Allowed 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.796 -0.565 . . . . 0.0 109.949 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.437 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER -63.83 150.19 91.65 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.816 0.846 . . . . 0.0 110.383 174.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.716 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' B' ' 281' ' ' PHE . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.716 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.509 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.447 ' NH1' HD13 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.477 ' HB2' HD22 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.493 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . 0.46 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.58 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.57 88.55 1.55 Allowed Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.69 89.22 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.636 2.224 . . . . 0.0 110.156 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.52 81.5 1.97 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.742 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -166.48 138.05 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 108.819 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 20.1 p -79.18 91.88 5.01 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.39 -83.07 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.63 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.5 m 39.32 75.49 0.57 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 126.006 1.722 . . . . 0.0 113.884 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 123.358 2.705 . . . . 12.529999999999999 112.135 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.423 HG13 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG12 HG13 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.1 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG23 HG23 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.444 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.442 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.484 HG23 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.556 ' HB3' HD13 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.577 ' HE2' HD12 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.577 HD12 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HG2' ' H ' ' B' ' 262' ' ' ALA . 36.8 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.494 ' HA ' HD11 ' B' ' 258' ' ' LEU . 24.8 mm-40 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.52 ' HA2' ' HB1' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.566 HG11 HG23 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.452 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.439 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 166' ' ' ILE . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.48 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' B' ' 242' ' ' TRP . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.613 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.613 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.566 HG23 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.52 ' HB1' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.521 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.539 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.48 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.429 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.452 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . 0.473 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.542 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.417 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.509 HD13 HD11 ' A' ' 351' ' ' LEU . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.509 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 115' ' ' VAL . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.499 ' HA ' HD11 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.719 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.719 ' HB3' ' HB3' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.589 ' HA ' HE21 ' A' ' 340' ' ' GLN . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.589 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.5 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 343' ' ' ARG . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.509 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.509 HD11 HD13 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.628 HG23 HD12 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 398' ' ' MET . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.713 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.402 ' HB3' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.713 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.54 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.54 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.453 ' HE3' ' HB3' ' A' ' 370' ' ' LEU . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.417 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.404 HD11 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.49 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.74 -46.99 16.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.358 -179.034 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.72 144.79 47.94 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.233 0.613 . . . . 0.0 110.275 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -97.38 125.27 41.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.394 0.677 . . . . 0.0 109.68 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.41 -31.41 71.58 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.126 0.489 . . . . 0.0 109.988 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.22 121.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.371 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 20.4 m -109.97 138.9 45.7 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.1 tp 65.1 -85.53 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.062 1.345 . . . . 0.0 111.335 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.05 68.77 1.52 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.18 169.37 54.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.471 0.558 . . . . 0.0 113.004 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.6 -165.24 39.42 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -121.16 -177.08 3.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 109.726 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 70.72 113.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.99 1.316 . . . . 0.0 110.114 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -148.33 106.52 3.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.213 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 -103.18 65.13 0.85 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' THR . . . . . 0.451 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.445 ' HB1' ' HE3' ' A' ' 194' ' ' MET . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.48 -80.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.456 ' HA ' HG22 ' A' ' 186' ' ' VAL . 14.4 m95 54.8 118.65 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.01 1.724 . . . . 0.0 113.75 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -54.71 139.4 39.19 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.18 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -49.36 -45.7 36.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 124.614 1.196 . . . . 0.0 112.722 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? 51.3 11.05 0.1 Allowed 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 126.801 2.041 . . . . 0.0 114.816 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.1 p -143.37 150.92 39.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.037 0.935 . . . . 0.0 109.662 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -26.76 66.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.127 0.571 . . . . 0.0 111.179 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.56 -43.45 93.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.406 0.682 . . . . 0.0 111.481 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -79.17 -14.34 59.15 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.047 0.539 . . . . 0.0 111.421 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -101.6 3.65 40.14 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.6 1.16 . . . . 0.0 111.139 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.43 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.043 0.937 . . . . 0.0 113.142 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -102.13 -79.03 0.53 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -116.54 -74.62 0.6 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 50.0 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.559 1.143 . . . . 0.0 111.489 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 52.99 -98.42 0.03 OUTLIER Glycine 0 C--N 1.359 1.821 0 O-C-N 124.001 0.813 . . . . 0.0 112.738 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -136.13 153.43 51.29 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.453 1.101 . . . . 0.0 108.398 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.18 93.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.371 0.605 . . . . 0.0 109.519 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 148' ' ' GLN . 24.5 tp -121.02 100.29 6.98 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.764 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.75 118.33 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' SER . . . . . 0.473 ' HA ' ' HE2' ' A' ' 256' ' ' PHE . 42.5 t 71.2 -64.17 0.39 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.268 1.427 . . . . 0.0 111.341 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . 0.465 ' HB2' ' NE2' ' A' ' 147' ' ' GLN . 3.1 p-10 -152.21 162.45 41.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.674 0.79 . . . . 0.0 109.532 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . 0.475 ' H ' ' HG2' ' A' ' 147' ' ' GLN . . . -106.39 -6.36 18.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.61 48.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.194 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 89.9 p -147.69 170.26 17.92 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.91 0.884 . . . . 0.0 109.623 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 30.3 tp -78.46 -7.58 57.58 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.56 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 74.57 160.31 0.23 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.09 1.756 . . . . 0.0 111.978 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.7 m -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.708 1.203 . . . . 0.0 111.688 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.73 131.99 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 25.1 m -78.83 76.1 5.33 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.636 0.775 . . . . 0.0 109.623 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -163.78 123.72 2.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.186 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -89.56 -17.66 28.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.201 1.0 . . . . 0.0 110.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -93.62 11.7 27.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.337 1.055 . . . . 0.0 111.213 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -91.48 131.53 36.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 122.614 0.366 . . . . 0.0 110.344 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.86 100.28 0.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 166.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -159.93 173.66 4.68 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.56 ' HB2' ' HE2' ' B' ' 281' ' ' PHE . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . 0.56 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.407 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.565 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.565 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.495 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -163.53 142.13 6.25 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.96 141.64 21.51 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.732 2.288 . . . . 0.0 112.482 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.65 50.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.087 0.955 . . . . 0.0 112.561 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -68.93 172.72 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.583 0.753 . . . . 0.0 110.601 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 4.9 t -62.73 92.85 0.05 Allowed 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 122.053 0.93 . . . . 0.0 110.819 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 38.5 t -79.04 79.52 5.44 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.879 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 m -120.65 84.33 36.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.624 1.17 . . . . 0.0 108.782 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 C--N 1.381 2.244 0 C-N-CA 123.359 2.706 . . . . 12.529999999999999 112.473 -176.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HG3' HG12 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.619 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.422 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.564 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HZ3' ' HB2' ' A' ' 29' ' ' LYS . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' O ' HG22 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.605 HG21 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 66.7 m-20 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.605 ' HE3' HG21 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' HD11 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.48 ' HA ' HG23 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.481 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.488 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.564 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.576 ' HA ' HD11 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.569 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.556 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 ' HB ' HD12 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG23 ' CD2' ' A' ' 424' ' ' PHE . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.415 ' HA ' ' ND2' ' A' ' 425' ' ' ASN . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.483 HG11 HG23 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.402 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.618 HG23 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.512 HD13 HG22 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.402 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' B' ' 242' ' ' TRP . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.599 ' HB1' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.599 HH21 ' HB1' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.483 HG23 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.486 ' HE1' ' HB3' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' B' ' 231' ' ' LYS . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.486 ' HB3' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.433 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.439 HD12 HG22 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.618 ' HD3' HG23 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.412 HG21 HG21 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.76 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.466 ' SD ' HD11 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.547 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.466 HD12 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.417 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.556 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.445 HD13 HG11 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.406 ' O ' HG22 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.65 HD11 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.466 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.764 ' HB2' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.764 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.412 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.41 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . 0.484 HD12 ' HB1' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . 0.427 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . 0.65 ' HG3' HD11 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . 0.427 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.424 ' HB2' HG22 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . 0.563 ' HA ' ' HB1' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.48 ' O ' HG22 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.455 ' HA ' ' HE1' ' A' ' 374' ' ' MET . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.603 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.603 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.448 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.446 ' O ' HG21 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.448 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.486 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.411 HD22 HD13 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.569 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.445 HG22 HG21 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.547 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 136' ' ' ASP . 42.9 m-80 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.85 -18.0 21.58 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.172 0.989 . . . . 15.0 109.33 177.081 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.31 99.42 0.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.511 0.724 . . . . 0.0 109.471 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.72 2.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.516 0.727 . . . . 0.0 110.384 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.09 -173.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.758 1.223 . . . . 0.0 112.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -88.64 136.33 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.6 p -79.08 76.48 5.59 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.085 0.945 . . . . 0.0 108.805 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.0 tt -167.57 -45.41 0.02 OUTLIER 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 72.2 -82.49 0.55 Allowed Glycine 0 C--N 1.355 1.592 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.672 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -165.5 -133.64 1.54 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.31 3.49 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.33 164.08 38.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 109.946 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 225' ' ' ASN . 0.0 OUTLIER -128.05 138.73 52.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 23.5 m -62.79 143.01 57.95 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.58 0.752 . . . . 0.0 110.675 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.472 ' CE1' HD23 ' A' ' 226' ' ' LEU . 34.1 t80 -60.13 151.79 26.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.908 0.883 . . . . 0.0 110.84 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.92 97.82 4.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . 0.634 ' HB3' HG11 ' A' ' 186' ' ' VAL . 0.4 OUTLIER -160.45 159.35 30.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.706 0.402 . . . . 0.0 110.894 175.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.535 ' HA ' ' OH ' ' B' ' 256' ' ' TYR . 4.7 pp0? -84.32 6.79 21.63 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.24 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -82.48 60.01 4.88 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.287 0.367 . . . . 0.0 112.809 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? 70.44 123.86 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.801 1.641 . . . . 0.0 112.939 171.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.6 p -70.85 -55.15 9.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.281 1.032 . . . . 0.0 112.156 -172.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -6.54 35.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -71.03 -83.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -102.83 -88.94 0.39 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.477 0.58 . . . . 0.0 111.243 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.722 ' HB2' HH12 ' B' ' 254' ' ' ARG . 23.2 pt20 -111.58 -5.83 14.47 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.68 -17.89 62.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -78.63 -34.67 46.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 0.0 110.682 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -54.6 -35.53 63.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.939 0.895 . . . . 0.0 112.513 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.722 HH12 ' HB2' ' B' ' 250' ' ' GLN . 0.0 OUTLIER -164.56 149.79 10.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.519 0.728 . . . . 0.0 110.629 176.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.68 172.74 13.3 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.606 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . 0.535 ' OH ' ' HA ' ' B' ' 243' ' ' GLN . 30.7 m-85 66.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.146 1.378 . . . . 0.0 112.414 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.62 -22.59 62.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.754 0.822 . . . . 0.0 111.369 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' B' ' 254' ' ' ARG . 74.8 mt -63.39 104.26 0.6 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.549 . . . . 0.0 110.403 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.6 155.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.672 0.789 . . . . 0.0 110.146 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.0 p -80.35 -87.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.288 0.635 . . . . 0.0 112.04 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.46 -37.79 56.4 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.448 0.699 . . . . 0.0 111.161 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.91 19.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.407 0.683 . . . . 0.0 112.758 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.29 -1.85 35.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.006 0.922 . . . . 0.0 111.745 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.1 t -151.55 -79.65 0.11 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.932 0.893 . . . . 0.0 109.861 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.93 114.94 26.9 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.184 0.994 . . . . 0.0 108.76 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.71 82.74 0.62 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.214 0.606 . . . . 0.0 109.885 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 91.8 p -68.38 -30.72 69.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.97 0.908 . . . . 0.0 112.822 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.34 71.51 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.869 0.842 . . . . 0.0 110.346 -170.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m -112.09 95.18 5.32 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.219 1.008 . . . . 0.0 109.1 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.86 99.41 7.52 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.966 0.889 . . . . 0.0 110.926 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . 0.421 ' HB2' ' HD1' ' A' ' 378' ' ' TYR . . . -85.76 -43.49 13.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.306 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -95.97 17.28 15.73 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.781 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 79.46 -44.25 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.004 1.722 . . . . 0.0 111.825 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.94 115.92 5.34 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 171.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.28 122.85 85.84 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.466 HD11 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . 0.454 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . 0.454 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . 0.45 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.486 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . 0.485 ' HE1' HD12 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.411 HD13 HD22 ' A' ' 403' ' ' LEU . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -50.92 -43.96 85.02 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.03 -39.48 2.38 Favored 'Trans proline' 0 C--N 1.405 3.533 0 C-N-CA 123.45 2.767 . . . . 0.0 115.012 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -72.57 95.59 1.85 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.98 107.83 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 10.0 t -78.62 161.37 27.01 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.321 0.388 . . . . 0.0 110.154 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 45.1 t -80.0 -48.44 13.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.137 0.575 . . . . 0.0 110.08 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 85.9 m 64.83 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 125.169 1.388 . . . . 0.0 111.43 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.381 2.254 0 C-N-CA 123.29 2.66 . . . . 12.529999999999999 112.114 178.315 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.673 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG12 HG13 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' HG21 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.536 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.695 ' HB2' ' HZ2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.501 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' HG21 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 76' ' ' ILE . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.487 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.501 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.697 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.594 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.547 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD13 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.57 ' HA ' HD23 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.565 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.722 ' H ' ' HB1' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.447 HG13 HG23 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.47 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.493 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.659 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.659 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.556 ' HB2' HG21 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.722 ' HB1' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.433 HG22 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.677 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.612 ' HZ1' ' HB2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.444 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.7 OUTLIER -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.603 ' HA ' HG23 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.502 HG13 HG21 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.565 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.424 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.659 HG22 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . 0.409 ' HZ1' ' HA ' ' A' ' 259' ' ' GLU . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.409 ' HA ' ' HZ1' ' A' ' 254' ' ' LYS . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.659 ' HA2' HG22 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.461 ' HB3' HD21 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.494 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 427' ' ' LEU . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.428 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . 0.478 HH11 ' HG3' ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.474 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . 0.547 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.47 ' HB2' HD22 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . . . . . . . . . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.43 HG21 HG23 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.426 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.488 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.424 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.426 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.556 HD12 HD23 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.407 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' B' ' 305' ' ' ALA . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.407 ' H ' ' HB3' ' B' ' 305' ' ' ALA . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.428 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.492 ' HZ1' HD12 ' A' ' 385' ' ' ILE . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.625 ' HB3' ' HE1' ' A' ' 398' ' ' MET . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . 0.476 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.516 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.516 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.424 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.492 HD12 ' HZ1' ' A' ' 368' ' ' LYS . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . 0.509 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.686 HD13 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' MET . . . . . 0.509 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.428 ' O ' HG21 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' MET . . . . . 0.625 ' HE1' ' HB3' ' A' ' 370' ' ' LEU . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.4 ' HG3' HG23 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.492 HD23 HD13 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.474 ' HG3' ' CE ' ' A' ' 287' ' ' LYS . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.47 HD22 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 274' ' ' MET . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.402 HD23 ' HB1' ' A' ' 281' ' ' ALA . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -99.4 -26.96 13.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.125 0.57 . . . . 15.0 109.543 178.531 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.34 -53.35 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.04 0.936 . . . . 0.0 110.084 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -149.46 97.37 2.63 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.001 0.52 . . . . 0.0 110.448 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 64.5 -82.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.009 1.323 . . . . 0.0 111.759 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.5 p -150.69 149.98 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 109.466 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -129.76 162.82 27.56 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.178 0.991 . . . . 0.0 109.262 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.6 mt 60.23 -160.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.332 1.053 . . . . 0.0 112.42 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.25 -31.09 8.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.11 158.63 24.01 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.89 78.38 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.674 0.279 . . . . 0.0 112.747 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.59 158.56 17.47 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.434 0.694 . . . . 0.0 110.882 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 70.29 32.09 2.93 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.247 1.419 . . . . 0.0 110.639 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -64.77 157.6 27.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.432 0.693 . . . . 0.0 111.412 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.502 ' CZ ' HD23 ' A' ' 226' ' ' LEU . 18.9 t80 -59.36 -68.17 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.997 0.919 . . . . 0.0 109.622 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.47 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 73.08 -31.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -84.61 59.64 5.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 162.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.66 87.05 0.11 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.239 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -72.53 -46.8 30.56 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 165.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.91 125.27 6.82 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 61.5 m 68.22 130.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.584 1.154 . . . . 0.0 110.58 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.34 -33.72 76.63 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.843 -0.536 . . . . 0.0 110.75 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 52.1 mtt-85 -73.45 -6.24 45.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.843 0.457 . . . . 0.0 112.207 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.03 -28.65 69.94 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.686 0.794 . . . . 0.0 111.102 171.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -44.71 -81.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.064 1.746 . . . . 0.0 114.441 -166.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -111.76 -81.77 0.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -99.43 -24.23 14.86 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 122.156 -0.34 . . . . 0.0 110.733 -168.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.99 -24.07 52.23 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.893 0.746 . . . . 0.0 111.971 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.3 ttm105 65.38 15.42 10.01 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.006 0.923 . . . . 0.0 112.758 163.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 143.88 -42.49 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -167.7 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.437 0.695 . . . . 0.0 109.889 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 64.85 -102.14 0.09 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.559 1.544 . . . . 0.0 111.798 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.39 170.06 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.36 1.064 . . . . 0.0 111.938 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.69 -26.15 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.157 0.583 . . . . 0.0 110.029 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 27.5 p -54.94 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.379 1.071 . . . . 0.0 111.228 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -166.54 159.18 14.1 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.686 0.794 . . . . 0.0 109.867 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -87.41 22.07 2.28 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.83 1.252 . . . . 0.0 112.939 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.84 85.94 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.9 t -77.22 -68.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . 0.572 ' H ' HD21 ' B' ' 265' ' ' LEU . 1.6 pt? -96.86 106.28 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -70.12 -53.56 16.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.94 0.496 . . . . 0.0 112.281 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 12.9 t 51.47 41.68 28.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.406 1.082 . . . . 0.0 111.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 18.9 m -87.79 1.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.605 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 8.1 m 61.75 90.45 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.171 1.388 . . . . 0.0 110.297 -172.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.32 -38.48 77.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.714 1.206 . . . . 0.0 112.112 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.78 -29.63 69.63 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.182 0.993 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -97.39 31.25 2.57 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.237 1.015 . . . . 0.0 109.516 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . 0.436 ' HG3' ' HD3' ' B' ' 276' ' ' PRO . 6.5 tp-100 70.5 122.83 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.365 1.466 . . . . 0.0 109.499 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.12 -65.23 0.66 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.022 0.826 . . . . 0.0 111.324 -169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -154.17 98.71 2.55 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.436 ' HD3' ' HG3' ' B' ' 273' ' ' GLN . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.576 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.576 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' B' ' 290' ' ' TRP . 30.7 t30 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . 0.508 ' HG3' ' HB1' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.686 ' HZ3' HD13 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 296' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . 0.586 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.685 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . 0.685 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp -77.64 123.53 86.61 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.88 99.3 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.304 2.003 . . . . 0.0 110.825 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . 0.512 ' HB1' ' HD3' ' A' ' 361' ' ' LYS . . . -65.24 94.02 0.15 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.129 0.572 . . . . 0.0 110.748 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.02 152.21 7.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.24 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 3.1 t -57.13 133.01 54.64 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.88 0.872 . . . . 0.0 109.631 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 87.4 m -69.57 88.13 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' B' ' 310' ' ' PRO . 7.6 t -136.59 136.24 21.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.699 0.8 . . . . 0.0 109.354 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 309' ' ' THR . 5.2 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 122.853 2.369 . . . . 12.529999999999999 111.48 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.571 HG23 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.568 HD13 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 HG23 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' HE3' HG23 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.423 HG13 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NH1' HG13 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HA ' HG21 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB3' HG23 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 HG12 ' HA ' ' A' ' 76' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HD2' HD13 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.446 ' HB3' HD13 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 117' ' ' LEU . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.429 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.672 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.442 ' HA ' ' HB1' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.471 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.643 HG21 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.444 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.491 ' HG1' ' HB2' ' A' ' 234' ' ' ALA . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.428 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.476 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 169' ' ' THR . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.487 ' HG3' HG21 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.471 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' MET . . . . . 0.541 ' HB2' HG23 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.66 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.542 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.442 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.447 HG22 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.457 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.476 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.491 ' HB2' ' HG1' ' A' ' 169' ' ' THR . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.643 ' HA ' HG21 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.471 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.546 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.546 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.428 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.648 ' HG3' HD21 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' VAL . . . . . 0.54 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' MET . . . . . 0.54 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLU . . . . . 0.554 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.748 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.483 HD22 ' HB2' ' B' ' 291' ' ' LEU . 91.7 m-20 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.467 ' HZ2' ' HB3' ' B' ' 295' ' ' ALA . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.551 HD11 HG23 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.403 HD22 HD22 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.543 ' HG3' HG23 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.474 HG22 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ALA . . . . . 0.415 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.474 ' HB2' HG22 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.543 HG23 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.412 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . 0.464 ' HA ' HG13 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ILE . . . . . 0.429 HD13 HD12 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ILE . . . . . 0.536 ' HA ' ' HE2' ' A' ' 374' ' ' MET . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.548 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.54 HD21 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.629 HD12 HD12 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.748 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . 0.4 ' HG2' HD13 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.47 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' LEU . . . . . 0.579 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.89 -24.87 61.73 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.355 0 C-N-CA 124.409 1.084 . . . . 15.0 108.296 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.15 178.62 7.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.458 0.703 . . . . 0.0 110.63 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.16 70.46 0.65 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.072 0.949 . . . . 0.0 110.034 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.22 136.33 52.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.176 0.99 . . . . 0.0 110.876 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.17 102.36 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.347 0.659 . . . . 0.0 109.803 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 32.1 m -125.03 84.76 2.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.63 95.08 9.92 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.19 156.26 52.99 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.283 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 176.43 151.13 8.64 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 117.056 0.428 . . . . 0.0 113.198 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -148.54 175.08 27.99 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.54 49.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.879 0.871 . . . . 0.0 110.935 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.69 103.28 13.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.644 0.778 . . . . 0.0 109.157 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 14.1 t -141.27 -177.96 5.38 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.119 0.968 . . . . 0.0 109.1 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 -61.0 142.44 56.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.103 0.961 . . . . 0.0 109.827 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' ALA . . . . . 0.411 ' H ' HD11 ' A' ' 226' ' ' LEU . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' THR . . . . . 0.541 HG23 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 65.73 10.6 6.92 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -83.28 49.96 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.673 0.749 . . . . 0.0 110.205 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.64 ' HG3' ' HA ' ' B' ' 248' ' ' ARG . 30.8 tt0 -147.04 6.0 0.87 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.314 1.046 . . . . 0.0 109.189 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.85 50.36 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-N 116.39 -0.368 . . . . 0.0 113.038 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 68.05 -69.24 0.15 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 125.688 1.595 . . . . 0.0 110.681 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.426 HG21 ' N ' ' B' ' 251' ' ' ALA . 14.7 t -94.23 -160.57 0.78 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.889 1.276 . . . . 0.0 109.675 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.56 -79.52 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ARG . . . . . 0.64 ' HA ' ' HG3' ' B' ' 243' ' ' GLN . 3.4 ptp180 -107.4 -90.53 0.43 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.576 ' H ' ' HG3' ' B' ' 248' ' ' ARG . 37.0 mt-10 -109.02 4.7 23.48 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.814 1.245 . . . . 0.0 110.477 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -67.61 3.43 1.39 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.644 1.178 . . . . 0.0 113.514 -166.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ALA . . . . . 0.426 ' N ' HG21 ' B' ' 246' ' ' THR . . . -62.2 -29.27 70.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.677 1.191 . . . . 0.0 112.255 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.82 -21.66 65.2 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.904 0.482 . . . . 0.0 110.892 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -86.91 21.19 2.35 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.99 2.36 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.839 0.856 . . . . 0.0 112.074 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 102.69 -58.98 0.56 Allowed Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -107.67 28.36 8.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.141 0.976 . . . . 0.0 111.508 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.72 167.65 13.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.124 0.57 . . . . 0.0 110.134 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 9.4 mp 71.7 -67.11 0.27 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.55 1.54 . . . . 0.0 111.433 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.0 m 44.51 38.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 126.284 1.833 . . . . 0.0 113.423 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.7 t -70.42 169.97 12.9 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.531 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.72 13.04 7.25 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.103 1.361 . . . . 0.0 112.37 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -72.17 -32.74 67.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.293 1.037 . . . . 0.0 110.712 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -106.26 21.05 18.01 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.787 0.835 . . . . 0.0 110.273 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 36.1 m 60.57 55.7 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.96 1.304 . . . . 0.0 111.993 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 138.79 16.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.795 0.838 . . . . 0.0 109.097 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -91.6 138.0 31.91 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.387 0.675 . . . . 0.0 110.315 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 43.3 p -81.64 79.16 8.28 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.667 0.787 . . . . 0.0 110.106 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.24 -0.88 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.649 0.78 . . . . 0.0 110.726 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 9.8 t 48.41 39.2 12.17 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.606 1.962 . . . . 0.0 112.853 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.39 144.72 37.7 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.034 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -110.08 -66.42 1.07 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -137.73 -45.13 0.53 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.98 146.7 52.52 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.366 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -39.39 -61.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.978 1.711 . . . . 0.0 113.033 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' LYS . . . . . 0.535 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt -140.88 157.21 67.96 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.003 0.921 . . . . 0.0 108.771 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' PRO . . . . . 0.407 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' LEU . . . . . 0.499 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' GLY . . . . . 0.499 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ASP . . . . . 0.554 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' MET . . . . . 0.504 ' HE2' ' HA ' ' A' ' 374' ' ' MET . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' ARG . . . . . 0.54 ' NH2' HD21 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' TRP . . . . . 0.548 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' LEU . . . . . 0.483 ' HB2' HD22 ' A' ' 284' ' ' ASN . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' ALA . . . . . 0.467 ' HB3' ' HZ2' ' A' ' 287' ' ' LYS . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ILE . . . . . 0.629 HD12 HD12 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 46.55 81.98 0.24 Allowed Pre-proline 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -32.9 100.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.28 3.986 . . . . 0.0 115.015 -159.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -143.02 161.09 39.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.202 1.001 . . . . 0.0 110.654 -171.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 10.4 p -93.0 160.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.886 0.874 . . . . 0.0 109.736 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 70.7 m -62.46 122.61 16.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.579 0.752 . . . . 0.0 110.106 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -68.39 -37.31 80.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.462 0.705 . . . . 0.0 111.813 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.4 m -128.68 88.8 51.08 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.373 1.847 0 C-N-CA 123.153 2.569 . . . . 12.529999999999999 111.403 177.041 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 17' ' ' ILE . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.718 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 23' ' ' SER . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' HG23 ' A' ' 19' ' ' ILE . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.689 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.689 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 1.8 p-10 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 HG21 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 14.2 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' HG11 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.613 ' H ' HD11 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' A' ' 300' ' ' ILE . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.476 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.427 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.449 ' HE ' HG21 ' A' ' 186' ' ' VAL . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.64 HG22 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.713 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.508 HG21 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.449 HG21 ' HE ' ' A' ' 163' ' ' ARG . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.604 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.411 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.437 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.411 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.708 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.713 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.644 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.595 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.659 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 123' ' ' ILE . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.604 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.411 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 294' ' ' LEU . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.496 ' HA ' HG12 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.585 HG21 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 380' ' ' ASP . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 379' ' ' GLU . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.552 HD11 HD11 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.404 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.471 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.404 ' HG2' HG21 ' A' ' 422' ' ' THR . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' THR . . . . . 0.542 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.604 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 . . . . . 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' LEU . . . . . 0.667 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 284' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 289' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 296' ' ' THR . . . . . 0.682 HG22 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 297' ' ' TYR . . . . . 0.682 ' H ' HG22 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 51.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD11 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 50' ' ' PRO . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.608 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.485 HD12 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' A' ' 282' ' ' ILE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.736 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 202' ' ' ILE . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.576 HG21 HG23 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.656 HG22 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.58 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.423 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.634 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' SD ' ' A' ' 189' ' ' MET . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.442 HG21 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 157' ' ' ALA . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.412 ' HG2' HD21 ' B' ' 278' ' ' LEU . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 130' ' ' VAL . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.553 HD12 HG13 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.495 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.576 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.412 ' HB3' HD22 ' A' ' 350' ' ' LEU . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.413 ' HG3' HD23 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.498 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.59 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.644 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.489 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.426 ' HB2' HG23 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.553 HG13 HD12 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.576 HD13 HD22 ' A' ' 294' ' ' LEU . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HA ' HD12 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.479 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.479 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.452 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PHE . . . . . 0.484 ' HE2' HG21 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 387' ' ' PHE . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 401' ' ' VAL . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.406 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.467 HG11 HD21 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.551 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.589 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.408 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.58 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.63 ' HG ' HD12 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.63 HD12 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 279' ' ' GLY . . . . . 0.437 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 284' ' ' GLY . . . . . 0.437 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.657 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 287' ' ' PRO . . . . . 0.657 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 288' ' ' VAL . . . . . 0.484 HG21 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 289' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' B' ' 289' ' ' ARG . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.664 ' H ' HD23 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 297' ' ' TYR . . . . . 0.55 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 303' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG12 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 28' ' ' VAL . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.418 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.702 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HB2' HD11 ' A' ' 300' ' ' ILE . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.679 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.586 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 202' ' ' ILE . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.524 HG21 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 194' ' ' MET . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.402 ' HG2' HD21 ' A' ' 187' ' ' LEU . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.521 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.452 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 2.1 m-20 -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.737 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.451 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 315' ' ' ARG . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLU . . . . . 0.499 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 367' ' ' VAL . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.477 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.668 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.692 HD22 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.577 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 172' ' ' VAL . 55.5 t80 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.511 ' HB3' HG11 ' A' ' 186' ' ' VAL . 10.0 tp10 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 287' ' ' PRO . . . . . 0.668 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 289' ' ' ARG . . . . . 0.692 ' H ' HD22 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.411 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 293' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.525 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 302' ' ' ASP . . . . . 0.525 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.655 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 19' ' ' ILE . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.551 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.73 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.643 ' HA ' HD13 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.426 HG23 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HA ' HG23 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.539 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.474 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.401 ' HB3' ' HD3' ' A' ' 163' ' ' ARG . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.726 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.575 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 165' ' ' THR . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.458 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.608 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.608 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.621 HG22 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.52 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.428 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.575 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.829 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.474 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.582 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 253' ' ' ILE . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASN . . . . . 0.476 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.556 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.426 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.73 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' ' HG3' ' A' ' 342' ' ' LYS . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HB2' HD13 ' A' ' 311' ' ' ILE . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.478 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' A' ' 337' ' ' PHE . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 341' ' ' ALA . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.432 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LEU . . . . . 0.487 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.491 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 412' ' ' LEU . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 409' ' ' GLU . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.556 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.547 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 . . . . . 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 275' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 276' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 256' ' ' PHE . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 283' ' ' ASP . . . . . 0.664 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 397' ' ' ASN . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.621 HG23 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HD2' HG23 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.526 HD11 HG23 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.61 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.516 HD21 HD11 ' B' ' 277' ' ' LEU . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.77 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.584 HG21 HG23 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.57 ' HA3' HG21 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.504 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.427 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.665 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 266' ' ' LEU . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' B' ' 278' ' ' LEU . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.44 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.465 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.548 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.548 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.673 HD13 HD22 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.568 ' HA ' HD12 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.643 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.643 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.506 ' HG2' HD22 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.574 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLU . . . . . 0.462 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' THR . . . . . 0.57 HG21 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.558 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.629 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 288' ' ' VAL . . . . . 0.405 HG21 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.5 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.5 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 298' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.507 HD12 HD23 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD13 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG23 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.618 HG21 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.605 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 198' ' ' PHE . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 194' ' ' MET . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 202' ' ' ILE . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.605 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ARG . . . . . 0.469 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASN . . . . . 0.51 HD22 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.542 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.524 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.582 ' HB3' HD21 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.52 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.433 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.465 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.428 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.44 ' HB2' HG23 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 342' ' ' LYS . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLY . . . . . 0.521 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.521 HD12 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.627 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.405 ' H ' HG21 ' B' ' 301' ' ' ILE . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.518 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.681 ' HB1' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.481 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.437 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 275' ' ' LYS . . . . . 0.447 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 276' ' ' PRO . . . . . 0.717 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.551 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 281' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 282' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.717 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 288' ' ' VAL . . . . . 0.518 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 289' ' ' ARG . . . . . 0.45 ' NH1' HD11 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.49 ' HB2' HD23 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.497 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 292' ' ' GLY . . . . . 0.417 ' H ' ' HE3' ' B' ' 290' ' ' TRP . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 293' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 294' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 296' ' ' THR . . . . . 0.588 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.627 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 28' ' ' VAL . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 66' ' ' VAL . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.5 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD13 HD13 ' A' ' 19' ' ' ILE . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.627 ' HE2' HD11 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.481 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.602 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.513 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.473 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.554 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.442 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.515 HD12 HG13 ' A' ' 347' ' ' VAL . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 113' ' ' PRO . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.722 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.401 ' HB3' HD21 ' A' ' 325' ' ' ASN . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.41 ' HB2' HG23 ' A' ' 311' ' ' ILE . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 291' ' ' ILE . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.415 ' HB2' HG21 ' A' ' 300' ' ' ILE . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.686 HG21 HD13 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.434 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 372' ' ' GLU . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.538 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.443 ' HB2' ' HE1' ' A' ' 388' ' ' TYR . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.404 HD11 HD11 ' B' ' 301' ' ' ILE . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.442 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.482 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.596 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' PHE . . . . . 0.563 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.412 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 287' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.627 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.627 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 297' ' ' TYR . . . . . 0.515 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG3' HG13 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.609 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.588 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 96' ' ' GLU . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.588 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.628 ' HA ' HD13 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.601 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.49 HG23 ' HG2' ' A' ' 275' ' ' GLU . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HG2' HD21 ' A' ' 245' ' ' LEU . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.754 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.628 HG22 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.539 HD13 HG23 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 229' ' ' LYS . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 165' ' ' THR . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.62 HH21 ' HB3' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.511 HG22 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 198' ' ' PHE . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.488 ' HE1' ' HB2' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.449 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.505 HD21 ' CE1' ' B' ' 233' ' ' PHE . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 173' ' ' ASP . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HD3' HG22 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 146' ' ' LYS . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.481 ' SD ' HD13 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.601 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.473 HD12 HG13 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.665 HD13 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.508 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.773 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HB2' HG23 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 297' ' ' TYR . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.406 ' HB2' HG23 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.615 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.615 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.458 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 395' ' ' MET . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.458 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.443 HD21 HD11 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.466 HG23 HG22 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.551 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' A' ' 226' ' ' LEU . 34.1 t80 . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 120.46 0.172 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.481 HD13 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' LEU . . . . . 0.464 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 284' ' ' GLY . . . . . 0.464 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 287' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 288' ' ' VAL . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 297' ' ' TYR . . . . . 0.509 ' HE1' HD13 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 355' ' ' ILE . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 302' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.484 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 11' ' ' LEU . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.605 ' HA ' HD21 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.746 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.459 HG11 HG22 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.466 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 163' ' ' ARG . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 199' ' ' GLU . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.63 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.63 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.584 ' HB2' HG23 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.421 ' HB3' HD21 ' A' ' 187' ' ' LEU . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.517 HD11 HD13 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.746 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.466 HG21 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.507 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.665 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.445 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.613 ' HA ' HG22 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.437 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.69 HG21 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 253' ' ' ILE . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' VAL . . . . . 0.604 HG22 HD23 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASN . . . . . 0.48 ' HB3' HD23 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 373' ' ' GLU . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.605 HD21 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.44 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.489 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.616 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.585 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.435 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.435 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.585 HD13 HD22 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.44 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' GLU . . . . . 0.541 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.401 ' HB3' ' NH2' ' A' ' 276' ' ' ARG . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.555 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.43 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 372' ' ' GLU . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' TYR . . . . . 0.512 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.687 HD11 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' MET . . . . . 0.512 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' HE2' ' A' ' 388' ' ' TYR . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' HG21 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.528 HD21 HD12 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' HG3' ' A' ' 287' ' ' LYS . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 226' ' ' LEU . 18.9 t80 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLU . . . . . 0.466 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.629 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 287' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.687 ' HZ3' HD11 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 296' ' ' THR . . . . . 0.635 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 298' ' ' HIS . . . . . 0.635 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.772 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' LYS . . . . . 0.772 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG12 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' NH1' HG12 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 303' ' ' PRO . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 303' ' ' PRO . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 298' ' ' ASN . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB3' HE22 ' A' ' 289' ' ' GLN . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 HD22 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.449 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.679 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.62 HG11 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.486 HG22 ' HG3' ' A' ' 181' ' ' LYS . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' MET . . . . . 0.544 ' HB2' HG21 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.431 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.62 HG21 HG11 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 237' ' ' LEU . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.431 HG21 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 220' ' ' GLU . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.439 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.641 ' HA ' HG22 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.42 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.562 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.536 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.449 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HG3' HD22 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' VAL . . . . . 0.547 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' MET . . . . . 0.547 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 427' ' ' LEU . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.768 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.482 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ASN . . . . . 0.457 HD21 HD23 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 345' ' ' VAL . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.495 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 313' ' ' VAL . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 309' ' ' SER . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LEU . . . . . 0.486 ' HA ' HG12 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ILE . . . . . 0.581 HG21 HD13 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.553 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.716 HD11 HD11 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.768 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HG2' HD12 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.565 HG21 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' LEU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' LEU . . . . . 0.599 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 233' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 . . . . . 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 276' ' ' PRO . . . . . 0.41 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 277' ' ' LEU . . . . . 0.664 HD22 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 278' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 279' ' ' GLY . . . . . 0.495 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 283' ' ' ASP . . . . . 0.564 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 285' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 286' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' B' ' 285' ' ' ASN . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 289' ' ' ARG . . . . . 0.552 ' NH2' HD22 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 290' ' ' TRP . . . . . 0.553 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 291' ' ' LEU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 301' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 302' ' ' ASP . . . . . 0.493 ' N ' HD12 ' B' ' 301' ' ' ILE . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 17' ' ' ILE . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.718 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 23' ' ' SER . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' HG23 ' A' ' 19' ' ' ILE . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.689 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.689 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 1.8 p-10 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 HG21 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 14.2 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' HG11 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.613 ' H ' HD11 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' A' ' 300' ' ' ILE . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.476 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.427 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.449 ' HE ' HG21 ' A' ' 186' ' ' VAL . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.64 HG22 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.713 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.508 HG21 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.449 HG21 ' HE ' ' A' ' 163' ' ' ARG . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.604 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.411 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.437 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.411 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.708 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.713 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.644 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.595 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.659 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 123' ' ' ILE . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.604 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.411 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.411 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 294' ' ' LEU . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.496 ' HA ' HG12 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.585 HG21 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLU . . . . . 0.629 ' HB3' ' HA ' ' B' ' 274' ' ' GLN . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 379' ' ' GLU . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.552 HD11 HD11 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.404 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.471 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.404 ' HG2' HG21 ' A' ' 422' ' ' THR . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.45 -65.67 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.984 0.914 . . . . 15.0 109.019 179.432 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -84.7 -79.99 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 0.0 109.643 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -178.21 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.104 0.962 . . . . 0.0 108.986 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -76.76 110.39 11.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.06 0.544 . . . . 0.0 109.609 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.4 t -91.84 105.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 91.9 m -114.15 98.58 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 100.5 3.81 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.62 51.08 3.27 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.289 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.14 -99.36 1.92 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.289 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.4 -47.51 0.3 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 58.58 39.06 25.16 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.832 1.253 . . . . 0.0 112.629 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -80.31 10.91 3.97 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.996 0.519 . . . . 0.0 112.261 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 34.4 p -54.09 -69.27 0.13 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.372 1.469 . . . . 0.0 111.953 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 -119.08 87.15 2.68 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.542 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.604 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 -148.02 122.78 9.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -167.93 19.78 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.439 1.096 . . . . 0.0 109.339 165.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.434 ' O ' ' HD3' ' B' ' 248' ' ' ARG . 33.9 mm-40 -95.28 -44.63 7.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.623 0.769 . . . . 0.0 111.596 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.55 72.31 0.24 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 123.187 0.305 . . . . 0.0 113.809 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -144.38 47.77 1.38 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 108.598 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 78.9 m 77.23 -55.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.253 1.821 . . . . 0.0 113.087 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.455 ' HB3' ' HD2' ' B' ' 248' ' ' ARG . 55.4 tp -61.78 -40.59 95.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 0.0 113.414 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.455 ' HD2' ' HB3' ' B' ' 247' ' ' LEU . 7.0 mpt_? -88.09 -24.22 23.48 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.628 0.371 . . . . 0.0 111.635 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -73.07 -20.87 60.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.863 0.465 . . . . 0.0 110.552 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -37.85 84.65 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.68 . . . . 0.0 109.277 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.61 -31.75 72.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.326 0.651 . . . . 0.0 111.531 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -72.65 -38.02 67.81 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.007 0.523 . . . . 0.0 110.305 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.29 3.01 48.42 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.384 0.674 . . . . 0.0 111.71 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -75.04 99.05 3.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.57 0.748 . . . . 0.0 109.651 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 145.13 -58.13 0.52 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 49.8 t80 60.1 -76.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.628 1.571 . . . . 0.0 113.377 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.81 120.34 24.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.114 0.566 . . . . 0.0 109.565 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.575 HD22 HG22 ' B' ' 259' ' ' VAL . 0.0 OUTLIER -154.53 135.91 14.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.831 173.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.575 HG22 HD22 ' B' ' 258' ' ' LEU . 23.8 m 41.83 89.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 126.661 1.985 . . . . 0.0 114.908 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 42.6 p -91.87 -89.28 0.18 Allowed 'General case' 0 CA--C 1.553 1.066 0 O-C-N 121.872 -0.517 . . . . 0.0 110.182 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.9 t70 60.59 163.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.855 1.262 . . . . 0.0 112.061 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.18 90.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 110.335 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.52 -84.04 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.15 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 82.6 p -175.16 40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.183 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 83.6 mt 69.37 97.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.852 1.661 . . . . 0.0 111.017 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -84.44 75.61 10.23 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.895 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -140.73 13.19 2.3 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.544 167.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.8 148.69 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.102 1.361 . . . . 0.0 109.386 -172.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 380' ' ' ASP . 21.7 p -63.68 -42.48 98.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.877 0.471 . . . . 0.0 111.739 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.35 150.65 23.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.453 0.644 . . . . 0.0 111.364 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -99.78 21.31 12.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.0 -175.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -48.7 -52.05 25.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.959 1.304 . . . . 0.0 110.952 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -153.32 89.33 1.34 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 160.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' B' ' 275' ' ' LYS . 1.3 pm0 -69.73 -38.91 77.02 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' B' ' 274' ' ' GLN . 63.8 mttm -114.13 116.28 44.72 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.667 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.682 HG22 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.682 ' H ' HG22 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.85 122.38 16.7 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.09 74.16 0.73 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.406 2.737 . . . . 0.0 112.994 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.91 74.78 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.89 130.26 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -169.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 45.6 p -86.75 129.69 34.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 11.8 p -73.7 80.2 1.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.923 0.868 . . . . 0.0 109.675 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 24.0 p -126.28 96.25 36.95 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.483 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.977 2.451 . . . . 12.53 111.654 -178.277 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 51.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD11 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 50' ' ' PRO . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.608 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.485 HD12 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' A' ' 282' ' ' ILE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.736 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 202' ' ' ILE . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.576 HG21 HG23 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.656 HG22 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.503 ' HB3' ' HZ2' ' B' ' 242' ' ' TRP . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.58 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.423 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.634 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' SD ' ' A' ' 189' ' ' MET . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.442 HG21 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' B' ' 227' ' ' GLY . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' B' ' 231' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 157' ' ' ALA . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.613 ' HA ' ' HZ2' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.613 ' HZ2' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.412 ' HG2' HD21 ' B' ' 278' ' ' LEU . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 130' ' ' VAL . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.553 HD12 HG13 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.495 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.576 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.412 ' HB3' HD22 ' A' ' 350' ' ' LEU . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.413 ' HG3' HD23 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.498 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.59 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.644 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.489 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.426 ' HB2' HG23 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.553 HG13 HD12 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.576 HD13 HD22 ' A' ' 294' ' ' LEU . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 355' ' ' ILE . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HA ' HD12 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.479 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.479 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.452 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.484 ' HE2' HG21 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 387' ' ' PHE . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 401' ' ' VAL . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.406 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.467 HG11 HD21 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.551 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.589 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.408 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -96.79 26.19 4.72 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.764 1.225 . . . . 15.0 108.191 175.006 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 67.13 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.213 1.405 . . . . 0.0 110.503 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.98 130.46 6.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.48 102.58 0.72 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.87 106.88 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 29.1 m -66.72 91.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.469 0.708 . . . . 0.0 110.536 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.3 mt -120.11 175.11 6.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.379 1.072 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 222' ' ' HIS . . . 92.42 -59.11 2.64 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.01 -63.48 4.21 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.43 92.67 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.683 0.284 . . . . 0.0 112.875 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.13 57.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.554 0.742 . . . . 0.0 111.931 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 225' ' ' ASN . 13.3 mptt -92.9 -61.47 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.537 0.735 . . . . 0.0 110.114 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -89.78 63.31 6.07 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.788 0.804 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 65.26 133.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.538 1.535 . . . . 0.0 113.049 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.58 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 53.56 26.43 5.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.503 ' HZ2' ' HB3' ' A' ' 184' ' ' ASP . 98.8 m95 -87.79 74.7 9.04 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -68.37 114.3 6.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.414 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.49 -13.41 71.04 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.489 0.493 . . . . 0.0 113.593 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt 57.73 35.01 25.14 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.325 1.45 . . . . 0.0 111.172 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.54 HG23 ' HB2' ' B' ' 248' ' ' ARG . 5.9 t -82.16 173.56 12.01 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.42 -4.73 23.94 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.548 ' HA ' ' HB2' ' B' ' 252' ' ' GLN . 12.7 mpt_? -64.89 -46.46 81.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.841 0.456 . . . . 0.0 110.211 166.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.05 -15.55 61.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.377 0.671 . . . . 0.0 111.877 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -101.28 -75.82 0.58 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.593 0.757 . . . . 0.0 111.06 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.633 ' HA ' ' H ' ' B' ' 257' ' ' GLN . . . -81.63 -25.92 35.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.956 0.902 . . . . 0.0 113.412 -169.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLN . . . . . 0.548 ' HB2' ' HA ' ' B' ' 248' ' ' ARG . 26.0 mm-40 -103.55 4.0 35.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.77 0.428 . . . . 0.0 111.288 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.45 3.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.663 0.785 . . . . 0.0 111.492 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -148.29 16.35 1.04 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.635 0.774 . . . . 0.0 110.862 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 129.69 162.09 10.72 Favored Glycine 0 C--O 1.244 0.726 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -70.32 91.38 0.74 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.703 0.801 . . . . 0.0 111.801 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' GLN . . . . . 0.633 ' H ' ' HA ' ' B' ' 251' ' ' ALA . 90.0 mt-30 74.38 -68.78 0.2 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.927 1.691 . . . . 0.0 111.443 170.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 7.7 tt -145.18 116.02 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.77 135.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.393 0.677 . . . . 0.0 109.242 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -154.83 78.05 1.04 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.002 0.521 . . . . 0.0 110.517 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 56.72 74.33 0.41 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.347 1.059 . . . . 0.0 111.882 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -67.7 -28.01 67.31 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.795 0.438 . . . . 0.0 110.851 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.82 -43.3 72.28 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.1 m 73.48 -64.2 0.4 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.475 1.51 . . . . 0.0 111.355 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.8 tt -63.91 98.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.9 -65.8 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.077 1.751 . . . . 0.0 111.476 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 23.1 m 77.31 -28.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.746 1.619 . . . . 0.0 112.643 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.48 117.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 125.863 1.665 . . . . 0.0 112.027 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 81.7 p -74.41 151.95 39.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.132 0.573 . . . . 0.0 110.735 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -96.94 4.01 51.78 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.984 0.514 . . . . 0.0 111.609 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' B' ' 279' ' ' GLY . . . -94.04 -86.43 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.761 0.425 . . . . 0.0 110.929 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -140.12 -51.32 0.49 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.884 0.874 . . . . 0.0 109.307 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -173.87 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.576 1.55 . . . . 0.0 107.463 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -79.3 121.76 25.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.553 1.141 . . . . 0.0 108.648 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -72.38 -51.51 7.55 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.63 ' HG ' HD12 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.63 HD12 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 279' ' ' GLY . . . . . 0.437 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' GLY . . . . . 0.437 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.657 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.657 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.484 HG21 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' B' ' 289' ' ' ARG . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.664 ' H ' HD23 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.55 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 303' ' ' LYS . 0.1 OUTLIER -146.1 93.72 5.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -91.33 -173.03 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.421 2.747 . . . . 0.0 111.78 172.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.94 101.85 1.46 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.38 129.79 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 0.0 111.262 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.3 m -151.7 152.25 32.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.7 1.2 . . . . 0.0 108.16 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 17.1 p -67.08 84.83 0.13 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.879 0.872 . . . . 0.0 110.735 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 27.5 m -75.04 -41.71 4.13 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.301 1.04 . . . . 0.0 112.675 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.389 2.671 0 C-N-CA 122.059 1.839 . . . . 12.53 111.961 172.64 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG12 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 28' ' ' VAL . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.418 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.702 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HB2' HD11 ' A' ' 300' ' ' ILE . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.679 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.586 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 202' ' ' ILE . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.524 HG21 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 194' ' ' MET . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.402 ' HG2' HD21 ' A' ' 187' ' ' LEU . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.521 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.452 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 2.1 m-20 -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.737 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.451 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 315' ' ' ARG . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.499 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 367' ' ' VAL . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.477 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.668 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.692 HD22 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.577 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -84.76 -37.51 20.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 C-N-CA 123.894 0.878 . . . . 15.0 109.126 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.64 -0.134 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 66.67 -78.82 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.258 1.423 . . . . 0.0 112.204 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -91.24 68.39 5.95 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.98 144.34 25.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.456 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.16 176.83 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.28 1.032 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.7 p -77.93 176.49 9.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.944 0.497 . . . . 0.0 111.263 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.1 130.75 17.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -129.56 179.3 16.85 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -166.63 173.99 42.03 Favored Glycine 0 N--CA 1.469 0.873 0 CA-C-O 119.987 -0.34 . . . . 0.0 112.3 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.3 2.26 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 68.21 18.44 9.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.343 1.457 . . . . 0.0 113.039 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -164.38 77.84 0.35 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.196 0.598 . . . . 0.0 109.899 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 80.8 p 49.45 -158.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.753 1.221 . . . . 0.0 113.218 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 172' ' ' VAL . 55.5 t80 -130.19 -88.2 0.5 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.511 ' HB3' HG11 ' A' ' 186' ' ' VAL . 10.0 tp10 -157.95 158.02 34.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 2.9 m95 161.09 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 128.145 2.578 . . . . 0.0 109.147 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -158.93 16.09 0.18 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.656 0.782 . . . . 0.0 111.816 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.99 74.83 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.601 -0.272 . . . . 0.0 112.641 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -104.16 88.42 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.792 . . . . 0.0 109.841 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -176.56 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 36.9 tp -74.92 -39.75 61.24 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.148 0.431 . . . . 0.0 111.016 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -93.24 6.45 48.01 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.723 0.809 . . . . 0.0 111.523 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.31 -45.2 72.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.917 1.287 . . . . 0.0 112.571 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -57.77 -27.41 63.04 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.037 0.836 . . . . 0.0 112.554 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.09 -55.9 18.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.745 0.418 . . . . 0.0 110.756 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -6.21 59.34 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.138 0.575 . . . . 0.0 111.915 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.34 -43.41 13.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.094 0.557 . . . . 0.0 109.864 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -58.82 5.29 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -73.73 87.35 0.64 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.18 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -58.23 175.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.386 1.074 . . . . 0.0 112.277 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -65.52 87.58 0.08 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.847 0.832 . . . . 0.0 111.407 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.76 -52.34 2.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.168 1.387 . . . . 0.0 107.436 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.6 141.11 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.896 1.278 . . . . 0.0 108.271 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 54.1 m -71.22 133.76 46.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.865 0.466 . . . . 0.0 110.765 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.56 114.11 7.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.576 0.75 . . . . 0.0 109.4 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -106.02 2.08 27.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.719 0.808 . . . . 0.0 110.772 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -89.44 -17.36 28.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.823 0.849 . . . . 0.0 112.142 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 21.7 t 66.24 19.88 11.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.853 1.261 . . . . 0.0 110.412 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 92.8 mt 57.59 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.366 1.29 0 C-N-CA 124.773 1.229 . . . . 0.0 109.742 -166.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -132.67 -63.21 0.79 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.9 p -178.8 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.403 1.481 . . . . 0.0 107.014 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.97 162.44 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.706 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 24.2 m -69.19 102.3 1.65 Allowed 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.21 147.08 50.23 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.941 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -111.06 -17.75 13.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.256 1.022 . . . . 0.0 110.585 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -66.37 -54.59 22.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.337 0.655 . . . . 0.0 111.09 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 76.33 -29.74 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.236 1.414 . . . . 0.0 112.191 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -98.6 101.77 13.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -105.6 140.95 21.68 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 122.969 0.508 . . . . 0.0 109.974 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.668 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.692 ' H ' HD22 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.411 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.525 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.525 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.58 115.44 55.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -22.13 95.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.393 2.878 1 C-N-CA 126.42 4.747 . . . . 0.0 115.446 -164.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.35 79.79 0.54 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.718 0.77 . . . . 0.0 111.293 -174.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.5 160.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.707 1.203 . . . . 0.0 109.723 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.5 m -65.35 99.65 0.42 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 23.8 p -122.84 159.05 28.95 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.642 1.177 . . . . 0.0 108.641 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' B' ' 310' ' ' PRO . 6.7 t -87.63 102.66 3.63 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 122.925 0.49 . . . . 0.0 110.27 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 309' ' ' THR . 18.5 Cg_endo . . . . . 0 C--N 1.385 2.459 0 C-N-CA 122.994 2.463 . . . . 12.53 110.973 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.655 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 19' ' ' ILE . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.551 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.73 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.643 ' HA ' HD13 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.426 HG23 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HA ' HG23 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.539 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.474 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HB2' ' HG2' ' B' ' 243' ' ' GLN . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.726 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.575 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 165' ' ' THR . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.458 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.608 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.608 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.621 HG22 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.52 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.428 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.575 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.829 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.474 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.582 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 253' ' ' ILE . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.476 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.556 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.426 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.73 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' ' HG3' ' A' ' 342' ' ' LYS . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HB2' HD13 ' A' ' 311' ' ' ILE . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.478 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' A' ' 337' ' ' PHE . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 341' ' ' ALA . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.432 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.487 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.491 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 412' ' ' LEU . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 409' ' ' GLU . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.556 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.88 99.68 7.67 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.8 0.84 . . . . 15.0 108.815 177.485 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -77.73 149.37 34.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.808 0.843 . . . . 0.0 108.941 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 65.77 -71.66 0.08 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.473 1.109 . . . . 0.0 110.584 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 37.6 t70 68.97 168.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.029 1.331 . . . . 0.0 111.821 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.78 157.12 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 24.5 m -59.04 89.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.701 0.8 . . . . 0.0 109.594 171.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 40.3 tp -75.04 88.91 2.41 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.868 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.47 114.18 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.346 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -84.64 -2.76 88.66 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 122.81 0.243 . . . . 0.0 113.061 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.85 -160.79 20.33 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 123.406 0.527 . . . . 0.0 111.845 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.21 165.09 25.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.358 0.663 . . . . 0.0 110.885 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -138.98 96.38 3.11 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 20.7 m 66.56 161.71 0.16 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.497 1.119 . . . . 0.0 111.07 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 -163.61 -55.69 0.04 OUTLIER 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.734 -0.604 . . . . 0.0 110.593 170.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.547 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 -80.4 135.8 36.24 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -149.64 177.0 10.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.312 1.445 . . . . 0.0 108.274 168.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 151' ' ' TRP . 52.8 mt-30 -86.68 156.08 20.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.586 0.754 . . . . 0.0 109.912 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -57.31 -73.53 0.44 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.814 . . . . 0.0 113.048 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 66.96 83.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.474 1.11 . . . . 0.0 112.782 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 17.3 m 66.27 -68.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 160.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 247' ' ' LEU . 2.1 pt? -111.99 2.14 16.75 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.548 ' HG2' ' HG3' ' B' ' 249' ' ' GLU . 62.6 ttm-85 -62.51 -82.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -167.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.548 ' HG3' ' HG2' ' B' ' 248' ' ' ARG . 43.5 mt-10 -101.84 -81.79 0.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.87 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -101.81 -77.42 0.55 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.99 -78.12 0.59 Allowed 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.85 -76.73 0.45 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -114.23 -85.24 0.6 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' B' ' 250' ' ' GLN . 99.2 mtt180 59.04 17.88 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.893 1.277 . . . . 0.0 113.453 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.33 -73.02 0.14 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.88 -174.16 0.15 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.254 1.422 . . . . 0.0 111.328 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -82.33 73.55 9.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.692 0.758 . . . . 0.0 109.727 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.76 134.34 41.06 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -65.4 92.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.21 1.005 . . . . 0.0 110.06 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 35.3 t -129.3 124.54 34.62 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.5 1.12 . . . . 0.0 108.844 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.83 -77.75 0.21 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.156 0.583 . . . . 0.0 110.512 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -111.0 -73.32 0.68 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.614 0.766 . . . . 0.0 109.908 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.19 -49.65 3.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.53 0.732 . . . . 0.0 110.106 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.6 m 75.78 -49.3 0.61 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.951 1.701 . . . . 0.0 112.678 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 78.9 mt 59.94 -158.73 0.31 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.166 0.987 . . . . 0.0 111.054 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 8.8 t30 76.21 -60.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.238 1.415 . . . . 0.0 111.246 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.6 t -65.95 86.96 0.1 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.677 0.791 . . . . 0.0 110.018 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.89 133.21 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.825 1.25 . . . . 0.0 108.219 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 15.3 t -94.49 45.25 1.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 122.353 1.073 . . . . 0.0 110.559 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' GLU . . . . . 0.551 ' HG2' ' H ' ' B' ' 271' ' ' ALA . 20.8 tt0 -72.33 -164.05 0.13 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.095 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.551 ' H ' ' HG2' ' B' ' 270' ' ' GLU . . . -48.28 -31.34 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.264 1.026 . . . . 0.0 113.539 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -86.87 29.8 0.79 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.094 0.957 . . . . 0.0 112.119 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 8.66 2.28 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.445 0.698 . . . . 0.0 112.432 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -65.24 -1.94 2.66 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.214 1.006 . . . . 0.0 112.227 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER -58.02 119.76 37.12 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 256' ' ' PHE . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.664 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 397' ' ' ASN . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -78.85 -57.07 0.82 Allowed Pre-proline 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.32 135.99 4.63 Favored 'Trans proline' 0 C--N 1.402 3.358 0 C-N-CA 122.131 1.888 . . . . 0.0 112.14 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.48 121.46 17.82 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.8 m -151.36 144.35 24.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.831 1.252 . . . . 0.0 108.54 -171.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -77.08 83.35 3.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.345 0.593 . . . . 0.0 109.539 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 9.1 t -148.85 135.0 9.97 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.046 0.938 . . . . 0.0 109.711 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--N 1.377 2.052 0 C-N-CA 122.506 2.137 . . . . 12.53 112.211 179.468 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.621 HG23 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HD2' HG23 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.526 HD11 HG23 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.61 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.516 HD21 HD11 ' B' ' 277' ' ' LEU . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.77 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.584 HG21 HG23 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.57 ' HA3' HG21 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.504 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.427 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.665 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 266' ' ' LEU . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' B' ' 278' ' ' LEU . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.44 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.465 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.548 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.548 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.673 HD13 HD22 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.568 ' HA ' HD12 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.643 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.643 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.506 ' HG2' HD22 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.574 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLU . . . . . 0.462 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.12 -35.8 64.15 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 C-N-CA 123.288 0.635 . . . . 15.0 109.569 176.416 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 66.23 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.68 1.192 . . . . 0.0 111.227 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.77 98.66 1.1 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.504 0.721 . . . . 0.0 109.058 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -131.44 125.54 32.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.206 1.002 . . . . 0.0 109.501 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.53 101.07 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.3 m -86.79 140.89 29.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.397 0.679 . . . . 0.0 109.76 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 77.1 mt -73.86 92.7 2.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 109.922 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.57 100.53 2.55 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.866 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 128.41 -154.2 19.89 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.81 0.243 . . . . 0.0 112.978 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.85 14.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.0 120.06 21.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.626 0.771 . . . . 0.0 108.932 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' B' ' 231' ' ' LYS . 6.8 tmtm? 69.28 -12.12 0.44 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.091 1.356 . . . . 0.0 111.174 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.8 p 57.77 -89.61 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.586 1.554 . . . . 0.0 110.112 -155.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 175.15 -130.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.57 HG21 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.558 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -83.13 92.33 7.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -115.12 84.69 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.808 0.843 . . . . 0.0 109.133 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -97.66 -42.22 7.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.134 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.32 79.84 0.76 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.774 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' HG3' ' B' ' 248' ' ' ARG . 74.6 mmtt -88.9 125.98 35.18 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 66.0 p -67.29 -2.05 5.46 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' LEU . . . . . 0.604 ' H ' HD23 ' B' ' 247' ' ' LEU . 2.0 pt? -111.85 -11.18 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' B' ' 245' ' ' LYS . 75.0 mtm180 -59.11 -60.98 2.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.727 0.775 . . . . 0.0 111.95 -169.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.76 -21.81 61.69 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.558 -1.655 . . . . 0.0 111.714 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -76.22 -48.38 20.56 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.138 0.495 . . . . 0.0 110.447 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.468 ' HA ' ' HA3' ' B' ' 255' ' ' GLY . . . -64.64 -39.72 94.19 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.748 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -70.09 -32.61 70.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.381 0.672 . . . . 0.0 110.806 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.5 -66.87 0.55 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.356 0.662 . . . . 0.0 111.942 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -148.74 5.92 0.7 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 111.787 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' B' ' 251' ' ' ALA . . . -83.98 -15.98 68.64 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.475 0.484 . . . . 0.0 112.784 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 55.7 t80 69.93 88.23 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 109.589 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -98.26 120.65 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.81 143.96 55.56 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.92 123.73 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 123.112 0.565 . . . . 0.0 110.115 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 25.5 t -63.2 -39.78 95.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.603 0.761 . . . . 0.0 110.598 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -162.77 129.18 3.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.929 0.892 . . . . 0.0 109.197 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -86.51 -11.57 51.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 0.0 110.885 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -64.07 -63.16 1.23 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.896 0.878 . . . . 0.0 110.394 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.8 m 51.3 71.34 0.45 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 111.909 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 29.0 tp 66.85 10.97 8.0 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 124.772 1.229 . . . . 0.0 111.296 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.32 37.04 28.47 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.595 1.158 . . . . 0.0 110.805 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -68.28 96.3 0.65 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.96 -40.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.812 0.845 . . . . 0.0 109.979 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 19.1 p -95.82 -10.14 29.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.306 0.642 . . . . 0.0 110.884 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -144.78 89.19 1.96 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.121 0.968 . . . . 0.0 108.645 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.52 -5.06 14.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.495 1.118 . . . . 0.0 110.985 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.63 -26.73 62.68 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.397 0.679 . . . . 0.0 110.156 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 66.45 33.6 6.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.057 1.343 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -144.48 107.22 4.45 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -149.25 135.61 10.32 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.629 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.405 HG21 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.5 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.5 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' B' ' 304' ' ' PRO . 20.9 tptm -149.23 -40.36 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' B' ' 303' ' ' LYS . 69.6 Cg_exo -47.78 -30.8 13.67 Favored 'Trans proline' 0 C--N 1.404 3.454 0 C-N-CA 122.295 1.996 . . . . 0.0 113.666 171.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.48 82.42 7.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.39 167.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.159 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.4 t -107.5 156.87 18.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.275 0.63 . . . . 0.0 109.494 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.44 -15.72 39.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.922 0.489 . . . . 0.0 111.28 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.1 t -97.32 127.35 38.54 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.07 0.548 . . . . 0.0 110.379 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.308 2.672 . . . . 12.53 111.902 176.379 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.507 HD12 HD23 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD13 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG23 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.618 HG21 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.605 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 198' ' ' PHE . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 194' ' ' MET . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 202' ' ' ILE . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.605 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.469 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.51 HD22 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.542 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.524 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.582 ' HB3' HD21 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.52 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.433 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.465 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.428 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.44 ' HB2' HG23 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 342' ' ' LYS . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLY . . . . . 0.521 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.521 HD12 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.627 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.405 ' H ' HG21 ' B' ' 301' ' ' ILE . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.518 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.681 ' HB1' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.481 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.437 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.98 71.99 10.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.342 -1.299 . . . . 15.0 108.608 -174.057 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.43 172.88 8.42 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.604 0.762 . . . . 0.0 111.228 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.55 64.85 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.874 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -128.15 104.99 8.07 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.778 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.48 123.01 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.742 0.817 . . . . 0.0 109.624 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 14.9 p -68.79 135.23 50.87 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.085 0.554 . . . . 0.0 109.959 170.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.04 135.05 16.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -159.5 -140.9 3.0 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 172.66 141.12 3.34 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.694 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -76.27 118.12 5.22 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.45 1.03 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.512 0.725 . . . . 0.0 111.583 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -85.26 117.92 24.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.39 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 75.0 p -119.42 -168.29 1.55 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.431 1.092 . . . . 0.0 110.31 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -58.92 102.29 0.12 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.467 0.707 . . . . 0.0 109.844 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -80.61 -10.27 59.74 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -119.05 -171.63 2.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 109.931 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.87 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.337 1.455 . . . . 0.0 111.7 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.58 -17.94 60.71 Favored Glycine 0 C--N 1.352 1.435 0 O-C-N 123.643 0.59 . . . . 0.0 114.314 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -70.43 78.29 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.173 0.989 . . . . 0.0 109.786 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.5 p -110.64 108.23 18.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.628 0.771 . . . . 0.0 111.371 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.98 -16.66 59.95 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.203 0.601 . . . . 0.0 110.862 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -50.25 -33.84 21.08 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.715 1.206 . . . . 0.0 110.774 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.43 -51.23 69.59 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.729 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' B' ' 253' ' ' ALA . 1.0 OUTLIER -71.54 -18.0 62.28 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.65 -45.75 64.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.206 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.96 -20.03 39.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.025 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . . . -89.06 16.85 6.46 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.453 0.701 . . . . 0.0 111.301 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.46 48.52 8.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 113.273 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -61.49 102.63 0.45 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.256 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.8 t80 73.37 96.86 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.138 1.375 . . . . 0.0 109.818 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -116.31 -163.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.973 0.909 . . . . 0.0 111.917 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.41 ' O ' HG22 ' B' ' 259' ' ' VAL . 1.2 pp -56.97 165.82 1.17 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.777 1.231 . . . . 0.0 112.814 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 259' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 258' ' ' LEU . 3.1 m 61.97 7.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 126.683 1.993 . . . . 0.0 112.678 -174.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 78.7 p -149.34 -7.46 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 109.566 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -62.47 -44.04 97.36 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.469 1.108 . . . . 0.0 111.45 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.69 59.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.798 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.96 -32.67 74.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.064 0.546 . . . . 0.0 111.024 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t 59.91 28.92 18.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.43 1.092 . . . . 0.0 111.609 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.7 tt 66.1 86.48 0.13 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.059 1.344 . . . . 0.0 108.505 -167.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -92.92 -48.94 6.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.713 0.805 . . . . 0.0 109.826 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 47.0 t 62.91 14.42 7.45 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.303 1.041 . . . . 0.0 112.087 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.6 m 48.57 13.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 126.769 2.028 . . . . 0.0 114.211 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' B' ' 273' ' ' GLN . 39.2 p -124.66 53.79 1.44 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.951 1.301 . . . . 0.0 107.978 -176.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 64.59 -86.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.878 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.88 -64.82 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -138.34 -21.77 1.04 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.468 0.707 . . . . 0.0 111.276 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 273' ' ' GLN . . . . . 0.581 ' HB2' ' HB ' ' B' ' 269' ' ' THR . 17.9 tm0? 66.2 172.94 0.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.502 1.521 . . . . 0.0 110.494 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.81 95.75 0.38 Allowed 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.796 -0.565 . . . . 0.0 109.949 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.447 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER -63.83 150.19 91.65 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.816 0.846 . . . . 0.0 110.383 174.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.717 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.551 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 282' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.717 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.518 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.45 ' NH1' HD11 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.49 ' HB2' HD23 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.497 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 292' ' ' GLY . . . . . 0.417 ' H ' ' HE3' ' B' ' 290' ' ' TRP . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 294' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.588 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.627 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.57 88.55 1.55 Allowed Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.69 89.22 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.636 2.224 . . . . 0.0 110.156 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.52 81.5 1.97 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.742 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -166.48 138.05 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 108.819 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 20.1 p -79.18 91.88 5.01 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.39 -83.07 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.63 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.5 m 39.32 75.49 0.57 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 126.006 1.722 . . . . 0.0 113.884 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 123.358 2.705 . . . . 12.53 112.135 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 28' ' ' VAL . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 66' ' ' VAL . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.5 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD13 HD13 ' A' ' 19' ' ' ILE . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.627 ' HE2' HD11 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' B' ' 262' ' ' ALA . 6.5 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' B' ' 258' ' ' LEU . 15.4 mm100 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.481 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' B' ' 242' ' ' TRP . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.602 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.513 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.473 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.554 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.442 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.515 HD12 HG13 ' A' ' 347' ' ' VAL . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 113' ' ' PRO . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.722 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.401 ' HB3' HD21 ' A' ' 325' ' ' ASN . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.41 ' HB2' HG23 ' A' ' 311' ' ' ILE . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 291' ' ' ILE . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.415 ' HB2' HG21 ' A' ' 300' ' ' ILE . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.686 HG21 HD13 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.434 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 372' ' ' GLU . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.538 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.443 ' HB2' ' HE1' ' A' ' 388' ' ' TYR . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.404 HD11 HD11 ' B' ' 301' ' ' ILE . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.442 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.482 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.74 -46.99 16.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.358 -179.034 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.72 144.79 47.94 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.233 0.613 . . . . 0.0 110.275 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -97.38 125.27 41.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.394 0.677 . . . . 0.0 109.68 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.41 -31.41 71.58 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.126 0.489 . . . . 0.0 109.988 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.22 121.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.371 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 20.4 m -109.97 138.9 45.7 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.1 tp 65.1 -85.53 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.062 1.345 . . . . 0.0 111.335 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.05 68.77 1.52 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.18 169.37 54.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.471 0.558 . . . . 0.0 113.004 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.6 -165.24 39.42 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -121.16 -177.08 3.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 109.726 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 70.72 113.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.99 1.316 . . . . 0.0 110.114 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -148.33 106.52 3.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.213 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 -103.18 65.13 0.85 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.48 -80.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.478 ' HA ' HG21 ' A' ' 186' ' ' VAL . 14.4 m95 54.8 118.65 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.01 1.724 . . . . 0.0 113.75 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -54.71 139.4 39.19 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.18 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -49.36 -45.7 36.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 124.614 1.196 . . . . 0.0 112.722 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? 51.3 11.05 0.1 Allowed 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 126.801 2.041 . . . . 0.0 114.816 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.1 p -143.37 150.92 39.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.037 0.935 . . . . 0.0 109.662 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -26.76 66.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.127 0.571 . . . . 0.0 111.179 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.56 -43.45 93.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.406 0.682 . . . . 0.0 111.481 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -79.17 -14.34 59.15 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.047 0.539 . . . . 0.0 111.421 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -101.6 3.65 40.14 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.6 1.16 . . . . 0.0 111.139 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.43 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.043 0.937 . . . . 0.0 113.142 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -102.13 -79.03 0.53 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -116.54 -74.62 0.6 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 50.0 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.559 1.143 . . . . 0.0 111.489 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 52.99 -98.42 0.03 OUTLIER Glycine 0 C--N 1.359 1.821 0 O-C-N 124.001 0.813 . . . . 0.0 112.738 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -136.13 153.43 51.29 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.453 1.101 . . . . 0.0 108.398 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.18 93.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.371 0.605 . . . . 0.0 109.519 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 148' ' ' GLN . 24.5 tp -121.02 100.29 6.98 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.764 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.75 118.33 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' SER . . . . . 0.47 ' HA ' ' HE2' ' A' ' 256' ' ' PHE . 42.5 t 71.2 -64.17 0.39 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.268 1.427 . . . . 0.0 111.341 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -152.21 162.45 41.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.674 0.79 . . . . 0.0 109.532 172.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ALA . . . . . 0.532 ' H ' ' HG2' ' A' ' 147' ' ' GLN . . . -106.39 -6.36 18.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.61 48.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.194 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 89.9 p -147.69 170.26 17.92 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.91 0.884 . . . . 0.0 109.623 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 30.3 tp -78.46 -7.58 57.58 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.56 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 74.57 160.31 0.23 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.09 1.756 . . . . 0.0 111.978 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.7 m -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.708 1.203 . . . . 0.0 111.688 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.73 131.99 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 25.1 m -78.83 76.1 5.33 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.636 0.775 . . . . 0.0 109.623 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -163.78 123.72 2.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.186 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -89.56 -17.66 28.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.201 1.0 . . . . 0.0 110.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -93.62 11.7 27.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.337 1.055 . . . . 0.0 111.213 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -91.48 131.53 36.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 122.614 0.366 . . . . 0.0 110.344 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.86 100.28 0.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 166.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -159.93 173.66 4.68 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.596 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' PHE . . . . . 0.563 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.412 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.627 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.627 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.515 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -163.53 142.13 6.25 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.96 141.64 21.51 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.732 2.288 . . . . 0.0 112.482 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.65 50.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.087 0.955 . . . . 0.0 112.561 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -68.93 172.72 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.583 0.753 . . . . 0.0 110.601 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 4.9 t -62.73 92.85 0.05 Allowed 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 122.053 0.93 . . . . 0.0 110.819 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 38.5 t -79.04 79.52 5.44 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.879 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 m -120.65 84.33 36.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.624 1.17 . . . . 0.0 108.782 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 C--N 1.381 2.244 0 C-N-CA 123.359 2.706 . . . . 12.53 112.473 -176.974 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG3' HG13 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.609 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.588 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 96' ' ' GLU . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.628 ' HA ' HD13 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.601 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.49 HG23 ' HG2' ' A' ' 275' ' ' GLU . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HG2' HD21 ' A' ' 245' ' ' LEU . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.754 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.628 HG22 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.539 HD13 HG23 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 229' ' ' LYS . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' B' ' 242' ' ' TRP . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.62 HH21 ' HB3' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.511 HG22 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 198' ' ' PHE . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.488 ' HE1' ' HB2' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' B' ' 231' ' ' LYS . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.505 HD21 ' CE1' ' B' ' 233' ' ' PHE . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 173' ' ' ASP . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HD3' HG22 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 146' ' ' LYS . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.481 ' SD ' HD13 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.601 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.473 HD12 HG13 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.665 HD13 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.508 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.773 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HB2' HG23 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 297' ' ' TYR . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.406 ' HB2' HG23 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.615 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.615 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.458 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 395' ' ' MET . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.458 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.443 HD21 HD11 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.466 HG23 HG22 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.551 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.85 -18.0 21.58 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.172 0.989 . . . . 15.0 109.33 177.081 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.31 99.42 0.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.511 0.724 . . . . 0.0 109.471 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.72 2.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.516 0.727 . . . . 0.0 110.384 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.09 -173.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.758 1.223 . . . . 0.0 112.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -88.64 136.33 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.6 p -79.08 76.48 5.59 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.085 0.945 . . . . 0.0 108.805 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.0 tt -167.57 -45.41 0.02 OUTLIER 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 72.2 -82.49 0.55 Allowed Glycine 0 C--N 1.355 1.592 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.672 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -165.5 -133.64 1.54 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.31 3.49 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.33 164.08 38.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 109.946 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 225' ' ' ASN . 0.0 OUTLIER -128.05 138.73 52.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 23.5 m -62.79 143.01 57.95 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.58 0.752 . . . . 0.0 110.675 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' A' ' 226' ' ' LEU . 34.1 t80 -60.13 151.79 26.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.908 0.883 . . . . 0.0 110.84 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.92 97.82 4.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' TRP . . . . . 0.652 ' HB3' HG11 ' A' ' 186' ' ' VAL . 0.4 OUTLIER -160.45 159.35 30.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.706 0.402 . . . . 0.0 110.894 175.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.543 ' HA ' ' OH ' ' B' ' 256' ' ' TYR . 4.7 pp0? -84.32 6.79 21.63 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.24 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -82.48 60.01 4.88 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.287 0.367 . . . . 0.0 112.809 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? 70.44 123.86 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.801 1.641 . . . . 0.0 112.939 171.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.6 p -70.85 -55.15 9.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.281 1.032 . . . . 0.0 112.156 -172.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -6.54 35.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -71.03 -83.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -102.83 -88.94 0.39 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.477 0.58 . . . . 0.0 111.243 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.741 ' HB2' HH12 ' B' ' 254' ' ' ARG . 23.2 pt20 -111.58 -5.83 14.47 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.68 -17.89 62.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -78.63 -34.67 46.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 0.0 110.682 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -54.6 -35.53 63.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.939 0.895 . . . . 0.0 112.513 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.741 HH12 ' HB2' ' B' ' 250' ' ' GLN . 0.0 OUTLIER -164.56 149.79 10.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.519 0.728 . . . . 0.0 110.629 176.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.68 172.74 13.3 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.606 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' B' ' 243' ' ' GLN . 30.7 m-85 66.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.146 1.378 . . . . 0.0 112.414 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.62 -22.59 62.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.754 0.822 . . . . 0.0 111.369 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' B' ' 254' ' ' ARG . 74.8 mt -63.39 104.26 0.6 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.549 . . . . 0.0 110.403 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.6 155.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.672 0.789 . . . . 0.0 110.146 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.0 p -80.35 -87.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.288 0.635 . . . . 0.0 112.04 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.46 -37.79 56.4 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.448 0.699 . . . . 0.0 111.161 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.91 19.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.407 0.683 . . . . 0.0 112.758 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.29 -1.85 35.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.006 0.922 . . . . 0.0 111.745 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.1 t -151.55 -79.65 0.11 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.932 0.893 . . . . 0.0 109.861 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.93 114.94 26.9 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.184 0.994 . . . . 0.0 108.76 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.71 82.74 0.62 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.214 0.606 . . . . 0.0 109.885 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 91.8 p -68.38 -30.72 69.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.97 0.908 . . . . 0.0 112.822 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.34 71.51 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.869 0.842 . . . . 0.0 110.346 -170.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m -112.09 95.18 5.32 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.219 1.008 . . . . 0.0 109.1 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.86 99.41 7.52 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.966 0.889 . . . . 0.0 110.926 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' ' 378' ' ' TYR . . . -85.76 -43.49 13.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.306 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -95.97 17.28 15.73 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.781 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 79.46 -44.25 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.004 1.722 . . . . 0.0 111.825 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.94 115.92 5.34 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 171.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.28 122.85 85.84 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.481 HD13 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' LEU . . . . . 0.464 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' GLY . . . . . 0.464 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' VAL . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 297' ' ' TYR . . . . . 0.509 ' HE1' HD13 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 355' ' ' ILE . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -50.92 -43.96 85.02 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.03 -39.48 2.38 Favored 'Trans proline' 0 C--N 1.405 3.533 0 C-N-CA 123.45 2.767 . . . . 0.0 115.012 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -72.57 95.59 1.85 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.98 107.83 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 10.0 t -78.62 161.37 27.01 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.321 0.388 . . . . 0.0 110.154 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 45.1 t -80.0 -48.44 13.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.137 0.575 . . . . 0.0 110.08 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 85.9 m 64.83 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 125.169 1.388 . . . . 0.0 111.43 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.381 2.254 0 C-N-CA 123.29 2.66 . . . . 12.53 112.114 178.315 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.484 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 11' ' ' LEU . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.605 ' HA ' HD21 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.746 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.459 HG11 HG22 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.466 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 163' ' ' ARG . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 199' ' ' GLU . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.63 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.63 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.584 ' HB2' HG23 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.421 ' HB3' HD21 ' A' ' 187' ' ' LEU . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.517 HD11 HD13 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.746 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.466 HG21 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.507 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.665 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.445 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.613 ' HA ' HG22 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.437 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.69 HG21 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 253' ' ' ILE . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' VAL . . . . . 0.604 HG22 HD23 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.48 ' HB3' HD23 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 373' ' ' GLU . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.605 HD21 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.44 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.489 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.616 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.585 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.435 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.435 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.585 HD13 HD22 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' B' ' 305' ' ' ALA . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' B' ' 305' ' ' ALA . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.44 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . 0.541 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.401 ' HB3' ' NH2' ' A' ' 276' ' ' ARG . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.555 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.43 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 372' ' ' GLU . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TYR . . . . . 0.512 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.687 HD11 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' MET . . . . . 0.512 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' HE2' ' A' ' 388' ' ' TYR . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' HG21 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.528 HD21 HD12 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' HG3' ' A' ' 287' ' ' LYS . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -99.4 -26.96 13.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.125 0.57 . . . . 15.0 109.543 178.531 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.34 -53.35 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.04 0.936 . . . . 0.0 110.084 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -149.46 97.37 2.63 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.001 0.52 . . . . 0.0 110.448 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 64.5 -82.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.009 1.323 . . . . 0.0 111.759 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.5 p -150.69 149.98 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 109.466 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -129.76 162.82 27.56 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.178 0.991 . . . . 0.0 109.262 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.6 mt 60.23 -160.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.332 1.053 . . . . 0.0 112.42 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.25 -31.09 8.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.11 158.63 24.01 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.89 78.38 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.674 0.279 . . . . 0.0 112.747 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.59 158.56 17.47 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.434 0.694 . . . . 0.0 110.882 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 70.29 32.09 2.93 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.247 1.419 . . . . 0.0 110.639 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -64.77 157.6 27.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.432 0.693 . . . . 0.0 111.412 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 226' ' ' LEU . 18.9 t80 -59.36 -68.17 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.997 0.919 . . . . 0.0 109.622 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.466 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 73.08 -31.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -84.61 59.64 5.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 162.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 62.66 87.05 0.11 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.239 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -72.53 -46.8 30.56 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 165.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.91 125.27 6.82 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 61.5 m 68.22 130.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.584 1.154 . . . . 0.0 110.58 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.34 -33.72 76.63 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.843 -0.536 . . . . 0.0 110.75 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 52.1 mtt-85 -73.45 -6.24 45.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.843 0.457 . . . . 0.0 112.207 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.03 -28.65 69.94 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.686 0.794 . . . . 0.0 111.102 171.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -44.71 -81.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.064 1.746 . . . . 0.0 114.441 -166.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -111.76 -81.77 0.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -99.43 -24.23 14.86 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 122.156 -0.34 . . . . 0.0 110.733 -168.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.99 -24.07 52.23 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.893 0.746 . . . . 0.0 111.971 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.3 ttm105 65.38 15.42 10.01 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.006 0.923 . . . . 0.0 112.758 163.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 143.88 -42.49 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -167.7 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.437 0.695 . . . . 0.0 109.889 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 64.85 -102.14 0.09 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.559 1.544 . . . . 0.0 111.798 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.39 170.06 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.36 1.064 . . . . 0.0 111.938 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.69 -26.15 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.157 0.583 . . . . 0.0 110.029 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 27.5 p -54.94 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.379 1.071 . . . . 0.0 111.228 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -166.54 159.18 14.1 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.686 0.794 . . . . 0.0 109.867 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -87.41 22.07 2.28 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.83 1.252 . . . . 0.0 112.939 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.84 85.94 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.9 t -77.22 -68.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' LEU . . . . . 0.647 ' H ' HD23 ' B' ' 265' ' ' LEU . 1.6 pt? -96.86 106.28 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -70.12 -53.56 16.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.94 0.496 . . . . 0.0 112.281 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 12.9 t 51.47 41.68 28.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.406 1.082 . . . . 0.0 111.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 18.9 m -87.79 1.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.605 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 8.1 m 61.75 90.45 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.171 1.388 . . . . 0.0 110.297 -172.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.32 -38.48 77.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.714 1.206 . . . . 0.0 112.112 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.78 -29.63 69.63 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.182 0.993 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -97.39 31.25 2.57 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.237 1.015 . . . . 0.0 109.516 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 273' ' ' GLN . . . . . 0.446 ' HG3' ' HD3' ' B' ' 276' ' ' PRO . 6.5 tp-100 70.5 122.83 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.365 1.466 . . . . 0.0 109.499 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.12 -65.23 0.66 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.022 0.826 . . . . 0.0 111.324 -169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -154.17 98.71 2.55 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.446 ' HD3' ' HG3' ' B' ' 273' ' ' GLN . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.629 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 287' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.687 ' HZ3' HD11 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 296' ' ' THR . . . . . 0.635 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 298' ' ' HIS . . . . . 0.635 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.772 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' LYS . . . . . 0.772 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp -77.64 123.53 86.61 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.88 99.3 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.304 2.003 . . . . 0.0 110.825 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 361' ' ' LYS . . . -65.24 94.02 0.15 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.129 0.572 . . . . 0.0 110.748 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.02 152.21 7.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.24 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 3.1 t -57.13 133.01 54.64 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.88 0.872 . . . . 0.0 109.631 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 87.4 m -69.57 88.13 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' B' ' 310' ' ' PRO . 7.6 t -136.59 136.24 21.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.699 0.8 . . . . 0.0 109.354 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 309' ' ' THR . 5.2 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 122.853 2.369 . . . . 12.53 111.48 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG12 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' NH1' HG12 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 303' ' ' PRO . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 303' ' ' PRO . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 298' ' ' ASN . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB3' HE22 ' A' ' 289' ' ' GLN . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 HD22 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.679 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.62 HG11 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.486 HG22 ' HG3' ' A' ' 181' ' ' LYS . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' MET . . . . . 0.544 ' HB2' HG21 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.431 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.62 HG21 HG11 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 237' ' ' LEU . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.431 HG21 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 220' ' ' GLU . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.439 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.641 ' HA ' HG22 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.42 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.562 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.536 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.449 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HG3' HD22 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' VAL . . . . . 0.547 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' MET . . . . . 0.547 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 427' ' ' LEU . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.768 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.482 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.457 HD21 HD23 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 345' ' ' VAL . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.495 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 313' ' ' VAL . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 309' ' ' SER . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.486 ' HA ' HG12 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ILE . . . . . 0.581 HG21 HD13 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.553 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.716 HD11 HD11 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.768 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HG2' HD12 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.565 HG21 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LEU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' LEU . . . . . 0.599 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.89 -24.87 61.73 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.355 0 C-N-CA 124.409 1.084 . . . . 15.0 108.296 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.15 178.62 7.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.458 0.703 . . . . 0.0 110.63 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.16 70.46 0.65 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.072 0.949 . . . . 0.0 110.034 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.22 136.33 52.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.176 0.99 . . . . 0.0 110.876 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.17 102.36 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.347 0.659 . . . . 0.0 109.803 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 32.1 m -125.03 84.76 2.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.63 95.08 9.92 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.19 156.26 52.99 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.283 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 176.43 151.13 8.64 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 117.056 0.428 . . . . 0.0 113.198 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -148.54 175.08 27.99 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.54 49.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.879 0.871 . . . . 0.0 110.935 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.69 103.28 13.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.644 0.778 . . . . 0.0 109.157 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 14.1 t -141.27 -177.96 5.38 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.119 0.968 . . . . 0.0 109.1 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 -61.0 142.44 56.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.103 0.961 . . . . 0.0 109.827 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 65.73 10.6 6.92 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -83.28 49.96 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.673 0.749 . . . . 0.0 110.205 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' B' ' 248' ' ' ARG . 30.8 tt0 -147.04 6.0 0.87 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.314 1.046 . . . . 0.0 109.189 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.85 50.36 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-N 116.39 -0.368 . . . . 0.0 113.038 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 68.05 -69.24 0.15 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 125.688 1.595 . . . . 0.0 110.681 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.425 HG21 ' N ' ' B' ' 251' ' ' ALA . 14.7 t -94.23 -160.57 0.78 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.889 1.276 . . . . 0.0 109.675 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.56 -79.52 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ARG . . . . . 0.661 ' HA ' ' HG3' ' B' ' 243' ' ' GLN . 3.4 ptp180 -107.4 -90.53 0.43 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.587 ' H ' ' HG3' ' B' ' 248' ' ' ARG . 37.0 mt-10 -109.02 4.7 23.48 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.814 1.245 . . . . 0.0 110.477 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -67.61 3.43 1.39 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.644 1.178 . . . . 0.0 113.514 -166.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ALA . . . . . 0.425 ' N ' HG21 ' B' ' 246' ' ' THR . . . -62.2 -29.27 70.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.677 1.191 . . . . 0.0 112.255 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.82 -21.66 65.2 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.904 0.482 . . . . 0.0 110.892 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -86.91 21.19 2.35 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.99 2.36 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.839 0.856 . . . . 0.0 112.074 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 102.69 -58.98 0.56 Allowed Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -107.67 28.36 8.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.141 0.976 . . . . 0.0 111.508 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.72 167.65 13.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.124 0.57 . . . . 0.0 110.134 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 9.4 mp 71.7 -67.11 0.27 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.55 1.54 . . . . 0.0 111.433 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.0 m 44.51 38.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 126.284 1.833 . . . . 0.0 113.423 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.7 t -70.42 169.97 12.9 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.531 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.72 13.04 7.25 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.103 1.361 . . . . 0.0 112.37 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -72.17 -32.74 67.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.293 1.037 . . . . 0.0 110.712 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -106.26 21.05 18.01 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.787 0.835 . . . . 0.0 110.273 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 36.1 m 60.57 55.7 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.96 1.304 . . . . 0.0 111.993 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 138.79 16.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.795 0.838 . . . . 0.0 109.097 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -91.6 138.0 31.91 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.387 0.675 . . . . 0.0 110.315 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 43.3 p -81.64 79.16 8.28 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.667 0.787 . . . . 0.0 110.106 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.24 -0.88 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.649 0.78 . . . . 0.0 110.726 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 9.8 t 48.41 39.2 12.17 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.606 1.962 . . . . 0.0 112.853 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.39 144.72 37.7 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.034 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -110.08 -66.42 1.07 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -137.73 -45.13 0.53 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.98 146.7 52.52 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.366 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -39.39 -61.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.978 1.711 . . . . 0.0 113.033 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt -140.88 157.21 67.96 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.003 0.921 . . . . 0.0 108.771 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' PRO . . . . . 0.41 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 277' ' ' LEU . . . . . 0.664 HD22 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 278' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 279' ' ' GLY . . . . . 0.495 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ASP . . . . . 0.564 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 286' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' B' ' 285' ' ' ASN . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' ARG . . . . . 0.552 ' NH2' HD22 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 290' ' ' TRP . . . . . 0.553 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 291' ' ' LEU . . . . . 0.449 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 302' ' ' ASP . . . . . 0.493 ' N ' HD12 ' B' ' 301' ' ' ILE . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 46.55 81.98 0.24 Allowed Pre-proline 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -32.9 100.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.28 3.986 . . . . 0.0 115.015 -159.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -143.02 161.09 39.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.202 1.001 . . . . 0.0 110.654 -171.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 10.4 p -93.0 160.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.886 0.874 . . . . 0.0 109.736 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 70.7 m -62.46 122.61 16.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.579 0.752 . . . . 0.0 110.106 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -68.39 -37.31 80.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.462 0.705 . . . . 0.0 111.813 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.4 m -128.68 88.8 51.08 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.373 1.847 0 C-N-CA 123.153 2.569 . . . . 12.53 111.403 177.041 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 17' ' ' ILE . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.718 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 23' ' ' SER . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' HG23 ' A' ' 19' ' ' ILE . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.504 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.689 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.689 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 50' ' ' PRO . 8.1 p30 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 HG21 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.6 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' HG11 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.613 ' H ' HD11 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' A' ' 300' ' ' ILE . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.476 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.427 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.449 ' HE ' HG21 ' A' ' 186' ' ' VAL . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.64 HG22 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.713 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.508 HG21 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.449 HG21 ' HE ' ' A' ' 163' ' ' ARG . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.604 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.411 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.437 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.411 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.708 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.713 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.644 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.595 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.659 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 123' ' ' ILE . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.604 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.411 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HA ' HE21 ' A' ' 340' ' ' GLN . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 337' ' ' PHE . 27.7 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.411 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 294' ' ' LEU . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.496 ' HA ' HG12 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.585 HG21 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 380' ' ' ASP . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 379' ' ' GLU . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.505 HD21 ' HB2' ' B' ' 291' ' ' LEU . 56.4 t30 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.552 HD11 HD11 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.404 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.471 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.404 ' HG2' HG21 ' A' ' 422' ' ' THR . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . 0.542 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.604 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 . . . . . 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . 0.667 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.505 ' HB2' HD21 ' A' ' 397' ' ' ASN . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . 0.682 HG22 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . 0.682 ' H ' HG22 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD11 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 50' ' ' PRO . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.608 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.485 HD12 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' A' ' 282' ' ' ILE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.736 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.402 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 202' ' ' ILE . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.576 HG21 HG23 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.656 HG22 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.58 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.423 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.634 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' SD ' ' A' ' 189' ' ' MET . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.442 HG21 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' A' ' 229' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 157' ' ' ALA . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.403 ' HZ2' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.412 ' HG2' HD21 ' B' ' 278' ' ' LEU . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 130' ' ' VAL . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.553 HD12 HG13 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.495 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.576 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.412 ' HB3' HD22 ' A' ' 350' ' ' LEU . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.413 ' HG3' HD23 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.498 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.59 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.644 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.489 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.426 ' HB2' HG23 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.553 HG13 HD12 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.576 HD13 HD22 ' A' ' 294' ' ' LEU . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.485 ' HB2' ' HE1' ' B' ' 298' ' ' HIS . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HA ' HD12 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.479 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.479 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.452 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . 0.484 ' HE2' HG21 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 387' ' ' PHE . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 401' ' ' VAL . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.406 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.467 HG11 HD21 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.551 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.589 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.408 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 . . . . . 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.58 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 . . . . . 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.63 ' HG ' HD12 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.63 HD12 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . 0.437 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . 0.437 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.657 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.657 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . 0.484 HG21 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' B' ' 289' ' ' ARG . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.664 ' H ' HD23 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . 0.55 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . 0.485 ' HE1' ' HB2' ' A' ' 351' ' ' LEU . 22.9 m-70 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 303' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.462 HG12 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 28' ' ' VAL . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.418 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.702 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HB2' HD11 ' A' ' 300' ' ' ILE . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.679 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.586 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 202' ' ' ILE . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.524 HG21 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 194' ' ' MET . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.402 ' HG2' HD21 ' A' ' 187' ' ' LEU . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.521 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.452 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.737 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.451 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 315' ' ' ARG . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HA ' HE21 ' A' ' 340' ' ' GLN . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.0 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . 0.499 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 367' ' ' VAL . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.477 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.668 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.692 HD22 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.577 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 172' ' ' VAL . 55.5 t80 . . . . . 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.511 ' HB3' HG11 ' A' ' 186' ' ' VAL . 10.0 tp10 . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.668 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . 0.692 ' H ' HD22 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.411 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.525 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . 0.525 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.655 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 19' ' ' ILE . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.551 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.73 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.643 ' HA ' HD13 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.426 HG23 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HA ' HG23 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.539 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.474 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.401 ' HB3' ' HD3' ' A' ' 163' ' ' ARG . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.726 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.575 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 165' ' ' THR . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.458 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.608 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.608 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.621 HG22 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.52 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.428 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.575 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.829 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.474 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.582 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 253' ' ' ILE . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.476 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.556 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.426 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.73 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' ' HG3' ' A' ' 342' ' ' LYS . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HB2' HD13 ' A' ' 311' ' ' ILE . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.478 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' A' ' 337' ' ' PHE . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 341' ' ' ALA . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.432 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . 0.487 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.491 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 412' ' ' LEU . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 409' ' ' GLU . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.556 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.547 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 . . . . . 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 256' ' ' PHE . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . 0.664 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 397' ' ' ASN . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.621 HG23 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HD2' HG23 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.526 HD11 HG23 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 70' ' ' LEU . 38.0 m-80 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.61 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.516 HD21 HD11 ' B' ' 277' ' ' LEU . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.77 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.584 HG21 HG23 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.57 ' HA3' HG21 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.504 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.427 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.665 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 266' ' ' LEU . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' B' ' 278' ' ' LEU . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.44 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.465 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.548 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.548 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.673 HD13 HD22 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.568 ' HA ' HD12 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.643 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.643 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.506 ' HG2' HD22 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.574 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . 0.462 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . 0.57 HG21 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.558 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.629 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.406 HD21 ' HB2' ' B' ' 287' ' ' PRO . 6.4 t30 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.406 ' HB2' HD21 ' B' ' 285' ' ' ASN . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . 0.405 HG21 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.5 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.5 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.507 HD12 HD23 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD13 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.52 HG23 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.494 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.618 HG21 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.605 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 198' ' ' PHE . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 194' ' ' MET . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 202' ' ' ILE . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.605 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . 0.469 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.51 HD22 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.542 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.524 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.582 ' HB3' HD21 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.52 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.433 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.465 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.428 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.44 ' HB2' HG23 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 337' ' ' PHE . 24.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 342' ' ' LYS . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . 0.521 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.521 HD12 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.627 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.405 ' H ' HG21 ' B' ' 301' ' ' ILE . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.518 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.681 ' HB1' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.481 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.437 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . 0.447 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . 0.717 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.551 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.717 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . 0.518 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . 0.45 ' NH1' HD11 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.49 ' HB2' HD23 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.497 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . 0.417 ' H ' ' HE3' ' B' ' 290' ' ' TRP . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . 0.588 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.627 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 28' ' ' VAL . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 66' ' ' VAL . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.1 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.411 HD13 HD13 ' A' ' 19' ' ' ILE . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.627 ' HE2' HD11 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.481 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.602 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.513 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.473 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.554 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.442 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.515 HD12 HG13 ' A' ' 347' ' ' VAL . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 113' ' ' PRO . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.722 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.401 ' HB3' HD21 ' A' ' 325' ' ' ASN . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.647 ' HA ' HE21 ' A' ' 340' ' ' GLN . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.5 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 291' ' ' ILE . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.415 ' HB2' HG21 ' A' ' 300' ' ' ILE . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.686 HG21 HD13 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.434 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 372' ' ' GLU . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.538 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.443 ' HB2' ' HE1' ' A' ' 388' ' ' TYR . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.404 HD11 HD11 ' B' ' 301' ' ' ILE . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.442 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.482 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.596 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . 0.563 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.412 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.627 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.627 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . 0.515 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG3' HG13 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.609 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.588 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 66.7 m-20 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 96' ' ' GLU . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.588 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.628 ' HA ' HD13 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.601 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.49 HG23 ' HG2' ' A' ' 275' ' ' GLU . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' ND2' ' A' ' 425' ' ' ASN . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HG2' HD21 ' A' ' 245' ' ' LEU . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.754 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.628 HG22 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.539 HD13 HG23 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 229' ' ' LYS . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 165' ' ' THR . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.62 HH21 ' HB3' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.511 HG22 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 198' ' ' PHE . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.488 ' HE1' ' HB2' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.449 ' OD1' ' HG ' ' A' ' 226' ' ' LEU . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.505 HD21 ' CE1' ' B' ' 233' ' ' PHE . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 173' ' ' ASP . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HD3' HG22 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 146' ' ' LYS . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.481 ' SD ' HD13 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.601 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.473 HD12 HG13 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.665 HD13 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.508 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.773 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HB2' HG23 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 297' ' ' TYR . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.406 ' HB2' HG23 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.615 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.615 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.458 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 395' ' ' MET . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.458 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.443 HD21 HD11 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.466 HG23 HG22 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.551 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 136' ' ' ASP . 42.9 m-80 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' A' ' 226' ' ' LEU . 34.1 t80 . . . . . 0 CA--C 1.547 0.864 0 CA-C-O 120.46 0.172 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.481 HD13 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . 0.464 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . 0.464 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . 0.509 ' HE1' HD13 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 355' ' ' ILE . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.484 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 11' ' ' LEU . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.605 ' HA ' HD21 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.436 HE21 ' NE2' ' A' ' 148' ' ' GLN . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.436 ' NE2' HE21 ' A' ' 147' ' ' GLN . 73.7 mm-40 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.746 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.459 HG11 HG22 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.466 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 163' ' ' ARG . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 199' ' ' GLU . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.63 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.63 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.584 ' HB2' HG23 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.421 ' HB3' HD21 ' A' ' 187' ' ' LEU . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.517 HD11 HD13 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.746 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.466 HG21 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.507 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.665 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.413 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.445 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.613 ' HA ' HG22 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.437 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.69 HG21 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 253' ' ' ILE . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . 0.604 HG22 HD23 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . 0.48 ' HB3' HD23 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 373' ' ' GLU . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.605 HD21 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.44 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.489 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.616 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.585 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.435 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.435 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.585 HD13 HD22 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.44 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . 0.541 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.401 ' HB3' ' NH2' ' A' ' 276' ' ' ARG . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.555 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.43 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 372' ' ' GLU . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . 0.512 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.687 HD11 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . 0.512 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' HE2' ' A' ' 388' ' ' TYR . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' HG21 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.528 HD21 HD12 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' HG3' ' A' ' 287' ' ' LYS . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 226' ' ' LEU . 18.9 t80 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . 0.466 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.629 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' B' ' 290' ' ' TRP . 30.7 t30 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.687 ' HZ3' HD11 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . 0.635 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . 0.635 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.772 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . 0.772 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp . . . . . 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG12 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' NH1' HG12 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 303' ' ' PRO . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 303' ' ' PRO . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 298' ' ' ASN . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB3' HE22 ' A' ' 289' ' ' GLN . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 HD22 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.449 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.679 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.62 HG11 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.486 HG22 ' HG3' ' A' ' 181' ' ' LYS . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' MET . . . . . 0.544 ' HB2' HG21 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.431 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.62 HG21 HG11 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 237' ' ' LEU . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.431 HG21 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 220' ' ' GLU . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.439 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.641 ' HA ' HG22 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.42 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.562 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.536 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.449 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HG3' HD22 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' VAL . . . . . 0.547 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' MET . . . . . 0.547 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 427' ' ' LEU . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.768 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' B' ' 291' ' ' LEU . 91.7 m-20 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.482 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ASN . . . . . 0.457 HD21 HD23 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 345' ' ' VAL . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.495 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 313' ' ' VAL . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 309' ' ' SER . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LEU . . . . . 0.486 ' HA ' HG12 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ILE . . . . . 0.581 HG21 HD13 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.553 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.716 HD11 HD11 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.768 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HG2' HD12 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.565 HG21 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' LEU . . . . . 0.599 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 . . . . . 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt . . . . . 0 C--O 1.241 0.623 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' PRO . . . . . 0.41 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' LEU . . . . . 0.664 HD22 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' GLY . . . . . 0.495 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' ASP . . . . . 0.564 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' B' ' 285' ' ' ASN . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 289' ' ' ARG . . . . . 0.552 ' NH2' HD22 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 290' ' ' TRP . . . . . 0.553 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 291' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 284' ' ' ASN . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' ASP . . . . . 0.493 ' N ' HD12 ' B' ' 301' ' ' ILE . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt . . . . . 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 120.909 0.385 . . . . 15.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 7.8 tt0 -83.56 108.11 16.46 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.418 HG12 HG12 ' A' ' 17' ' ' ILE . 33.8 m -103.05 140.69 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.063 0.545 . . . . 15.0 110.391 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -107.6 -175.55 2.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.043 0.537 . . . . 15.0 110.668 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -143.17 28.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.737 0.815 . . . . 15.0 108.911 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.718 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.4 mt-10 -53.52 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.404 -1.271 . . . . 15.0 112.461 -170.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m -73.17 85.93 1.38 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.851 0.86 . . . . 15.0 108.898 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.29 -63.81 1.25 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.854 -1.067 . . . . 15.0 110.167 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -90.89 22.26 3.72 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.758 0.823 . . . . 15.0 110.925 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.28 -72.8 1.39 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-O 121.272 0.373 . . . . 15.0 112.173 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.69 -48.91 65.23 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 168.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 100.4 0.65 Allowed Glycine 0 C--N 1.352 1.421 0 CA-C-N 114.916 -1.038 . . . . 15.0 113.114 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.5 138.68 37.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.943 0.897 . . . . 15.0 110.185 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 35.2 ttm180 -109.24 104.56 13.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.569 1.147 . . . . 15.0 109.099 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.9 t -93.5 87.94 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 89.0 m -71.82 95.79 1.56 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.824 -1.08 . . . . 15.0 109.183 174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 3' ' ' VAL . 50.1 mt -84.83 112.91 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 108.74 -0.837 . . . . 15.0 108.74 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 30.9 m -104.94 78.06 1.38 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.321 -0.992 . . . . 15.0 108.321 -175.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.425 HG23 ' HB2' ' A' ' 23' ' ' SER . 47.7 mt -66.85 106.31 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.226 -0.897 . . . . 15.0 109.749 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.25 165.23 24.09 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.214 0.606 . . . . 15.0 111.404 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.8 -19.27 59.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.204 1.002 . . . . 15.0 113.525 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -64.24 -40.39 95.93 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.198 0.599 . . . . 15.0 110.986 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' HG23 ' A' ' 19' ' ' ILE . 44.5 m -90.44 -29.49 17.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.281 0.632 . . . . 15.0 111.238 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.613 HD11 ' H ' ' A' ' 103' ' ' PHE . 87.2 mt -58.95 -66.13 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.938 0.495 . . . . 15.0 109.839 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.59 -23.15 65.35 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.185 -0.916 . . . . 15.0 112.375 -168.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -77.26 -49.22 15.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 122.406 0.283 . . . . 15.0 110.738 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.69 75.75 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.576 0.584 . . . . 15.0 112.576 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' A' ' 63' ' ' ARG . 91.9 t -65.25 -45.2 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.309 -0.626 . . . . 15.0 109.309 173.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 5.0 ttmp? -66.15 -27.52 68.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.006 -0.997 . . . . 15.0 112.166 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.1 m -61.02 -40.91 95.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.345 0.658 . . . . 15.0 110.14 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 35' ' ' VAL . 19.5 tp10 -72.51 -44.54 62.07 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.838 -0.619 . . . . 15.0 110.612 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 55' ' ' ALA . 69.7 mt -59.95 -43.26 95.13 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.081 0.952 . . . . 15.0 112.711 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG22 ' HE3' ' A' ' 37' ' ' LYS . 14.7 p -68.3 -32.43 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -71.69 -32.41 67.81 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 118.672 -0.68 . . . . 15.0 111.713 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 31' ' ' GLU . 94.0 t -62.51 -42.41 95.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 118.568 0.622 . . . . 15.0 109.821 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.65 90.57 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.027 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.504 ' HE3' HG22 ' A' ' 33' ' ' VAL . 95.2 mttt -77.91 -28.88 49.89 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.435 0.694 . . . . 15.0 111.922 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HE2' ' HA ' ' A' ' 35' ' ' VAL . 32.2 ttpt -74.95 -34.46 62.07 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.321 1.049 . . . . 15.0 110.534 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 t -98.38 -2.63 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 C-N-CA 123.471 0.709 . . . . 15.0 110.259 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 71.81 10.66 6.28 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.758 1.623 . . . . 15.0 113.182 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -67.0 -20.05 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.143 0.977 . . . . 15.0 111.302 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -59.04 -33.49 70.82 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.063 0.945 . . . . 15.0 111.769 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.35 -29.49 75.38 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.793 -0.639 . . . . 15.0 112.669 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -91.5 -26.42 18.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.071 0.948 . . . . 15.0 110.575 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.689 HH22 ' HA ' ' A' ' 51' ' ' MET . 60.3 ttt180 -75.77 104.63 6.4 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.571 -0.529 . . . . 15.0 109.571 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.47 -18.54 65.11 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.854 0.862 . . . . 15.0 112.183 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.57 6.59 70.27 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 123.497 0.498 . . . . 15.0 112.363 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -57.11 -50.43 72.81 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.166 0.986 . . . . 15.0 110.568 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.11 115.99 51.79 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.458 -0.942 . . . . 15.0 108.458 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 37.6 Cg_endo -64.63 145.28 86.74 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.303 2.002 . . . . 15.0 111.394 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.689 ' HA ' HH22 ' A' ' 45' ' ' ARG . 49.0 tpp -59.46 -29.5 67.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.484 0.714 . . . . 15.0 112.109 -170.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 50' ' ' PRO . 8.1 p30 -56.35 -38.71 71.75 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.452 0.701 . . . . 15.0 112.761 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.7 mt -61.46 -52.34 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.096 0.558 . . . . 15.0 110.156 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 HG21 HH12 ' A' ' 45' ' ' ARG . 21.8 m -81.27 -2.52 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-N 115.937 -0.574 . . . . 15.0 112.007 -177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.64 ' HA ' HD13 ' A' ' 32' ' ' LEU . . . -92.18 -48.47 6.69 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.161 0.584 . . . . 15.0 111.623 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 52' ' ' ASN . 3.6 pt20 -86.73 -42.67 13.16 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.73 -0.668 . . . . 15.0 111.175 -177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.3 mtt180 -82.98 -69.96 0.59 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.013 0.525 . . . . 15.0 110.357 -174.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -72.71 -30.5 64.26 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.213 0.605 . . . . 15.0 111.11 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.12 -1.66 90.39 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-O 118.579 -1.123 . . . . 15.0 113.595 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.9 67.29 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 117.915 0.857 . . . . 15.0 112.403 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -66.08 -40.92 91.21 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.586 -0.734 . . . . 15.0 110.842 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 66' ' ' VAL . 34.9 t -74.89 -22.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.77 0.828 . . . . 15.0 111.607 -175.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.618 ' HG2' HG11 ' A' ' 28' ' ' VAL . 45.6 mtp85 -61.17 -28.27 69.01 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 122.781 0.432 . . . . 15.0 111.003 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -67.12 -42.75 83.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.222 -0.899 . . . . 15.0 110.789 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.83 -29.54 70.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.549 0.74 . . . . 15.0 111.753 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' A' ' 28' ' ' VAL . 21.9 t -84.66 -11.84 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 122.923 0.489 . . . . 15.0 111.532 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -55.93 -48.87 74.93 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 112.482 0.549 . . . . 15.0 112.482 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -67.12 -34.13 85.45 Favored Glycine 0 C--N 1.343 0.917 0 O-C-N 123.573 0.546 . . . . 15.0 112.982 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.56 -42.95 98.31 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.141 0.976 . . . . 15.0 110.606 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 97.4 mt -66.59 -46.82 74.69 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.589 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 73.4 mtm -67.21 -36.17 81.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.954 0.502 . . . . 15.0 111.9 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.7 t -78.45 -64.51 1.15 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.899 0.48 . . . . 15.0 111.684 -174.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -69.74 -38.41 76.82 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.941 -0.572 . . . . 15.0 112.036 -168.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.454 0.301 . . . . 15.0 111.094 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -71.17 -56.2 6.58 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.746 0.418 . . . . 15.0 111.124 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.8 tt -64.03 -33.02 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 O-C-N 123.778 0.674 . . . . 15.0 110.359 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.0 -48.59 79.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.693 0.797 . . . . 15.0 110.693 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.88 -56.92 15.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.346 -0.843 . . . . 15.0 111.903 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 pt -63.19 -29.21 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 113.304 0.854 . . . . 15.0 113.304 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.4 mt -68.14 -51.01 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.663 0.385 . . . . 15.0 110.552 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -73.08 -22.6 60.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.315 0.246 . . . . 15.0 111.482 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -83.73 -3.63 57.95 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.4 0.68 . . . . 15.0 111.628 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm 65.9 16.28 10.41 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.62 1.168 . . . . 15.0 111.815 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.6 mt -92.0 109.92 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.108 0.963 . . . . 15.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.08 119.3 69.31 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.947 -0.549 . . . . 15.0 109.752 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.57 171.21 18.22 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.648 2.232 . . . . 15.0 113.376 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.59 130.56 15.29 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.062 0.945 . . . . 15.0 109.08 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.95 -98.09 2.02 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-O 119.872 -0.404 . . . . 15.0 112.445 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -158.29 140.25 10.09 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 122.931 0.493 . . . . 15.0 110.755 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -88.44 136.58 3.35 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.017 2.478 . . . . 15.0 114.307 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 88.9 m -101.1 112.01 24.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.015 0.926 . . . . 15.0 109.988 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -88.31 114.93 25.42 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.519 0.728 . . . . 15.0 109.477 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 55.1 t -101.94 91.64 2.53 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.6 100.08 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 121.887 1.725 . . . . 15.0 111.206 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -53.22 -60.1 8.61 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.834 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.63 149.92 9.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.875 0.47 . . . . 15.0 110.783 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -126.17 117.8 23.88 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.234 -1.024 . . . . 15.0 108.234 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 87.7 mttt -145.03 160.15 41.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.796 0.838 . . . . 15.0 109.231 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.0 tp -80.84 133.92 35.68 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.648 -0.871 . . . . 15.0 108.648 169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.0 -51.09 2.84 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.966 -0.454 . . . . 15.0 111.966 -176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 25.2 mt-10 -82.29 171.99 13.61 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.967 0.413 . . . . 15.0 110.666 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -91.78 129.78 37.69 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.285 -0.87 . . . . 15.0 111.008 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.613 ' H ' HD11 ' A' ' 24' ' ' ILE . 11.4 t80 -70.45 88.61 0.67 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.605 0.717 . . . . 15.0 109.1 170.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 m -92.19 126.28 37.21 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.473 -1.24 . . . . 15.0 109.035 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -144.84 118.77 9.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.307 0.575 . . . . 15.0 110.292 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 28.4 m -84.25 97.39 9.39 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 15.0 110.796 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.12 99.93 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -93.84 110.57 22.21 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.888 0.875 . . . . 15.0 109.947 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -137.83 151.08 47.73 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.269 1.027 . . . . 15.0 108.944 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -92.6 148.72 21.84 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.476 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.9 m -125.17 173.14 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.142 0.977 . . . . 15.0 109.721 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -75.16 139.6 72.58 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 119.391 -0.338 . . . . 15.0 110.658 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 300' ' ' ILE . 68.7 Cg_endo -87.42 -179.5 2.72 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.888 2.392 . . . . 15.0 112.55 172.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.39 98.87 3.98 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.667 -0.864 . . . . 15.0 108.667 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' HA ' HD13 ' A' ' 300' ' ' ILE . 72.2 t -67.58 103.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.502 0 O-C-N 123.631 0.582 . . . . 15.0 110.479 -175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -69.33 112.82 6.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.414 -0.812 . . . . 15.0 110.312 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 120' ' ' LEU . 61.2 mt -107.4 130.97 54.75 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.881 0.872 . . . . 15.0 108.694 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -154.13 152.59 30.6 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.67 0.788 . . . . 15.0 110.076 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 55.69 25.03 42.33 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 124.059 0.849 . . . . 15.0 114.718 173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 117' ' ' LEU . 87.2 mt -69.05 -21.17 64.11 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.998 0.519 . . . . 15.0 111.318 -176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 12.2 mp0 -82.04 -27.08 33.22 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 15.0 110.361 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.87 -22.38 49.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.15 0.58 . . . . 15.0 111.18 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.0 mt -62.95 114.99 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.741 0.817 . . . . 15.0 110.329 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.78 107.05 19.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.321 0.648 . . . . 15.0 109.488 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.81 128.65 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.326 0.651 . . . . 15.0 109.704 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 418' ' ' THR . 35.9 tt0 -77.42 138.13 39.1 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.549 0.531 . . . . 15.0 110.761 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 419' ' ' GLU . 86.6 tttt -122.42 95.43 46.95 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.073 0.949 . . . . 15.0 108.7 176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.476 ' HB3' ' HE2' ' A' ' 420' ' ' LYS . 92.0 Cg_endo -78.55 106.22 2.09 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.892 1.728 . . . . 15.0 112.198 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.24 84.73 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.003 -1.11 . . . . 15.0 108.003 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 282' ' ' ILE . 64.9 t -97.12 139.08 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 113.917 -1.492 . . . . 15.0 108.655 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -151.9 165.9 33.14 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.658 0.383 . . . . 15.0 110.292 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 270' ' ' VAL . 11.4 t -91.11 81.46 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.092 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 137' ' ' VAL . 20.9 p -68.53 172.96 5.45 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.557 0.743 . . . . 15.0 109.819 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -58.86 -34.81 72.02 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.536 0.334 . . . . 15.0 111.358 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -42.49 89.63 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.943 0.497 . . . . 15.0 110.882 174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -74.1 -35.66 64.2 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.286 -0.87 . . . . 15.0 111.526 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 92.1 t -66.86 -55.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.19 -45.15 91.82 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.709 0.63 . . . . 15.0 110.466 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.76 -41.31 93.86 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.918 0.761 . . . . 15.0 113.044 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.427 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 13.5 tpt -63.61 -53.5 50.63 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.994 0.918 . . . . 15.0 110.741 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 71.5 mt -61.89 -41.43 97.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.337 0.655 . . . . 15.0 110.636 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.68 -44.61 95.81 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.101 -0.954 . . . . 15.0 110.987 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 90.0 m -61.93 -42.39 99.04 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.15 -0.477 . . . . 15.0 111.061 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 140' ' ' MET . 96.6 mt -58.87 -48.13 82.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.072 0.549 . . . . 15.0 110.313 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -65.74 -35.66 81.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.85 -0.614 . . . . 15.0 111.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -71.24 -37.17 72.01 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.867 0.467 . . . . 15.0 111.98 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 143' ' ' THR . 31.7 mm-40 -75.32 -32.25 60.89 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.95 0.5 . . . . 15.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -99.82 20.84 13.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.473 0.709 . . . . 15.0 111.325 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.519 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -78.55 140.75 38.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.04 0.536 . . . . 15.0 112.281 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -84.44 131.47 34.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.756 0.822 . . . . 15.0 109.589 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -78.4 110.38 13.4 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.342 0.657 . . . . 15.0 110.373 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -106.56 113.21 26.58 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.505 1.122 . . . . 15.0 109.552 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 37.8 tt0 -62.34 119.95 10.07 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 123.579 0.549 . . . . 15.0 110.272 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 63.6 pttt -127.06 -175.92 3.56 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.919 0.888 . . . . 15.0 110.638 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -144.12 157.76 44.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.13 -0.941 . . . . 15.0 108.67 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.15 -51.62 0.76 Allowed Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.556 -0.58 . . . . 15.0 114.312 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -151.49 134.37 15.73 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 117.89 0.845 . . . . 15.0 112.36 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.22 118.16 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.573 0.749 . . . . 15.0 109.122 170.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -90.58 162.39 15.02 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.395 -0.965 . . . . 15.0 108.395 168.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.02 66.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.597 0.962 . . . . 15.0 113.597 -168.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.13 18.62 9.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.26 0.624 . . . . 15.0 111.618 -174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.3 -176.8 2.77 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.042 0.925 . . . . 15.0 112.601 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.449 ' HE ' HG21 ' A' ' 186' ' ' VAL . 18.6 ttt85 -117.48 99.77 7.21 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 107.515 -1.291 . . . . 15.0 107.515 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.64 HG22 HG13 ' A' ' 240' ' ' VAL . 47.6 t -105.11 133.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 122.682 0.393 . . . . 15.0 110.933 -173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.713 HG22 ' HD3' ' A' ' 238' ' ' LYS . 25.8 m -95.5 128.52 42.43 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.893 0.877 . . . . 15.0 110.054 175.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 202' ' ' ILE . 44.6 pt -135.86 175.54 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.844 1.258 . . . . 15.0 110.399 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.21 109.34 12.21 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 106.693 -1.595 . . . . 15.0 106.693 162.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -112.53 137.16 51.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 118.408 0.549 . . . . 15.0 110.099 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 181' ' ' LYS . 19.1 p -141.94 134.82 28.71 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.882 0.873 . . . . 15.0 109.08 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . 173.2 -157.1 25.76 Favored Glycine 0 C--O 1.24 0.513 0 N-CA-C 111.936 -0.466 . . . . 15.0 111.936 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.6 m -140.65 147.44 39.3 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 122.844 0.457 . . . . 15.0 110.239 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.508 HG21 ' HE2' ' B' ' 233' ' ' PHE . 96.9 t -91.22 120.91 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.464 0.706 . . . . 15.0 109.456 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 26.0 t0 64.94 23.86 12.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.114 0.966 . . . . 15.0 110.612 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 18.84 77.19 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 115.618 -0.719 . . . . 15.0 113.271 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -128.76 148.74 50.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.739 0.816 . . . . 15.0 109.95 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.56 114.3 3.18 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.965 0.791 . . . . 15.0 111.107 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -137.13 152.82 50.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.698 -1.223 . . . . 15.0 107.698 170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.29 170.1 10.93 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.336 -0.616 . . . . 15.0 109.336 170.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.09 -9.21 9.79 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 114.265 0.466 . . . . 15.0 114.265 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -95.23 22.29 39.44 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 123.187 0.422 . . . . 15.0 112.165 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.503 ' HG3' HG22 ' A' ' 169' ' ' THR . 80.6 tttt -161.25 119.63 2.42 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.332 1.053 . . . . 15.0 108.181 -174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.99 112.82 2.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.079 0.552 . . . . 15.0 109.962 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 p -86.37 142.1 28.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.981 0.913 . . . . 15.0 110.182 176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.31 25.65 15.13 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.214 1.405 . . . . 15.0 110.484 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.96 145.46 52.89 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 125.497 1.519 . . . . 15.0 109.659 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.449 HG21 ' HE ' ' A' ' 163' ' ' ARG . 4.9 p -133.81 142.25 41.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.041 0.448 . . . . 15.0 110.319 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 202' ' ' ILE . 22.1 tp -136.14 108.16 7.18 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.106 0.962 . . . . 15.0 110.575 -167.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.8 87.2 4.68 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.142 -1.059 . . . . 15.0 108.142 166.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 13.5 ptp -72.17 167.25 20.7 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.91 -1.041 . . . . 15.0 111.46 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 74.17 -9.34 9.77 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 116.156 -0.474 . . . . 15.0 113.03 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -107.46 144.04 34.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.598 -1.26 . . . . 15.0 107.598 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.46 75.68 0.52 Allowed Glycine 0 N--CA 1.476 1.312 0 N-CA-C 111.881 -0.487 . . . . 15.0 111.881 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.604 HH11 ' HB2' ' B' ' 241' ' ' GLU . 69.3 mtt180 -132.56 -36.44 1.09 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.493 1.117 . . . . 15.0 110.876 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' B' ' 239' ' ' ALA . 11.6 tpt -135.56 175.41 9.61 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.775 0.83 . . . . 15.0 109.009 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.7 mt -60.33 121.97 63.75 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.546 1.138 . . . . 15.0 111.482 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -64.11 116.91 3.99 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.324 2.016 . . . . 15.0 109.41 163.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.26 -41.18 1.88 Allowed Glycine 0 N--CA 1.469 0.857 0 N-CA-C 111.272 -0.731 . . . . 15.0 111.272 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.411 ' HD1' HG11 ' A' ' 215' ' ' VAL . 81.0 t80 -66.34 -50.12 64.64 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 173.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -64.03 -36.71 84.89 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.66 -1.155 . . . . 15.0 111.599 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.7 m-20 -67.08 -28.71 68.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.466 0.706 . . . . 15.0 111.682 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.437 ' HA3' HD13 ' A' ' 213' ' ' ILE . . . -55.14 -40.95 76.67 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.814 0.696 . . . . 15.0 112.009 170.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 166' ' ' ILE . 78.8 mt -78.54 -40.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.095 0.958 . . . . 15.0 111.085 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 49.0 mtpt -63.46 -22.71 67.04 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.902 0.881 . . . . 15.0 112.737 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.74 24.33 6.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 120.166 -0.241 . . . . 15.0 112.856 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -143.74 179.75 6.96 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.361 1.064 . . . . 15.0 110.509 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -115.44 -65.72 1.16 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -145.21 -61.18 0.35 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.412 0.893 . . . . 15.0 113.412 -170.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -142.45 45.24 0.93 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 114.767 0.667 . . . . 15.0 114.767 -163.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.57 -175.07 3.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.073 0.549 . . . . 15.0 110.783 171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -143.87 134.3 24.68 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.171 0.589 . . . . 15.0 109.848 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.12 -178.87 7.63 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.005 0.922 . . . . 15.0 109.786 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.8 m -141.3 125.78 17.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.758 0.823 . . . . 15.0 109.308 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.437 HD13 ' HA3' ' A' ' 201' ' ' GLY . 33.9 pt -117.46 155.54 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-O 121.3 0.572 . . . . 15.0 110.999 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -103.18 112.51 25.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.999 -1.0 . . . . 15.0 108.508 170.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.411 HG11 ' HD1' ' A' ' 198' ' ' PHE . 26.8 m -95.66 127.64 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.697 0.399 . . . . 15.0 110.24 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 33.7 m -94.22 105.46 17.45 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.985 -1.117 . . . . 15.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.46 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 73.9 m-85 -49.29 140.26 13.0 Favored Pre-proline 0 CA--C 1.547 0.847 0 O-C-N 124.194 0.934 . . . . 15.0 110.585 168.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 5.1 Cg_exo -80.02 161.99 23.52 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.0 2.467 . . . . 15.0 112.477 -175.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -76.42 0.81 18.33 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.588 0.755 . . . . 15.0 110.904 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -85.66 -26.96 25.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.202 1.401 . . . . 15.0 108.929 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.45 124.62 21.14 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.276 -1.329 . . . . 15.0 110.25 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -76.16 -14.41 60.16 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.82 0.848 . . . . 15.0 110.624 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.37 102.15 0.38 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -61.63 -41.55 97.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.614 1.165 . . . . 15.0 113.664 -161.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.05 -1.59 48.48 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.818 0.303 . . . . 15.0 111.818 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.708 HD11 ' HA ' ' B' ' 233' ' ' PHE . 84.1 mt -99.38 -29.28 12.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.808 0.443 . . . . 15.0 110.977 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -61.7 110.82 1.62 Allowed 'General case' 0 CA--C 1.553 1.064 0 O-C-N 123.597 0.561 . . . . 15.0 110.794 -174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.39 7.9 60.25 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.558 -0.746 . . . . 15.0 114.198 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -84.47 161.3 20.33 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 118.235 1.017 . . . . 15.0 111.785 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -118.11 115.01 23.95 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.082 0.953 . . . . 15.0 109.809 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -108.68 144.74 36.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.734 0.813 . . . . 15.0 111.037 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 23.6 mtpp -108.59 110.01 21.37 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.098 -0.704 . . . . 15.0 109.098 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -121.08 126.62 50.28 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.837 0.455 . . . . 15.0 111.37 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -83.36 92.69 7.59 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 123.821 0.848 . . . . 15.0 109.422 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.4 mm -77.88 104.6 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.694 -0.684 . . . . 15.0 110.07 -175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -89.15 91.83 8.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.634 -1.247 . . . . 15.0 107.634 173.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.534 ' HA ' HG22 ' A' ' 166' ' ' ILE . 27.2 tp -69.03 120.77 15.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 109.622 -0.511 . . . . 15.0 109.622 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.713 ' HD3' HG22 ' A' ' 165' ' ' THR . 46.2 mtpt -101.8 -72.08 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.968 0.507 . . . . 15.0 110.862 -173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -143.56 169.3 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.266 1.026 . . . . 15.0 109.803 -172.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 164' ' ' VAL . 2.9 t -120.31 153.43 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 107.199 -1.408 . . . . 15.0 107.199 172.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 34.0 mt-10 -135.25 114.69 12.53 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.644 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.9 tt0 -70.03 140.89 52.94 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.671 0.789 . . . . 15.0 110.629 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -78.38 79.24 4.82 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.296 -1.001 . . . . 15.0 108.296 167.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.84 116.88 10.74 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 115.397 -0.82 . . . . 15.0 109.378 -177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.1 mt -69.15 137.15 89.27 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.783 0.833 . . . . 15.0 110.789 -171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 93.7 Cg_endo -75.37 176.18 10.29 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.499 2.133 . . . . 15.0 111.733 -177.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.98 172.64 9.65 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.094 -0.957 . . . . 15.0 111.408 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 22.3 tp -141.09 33.99 1.73 Allowed 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 107.752 -1.203 . . . . 15.0 107.752 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.15 163.43 26.33 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 114.487 -1.233 . . . . 15.0 110.061 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -48.9 -49.75 38.41 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.287 1.035 . . . . 15.0 113.023 -171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.6 -25.95 67.62 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.007 0.923 . . . . 15.0 112.681 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -79.09 -58.66 3.12 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.111 -0.699 . . . . 15.0 109.111 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.77 -33.73 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 123.443 0.697 . . . . 15.0 111.703 -172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -70.62 -22.77 62.49 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.114 0.412 . . . . 15.0 112.114 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -69.78 -24.07 63.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.879 0.472 . . . . 15.0 110.454 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -85.02 -12.91 52.11 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.103 0.961 . . . . 15.0 111.425 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.66 -25.83 7.11 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.478 -0.623 . . . . 15.0 112.884 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 266' ' ' LEU . 30.0 t -72.73 84.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.289 0.566 . . . . 15.0 109.488 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -58.7 -29.09 66.39 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.081 1.352 . . . . 15.0 112.405 -173.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -83.83 138.13 33.36 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.904 0.482 . . . . 15.0 110.17 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -75.38 -15.56 81.12 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.114 -0.493 . . . . 15.0 113.585 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.436 ' HB2' ' HG2' ' A' ' 264' ' ' GLU . 57.4 p -67.81 122.59 18.45 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.949 0.5 . . . . 15.0 110.767 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.46 -30.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.207 0.603 . . . . 15.0 110.834 -175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 262' ' ' SER . 11.3 pt-20 -57.43 -23.61 50.57 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.409 1.084 . . . . 15.0 112.298 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.28 -34.6 50.75 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 112.009 -0.437 . . . . 15.0 112.009 174.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 270' ' ' VAL . 46.0 tp -75.23 -31.13 60.76 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.602 -0.518 . . . . 15.0 109.602 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -67.05 -45.47 77.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.464 0.706 . . . . 15.0 110.123 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -62.45 -38.31 89.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.722 -1.126 . . . . 15.0 110.287 175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.515 ' HG2' HD21 ' B' ' 277' ' ' LEU . 6.6 tp10 -61.43 -49.11 78.15 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 15.0 110.638 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 132' ' ' VAL . 75.4 t -58.71 -44.77 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.291 0.636 . . . . 15.0 110.454 177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -55.99 -64.93 0.7 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 122.732 0.413 . . . . 15.0 111.538 176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 11.6 ptmm? -63.3 -40.48 97.46 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.788 0.662 . . . . 15.0 112.788 -171.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.71 -56.0 5.26 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.531 0.332 . . . . 15.0 110.469 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 278' ' ' LEU . 0.0 OUTLIER -62.21 -28.47 69.71 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 118.209 -0.9 . . . . 15.0 111.502 -174.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 16.2 mt-10 -74.09 -32.16 63.12 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 118.37 0.532 . . . . 15.0 112.085 172.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -61.32 -47.16 87.19 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.009 0.523 . . . . 15.0 109.643 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.595 ' HG3' ' HA3' ' B' ' 284' ' ' GLY . 1.2 mp0 -68.23 -39.19 82.38 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 115.572 -0.74 . . . . 15.0 111.093 172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.566 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 49.8 tp -62.01 -45.21 94.61 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.303 1.041 . . . . 15.0 112.916 -173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -60.69 -40.19 91.28 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.098 0.408 . . . . 15.0 110.72 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 23.0 t -67.34 -40.39 85.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.073 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.91 87.81 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 115.715 -0.675 . . . . 15.0 112.08 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 130' ' ' VAL . 71.5 mt -72.78 -35.37 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.664 0.786 . . . . 15.0 109.166 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -48.55 79.17 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -68.38 -29.15 67.79 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.827 0.851 . . . . 15.0 111.849 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -65.63 -63.2 1.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.877 0.871 . . . . 15.0 110.277 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.7 t -59.92 -34.96 57.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 123.797 0.839 . . . . 15.0 110.375 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.659 ' HA ' HG11 ' A' ' 408' ' ' VAL . 85.9 tttt -59.43 -55.69 31.47 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.799 0.84 . . . . 15.0 111.609 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 76.1 p -63.7 -37.57 87.86 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.399 0.437 . . . . 15.0 111.131 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 126' ' ' GLU . 51.1 mt-30 -68.29 -39.95 81.92 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.562 0.539 . . . . 15.0 111.148 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -63.66 -43.95 95.22 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.003 0.521 . . . . 15.0 110.997 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.493 HD12 HG13 ' A' ' 347' ' ' VAL . 26.8 mm -66.77 -41.71 88.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.374 1.046 . . . . 15.0 110.432 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -57.07 -53.38 58.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.873 0.733 . . . . 15.0 109.947 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.29 -30.23 71.64 Favored Glycine 0 CA--C 1.532 1.13 0 O-C-N 124.022 0.826 . . . . 15.0 113.714 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 123' ' ' ILE . 1.3 tt -64.48 -57.12 10.11 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 -36.75 77.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.296 -0.866 . . . . 15.0 110.208 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -62.88 -30.46 71.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 122.152 -0.342 . . . . 15.0 111.386 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -95.88 -1.55 49.13 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.706 0.632 . . . . 15.0 112.706 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -137.06 157.83 45.83 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.589 0.709 . . . . 15.0 112.274 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -141.12 138.94 33.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.432 0.693 . . . . 15.0 109.335 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.0 tp -161.6 132.06 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 109.114 -0.699 . . . . 15.0 109.114 175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.72 135.65 41.82 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 116.129 -0.487 . . . . 15.0 109.86 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.87 137.78 19.87 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 115.307 -0.86 . . . . 15.0 109.74 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.72 126.42 19.7 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.523 2.149 . . . . 15.0 111.372 164.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.5 62.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.704 0.802 . . . . 15.0 111.868 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.09 75.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.003 0.921 . . . . 15.0 112.185 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.9 mt -70.41 -37.95 74.54 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 123.391 0.676 . . . . 15.0 111.027 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 40.7 mt -65.32 -44.14 94.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.26 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.7 -44.37 85.84 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.036 0.934 . . . . 15.0 110.808 176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 49.9 m -58.2 -51.79 68.25 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 123.813 0.696 . . . . 15.0 111.322 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.604 ' HB3' ' HB1' ' A' ' 341' ' ' ALA . 0.4 OUTLIER -64.45 -46.47 83.0 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 122.72 0.408 . . . . 15.0 110.422 -177.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 68.9 mt -52.24 -46.55 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.318 1.047 . . . . 15.0 110.599 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.26 -43.02 96.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.888 0.743 . . . . 15.0 111.618 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.7 t -59.54 -42.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.696 0.398 . . . . 15.0 110.152 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.411 HD21 ' NH1' ' A' ' 344' ' ' ARG . 83.3 mt -63.9 -36.02 82.57 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.97 176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 46.4 mtm180 -67.45 -45.96 74.45 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.932 0.493 . . . . 15.0 110.281 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -59.08 -50.31 74.54 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.048 0.539 . . . . 15.0 110.186 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -61.83 -40.09 94.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.072 -0.967 . . . . 15.0 111.218 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.41 -60.31 3.91 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.107 0.563 . . . . 15.0 109.866 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 329' ' ' ALA . . . -54.01 -39.56 66.21 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.127 0.971 . . . . 15.0 112.374 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.08 -42.47 94.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.305 1.042 . . . . 15.0 110.117 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.09 -12.17 36.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.181 0.592 . . . . 15.0 111.095 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -85.25 -32.21 22.71 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 15.0 110.197 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . -175.74 -43.08 0.05 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.784 -0.526 . . . . 15.0 111.784 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 129.87 39.27 0.29 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.167 -0.773 . . . . 15.0 111.167 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 17.8 m120 -77.42 131.32 37.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.112 0.565 . . . . 15.0 111.12 -173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.45 104.66 16.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.173 0.989 . . . . 15.0 110.674 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm 63.37 4.41 1.7 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.905 1.282 . . . . 15.0 114.225 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -66.22 -31.8 72.83 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.72 0.808 . . . . 15.0 109.633 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.711 ' HB2' ' HB2' ' A' ' 319' ' ' ALA . . . -61.5 -18.7 60.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.128 1.371 . . . . 15.0 113.448 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 62.2 tp -52.58 -28.27 20.36 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.275 1.03 . . . . 15.0 111.561 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -90.21 -14.59 33.13 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.395 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 329' ' ' ALA . 52.0 mt -55.23 140.71 63.03 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 123.078 0.551 . . . . 15.0 111.017 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.422 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 67.4 Cg_exo -52.63 110.71 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.305 2.67 . . . . 15.0 113.547 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -56.43 -37.26 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.0 0.92 . . . . 15.0 112.115 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.23 -20.79 64.58 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.715 0.635 . . . . 15.0 112.715 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 92.7 mt -70.03 -27.9 65.04 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.307 0.575 . . . . 15.0 110.576 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.438 ' HA ' HE21 ' A' ' 340' ' ' GLN . 53.0 m-85 -105.09 -26.23 12.19 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 15.0 111.663 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -51.86 -56.54 13.4 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.957 1.303 . . . . 15.0 112.361 -168.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -60.27 -56.09 25.74 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.447 -1.251 . . . . 15.0 111.385 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.438 HE21 ' HA ' ' A' ' 337' ' ' PHE . 27.7 pt20 -67.73 -38.65 83.85 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.642 0.589 . . . . 15.0 111.665 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 310' ' ' GLU . . . -63.72 -57.51 9.74 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 122.95 0.5 . . . . 15.0 110.232 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.2 tttt -51.79 -41.27 61.57 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 123.997 0.811 . . . . 15.0 110.842 176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.51 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.2 OUTLIER -62.64 -39.91 95.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.067 0.947 . . . . 15.0 109.811 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.411 ' NH1' HD21 ' A' ' 314' ' ' LEU . 62.7 mtt180 -71.35 -29.86 65.49 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 122.912 0.133 . . . . 15.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.7 -29.6 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 110.183 -0.303 . . . . 15.0 110.183 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 342' ' ' LYS . 61.0 t -59.65 -43.9 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 108.5 -0.926 . . . . 15.0 108.5 170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 343' ' ' ARG . 95.7 t -55.4 -46.43 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.267 0.627 . . . . 15.0 110.426 170.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -65.95 -28.26 73.51 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.922 -0.581 . . . . 15.0 114.464 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.3 mt -83.77 -42.16 16.82 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.425 0.613 . . . . 15.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 294' ' ' LEU . 88.4 mt -65.75 -50.93 62.99 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.289 0.636 . . . . 15.0 110.028 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.496 ' HA ' HG12 ' A' ' 354' ' ' VAL . 49.0 mt -60.98 -37.58 82.97 Favored 'General case' 0 C--O 1.211 -0.941 0 CA-C-N 115.362 -0.836 . . . . 15.0 110.08 170.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.1 -43.8 93.24 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.228 0.33 . . . . 15.0 113.093 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.14 -45.46 40.75 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 119.26 -0.4 . . . . 15.0 111.774 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.7 p -62.91 -34.72 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 118.707 0.685 . . . . 15.0 110.542 179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.585 HG21 HD13 ' B' ' 301' ' ' ILE . 24.8 mt -60.83 -56.37 18.35 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 123.671 0.788 . . . . 15.0 110.027 173.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -52.44 -53.91 39.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 124.3 1.0 . . . . 15.0 111.296 -177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 63.1 m -59.89 -45.83 91.27 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.341 1.056 . . . . 15.0 111.619 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.71 11.95 13.98 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 118.819 -0.61 . . . . 15.0 112.376 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 42.27 55.22 4.05 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.825 1.65 . . . . 15.0 113.666 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 355' ' ' ILE . 82.5 mt -85.16 164.86 17.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.846 0.458 . . . . 15.0 111.928 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -154.67 166.76 32.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.942 0.897 . . . . 15.0 110.091 -168.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -80.11 85.61 5.65 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.329 -1.36 . . . . 15.0 107.329 165.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.95 117.16 5.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.449 1.1 . . . . 15.0 111.359 -170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -54.53 -40.89 69.07 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.532 1.133 . . . . 15.0 112.553 -174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -72.35 -24.58 61.31 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.082 -0.508 . . . . 15.0 111.008 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 405' ' ' GLU . 17.7 ttt180 -78.54 -47.28 17.62 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 109.624 -0.51 . . . . 15.0 109.624 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 65.9 t -57.79 -55.03 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.707 0.803 . . . . 15.0 109.125 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -62.14 -38.9 90.76 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 15.0 112.498 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.16 -50.37 59.58 Favored Glycine 0 C--N 1.347 1.17 0 O-C-N 123.415 0.447 . . . . 15.0 112.264 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 88.4 mt -69.95 -29.42 66.56 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.64 -0.78 . . . . 15.0 111.233 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.62 -40.92 89.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 123.227 0.611 . . . . 15.0 110.87 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -49.93 54.2 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.632 0.196 . . . . 15.0 110.472 175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -57.0 -34.32 68.01 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.695 0.398 . . . . 15.0 111.824 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 40.6 ttp -66.7 -70.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.997 0.919 . . . . 15.0 110.331 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.32 -41.76 96.65 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.72 -1.127 . . . . 15.0 112.676 -164.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' A' ' 381' ' ' PRO . 37.4 m -62.6 -28.65 70.04 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.71 0.631 . . . . 15.0 111.337 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -71.43 -12.25 61.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.041 0.537 . . . . 15.0 112.283 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -91.41 -175.39 4.22 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.663 0.744 . . . . 15.0 111.365 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . 0.629 ' HB3' ' HA ' ' B' ' 274' ' ' GLN . 7.2 pt-20 -62.76 -60.76 3.04 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-N 114.143 -1.39 . . . . 15.0 110.975 169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.421 ' H ' ' HG3' ' A' ' 379' ' ' GLU . 10.4 t70 -128.23 93.2 39.38 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 376' ' ' SER . 94.4 Cg_exo -49.39 -44.88 32.8 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.181 2.587 . . . . 15.0 113.085 176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -49.08 -64.49 0.79 Allowed 'General case' 0 C--O 1.248 1.003 0 O-C-N 124.571 1.169 . . . . 15.0 111.328 -169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.04 -18.05 63.28 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 115.649 -0.705 . . . . 15.0 112.257 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 60.0 t -76.89 -39.96 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.56 -40.74 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.867 0.867 . . . . 15.0 110.217 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.87 -52.41 64.25 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.854 -0.612 . . . . 15.0 110.492 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -58.2 -39.64 79.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.301 0.641 . . . . 15.0 111.288 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 384' ' ' VAL . 9.4 t80 -63.0 -56.36 17.7 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.844 0.715 . . . . 15.0 110.528 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 63.4 p -59.25 -28.86 67.1 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.433 -0.803 . . . . 15.0 111.733 -176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.37 -21.68 24.19 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.932 0.893 . . . . 15.0 111.573 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -88.21 83.02 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 106.886 -1.524 . . . . 15.0 106.886 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -58.74 -30.32 67.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.424 1.09 . . . . 15.0 111.894 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.431 ' HG3' ' NH1' ' B' ' 289' ' ' ARG . 12.1 tp10 -56.6 -39.05 72.9 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.173 0.989 . . . . 15.0 111.228 175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 19.6 tp -98.02 -29.49 13.24 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.752 0.821 . . . . 15.0 111.668 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -37.67 79.07 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.408 -0.96 . . . . 15.0 108.408 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.51 -55.6 24.03 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.062 -0.972 . . . . 15.0 110.121 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.505 HD21 ' HB2' ' B' ' 291' ' ' LEU . 56.4 t30 -53.34 -34.96 59.58 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.768 0.827 . . . . 15.0 111.581 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 2.1 tpt -68.99 -40.87 78.52 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.939 0.496 . . . . 15.0 112.204 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -65.48 -46.32 80.21 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.574 0.702 . . . . 15.0 109.492 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.4 -45.5 90.74 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 113.456 -1.702 . . . . 15.0 110.406 -173.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.5 -42.73 90.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-O 118.947 -0.549 . . . . 15.0 110.218 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -60.38 -45.66 92.73 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.694 0.759 . . . . 15.0 111.081 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.552 HD11 HD11 ' B' ' 301' ' ' ILE . 38.4 tp -66.95 -44.47 80.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.221 -1.354 . . . . 15.0 111.056 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.45 -38.07 88.75 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.254 0.621 . . . . 15.0 111.166 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.415 ' HB3' ' NH2' ' A' ' 366' ' ' ARG . 40.7 mt-10 -62.95 -54.88 31.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.134 -0.691 . . . . 15.0 109.134 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.08 -36.27 81.16 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 123.726 0.641 . . . . 15.0 110.86 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -61.39 -50.82 71.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.072 0.949 . . . . 15.0 111.35 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 287' ' ' LYS . 53.8 t -67.3 -42.59 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.859 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' A' ' 412' ' ' LEU . 51.2 mt-10 -69.53 -25.19 63.91 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.037 0.535 . . . . 15.0 111.721 -176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.15 71.6 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.668 -0.242 . . . . 15.0 111.304 168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.22 -31.38 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.442 HD12 ' HG2' ' A' ' 409' ' ' GLU . 98.1 mt -68.32 -37.03 80.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.527 0.731 . . . . 15.0 110.558 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.65 65.1 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.429 0.692 . . . . 15.0 111.104 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -88.02 -36.04 17.24 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.12 0.968 . . . . 15.0 110.905 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.36 159.64 18.66 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.062 0.945 . . . . 15.0 112.325 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 96.4 mttt -76.73 92.09 3.53 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.993 0.917 . . . . 15.0 110.576 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.22 90.36 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.656 -0.702 . . . . 15.0 109.648 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.0 t -77.7 92.48 4.15 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.975 0.893 . . . . 15.0 109.91 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 33.9 tt0 -79.54 142.03 36.11 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.847 -1.07 . . . . 15.0 110.704 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 128' ' ' PRO . 57.6 pttt -137.53 152.68 49.74 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.435 0.694 . . . . 15.0 109.519 177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.24 131.27 47.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.136 -0.69 . . . . 15.0 109.136 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.404 HG21 ' HG2' ' A' ' 426' ' ' GLU . 7.7 t -162.75 160.46 25.42 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.725 0.639 . . . . 15.0 112.725 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 69.0 p -83.61 174.62 10.39 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.907 0.883 . . . . 15.0 111.768 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.471 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 53.5 t80 -65.5 -21.73 66.66 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.212 1.005 . . . . 15.0 112.579 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -55.09 -31.96 61.61 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.079 0.552 . . . . 15.0 112.237 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.404 ' HG2' HG21 ' A' ' 422' ' ' THR . 16.3 tp10 -52.12 -49.96 62.63 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.316 1.046 . . . . 15.0 112.025 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.22 -31.71 73.02 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.589 -1.187 . . . . 15.0 110.925 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 23.8 mmt -82.33 -27.56 32.14 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.512 -0.767 . . . . 15.0 112.107 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -82.7 43.74 0.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.905 0.482 . . . . 15.0 110.889 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -117.79 81.49 1.67 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.759 0.823 . . . . 15.0 109.14 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.45 -65.67 0.98 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.654 -0.703 . . . . 15.0 109.312 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 C-N-CA 123.984 0.914 . . . . 15.0 109.019 179.432 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -84.7 -79.99 0.21 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.169 0.588 . . . . 0.0 109.643 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -178.21 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.104 0.962 . . . . 0.0 108.986 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -76.76 110.39 11.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.06 0.544 . . . . 0.0 109.609 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.4 t -91.84 105.07 16.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 91.9 m -114.15 98.58 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 100.5 3.81 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.62 51.08 3.27 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.289 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 81.14 -99.36 1.92 Allowed Glycine 0 C--N 1.34 0.804 0 CA-C-O 120.256 -0.191 . . . . 0.0 113.289 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 164.4 -47.51 0.3 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 58.58 39.06 25.16 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.832 1.253 . . . . 0.0 112.629 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -80.31 10.91 3.97 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.996 0.519 . . . . 0.0 112.261 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 34.4 p -54.09 -69.27 0.13 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.372 1.469 . . . . 0.0 111.953 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 226' ' ' LEU . 27.0 t80 -119.08 87.15 2.68 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 168.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.08 161.21 13.92 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.918 0.887 . . . . 0.0 109.45 174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 56.49 55.97 6.05 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.996 0.919 . . . . 0.0 110.721 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.542 ' HA ' ' HE1' ' B' ' 233' ' ' PHE . 48.5 m -56.67 -32.93 65.89 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.393 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 70.69 -64.75 0.36 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.606 . . . . 0.0 111.7 175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 4.1 m 61.29 33.97 18.79 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.725 1.21 . . . . 0.0 109.52 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.452 ' HA ' ' HB2' ' A' ' 194' ' ' MET . . . 61.62 11.61 4.01 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.171 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.6 28.05 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.634 0.584 . . . . 0.0 114.339 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.604 ' HB2' HH11 ' A' ' 193' ' ' ARG . 10.4 tp10 -148.02 122.78 9.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.991 0.396 . . . . 0.0 110.874 -170.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -167.93 19.78 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.439 1.096 . . . . 0.0 109.339 165.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.434 ' O ' ' HD3' ' B' ' 248' ' ' ARG . 33.9 mm-40 -95.28 -44.63 7.51 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.623 0.769 . . . . 0.0 111.596 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.55 72.31 0.24 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 123.187 0.305 . . . . 0.0 113.809 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -144.38 47.77 1.38 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.817 1.247 . . . . 0.0 108.598 -172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 78.9 m 77.23 -55.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.253 1.821 . . . . 0.0 113.087 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.455 ' HB3' ' HD2' ' B' ' 248' ' ' ARG . 55.4 tp -61.78 -40.59 95.71 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 0.0 113.414 -170.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.455 ' HD2' ' HB3' ' B' ' 247' ' ' LEU . 7.0 mpt_? -88.09 -24.22 23.48 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 122.628 0.371 . . . . 0.0 111.635 -168.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -73.07 -20.87 60.88 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.863 0.465 . . . . 0.0 110.552 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -37.85 84.65 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.399 0.68 . . . . 0.0 109.277 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -67.61 -31.75 72.01 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.326 0.651 . . . . 0.0 111.531 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -72.65 -38.02 67.81 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.007 0.523 . . . . 0.0 110.305 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -87.29 3.01 48.42 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.384 0.674 . . . . 0.0 111.71 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -75.04 99.05 3.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.57 0.748 . . . . 0.0 109.651 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 145.13 -58.13 0.52 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 49.8 t80 60.1 -76.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.628 1.571 . . . . 0.0 113.377 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.81 120.34 24.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.114 0.566 . . . . 0.0 109.565 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.575 HD22 HG22 ' B' ' 259' ' ' VAL . 0.0 OUTLIER -154.53 135.91 14.14 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.831 173.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.575 HG22 HD22 ' B' ' 258' ' ' LEU . 23.8 m 41.83 89.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 126.661 1.985 . . . . 0.0 114.908 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 42.6 p -91.87 -89.28 0.18 Allowed 'General case' 0 CA--C 1.553 1.066 0 O-C-N 121.872 -0.517 . . . . 0.0 110.182 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 28.9 t70 60.59 163.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.855 1.262 . . . . 0.0 112.061 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.18 90.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 110.335 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.52 -84.04 0.54 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.811 0.844 . . . . 0.0 111.15 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 82.6 p -175.16 40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.282 1.033 . . . . 0.0 109.183 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 83.6 mt 69.37 97.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.852 1.661 . . . . 0.0 111.017 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.44 75.61 10.23 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.714 0.769 . . . . 0.0 110.895 175.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 58.2 m -140.73 13.19 2.3 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.544 167.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.8 148.69 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.102 1.361 . . . . 0.0 109.386 -172.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 380' ' ' ASP . 21.7 p -63.68 -42.48 98.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.877 0.471 . . . . 0.0 111.739 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.35 150.65 23.79 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.453 0.644 . . . . 0.0 111.364 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -99.78 21.31 12.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.0 -175.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -48.7 -52.05 25.49 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 124.959 1.304 . . . . 0.0 110.952 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -153.32 89.33 1.34 Allowed 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 160.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . 0.665 ' HG2' ' HG3' ' B' ' 275' ' ' LYS . 1.3 pm0 -69.73 -38.91 77.02 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.233 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' B' ' 274' ' ' GLN . 63.8 mttm -114.13 116.28 44.72 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.101 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.71 87.97 0.54 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.529 2.153 . . . . 0.0 112.241 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.515 HD21 ' HG2' ' A' ' 269' ' ' GLU . 3.8 pp -74.83 -19.57 60.12 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.854 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -80.88 128.99 34.29 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.681 0.792 . . . . 0.0 109.78 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.7 -147.46 22.68 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.792 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.667 HD23 ' H ' ' B' ' 280' ' ' LEU . 2.0 pt? -83.23 51.18 1.91 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.198 0.999 . . . . 0.0 111.916 -172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -87.39 88.28 7.64 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.265 0.626 . . . . 0.0 111.262 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.77 -77.77 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.359 1.464 . . . . 0.0 113.222 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.79 164.17 33.65 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . 0.595 ' HA3' ' HG3' ' A' ' 277' ' ' GLU . . . 87.64 -77.5 1.9 Allowed Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -174.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 76.48 -32.27 0.2 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 124.668 1.187 . . . . 0.0 113.805 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . 0.278 84.2 mmm 105.21 -57.7 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.946 0 C-N-CA 128.428 2.691 . . . . 0.0 112.323 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -47.16 126.88 12.12 Favored 'Trans proline' 0 C--N 1.401 3.292 0 CA-C-N 123.257 2.199 . . . . 0.0 114.202 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 6.3 m -55.3 89.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.36 0 C-N-CA 124.134 0.974 . . . . 0.0 112.741 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 393' ' ' GLU . 18.2 tpp180 -168.72 -68.44 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.183 0.993 . . . . 0.0 108.568 175.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 43.66 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.366 1.466 . . . . 0.0 113.183 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.505 ' HB2' HD21 ' A' ' 397' ' ' ASN . 81.4 mt 56.39 -148.08 0.5 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.049 0.94 . . . . 0.0 111.718 170.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.66 -66.94 0.48 Allowed Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.212 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -58.38 113.65 1.64 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.953 2.436 . . . . 0.0 112.27 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -131.7 -176.62 4.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.383 1.073 . . . . 0.0 109.539 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -138.87 -58.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.682 HG22 ' H ' ' B' ' 297' ' ' TYR . 2.3 m 62.1 -171.37 0.16 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.901 1.28 . . . . 0.0 111.674 168.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.682 ' H ' HG22 ' B' ' 296' ' ' THR . 64.4 t80 69.07 -88.18 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.941 1.296 . . . . 0.0 110.063 177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 61.03 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.162 1.385 . . . . 0.0 111.292 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -156.03 28.32 0.58 Allowed Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 56.26 42.46 27.92 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.654 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.585 HD13 HG21 ' A' ' 355' ' ' ILE . 28.1 pt -79.68 -4.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.383 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -53.72 161.26 1.14 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.111 1.364 . . . . 0.0 112.364 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -50.85 122.38 16.7 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.077 0.951 . . . . 0.0 109.62 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.09 74.16 0.73 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.406 2.737 . . . . 0.0 112.994 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.91 74.78 0.59 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 57.3 t -133.89 130.26 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -169.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 45.6 p -86.75 129.69 34.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 11.8 p -73.7 80.2 1.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.923 0.868 . . . . 0.0 109.675 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 24.0 p -126.28 96.25 36.95 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.483 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.977 2.451 . . . . 12.53 111.654 -178.277 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptm . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.856 0.36 . . . . 15.0 110.138 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.0 tt0 -95.88 136.51 36.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.023 -1.103 . . . . 15.0 108.023 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG12 HG12 ' A' ' 17' ' ' ILE . 28.0 m -129.33 154.75 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 122.992 0.517 . . . . 15.0 111.121 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -151.14 97.92 2.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.867 0.867 . . . . 15.0 109.148 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -74.96 137.18 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.613 0.765 . . . . 15.0 111.1 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 28.5 mt-10 -134.77 94.58 3.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.011 0.925 . . . . 15.0 108.987 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.3 m -69.19 92.27 0.55 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.513 0.725 . . . . 15.0 109.815 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.4 p -87.06 -59.05 2.36 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.859 0.863 . . . . 15.0 111.036 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -100.91 15.26 29.13 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.709 0.804 . . . . 15.0 110.512 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.91 -69.55 2.88 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD23 ' HG3' ' A' ' 303' ' ' PRO . 6.1 mp -71.44 -39.79 70.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.111 -1.07 . . . . 15.0 108.111 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.48 106.25 1.86 Allowed Glycine 0 C--N 1.356 1.677 0 CA-C-N 115.239 -0.891 . . . . 15.0 112.16 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -121.56 105.98 10.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.939 0.896 . . . . 15.0 109.018 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.585 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 39.2 ttm180 -74.16 93.54 2.32 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.186 0.995 . . . . 15.0 110.949 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -83.22 86.49 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.357 -0.979 . . . . 15.0 108.357 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 52.7 m -75.53 101.35 4.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.231 -0.441 . . . . 15.0 110.04 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG12 HG12 ' A' ' 3' ' ' VAL . 58.3 mt -90.05 116.13 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.724 -0.671 . . . . 15.0 109.59 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 94.7 m -89.66 108.0 19.42 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.557 -0.905 . . . . 15.0 108.557 165.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.752 HD13 ' HB3' ' A' ' 70' ' ' LEU . 38.0 mt -80.68 105.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 107.615 -1.254 . . . . 15.0 107.615 173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.06 160.87 30.19 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 120.96 0.41 . . . . 15.0 111.481 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.11 -20.7 55.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.528 1.131 . . . . 15.0 113.569 -171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.32 -45.88 85.95 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.657 0.383 . . . . 15.0 110.867 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.7 m -77.38 -34.03 55.03 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.289 0.636 . . . . 15.0 111.116 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.515 ' HA ' HD11 ' A' ' 70' ' ' LEU . 53.6 mt -65.6 -60.76 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 123.506 0.504 . . . . 15.0 109.712 177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 11.2 tp10 -57.39 -33.38 67.77 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.563 1.145 . . . . 15.0 112.466 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.4 m -72.15 -48.53 42.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.361 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -21.07 65.79 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.832 0.453 . . . . 15.0 111.902 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.666 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.2 t -62.41 -50.19 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.354 -0.61 . . . . 15.0 109.354 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 58.9 mttp -70.63 -25.32 62.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.782 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.2 m -65.75 -40.99 92.65 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 35' ' ' VAL . 8.9 tp10 -73.09 -37.0 66.9 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.805 -0.634 . . . . 15.0 110.971 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 54' ' ' VAL . 91.6 mt -67.84 -37.87 82.46 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.987 0.515 . . . . 15.0 111.684 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -73.14 -25.36 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 110.058 -0.349 . . . . 15.0 110.058 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -63.69 -62.05 1.91 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 31' ' ' GLU . 62.6 t -55.51 -42.98 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.063 0.945 . . . . 15.0 111.376 -176.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -57.9 10.59 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.565 -0.743 . . . . 15.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -74.49 -22.58 59.0 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.834 0.679 . . . . 15.0 112.834 -174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -75.0 -46.31 36.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.366 0.667 . . . . 15.0 110.156 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.0 t -93.1 4.07 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.484 0 CA-C-N 115.917 -0.583 . . . . 15.0 109.705 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 67.18 18.16 10.37 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.528 1.531 . . . . 15.0 112.474 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -63.2 -24.31 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.841 1.256 . . . . 15.0 110.926 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.11 -32.19 73.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.584 0.754 . . . . 15.0 111.149 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.58 -24.7 76.09 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.039 -0.528 . . . . 15.0 112.59 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -90.26 -15.47 31.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.412 0.685 . . . . 15.0 110.998 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.454 HH22 ' HA ' ' A' ' 50' ' ' PRO . 51.1 ttt85 -61.11 112.94 2.3 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.101 0.56 . . . . 15.0 110.263 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -83.37 -17.82 41.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.979 0.912 . . . . 15.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.27 2.94 82.57 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.908 -0.587 . . . . 15.0 113.642 174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -60.19 -46.42 89.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.434 0.694 . . . . 15.0 110.301 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.99 107.91 31.53 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.791 -1.189 . . . . 15.0 107.791 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 53' ' ' ILE . 50.8 Cg_exo -56.24 150.66 47.98 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.185 2.59 . . . . 15.0 113.524 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.5 tpt -69.31 -13.99 62.69 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.976 0.91 . . . . 15.0 112.259 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.608 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 26.7 p-10 -82.26 -36.37 27.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.677 0.391 . . . . 15.0 111.32 172.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.485 HD12 ' HD2' ' A' ' 50' ' ' PRO . 46.7 mt -75.41 -26.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.446 0.699 . . . . 15.0 111.072 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 32' ' ' LEU . 11.4 m -69.19 -16.32 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 122.064 -0.397 . . . . 15.0 111.009 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -82.4 -33.88 28.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.89 0.876 . . . . 15.0 112.547 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -84.57 -19.5 33.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 116.349 -0.387 . . . . 15.0 110.815 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -98.72 -75.29 0.56 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.145 0.578 . . . . 15.0 110.697 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -79.86 -30.86 40.39 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.693 0.797 . . . . 15.0 111.387 -173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.29 -9.14 84.25 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 115.548 -0.751 . . . . 15.0 113.45 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.46 -37.85 82.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.953 0.901 . . . . 15.0 112.495 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.1 p -75.78 -38.83 57.9 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.563 0.745 . . . . 15.0 110.638 175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.06 -23.31 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.854 1.262 . . . . 15.0 111.827 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.514 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 51.0 mtp85 -53.87 -28.95 39.22 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.228 1.011 . . . . 15.0 112.347 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -56.88 -54.78 42.58 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.491 1.117 . . . . 15.0 111.309 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.54 -35.28 77.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.818 0.847 . . . . 15.0 110.51 -177.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.666 HG21 ' HA ' ' A' ' 28' ' ' VAL . 54.8 t -56.1 -38.02 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 114.473 -1.24 . . . . 15.0 111.168 175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 78.3 mt -59.01 -41.08 86.87 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.184 0.594 . . . . 15.0 111.174 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.1 -42.32 99.72 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.666 0.604 . . . . 15.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -63.74 -41.79 97.98 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 124.083 0.953 . . . . 15.0 111.174 174.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.752 ' HB3' HD13 ' A' ' 19' ' ' ILE . 68.0 mt -63.26 -44.02 96.34 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.971 0.908 . . . . 15.0 111.531 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 67.8 mtm -60.65 -40.15 90.96 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.433 0.693 . . . . 15.0 111.421 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.0 t -65.7 -46.9 77.28 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.325 -0.852 . . . . 15.0 110.785 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -74.74 -26.85 60.08 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.075 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.99 -34.1 38.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -69.05 -49.33 58.46 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.012 0.195 . . . . 15.0 111.07 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.73 -35.31 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 123.367 0.417 . . . . 15.0 110.152 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.7 -41.39 92.41 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.662 0.785 . . . . 15.0 109.934 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.79 82.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.943 -1.026 . . . . 15.0 112.453 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.5 pt -74.02 -22.56 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 111.784 0.29 . . . . 15.0 111.784 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.0 mt -74.82 -49.27 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 122.546 0.338 . . . . 15.0 110.276 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 18.4 ptpt -71.2 -34.96 71.35 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.824 0.45 . . . . 15.0 111.558 -175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 42.2 mm-40 -101.05 0.86 38.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.377 0.671 . . . . 15.0 112.231 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm 58.02 40.0 25.85 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.848 0.859 . . . . 15.0 112.11 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.8 133.69 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 15.0 110.708 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -111.56 104.13 55.79 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.248 -1.019 . . . . 15.0 108.248 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.3 138.57 43.28 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.252 2.635 . . . . 15.0 113.218 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' HB1' ' HG ' ' A' ' 306' ' ' LEU . . . -80.88 91.58 6.01 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.795 0.838 . . . . 15.0 110.026 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.42 -88.0 1.5 Allowed Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.131 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.03 145.52 30.43 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.676 0.791 . . . . 15.0 110.665 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 95.6 Cg_endo -90.07 136.93 2.56 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.015 2.477 . . . . 15.0 113.271 175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.4 m -85.98 104.64 15.8 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.22 -0.659 . . . . 15.0 109.22 175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.03 107.04 14.43 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 174.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 77.4 t -103.3 95.81 7.47 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.768 0.827 . . . . 15.0 108.873 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.18 105.04 0.37 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.649 2.233 . . . . 15.0 111.415 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.418 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -58.79 -52.39 53.46 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.922 0.764 . . . . 15.0 111.848 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -172.12 160.87 5.36 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.343 0.657 . . . . 15.0 110.89 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -139.35 128.7 24.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.125 -0.943 . . . . 15.0 108.908 167.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.635 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 94.5 mttt -100.54 152.9 19.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.752 0.821 . . . . 15.0 109.449 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.83 98.2 0.09 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.987 0.804 . . . . 15.0 110.888 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.36 -28.32 12.44 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.702 -0.681 . . . . 15.0 113.362 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 40.2 mt-10 -80.17 -166.91 1.13 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.66 0.784 . . . . 15.0 112.268 -173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.66 152.1 46.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.786 1.234 . . . . 15.0 111.369 -175.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' HD2' HD12 ' A' ' 19' ' ' ILE . 27.1 t80 -107.66 147.9 30.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.179 0.992 . . . . 15.0 109.081 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.5 m -138.72 134.14 33.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.664 0.786 . . . . 15.0 109.185 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.418 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 2.4 p90 -150.59 133.78 16.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.272 0.629 . . . . 15.0 110.387 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 41.2 m -82.61 104.18 12.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.99 1.316 . . . . 15.0 110.919 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.67 86.42 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.685 -0.857 . . . . 15.0 108.685 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -87.2 111.85 21.4 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.265 -0.88 . . . . 15.0 109.599 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 18.0 p90 -154.19 163.09 40.67 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.287 -0.634 . . . . 15.0 109.287 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -105.14 159.52 15.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.785 -0.643 . . . . 15.0 110.387 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.7 m -117.02 159.66 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.874 0.87 . . . . 15.0 109.871 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.31 120.75 81.51 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.749 0.42 . . . . 15.0 110.108 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.74 156.12 27.48 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.866 2.377 . . . . 15.0 113.388 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -73.73 114.07 11.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.068 -0.969 . . . . 15.0 108.907 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.534 HG22 HG12 ' A' ' 300' ' ' ILE . 59.0 t -85.1 130.88 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.155 0.582 . . . . 15.0 110.348 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -92.19 103.92 16.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.621 0.769 . . . . 15.0 109.675 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 120' ' ' LEU . 96.1 mt -84.18 131.08 34.8 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.281 0.632 . . . . 15.0 109.907 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -153.06 146.61 25.02 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.415 1.086 . . . . 15.0 109.932 -174.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.0 16.63 64.44 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-O 119.339 -0.701 . . . . 15.0 114.684 175.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.4 mt -60.29 -37.56 80.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.762 0.825 . . . . 15.0 111.322 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.26 -18.98 61.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.88 0.872 . . . . 15.0 111.352 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.2 -13.6 30.31 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.192 0.597 . . . . 15.0 112.0 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 294' ' ' LEU . 63.9 mt -68.08 110.85 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.485 0.714 . . . . 15.0 110.002 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -95.41 102.57 14.38 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.275 0.63 . . . . 15.0 109.629 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.55 137.44 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.231 1.012 . . . . 15.0 109.386 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -82.3 149.31 27.85 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.314 0.646 . . . . 15.0 110.956 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -132.3 88.64 39.37 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.678 1.191 . . . . 15.0 108.374 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.11 112.92 3.32 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 121.868 1.712 . . . . 15.0 111.83 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.589 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 49.7 mm -72.35 83.46 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.898 -1.149 . . . . 15.0 107.898 169.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' A' ' 282' ' ' ILE . 41.1 t -91.9 130.79 40.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.601 -1.182 . . . . 15.0 107.855 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.37 159.68 43.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.013 0.435 . . . . 15.0 110.275 171.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.88 84.55 2.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.01 -0.995 . . . . 15.0 108.558 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.9 p -70.56 174.48 5.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.454 -0.793 . . . . 15.0 109.172 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.56 -32.51 67.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.176 0.59 . . . . 15.0 110.842 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.65 87.05 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.888 0.875 . . . . 15.0 111.374 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.34 -32.29 60.84 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.073 -0.512 . . . . 15.0 111.23 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -67.77 -50.9 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 176.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.69 -42.92 89.66 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.486 0.491 . . . . 15.0 110.625 174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.96 -36.53 93.19 Favored Glycine 0 C--N 1.349 1.252 0 O-C-N 123.98 0.8 . . . . 15.0 113.04 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.7 tpt -67.14 -52.99 34.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.378 0.671 . . . . 15.0 110.091 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 267' ' ' ARG . 73.6 mt -61.07 -38.22 85.47 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.601 -0.727 . . . . 15.0 110.522 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.51 -53.36 58.99 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.886 1.274 . . . . 15.0 110.589 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 96.8 m -58.56 -46.73 86.26 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.916 -1.038 . . . . 15.0 111.5 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.62 -46.71 83.77 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.263 0.625 . . . . 15.0 110.631 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -74.82 -22.96 58.42 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.168 -0.924 . . . . 15.0 112.478 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.4 ' O ' ' HD3' ' A' ' 243' ' ' ARG . 92.6 mttt -88.88 -27.84 20.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 118.415 0.552 . . . . 15.0 112.464 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -73.45 -44.85 57.25 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.149 -0.686 . . . . 15.0 109.149 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -95.77 29.33 2.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.838 0.855 . . . . 15.0 111.001 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 243' ' ' ARG . . . -80.83 143.58 32.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.295 0.638 . . . . 15.0 110.961 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.3 m -81.78 141.01 33.9 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.34 -0.846 . . . . 15.0 108.725 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -83.65 139.8 32.57 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.356 0.662 . . . . 15.0 109.479 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -142.45 105.94 4.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.752 0.821 . . . . 15.0 109.542 -174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 28.1 tt0 -59.75 118.63 6.38 Favored 'General case' 0 C--O 1.242 0.71 0 O-C-N 123.581 0.551 . . . . 15.0 110.933 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 58.5 pttt -126.06 -177.77 4.07 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-N 115.262 -0.881 . . . . 15.0 110.8 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.98 153.57 42.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.133 -0.94 . . . . 15.0 109.39 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.736 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 76.19 8.58 85.39 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 115.845 1.098 . . . . 15.0 115.845 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.402 ' O ' HG11 ' A' ' 240' ' ' VAL . . . -154.57 118.43 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.386 1.093 . . . . 15.0 112.345 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 202' ' ' ILE . 47.3 t -109.07 135.31 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.455 -0.943 . . . . 15.0 108.455 164.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -133.11 175.67 9.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.15 1.38 . . . . 15.0 109.171 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.99 68.12 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.686 0.995 . . . . 15.0 113.686 -168.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.59 32.28 5.35 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.89 0.876 . . . . 15.0 110.218 -172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.8 177.35 6.74 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.918 0.866 . . . . 15.0 111.531 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.528 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 42.1 ttt85 -128.81 96.67 4.43 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.747 -1.205 . . . . 15.0 107.747 -176.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.541 HG21 HG21 ' A' ' 202' ' ' ILE . 30.5 m -106.63 132.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.321 0.649 . . . . 15.0 111.311 -169.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.6 m -98.5 121.31 40.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.648 0.779 . . . . 15.0 109.23 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.576 HG21 HG23 ' A' ' 235' ' ' ILE . 9.4 mt -129.83 159.56 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.684 0.794 . . . . 15.0 110.347 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 5.7 m-20 -110.26 105.63 14.74 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 105.814 -1.921 . . . . 15.0 105.814 153.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 38.8 p90 -98.84 117.59 33.67 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 -177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.656 HG22 ' HG3' ' A' ' 181' ' ' LYS . 47.0 p -129.76 101.16 5.76 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.852 0.861 . . . . 15.0 110.4 -167.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -161.27 -169.85 25.11 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 115.514 0.966 . . . . 15.0 115.514 -173.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.4 m -129.38 130.64 46.28 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.223 1.009 . . . . 15.0 110.602 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.18 125.57 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.797 0.839 . . . . 15.0 108.959 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 35.1 t70 61.56 21.85 12.43 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.957 0.884 . . . . 15.0 111.033 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.05 6.0 82.53 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-N 115.827 -0.624 . . . . 15.0 114.275 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -130.0 144.7 51.47 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.253 0.621 . . . . 15.0 109.919 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -82.24 128.9 34.64 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.27 0.628 . . . . 15.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.98 -166.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.289 1.036 . . . . 15.0 109.318 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 2.5 tm-20 -57.62 140.23 51.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 107.905 -1.146 . . . . 15.0 107.905 171.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 70.0 14.72 71.1 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.956 -0.64 . . . . 15.0 113.366 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -71.71 -11.18 72.88 Favored Glycine 0 C--N 1.36 1.901 0 N-CA-C 112.259 -0.337 . . . . 15.0 112.259 175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.1 tttt -148.72 127.98 12.94 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.121 0.968 . . . . 15.0 108.783 172.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -148.39 108.09 4.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.122 0.569 . . . . 15.0 109.624 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 p -86.87 140.15 29.94 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.82 0.848 . . . . 15.0 111.099 -177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.503 ' HB3' ' HZ2' ' B' ' 242' ' ' TRP . 11.2 m-20 64.08 30.33 13.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.135 1.374 . . . . 15.0 111.979 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.58 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 86.7 t80 -66.29 102.48 0.86 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.691 1.197 . . . . 15.0 110.054 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' B' ' 241' ' ' GLU . 20.7 t -90.88 87.01 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 123.199 0.599 . . . . 15.0 109.746 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 63.5 tp -77.9 111.06 13.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.367 0.667 . . . . 15.0 111.843 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -81.72 88.98 6.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.606 -0.887 . . . . 15.0 108.606 163.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.405 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 23.6 ptp -73.57 171.44 13.21 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.958 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 76.9 10.57 86.09 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.306 -171.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.423 ' NE2' HH12 ' A' ' 243' ' ' ARG . 98.5 mt-30 -137.75 141.65 40.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.521 1.528 . . . . 15.0 107.6 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.84 73.09 1.02 Allowed Glycine 0 C--N 1.351 1.383 0 O-C-N 123.812 0.695 . . . . 15.0 112.984 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -115.87 -53.77 2.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.088 0.955 . . . . 15.0 109.231 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.634 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -105.5 174.04 6.05 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.407 -0.815 . . . . 15.0 109.98 -177.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.634 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -65.77 128.97 94.21 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-N 115.54 -0.755 . . . . 15.0 110.581 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -60.99 134.74 54.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 123.035 2.49 . . . . 15.0 111.04 170.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.23 -35.75 4.79 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.402 -0.679 . . . . 15.0 111.402 -170.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.572 ' HB2' HG23 ' A' ' 195' ' ' ILE . 70.9 t80 -66.13 -52.0 52.59 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.112 -0.699 . . . . 15.0 109.112 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 202' ' ' ILE . 7.5 pt-20 -62.93 -40.04 96.42 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.366 -0.833 . . . . 15.0 111.187 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.47 -32.3 73.04 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.699 0.8 . . . . 15.0 111.459 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.442 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -61.32 -36.0 91.81 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.169 -0.469 . . . . 15.0 112.665 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 199' ' ' GLU . 16.7 mt -75.84 -37.39 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.427 1.091 . . . . 15.0 109.959 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' SD ' ' A' ' 189' ' ' MET . 45.7 mtpt -71.38 -3.45 20.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.795 1.238 . . . . 15.0 112.868 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -93.12 14.0 66.32 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 112.141 -0.384 . . . . 15.0 112.141 167.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -140.44 -174.0 3.83 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.366 1.067 . . . . 15.0 110.593 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -120.9 -64.63 1.22 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.516 1.302 . . . . 15.0 114.516 -165.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.736 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.09 -60.47 0.25 Allowed 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 114.781 1.401 . . . . 15.0 114.781 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.85 52.09 0.8 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.892 -0.595 . . . . 15.0 113.116 -160.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -126.39 148.95 49.52 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.395 0.678 . . . . 15.0 110.798 -175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -98.29 132.41 43.8 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.777 -1.101 . . . . 15.0 109.747 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.41 176.69 12.37 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.46 0.704 . . . . 15.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 91.3 m -131.2 132.04 44.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.803 0.841 . . . . 15.0 109.091 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.442 HG21 ' HA3' ' A' ' 201' ' ' GLY . 37.5 pt -123.7 141.39 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.346 0.659 . . . . 15.0 109.938 177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.76 102.25 13.93 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.049 0.94 . . . . 15.0 108.686 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.507 ' HB ' HD13 ' A' ' 195' ' ' ILE . 22.6 m -91.52 115.12 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.982 0.513 . . . . 15.0 111.185 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 32.1 m -84.74 96.74 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.531 -0.914 . . . . 15.0 108.531 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 231' ' ' ALA . 82.6 m-85 -47.25 144.47 4.3 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.872 1.269 . . . . 15.0 113.261 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 3.6 Cg_exo -79.67 155.95 24.28 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 123.165 2.577 . . . . 15.0 111.672 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.66 -5.81 42.82 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.47 -0.787 . . . . 15.0 110.781 172.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -70.32 -35.22 73.49 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.112 0.965 . . . . 15.0 109.533 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.28 131.83 39.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.794 -1.094 . . . . 15.0 110.145 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.458 ' HB3' ' O ' ' B' ' 227' ' ' GLY . 58.2 m-70 -90.77 -4.0 57.0 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.906 0.882 . . . . 15.0 113.294 -171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.85 107.4 5.24 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.868 -1.16 . . . . 15.0 107.868 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.85 -42.73 98.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.868 1.267 . . . . 15.0 112.876 -167.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.507 ' HB3' ' HA ' ' B' ' 231' ' ' LYS . 7.3 t30 -76.6 -14.64 59.98 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.633 0.373 . . . . 15.0 111.459 -178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' B' ' 233' ' ' PHE . 21.1 mt -91.32 -46.82 7.82 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 122.232 -0.292 . . . . 15.0 111.272 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -58.16 126.93 29.62 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.188 0.595 . . . . 15.0 111.911 -168.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.89 -0.55 82.31 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 115.274 0.87 . . . . 15.0 115.274 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 225' ' ' ASN . 73.0 mmtt -91.71 151.15 20.78 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 118.068 0.934 . . . . 15.0 110.78 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -100.23 107.5 19.36 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.364 0.666 . . . . 15.0 109.537 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 217' ' ' PHE . . . -91.39 125.11 36.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.374 0.67 . . . . 15.0 110.3 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -92.1 94.66 9.34 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.784 -1.191 . . . . 15.0 107.784 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.45 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 19.0 m-85 -99.56 122.79 43.12 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.004 0.522 . . . . 15.0 110.188 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.35 93.31 5.3 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.576 HG23 HG21 ' A' ' 166' ' ' ILE . 45.5 mm -70.73 106.76 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-N 114.54 -1.209 . . . . 15.0 109.572 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 40.7 m-80 -95.15 72.59 3.36 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 106.826 -1.546 . . . . 15.0 106.826 175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 42.6 tp -66.57 109.51 2.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.275 -1.33 . . . . 15.0 109.55 -173.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -84.45 -65.82 0.97 Allowed 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.818 0.699 . . . . 15.0 111.419 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -130.62 168.03 17.77 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.416 0.687 . . . . 15.0 111.428 -170.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 157' ' ' ALA . 16.4 t -130.87 149.74 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.381 -1.281 . . . . 15.0 107.563 167.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 163' ' ' ARG . 34.0 mt-10 -139.15 118.09 12.47 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.42 -0.956 . . . . 15.0 108.42 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.5 tt0 -72.42 139.34 47.72 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 122.979 0.512 . . . . 15.0 110.215 176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 16.5 ptp180 -82.75 76.94 9.57 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.056 -1.09 . . . . 15.0 108.056 168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.84 132.92 47.56 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 109.169 -0.678 . . . . 15.0 109.169 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 82.4 mt -56.22 134.55 75.24 Favored Pre-proline 0 CA--C 1.545 0.771 0 O-C-N 124.529 1.143 . . . . 15.0 110.766 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 72.0 Cg_endo -70.73 -169.19 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.988 2.459 . . . . 15.0 111.688 -175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.34 156.67 28.38 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.04 0.536 . . . . 15.0 110.681 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 21.9 tp -128.67 19.6 6.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 107.579 -1.267 . . . . 15.0 107.579 168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.2 m -69.96 163.98 24.86 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.206 1.402 . . . . 15.0 110.439 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -44.44 -49.25 9.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.899 1.28 . . . . 15.0 112.975 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -69.22 -22.9 63.84 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.87 -52.52 8.19 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.64 0.733 . . . . 15.0 109.529 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 10.2 tp -71.81 -22.05 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 115.327 -0.851 . . . . 15.0 111.345 -171.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -87.92 -14.21 39.88 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 122.244 -0.285 . . . . 15.0 111.585 171.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.73 -27.1 68.07 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.705 0.802 . . . . 15.0 111.298 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -61.29 -31.95 71.79 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.271 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.85 22.37 8.94 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.614 -0.721 . . . . 15.0 112.01 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.29 149.31 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 123.553 0.741 . . . . 15.0 109.291 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -52.62 -33.22 45.64 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.814 1.246 . . . . 15.0 112.304 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -149.01 155.65 41.11 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.163 0.585 . . . . 15.0 109.425 172.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -74.69 80.7 0.9 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 123.602 0.564 . . . . 15.0 112.403 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.4 p -130.6 122.89 28.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.952 0.901 . . . . 15.0 109.62 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.34 -51.57 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.649 0.78 . . . . 15.0 110.284 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.93 -16.25 58.51 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.424 -0.807 . . . . 15.0 112.02 172.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.33 -28.12 45.64 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.557 -0.617 . . . . 15.0 111.557 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 57.3 tp -79.69 -29.67 40.83 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 109.339 -0.615 . . . . 15.0 109.339 173.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.439 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.0 mtp85 -67.34 -40.99 85.91 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.865 0.466 . . . . 15.0 109.842 173.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.54 -30.01 61.59 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.537 0.735 . . . . 15.0 111.264 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.613 ' HA ' ' HZ2' ' A' ' 272' ' ' LYS . 16.7 tp10 -60.29 -59.44 5.4 Favored 'General case' 0 C--O 1.253 1.271 0 C-N-CA 124.314 1.046 . . . . 15.0 109.804 173.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 45.0 t -52.9 -53.48 21.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.345 175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 275' ' ' GLU . 15.5 tpt180 -55.7 -57.53 11.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.15 0.58 . . . . 15.0 111.771 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.613 ' HZ2' ' HA ' ' A' ' 269' ' ' GLU . 22.1 pttm -66.77 -39.08 87.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.785 0.434 . . . . 15.0 111.519 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.95 -45.39 70.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.383 -0.599 . . . . 15.0 109.383 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.412 ' HG2' HD21 ' B' ' 278' ' ' LEU . 45.3 mtt -61.09 -41.71 97.16 Favored 'General case' 0 C--O 1.179 -2.652 0 CA-C-O 117.679 -1.153 . . . . 15.0 111.361 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 271' ' ' ARG . 50.3 mt-10 -54.3 -39.21 66.77 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.923 1.238 . . . . 15.0 111.231 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -57.8 5.04 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.9 0.88 . . . . 15.0 111.151 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -31.1 72.17 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.035 0.534 . . . . 15.0 112.163 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.12 -32.13 33.94 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.395 1.078 . . . . 15.0 110.232 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 38.2 ttpt -58.09 -45.18 87.61 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 15.0 109.276 170.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.8 t -66.2 -37.21 85.04 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.004 0.922 . . . . 15.0 110.989 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -65.49 -52.23 54.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.392 0.677 . . . . 15.0 112.355 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 130' ' ' VAL . 67.1 mt -65.11 -31.44 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.877 0.871 . . . . 15.0 109.635 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 20.4 tpt180 -58.08 -58.91 6.36 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 109.145 -0.687 . . . . 15.0 109.145 175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -67.17 -23.15 65.74 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.885 0.74 . . . . 15.0 111.933 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -61.65 1.72 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.115 0.566 . . . . 15.0 110.824 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.71 -37.63 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.205 0.602 . . . . 15.0 109.829 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.3 tttt -60.96 -49.66 76.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.365 1.066 . . . . 15.0 111.146 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 77.8 p -67.54 -38.12 83.72 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.556 0.342 . . . . 15.0 111.298 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -69.85 -31.99 70.14 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.777 0.431 . . . . 15.0 110.714 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -67.18 -48.06 69.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.251 0.62 . . . . 15.0 110.901 175.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.553 HD12 HG13 ' A' ' 347' ' ' VAL . 31.1 mm -63.97 -39.54 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.318 1.011 . . . . 15.0 110.227 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.495 ' HA ' HH21 ' A' ' 343' ' ' ARG . 15.5 tp10 -61.24 -53.51 55.99 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.056 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -65.49 -32.97 85.09 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 124.085 0.865 . . . . 15.0 113.641 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.576 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -68.04 -55.44 12.57 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 -176.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 62.9 t -65.24 -37.94 81.4 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 O-C-N 123.922 0.764 . . . . 15.0 110.07 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -56.28 -40.54 74.44 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.772 0.829 . . . . 15.0 111.24 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -84.8 -18.33 35.32 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.708 -0.678 . . . . 15.0 112.645 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.412 ' HB3' HD22 ' A' ' 350' ' ' LEU . 33.9 m-80 -145.88 106.69 4.12 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.677 -0.49 . . . . 15.0 109.677 -166.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -113.23 143.12 44.95 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.349 -0.982 . . . . 15.0 108.349 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 115' ' ' VAL . 7.5 tp -135.58 134.32 51.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 107.686 -1.227 . . . . 15.0 107.686 173.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -74.77 110.07 8.76 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.546 -0.909 . . . . 15.0 108.546 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 345' ' ' VAL . 96.3 t -72.05 142.23 84.91 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 114.789 -1.096 . . . . 15.0 110.726 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.413 ' HG3' HD23 ' A' ' 11' ' ' LEU . 82.2 Cg_exo -50.01 131.32 29.97 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.773 2.316 . . . . 15.0 112.218 165.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.31 67.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.108 0.963 . . . . 15.0 112.126 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.24 -50.34 71.59 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.399 0.68 . . . . 15.0 110.44 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.498 ' HG ' ' HB1' ' A' ' 87' ' ' ALA . 95.2 mt -58.77 -48.42 81.31 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-N 115.259 -0.882 . . . . 15.0 110.692 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 311' ' ' ILE . 56.1 mt -59.55 -63.43 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 124.018 0.824 . . . . 15.0 110.343 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -49.71 25.35 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 124.795 1.238 . . . . 15.0 112.472 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 313' ' ' VAL . 49.6 m -58.9 -50.4 74.18 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.51 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.424 ' HG3' ' HE1' ' B' ' 297' ' ' TYR . 28.0 mm-40 -73.47 -26.9 61.12 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.477 0.547 . . . . 15.0 112.477 -175.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.511 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 96.9 mt -58.71 -53.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 107.301 -1.37 . . . . 15.0 107.301 170.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.59 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 32.5 t70 -61.51 -38.94 89.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.601 -1.181 . . . . 15.0 111.581 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 309' ' ' SER . 96.9 t -61.42 -44.67 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 122.88 0.472 . . . . 15.0 110.662 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.51 -31.04 71.89 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 122.797 0.439 . . . . 15.0 111.324 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.644 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 63.0 mtm180 -71.09 -32.69 69.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.168 0.587 . . . . 15.0 110.706 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 66.7 mtt180 -69.56 -43.96 71.85 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.137 0.575 . . . . 15.0 109.943 175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.77 -37.2 78.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.369 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -66.72 -57.02 7.97 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.356 -0.838 . . . . 15.0 110.486 174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 322' ' ' PHE . . . -60.14 -25.42 65.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.771 1.228 . . . . 15.0 112.401 -174.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.28 -43.91 71.43 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.861 1.265 . . . . 15.0 110.415 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -96.72 -28.54 14.25 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.173 0.589 . . . . 15.0 110.845 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.558 ' HB3' ' HA ' ' A' ' 319' ' ' ALA . 78.3 t80 -81.13 77.69 8.0 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.417 1.087 . . . . 15.0 108.484 177.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 86.06 -33.58 3.55 Favored Glycine 0 CA--C 1.538 1.469 0 CA-C-N 114.977 -1.01 . . . . 15.0 114.055 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 86.85 47.19 4.87 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 110.891 -0.884 . . . . 15.0 110.891 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -101.37 124.01 46.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.416 0.687 . . . . 15.0 110.9 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -71.99 110.86 6.77 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.503 1.121 . . . . 15.0 111.72 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm 64.27 8.51 4.2 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 114.191 1.182 . . . . 15.0 114.191 168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? -67.83 -16.9 64.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.113 0.965 . . . . 15.0 109.093 164.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -41.22 -41.25 1.8 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.171 1.788 . . . . 15.0 113.18 168.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.42 -28.35 53.63 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.283 1.033 . . . . 15.0 112.667 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -77.14 -29.81 54.84 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.692 0.797 . . . . 15.0 111.909 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 90.7 mt -61.3 125.81 84.94 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 122.654 0.382 . . . . 15.0 110.299 -172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.43 ' HB2' ' HG ' ' A' ' 336' ' ' LEU . 80.1 Cg_exo -48.56 127.23 15.7 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.864 3.042 . . . . 15.0 114.485 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.489 ' HG3' HD13 ' A' ' 311' ' ' ILE . 27.3 ttt85 -49.21 -55.82 11.28 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.569 1.548 . . . . 15.0 112.884 -169.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -60.76 -22.04 63.65 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.601 -1.181 . . . . 15.0 112.989 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 73.5 mt -65.27 -23.11 66.96 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 117.989 0.359 . . . . 15.0 110.762 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.426 ' HB2' HG23 ' A' ' 311' ' ' ILE . 93.9 m-85 -121.13 -22.7 6.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.311 0.644 . . . . 15.0 111.856 -176.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.99 -38.15 85.49 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.092 0.557 . . . . 15.0 111.947 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -52.72 -37.91 59.9 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 124.426 1.079 . . . . 15.0 111.323 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 10.9 pt20 -94.1 -34.6 12.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 119.046 -0.502 . . . . 15.0 110.96 174.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -58.42 -62.35 1.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.233 0.613 . . . . 15.0 111.339 -173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.504 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.5 tttt -56.71 -38.47 72.36 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 123.983 0.802 . . . . 15.0 110.235 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 347' ' ' VAL . 2.3 tmt_? -60.22 -41.44 93.07 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.289 0.993 . . . . 15.0 110.447 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 96.2 mtt-85 -69.07 -36.22 77.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.82 0.448 . . . . 15.0 109.968 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 302' ' ' VAL . 3.5 t -70.2 -38.12 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 109.95 -0.389 . . . . 15.0 109.95 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 61.0 t -57.03 -48.2 82.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 N-CA-C 109.025 -0.731 . . . . 15.0 109.025 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.553 HG13 HD12 ' A' ' 291' ' ' ILE . 98.6 t -48.29 -49.21 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.934 0.893 . . . . 15.0 110.813 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -66.66 -36.15 90.89 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-N 114.581 -1.19 . . . . 15.0 114.418 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 345' ' ' VAL . 60.7 mt -76.23 -34.02 59.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.832 0.453 . . . . 15.0 110.889 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.576 HD13 HD22 ' A' ' 294' ' ' LEU . 91.4 mt -67.46 -56.51 9.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.574 0.75 . . . . 15.0 109.435 178.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.485 ' HB2' ' HE1' ' B' ' 298' ' ' HIS . 95.6 mt -62.4 -35.79 80.3 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.054 -0.976 . . . . 15.0 110.837 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.17 -37.99 94.71 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 123.658 0.599 . . . . 15.0 112.31 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -67.0 -39.79 87.2 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.767 0.427 . . . . 15.0 110.73 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 411' ' ' VAL . 95.0 t -65.33 -34.57 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.053 0.541 . . . . 15.0 110.413 175.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 360' ' ' LEU . 52.9 mt -64.05 -47.04 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.234 0.614 . . . . 15.0 110.149 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -61.29 -56.49 19.93 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 123.566 0.541 . . . . 15.0 110.499 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 28.9 m -56.23 -44.39 79.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.215 1.006 . . . . 15.0 112.296 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -96.58 14.17 25.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.521 0.729 . . . . 15.0 111.255 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 44.18 33.52 0.83 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 125.414 1.486 . . . . 15.0 113.766 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 355' ' ' ILE . 76.5 mt -63.73 152.02 40.4 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.628 0.771 . . . . 15.0 112.256 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HA ' HD12 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -141.79 166.33 25.02 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.743 1.217 . . . . 15.0 108.797 171.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -67.86 95.97 0.55 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.22 111.11 1.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 15.0 111.011 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -56.9 -31.31 64.76 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.971 0.794 . . . . 15.0 113.031 -173.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.7 -38.54 91.5 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.658 0.742 . . . . 15.0 110.093 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.551 ' NH2' ' HB2' ' A' ' 405' ' ' GLU . 20.7 ttt180 -76.41 -43.34 40.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.329 -1.305 . . . . 15.0 110.716 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.29 -44.91 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.326 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -59.52 -52.12 66.92 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.252 -0.886 . . . . 15.0 110.544 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -50.93 -48.47 45.2 Favored Glycine 0 C--N 1.356 1.654 0 O-C-N 124.092 0.87 . . . . 15.0 113.375 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.08 -54.3 48.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.143 0.577 . . . . 15.0 110.892 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.59 -29.14 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.703 0.801 . . . . 15.0 112.258 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -83.63 -43.83 15.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.907 0.483 . . . . 15.0 111.202 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.64 -40.89 89.12 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.185 0.517 . . . . 15.0 109.938 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.479 ' HG2' ' HE1' ' A' ' 378' ' ' TYR . 43.6 ttp -61.97 -55.95 24.17 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.539 -1.21 . . . . 15.0 110.86 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -66.52 -28.7 68.76 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.913 0.885 . . . . 15.0 112.129 -172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.8 t -58.42 -23.19 56.64 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.84 0.856 . . . . 15.0 112.128 175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -78.29 -33.28 49.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.418 0.687 . . . . 15.0 111.321 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.479 ' HE1' ' HG2' ' A' ' 374' ' ' MET . 41.2 m-85 -78.06 160.21 28.24 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.962 0.505 . . . . 15.0 111.284 -172.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.99 -45.33 92.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.602 1.161 . . . . 15.0 110.204 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -135.03 111.59 11.08 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.123 -0.944 . . . . 15.0 109.495 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.452 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 61.0 Cg_exo -56.73 -41.35 76.59 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.887 2.391 . . . . 15.0 112.861 174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -61.08 -43.63 98.59 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.927 -1.033 . . . . 15.0 111.806 -166.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.64 -26.27 66.99 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.872 0.469 . . . . 15.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 31.9 t -82.46 -39.24 15.91 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 N-CA-C 109.375 -0.602 . . . . 15.0 109.375 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 82.6 mt -62.0 -40.71 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.871 0.869 . . . . 15.0 109.561 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.96 -48.05 80.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.935 -1.03 . . . . 15.0 110.252 172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.484 ' HE2' HG21 ' B' ' 288' ' ' VAL . 26.5 t80 -58.94 -30.09 67.61 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 123.73 0.644 . . . . 15.0 111.404 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 398' ' ' MET . 8.3 m-85 -65.36 -58.45 5.85 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.491 -0.559 . . . . 15.0 109.491 170.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 62.7 p -65.86 -12.8 57.23 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.015 0.746 . . . . 15.0 113.015 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.04 -9.16 15.08 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.862 0.865 . . . . 15.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 387' ' ' PHE . 27.6 t-20 -142.29 89.68 2.18 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -70.57 -11.44 60.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.194 -0.912 . . . . 15.0 111.182 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -58.75 -32.46 69.28 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.269 0.627 . . . . 15.0 110.198 170.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.65 -38.14 9.24 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 123.449 0.7 . . . . 15.0 111.446 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 399' ' ' ARG . 0.0 OUTLIER -61.9 -52.19 65.09 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.098 0.559 . . . . 15.0 109.83 -176.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.67 -35.76 77.04 Favored 'General case' 0 N--CA 1.483 1.2 0 O-C-N 123.968 0.793 . . . . 15.0 110.608 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 401' ' ' VAL . 11.2 t30 -59.53 -65.74 0.62 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.463 0.305 . . . . 15.0 110.318 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.406 ' HB3' ' HE2' ' A' ' 388' ' ' TYR . 59.8 tpp -60.66 -35.76 77.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.599 0.562 . . . . 15.0 111.712 -176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.477 ' HD2' ' SD ' ' A' ' 395' ' ' MET . 44.3 ttt180 -72.9 -36.08 67.23 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.319 0.648 . . . . 15.0 110.885 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.616 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 15.3 m-80 -87.76 -10.08 52.07 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.693 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.467 HG11 HD21 ' B' ' 291' ' ' LEU . 41.0 t -76.02 -43.5 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.555 -0.906 . . . . 15.0 108.555 166.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -54.0 -55.99 22.05 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 114.92 -1.036 . . . . 15.0 109.03 170.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 62.2 tp -60.74 -37.11 80.69 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 114.788 -1.097 . . . . 15.0 112.505 177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 4.3 tp10 -57.16 -63.76 1.11 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.608 0.718 . . . . 15.0 110.058 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.551 ' HB2' ' NH2' ' A' ' 366' ' ' ARG . 51.6 mt-10 -71.72 -25.33 62.02 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 114.119 -1.4 . . . . 15.0 110.284 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -65.24 -45.17 85.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.586 0.754 . . . . 15.0 110.411 172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.63 84.29 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.549 -0.751 . . . . 15.0 110.209 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 404' ' ' GLU . 91.9 t -62.75 -50.3 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.838 0.711 . . . . 15.0 110.076 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 47.1 mt-10 -68.76 -22.05 64.32 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.76 0.824 . . . . 15.0 112.002 -177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -70.32 -27.27 64.25 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.284 0.365 . . . . 15.0 111.058 171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 294' ' ' LEU . 26.9 t -82.07 -36.18 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 108.755 -0.831 . . . . 15.0 108.755 173.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 409' ' ' GLU . 83.0 mt -64.05 -31.24 72.36 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.817 0.847 . . . . 15.0 111.34 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -64.41 -31.91 73.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.76 0.824 . . . . 15.0 111.002 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -86.5 -32.01 21.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.138 0.975 . . . . 15.0 110.481 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -86.67 -172.58 4.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.575 1.15 . . . . 15.0 111.576 -173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -108.52 101.08 10.28 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.892 0.877 . . . . 15.0 109.871 176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.18 89.34 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 108.319 -0.993 . . . . 15.0 108.319 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 5.9 t -80.06 113.61 18.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.625 -0.716 . . . . 15.0 110.213 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.34 143.64 27.76 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.2 0.6 . . . . 15.0 110.817 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -138.86 138.17 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.698 -0.853 . . . . 15.0 108.698 164.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.589 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 27.4 mt-10 -90.25 141.18 28.96 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.359 0.664 . . . . 15.0 109.911 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.7 t -162.83 178.3 8.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.972 0.509 . . . . 15.0 111.315 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 30.7 p -99.21 178.83 4.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.237 1.015 . . . . 15.0 110.894 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.408 ' HA ' ' CG1' ' A' ' 130' ' ' VAL . 49.7 t80 -66.04 -20.31 66.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.247 1.019 . . . . 15.0 112.018 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -53.23 -35.91 60.47 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.644 0.778 . . . . 15.0 111.865 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -51.39 -40.97 60.35 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.508 1.123 . . . . 15.0 112.026 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 31.1 tp -79.49 -43.07 23.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.609 -1.178 . . . . 15.0 111.264 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 83.5 mmm -75.81 -33.47 60.1 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.976 -0.556 . . . . 15.0 112.212 -170.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -83.15 47.99 1.31 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.894 0.478 . . . . 15.0 110.325 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -129.13 91.29 3.17 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.957 0.903 . . . . 15.0 108.869 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -96.79 26.19 4.72 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.638 0.775 . . . . 15.0 110.074 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.764 1.225 . . . . 15.0 108.191 175.006 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 67.13 -79.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.213 1.405 . . . . 0.0 110.503 -174.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -158.98 130.46 6.34 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.48 102.58 0.72 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.229 0.612 . . . . 0.0 110.353 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.87 106.88 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 29.1 m -66.72 91.12 0.18 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.469 0.708 . . . . 0.0 110.536 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.3 mt -120.11 175.11 6.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.379 1.072 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 222' ' ' HIS . . . 92.42 -59.11 2.64 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.01 -63.48 4.21 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 66.98 42.43 92.67 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.683 0.284 . . . . 0.0 112.875 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -66.26 142.13 57.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.554 0.742 . . . . 0.0 111.931 -175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 225' ' ' ASN . 13.3 mptt -92.9 -61.47 1.58 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.537 0.735 . . . . 0.0 110.114 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.8 t -89.78 63.31 6.07 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.788 0.804 . . . . 0.0 110.513 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . 2.8 m-85 65.26 133.11 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.538 1.535 . . . . 0.0 113.049 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.78 -46.55 24.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 165.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -156.04 151.78 27.26 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 174.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 2.7 m -77.88 -8.58 58.27 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.848 0.459 . . . . 0.0 112.06 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 66.11 45.69 2.3 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.427 1.091 . . . . 0.0 108.602 -169.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.58 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 23.1 m -72.62 88.76 1.28 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.612 -167.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -84.62 81.6 8.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 164.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -71.84 -44.31 47.72 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.462 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 34.9 mm-40 53.56 26.43 5.66 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.067 1.347 . . . . 0.0 114.42 176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.503 ' HZ2' ' HB3' ' A' ' 184' ' ' ASP . 98.8 m95 -87.79 74.7 9.04 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -68.37 114.3 6.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.414 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.49 -13.41 71.04 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.489 0.493 . . . . 0.0 113.593 -174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt 57.73 35.01 25.14 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.325 1.45 . . . . 0.0 111.172 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.54 HG23 ' HB2' ' B' ' 248' ' ' ARG . 5.9 t -82.16 173.56 12.01 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.673 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.42 -4.73 23.94 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.815 0.846 . . . . 0.0 111.803 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.548 ' HA ' ' HB2' ' B' ' 252' ' ' GLN . 12.7 mpt_? -64.89 -46.46 81.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.841 0.456 . . . . 0.0 110.211 166.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -73.05 -15.55 61.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.377 0.671 . . . . 0.0 111.877 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -101.28 -75.82 0.58 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.593 0.757 . . . . 0.0 111.06 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.633 ' HA ' ' H ' ' B' ' 257' ' ' GLN . . . -81.63 -25.92 35.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.956 0.902 . . . . 0.0 113.412 -169.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . 0.548 ' HB2' ' HA ' ' B' ' 248' ' ' ARG . 26.0 mm-40 -103.55 4.0 35.32 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.77 0.428 . . . . 0.0 111.288 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.45 3.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.663 0.785 . . . . 0.0 111.492 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -148.29 16.35 1.04 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.635 0.774 . . . . 0.0 110.862 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 129.69 162.09 10.72 Favored Glycine 0 C--O 1.244 0.726 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -169.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -70.32 91.38 0.74 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.703 0.801 . . . . 0.0 111.801 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . 0.633 ' H ' ' HA ' ' B' ' 251' ' ' ALA . 90.0 mt-30 74.38 -68.78 0.2 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.927 1.691 . . . . 0.0 111.443 170.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 7.7 tt -145.18 116.02 7.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.77 135.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.393 0.677 . . . . 0.0 109.242 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 22.5 p -154.83 78.05 1.04 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.002 0.521 . . . . 0.0 110.517 -176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 56.72 74.33 0.41 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.347 1.059 . . . . 0.0 111.882 173.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -67.7 -28.01 67.31 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.795 0.438 . . . . 0.0 110.851 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -69.82 -43.3 72.28 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 171.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.1 m 73.48 -64.2 0.4 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.475 1.51 . . . . 0.0 111.355 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.8 tt -63.91 98.21 0.19 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.9 -65.8 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.077 1.751 . . . . 0.0 111.476 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 23.1 m 77.31 -28.47 0.17 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.746 1.619 . . . . 0.0 112.643 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.48 117.13 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 125.863 1.665 . . . . 0.0 112.027 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 81.7 p -74.41 151.95 39.59 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.132 0.573 . . . . 0.0 110.735 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -96.94 4.01 51.78 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.984 0.514 . . . . 0.0 111.609 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.404 ' HA ' ' HA3' ' B' ' 279' ' ' GLY . . . -94.04 -86.43 0.27 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.761 0.425 . . . . 0.0 110.929 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -140.12 -51.32 0.49 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.884 0.874 . . . . 0.0 109.307 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -173.87 -37.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.576 1.55 . . . . 0.0 107.463 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -79.3 121.76 25.5 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.553 1.141 . . . . 0.0 108.648 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -72.38 -51.51 7.55 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 117.359 -1.305 . . . . 0.0 114.43 -171.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -24.58 -60.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.495 1 C-N-CA 125.56 4.174 . . . . 0.0 117.886 -169.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.63 ' HG ' HD12 ' B' ' 278' ' ' LEU . 2.3 pt? -158.61 -175.55 5.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.635 0.374 . . . . 0.0 110.92 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.63 HD12 ' HG ' ' B' ' 277' ' ' LEU . 5.3 mp 80.51 179.76 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.059 1.743 . . . . 0.0 113.102 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . 0.437 ' HA2' ' HA3' ' B' ' 284' ' ' GLY . . . 88.25 -53.91 4.18 Favored Glycine 0 C--N 1.359 1.86 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.426 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.15 -11.53 59.83 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.005 0.922 . . . . 0.0 112.053 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -68.55 -46.8 68.52 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.901 0.481 . . . . 0.0 111.364 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.4 -75.79 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.052 0.541 . . . . 0.0 110.052 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.59 157.28 16.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.975 0.91 . . . . 0.0 109.327 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . 0.437 ' HA3' ' HA2' ' B' ' 279' ' ' GLY . . . 137.29 137.45 3.61 Favored Glycine 0 C--N 1.34 0.781 0 O-C-N 123.836 0.71 . . . . 0.0 111.45 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -169.68 167.13 9.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.129 0.972 . . . . 0.0 109.142 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.657 ' H ' ' HD2' ' B' ' 287' ' ' PRO . 12.6 tpt -166.11 -36.85 0.0 OUTLIER Pre-proline 0 CA--C 1.567 1.605 0 C-N-CA 124.129 0.972 . . . . 0.0 112.619 -173.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.657 ' HD2' ' H ' ' B' ' 286' ' ' MET . 92.2 Cg_endo -76.7 49.35 2.69 Favored 'Trans proline' 0 C--N 1.395 3.022 0 CA-C-N 122.027 1.76 . . . . 0.0 113.433 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.484 HG21 ' HE2' ' A' ' 387' ' ' PHE . 17.9 m 47.16 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 126.71 2.004 . . . . 0.0 113.186 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' B' ' 289' ' ' ARG . 13.9 mmt180 79.41 -48.71 0.39 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.469 1.508 . . . . 0.0 111.369 177.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . . . . . . . . . 68.8 m95 65.38 -155.27 0.28 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.305 1.042 . . . . 0.0 111.046 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.664 ' H ' HD23 ' B' ' 291' ' ' LEU . 1.3 pt? -62.46 89.31 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.729 0.776 . . . . 0.0 111.006 175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.66 64.56 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-N 114.133 -1.394 . . . . 0.0 115.156 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.7 60.9 4.43 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.593 2.196 . . . . 0.0 112.706 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -78.29 156.39 29.67 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.006 0.923 . . . . 0.0 108.83 173.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.52 -75.72 0.22 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 32.1 m 62.36 -101.3 0.1 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.491 1.516 . . . . 0.0 110.88 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.55 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 86.5 m-85 52.28 17.71 0.78 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 119.935 1.243 . . . . 0.0 112.298 -171.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.485 ' HE1' ' HB2' ' A' ' 351' ' ' LEU . 22.9 m-70 -85.55 155.12 21.31 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -63.86 125.13 32.14 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 167.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.63 95.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.023 0.916 . . . . 0.0 109.53 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 361' ' ' LYS . 7.7 pt -93.61 22.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.76 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.46 137.85 58.3 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 303' ' ' LYS . 0.1 OUTLIER -146.1 93.72 5.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.446 0.698 . . . . 0.0 110.257 -176.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -91.33 -173.03 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.421 2.747 . . . . 0.0 111.78 172.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -68.94 101.85 1.46 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.38 129.79 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.348 0.659 . . . . 0.0 111.262 -174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.3 m -151.7 152.25 32.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.7 1.2 . . . . 0.0 108.16 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 17.1 p -67.08 84.83 0.13 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.879 0.872 . . . . 0.0 110.735 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 27.5 m -75.04 -41.71 4.13 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 124.301 1.04 . . . . 0.0 112.675 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 C--N 1.389 2.671 0 C-N-CA 122.059 1.839 . . . . 12.53 111.961 172.64 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.112 0.482 . . . . 15.0 109.795 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 6.0 tt0 -62.72 98.81 0.13 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.096 0.958 . . . . 15.0 110.73 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.462 HG12 HG12 ' A' ' 17' ' ' ILE . 31.2 m -87.07 136.29 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 122.764 0.426 . . . . 15.0 110.362 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -145.97 100.43 3.4 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.686 0.795 . . . . 15.0 109.391 177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.97 133.11 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.915 -0.584 . . . . 15.0 110.727 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.82 155.78 35.9 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.305 1.042 . . . . 15.0 109.202 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 m -120.38 105.19 10.66 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.382 0.673 . . . . 15.0 109.3 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -102.2 -57.27 2.09 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.587 0.755 . . . . 15.0 111.29 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -107.5 27.25 9.31 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 124.84 1.256 . . . . 15.0 110.176 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.67 -86.75 0.63 Allowed Glycine 0 C--N 1.35 1.317 0 O-C-N 121.983 -0.448 . . . . 15.0 112.294 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.6 -37.9 77.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -71.59 89.63 0.45 Allowed Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.997 -1.001 . . . . 15.0 111.682 171.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -90.47 -168.97 2.24 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.707 0.803 . . . . 15.0 111.207 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HD3' ' HB3' ' A' ' 106' ' ' SER . 38.1 ttm180 -151.48 146.41 25.9 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.002 1.321 . . . . 15.0 107.835 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.2 t -128.4 103.85 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 168.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -85.41 112.78 21.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.39 1.076 . . . . 15.0 109.316 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG12 HG12 ' A' ' 3' ' ' VAL . 56.3 mt -111.86 111.63 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.226 0.61 . . . . 15.0 109.95 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 31.9 m -86.11 94.44 9.26 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 168.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 49.9 mt -74.53 120.54 24.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.215 -1.031 . . . . 15.0 108.215 173.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 148.92 51.0 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.468 0.707 . . . . 15.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.71 -39.81 59.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.969 1.308 . . . . 15.0 113.345 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.81 -39.48 91.91 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.051 0.844 . . . . 15.0 111.151 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -71.7 -38.7 70.51 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.164 0.586 . . . . 15.0 110.812 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.6 mt -65.69 -51.26 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.864 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.93 -37.38 87.2 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.36 1.064 . . . . 15.0 111.506 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.8 m -60.72 -44.34 96.73 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.589 0.556 . . . . 15.0 110.086 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -35.5 76.97 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.599 -0.728 . . . . 15.0 112.003 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 24' ' ' ILE . 85.1 t -68.16 -47.76 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.336 0.654 . . . . 15.0 109.965 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 52' ' ' ASN . 4.2 ttmp? -65.71 -33.4 75.79 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.747 -1.115 . . . . 15.0 110.582 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 53.8 m -81.96 -20.75 37.93 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.621 0.768 . . . . 15.0 111.14 175.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.39 -40.28 62.14 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.513 -0.551 . . . . 15.0 109.513 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 55' ' ' ALA . 70.8 mt -67.5 -23.44 65.47 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.287 0.847 . . . . 15.0 113.287 -173.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG22 ' HE3' ' A' ' 37' ' ' LYS . 11.9 p -74.16 -32.66 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.424 -0.584 . . . . 15.0 109.424 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -68.19 -46.59 70.25 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.369 0.667 . . . . 15.0 109.496 173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.04 -34.94 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.881 -1.054 . . . . 15.0 110.466 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.08 -43.63 91.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.272 0.629 . . . . 15.0 110.855 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 33' ' ' VAL . 98.9 mttt -68.17 -32.41 72.65 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 15.0 111.587 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -65.53 -57.25 8.68 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.481 0.713 . . . . 15.0 110.279 176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.28 -0.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.495 0 C-N-CA 123.706 0.802 . . . . 15.0 111.105 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 74.48 8.94 4.4 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.76 1.624 . . . . 15.0 112.609 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.31 -31.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.692 1.197 . . . . 15.0 111.31 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.79 -36.18 78.34 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.288 1.035 . . . . 15.0 111.755 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.25 -25.84 75.06 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.748 -0.66 . . . . 15.0 112.389 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.66 -16.21 21.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.785 0.834 . . . . 15.0 110.367 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -76.75 100.0 5.3 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 123.189 0.596 . . . . 15.0 110.24 -177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -74.29 -35.3 63.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.653 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.05 16.04 31.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.268 -0.878 . . . . 15.0 112.336 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -62.36 -41.0 98.26 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.681 0.792 . . . . 15.0 109.85 174.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.22 113.67 56.1 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 15.0 108.51 170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD2' HD12 ' A' ' 53' ' ' ILE . 98.9 Cg_exo -48.94 152.03 5.05 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.678 2.919 . . . . 15.0 114.136 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.0 tpt -74.32 -22.21 59.36 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.004 0.922 . . . . 15.0 111.618 -172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.605 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 27.2 p-10 -71.3 -35.07 71.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.304 0.242 . . . . 15.0 111.116 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 50' ' ' PRO . 54.0 mt -62.35 -47.28 93.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.681 0.792 . . . . 15.0 109.898 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 m -74.54 -24.26 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 116.575 -0.284 . . . . 15.0 111.04 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . . . -70.19 -40.05 74.86 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.882 0.473 . . . . 15.0 111.983 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -86.11 -21.34 27.68 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.949 0.5 . . . . 15.0 111.619 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.93 -65.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.11 0.564 . . . . 15.0 111.326 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -70.2 -37.72 75.14 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.033 0.533 . . . . 15.0 110.591 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.16 -6.03 87.45 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.201 -0.909 . . . . 15.0 114.014 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.02 74.86 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.346 0.658 . . . . 15.0 111.101 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 p -94.04 -7.89 41.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.046 0.938 . . . . 15.0 111.713 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -98.93 -5.83 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.471 0.708 . . . . 15.0 110.28 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 15.1 mmt180 -52.89 -43.45 66.16 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.87 0.868 . . . . 15.0 111.32 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -53.9 -51.17 64.58 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.81 1.244 . . . . 15.0 111.631 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.94 -46.23 85.37 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.162 0.914 . . . . 15.0 110.557 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 28' ' ' VAL . 62.3 t -62.78 -43.14 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.083 -0.962 . . . . 15.0 110.495 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 96.8 mt -60.68 -43.0 98.23 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.624 0.77 . . . . 15.0 111.176 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.12 -42.27 99.73 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 123.882 0.739 . . . . 15.0 112.125 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -67.68 -35.58 79.1 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.329 1.052 . . . . 15.0 111.213 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.0 mt -70.11 -36.5 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.408 0.683 . . . . 15.0 110.662 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 68.3 mtm -70.98 -14.73 62.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.57 0.348 . . . . 15.0 111.673 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.7 t -89.74 -56.92 3.05 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.053 0.541 . . . . 15.0 109.885 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -71.75 -42.34 67.33 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.302 0.641 . . . . 15.0 112.474 -171.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.69 -29.47 64.62 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.677 0.217 . . . . 15.0 110.835 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.02 -53.28 32.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.773 0.429 . . . . 15.0 111.08 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.6 tt -63.57 -34.49 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 O-C-N 123.379 0.425 . . . . 15.0 110.479 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.69 -40.39 92.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.924 0.49 . . . . 15.0 110.542 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 81' ' ' LYS . . . -65.14 -53.19 48.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.519 0.728 . . . . 15.0 111.702 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.2 pt -61.27 -27.27 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 112.407 0.521 . . . . 15.0 112.407 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.1 mt -70.5 -50.84 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.47 0.708 . . . . 15.0 110.55 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 78' ' ' ALA . 16.9 ptpt -70.44 -32.31 69.83 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.297 0.239 . . . . 15.0 110.621 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -77.88 -23.2 48.85 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.89 0.876 . . . . 15.0 111.014 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 68.56 15.22 9.13 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.991 1.317 . . . . 15.0 112.338 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 60.5 mt -87.51 102.35 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.573 -0.899 . . . . 15.0 108.573 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -80.98 110.02 15.88 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 124.064 0.945 . . . . 15.0 110.341 -173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -64.94 154.94 70.72 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.416 2.744 . . . . 15.0 114.872 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 169.62 24.38 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.718 1.607 . . . . 15.0 108.103 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.48 -144.26 38.58 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.353 0.408 . . . . 15.0 112.558 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -104.97 120.83 48.65 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 123.656 0.782 . . . . 15.0 110.275 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.79 107.29 1.83 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.347 2.032 . . . . 15.0 110.977 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 47.6 m -94.31 92.38 7.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.788 1.235 . . . . 15.0 109.96 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -78.09 101.92 7.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.237 0.615 . . . . 15.0 109.889 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.6 t -107.5 90.98 6.5 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.95 140.59 25.79 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.082 1.855 . . . . 15.0 111.668 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.86 -76.29 0.65 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.012 -0.835 . . . . 15.0 111.012 174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -172.73 162.53 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.075 0.95 . . . . 15.0 110.17 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.418 ' HD1' ' HB2' ' A' ' 103' ' ' PHE . 62.7 t80 -122.96 140.6 52.84 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.578 0.751 . . . . 15.0 109.123 170.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 90.4 mttt -113.68 145.06 41.9 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.566 -1.272 . . . . 15.0 107.566 170.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -58.25 112.65 1.62 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.17 0.588 . . . . 15.0 111.308 -174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.98 18.46 77.73 Favored Glycine 0 C--N 1.349 1.293 0 O-C-N 124.071 0.857 . . . . 15.0 113.619 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.702 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 45.4 mt-10 -120.78 -169.91 1.91 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.513 1.125 . . . . 15.0 109.536 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -74.59 158.43 33.7 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.167 0.587 . . . . 15.0 111.885 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' HB2' ' HD1' ' A' ' 97' ' ' TYR . 60.7 t80 -134.72 104.5 6.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.329 1.051 . . . . 15.0 109.198 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 28.0 m -95.36 130.73 42.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.615 0.766 . . . . 15.0 109.143 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -140.03 139.89 36.08 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.135 0.574 . . . . 15.0 109.906 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB3' ' HD3' ' A' ' 14' ' ' ARG . 49.1 m -110.53 96.61 6.3 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.743 1.217 . . . . 15.0 110.293 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.36 107.19 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 109.152 -0.685 . . . . 15.0 109.152 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -86.18 130.1 34.63 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.138 0.575 . . . . 15.0 109.824 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -152.18 154.85 36.64 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.48 -0.933 . . . . 15.0 108.48 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 24.0 mt-10 -93.46 174.28 7.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.81 -0.632 . . . . 15.0 109.555 -177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 32.8 m -127.39 159.47 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 122.595 0.358 . . . . 15.0 110.411 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -78.57 110.94 15.73 Favored Pre-proline 0 C--O 1.244 0.79 0 N-CA-C 108.621 -0.881 . . . . 15.0 108.621 169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.414 ' HB2' HD11 ' A' ' 300' ' ' ILE . 78.8 Cg_endo -77.93 145.58 22.52 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 121.714 1.609 . . . . 15.0 111.345 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.57 105.73 0.68 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 60.2 t -77.98 111.38 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.101 -171.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.99 89.65 1.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.511 0.724 . . . . 15.0 111.05 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 120' ' ' LEU . 36.7 mt -81.48 123.37 28.55 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.029 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -158.1 154.64 27.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.592 1.157 . . . . 15.0 109.425 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.57 14.1 64.23 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.678 -0.512 . . . . 15.0 113.501 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 117' ' ' LEU . 84.3 mt -64.64 -28.56 69.7 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.378 0.671 . . . . 15.0 111.271 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -79.96 -23.13 41.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.05 0.94 . . . . 15.0 110.772 175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.94 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.36 0.664 . . . . 15.0 111.252 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HA3' ' A' ' 293' ' ' GLY . 71.3 mt -67.33 111.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.577 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 70.3 mt-10 -101.82 102.12 12.68 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' A' ' 289' ' ' GLN . 38.4 t -97.34 129.9 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.925 . . . . 15.0 110.108 -175.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -77.06 131.78 38.58 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 123.638 0.586 . . . . 15.0 109.998 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.679 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.5 tttt -116.39 93.61 40.32 Favored Pre-proline 0 C--O 1.244 0.79 0 C-N-CA 124.251 1.02 . . . . 15.0 108.498 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.65 96.35 1.05 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.471 2.114 . . . . 15.0 111.758 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.679 HD11 ' HE2' ' A' ' 127' ' ' LYS . 46.1 mm -69.19 99.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.332 -0.988 . . . . 15.0 108.332 166.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -122.06 135.35 62.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.145 -176.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -130.52 143.2 50.61 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.991 -0.744 . . . . 15.0 108.991 174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.01 84.17 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 N-CA-C 108.561 -0.903 . . . . 15.0 108.561 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.7 p -67.49 166.38 14.85 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.017 0.527 . . . . 15.0 110.104 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.2 -19.0 62.67 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.283 0.492 . . . . 15.0 111.447 176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.41 84.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.41 0.684 . . . . 15.0 109.813 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.77 -35.76 70.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.435 0.694 . . . . 15.0 111.394 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.08 -49.02 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.447 0.699 . . . . 15.0 109.618 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.91 -41.15 97.76 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 123.543 0.527 . . . . 15.0 110.497 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.4 -36.04 92.55 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.93 0.769 . . . . 15.0 112.523 175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.586 ' HG2' ' SD ' ' A' ' 274' ' ' MET . 13.8 tpt -69.83 -50.6 41.22 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 123.403 0.681 . . . . 15.0 110.257 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' A' ' 267' ' ' ARG . 91.0 mt -60.88 -38.55 86.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.833 0.853 . . . . 15.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -54.92 -55.89 25.62 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 15.0 109.551 173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.0 m -58.45 -46.17 87.11 Favored 'General case' 0 CA--C 1.556 1.185 0 O-C-N 124.018 0.824 . . . . 15.0 111.889 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -58.76 -51.06 71.59 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.109 0.964 . . . . 15.0 110.628 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -75.58 -19.33 59.34 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.102 -0.954 . . . . 15.0 111.899 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -84.18 -27.23 28.2 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 118.062 0.392 . . . . 15.0 111.992 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -80.39 -33.03 37.44 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 120.731 0.301 . . . . 15.0 110.746 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -96.89 20.1 11.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.749 0.82 . . . . 15.0 110.778 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.65 149.12 31.38 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.507 0.723 . . . . 15.0 111.746 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.4 m -89.52 121.07 31.38 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.72 -0.845 . . . . 15.0 108.72 175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -75.58 121.04 21.82 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.107 0.563 . . . . 15.0 110.855 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 31.6 ttpt -116.52 110.8 19.06 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.883 1.273 . . . . 15.0 108.909 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -55.06 103.7 0.1 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.998 0.919 . . . . 15.0 109.394 175.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.625 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 49.6 pttt -103.18 153.45 20.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.439 0.696 . . . . 15.0 111.654 -172.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.98 121.71 33.03 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.703 1.201 . . . . 15.0 111.887 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.14 37.04 84.89 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.436 1.335 . . . . 15.0 116.436 164.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -153.7 104.17 2.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.449 0.625 . . . . 15.0 111.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 202' ' ' ILE . 93.7 t -91.16 132.27 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -122.64 159.64 27.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 15.0 109.516 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 203' ' ' LYS . . . -85.0 2.38 43.36 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.943 0.897 . . . . 15.0 113.204 -167.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -117.56 5.06 12.4 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.708 0.803 . . . . 15.0 110.26 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -111.5 -177.74 3.27 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.45 0.7 . . . . 15.0 111.989 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.496 ' CZ ' ' HB2' ' B' ' 241' ' ' GLU . 49.1 ttp180 -127.99 124.48 37.32 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.342 -0.845 . . . . 15.0 109.324 -168.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.508 HG21 HG21 ' A' ' 202' ' ' ILE . 31.8 m -109.21 176.1 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.493 0.717 . . . . 15.0 111.236 -176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.6 m -126.13 119.24 27.04 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.039 -1.097 . . . . 15.0 108.039 170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 237' ' ' LEU . 48.0 pt -130.97 163.98 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.511 0.724 . . . . 15.0 110.717 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 236' ' ' ASN . 1.2 m-20 -119.7 107.03 12.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.854 -1.535 . . . . 15.0 106.854 165.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 51.1 p90 -95.34 121.76 37.34 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.06 -1.089 . . . . 15.0 108.06 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.582 HG22 ' HG3' ' A' ' 181' ' ' LYS . 28.5 p -135.29 99.22 4.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.656 0.782 . . . . 15.0 108.907 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -159.41 -175.1 29.98 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.671 -0.24 . . . . 15.0 113.068 -176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.7 m -127.35 127.59 44.49 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.809 0.844 . . . . 15.0 109.928 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.524 HG21 ' HE2' ' B' ' 233' ' ' PHE . 24.5 t -97.27 120.85 47.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 9.3 t70 63.52 11.68 5.83 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 125.187 1.395 . . . . 15.0 111.627 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.29 9.31 34.07 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 119.279 -0.734 . . . . 15.0 114.296 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.37 145.72 34.17 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.84 0.82 . . . . 15.0 110.471 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -82.19 110.51 17.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.298 0.639 . . . . 15.0 109.82 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.1 -174.89 2.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.677 0.791 . . . . 15.0 110.361 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.31 111.13 6.4 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.833 -1.543 . . . . 15.0 106.833 165.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 107.19 3.12 35.92 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.509 -0.637 . . . . 15.0 111.509 -165.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -98.94 -29.56 7.19 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.568 -0.613 . . . . 15.0 111.568 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.582 ' HG3' HG22 ' A' ' 169' ' ' THR . 86.9 tttt -156.34 119.04 4.1 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.261 0.467 . . . . 15.0 112.261 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -147.3 149.48 32.92 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 15.0 109.501 170.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 47.8 p -112.92 139.0 48.93 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.733 0.813 . . . . 15.0 111.312 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 56.85 28.66 14.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.152 1.381 . . . . 15.0 111.455 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -66.47 105.12 1.4 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.178 1.391 . . . . 15.0 110.009 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 241' ' ' GLU . 34.7 t -79.88 129.43 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 194' ' ' MET . 61.6 tp -144.43 123.95 13.2 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.391 0.676 . . . . 15.0 110.699 -170.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.74 92.97 3.61 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.87 167.27 10.63 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.223 1.009 . . . . 15.0 110.196 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 88.48 -25.56 9.21 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.625 -0.716 . . . . 15.0 112.394 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -89.13 176.01 7.15 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.857 0.863 . . . . 15.0 109.179 168.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.72 4.62 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 116.703 -0.226 . . . . 15.0 113.063 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 54.2 mtt-85 -120.59 12.6 11.53 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.404 1.081 . . . . 15.0 110.111 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.402 ' HG2' HD21 ' A' ' 187' ' ' LEU . 31.2 tpp -161.75 159.96 27.83 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.413 1.085 . . . . 15.0 109.816 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.5 mt -50.91 123.4 18.66 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.836 1.254 . . . . 15.0 111.183 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.34 112.82 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.547 2.165 . . . . 15.0 109.921 166.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.42 -44.63 1.32 Allowed Glycine 0 N--CA 1.469 0.836 0 N-CA-C 111.863 -0.495 . . . . 15.0 111.863 -170.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.521 ' HD2' HG11 ' A' ' 215' ' ' VAL . 32.5 t80 -67.42 -44.97 77.45 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -59.48 -44.94 92.92 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.225 -1.352 . . . . 15.0 111.354 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.33 -29.46 66.17 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.1 0.96 . . . . 15.0 111.219 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.452 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -56.85 -39.76 88.62 Favored Glycine 0 C--N 1.349 1.25 0 O-C-N 124.114 0.884 . . . . 15.0 111.938 172.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 164' ' ' VAL . 77.9 mt -78.45 -43.3 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.912 0.885 . . . . 15.0 110.779 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 160' ' ' ALA . 47.7 mtpt -61.21 -34.15 74.63 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.445 1.098 . . . . 15.0 112.158 -174.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.01 6.76 55.3 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.593 0.558 . . . . 15.0 114.41 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -130.84 -179.51 5.35 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.717 0.807 . . . . 15.0 109.879 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -110.99 -64.44 1.28 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.979 1.103 . . . . 15.0 113.979 -165.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -146.89 -63.98 0.29 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.824 1.416 . . . . 15.0 114.824 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.77 54.58 0.77 Allowed Glycine 0 N--CA 1.476 1.335 0 N-CA-C 113.484 0.154 . . . . 15.0 113.484 -157.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -135.03 140.23 45.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.24 0.616 . . . . 15.0 111.191 -170.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.41 138.59 34.62 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.35 0.66 . . . . 15.0 109.693 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -155.16 169.2 24.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.195 0.998 . . . . 15.0 109.654 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 92.5 m -121.51 117.25 26.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.438 0.695 . . . . 15.0 109.309 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 201' ' ' GLY . 40.4 pt -108.73 143.62 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.04 0.536 . . . . 15.0 110.248 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.33 100.19 10.33 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.577 -1.268 . . . . 15.0 107.577 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 198' ' ' PHE . 34.5 m -88.82 133.71 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 123.242 0.617 . . . . 15.0 110.565 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 7.6 m -99.56 99.24 10.09 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.728 -1.212 . . . . 15.0 107.728 173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -46.69 136.04 7.73 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 124.413 1.071 . . . . 15.0 111.575 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.22 145.63 66.98 Favored 'Trans proline' 0 C--N 1.366 1.5 0 C-N-CA 123.264 2.643 . . . . 15.0 112.291 -168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -64.62 -18.22 64.72 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.611 0.764 . . . . 15.0 110.597 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.96 -9.08 58.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.855 0.862 . . . . 15.0 111.038 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 124.69 28.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.871 0.869 . . . . 15.0 108.924 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -73.2 -19.96 60.98 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.782 0.833 . . . . 15.0 111.974 -173.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.39 100.51 2.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.085 -0.709 . . . . 15.0 109.085 174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 0.0 OUTLIER -64.1 -24.43 67.69 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.465 1.106 . . . . 15.0 112.345 -177.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -77.18 -15.31 59.56 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.212 0.605 . . . . 15.0 111.365 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 80.7 mt -106.78 -44.85 4.34 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.567 0.747 . . . . 15.0 112.118 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 21.5 ptmt -58.06 121.18 10.02 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.137 0.494 . . . . 15.0 111.467 -171.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.6 13.68 69.68 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.649 -0.705 . . . . 15.0 114.161 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.48 149.58 21.62 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.685 0.743 . . . . 15.0 109.185 171.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -114.57 93.8 4.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.178 0.591 . . . . 15.0 109.725 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.17 154.65 17.94 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.127 0.571 . . . . 15.0 111.295 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -112.26 126.41 55.21 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.594 0.758 . . . . 15.0 109.375 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.78 125.88 38.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.837 0.855 . . . . 15.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -80.85 89.48 5.84 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 170.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 mm -76.83 107.99 9.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.969 0.907 . . . . 15.0 109.962 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.676 ' HB2' ' HB2' ' A' ' 167' ' ' ASP . 0.7 OUTLIER -87.31 80.16 8.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.267 -1.383 . . . . 15.0 107.267 171.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 59.5 tp -63.78 120.31 11.62 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.709 -1.219 . . . . 15.0 107.709 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.08 -60.83 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.706 0.802 . . . . 15.0 111.05 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -126.87 166.58 17.2 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.125 0.488 . . . . 15.0 110.894 -171.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.496 HG13 HG12 ' A' ' 164' ' ' VAL . 2.9 t -135.84 152.18 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 114.511 -1.222 . . . . 15.0 107.792 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -122.65 155.95 35.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.449 1.1 . . . . 15.0 108.688 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.625 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 32.9 tt0 -119.77 128.86 54.14 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.968 -1.123 . . . . 15.0 107.968 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -77.6 74.74 4.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 122.626 1.203 . . . . 15.0 107.976 172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.36 120.89 19.59 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.036 -1.438 . . . . 15.0 108.657 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 72.0 mt -49.79 133.78 20.7 Favored Pre-proline 0 N--CA 1.477 0.904 0 O-C-N 124.577 1.173 . . . . 15.0 110.683 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.08 -168.03 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 123.166 2.577 . . . . 15.0 112.135 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.16 161.51 26.85 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.734 0.778 . . . . 15.0 111.169 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 263' ' ' VAL . 28.7 tp -119.83 8.37 11.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.473 1.109 . . . . 15.0 108.947 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 18.9 m -51.63 139.59 20.43 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 125.401 1.48 . . . . 15.0 111.33 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -47.8 -46.32 30.43 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.433 1.093 . . . . 15.0 111.895 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.93 -31.76 72.91 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.274 1.029 . . . . 15.0 111.898 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.48 -55.57 4.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.796 0.838 . . . . 15.0 110.603 -177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.31 -26.57 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.906 0.482 . . . . 15.0 111.336 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -75.11 -15.09 60.62 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.956 0.354 . . . . 15.0 111.956 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -69.88 -15.27 63.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.995 0.518 . . . . 15.0 110.631 -176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -77.04 -12.52 59.95 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.27 1.028 . . . . 15.0 111.327 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 122.33 -26.73 6.27 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 123.442 0.544 . . . . 15.0 113.132 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 46.5 t -68.37 103.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.964 0.506 . . . . 15.0 109.872 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.63 -49.96 5.46 Favored 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 124.944 1.297 . . . . 15.0 113.109 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -97.16 143.08 28.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.656 -1.156 . . . . 15.0 110.155 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -84.28 65.29 4.12 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.535 -0.302 . . . . 15.0 112.901 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 33.4 m -120.7 118.09 29.19 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.564 0.746 . . . . 15.0 110.004 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 248' ' ' LEU . 42.7 t -56.58 -46.2 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.014 0.925 . . . . 15.0 112.072 -171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -21.55 66.38 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.428 0.455 . . . . 15.0 110.942 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.2 -31.87 37.09 Favored Glycine 0 C--N 1.36 1.883 0 N-CA-C 111.548 -0.621 . . . . 15.0 111.548 174.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.34 -38.7 81.76 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.438 -0.949 . . . . 15.0 108.438 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.737 ' HG2' HD11 ' A' ' 141' ' ' LEU . 52.6 mtp85 -67.18 -40.41 86.55 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 124.455 1.102 . . . . 15.0 110.684 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.87 89.24 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.899 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -67.44 -39.97 85.43 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.644 0.778 . . . . 15.0 110.658 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.451 HG13 ' SD ' ' A' ' 274' ' ' MET . 14.0 t -59.84 -50.79 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.808 0.843 . . . . 15.0 109.881 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -54.5 -50.95 66.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.959 0.904 . . . . 15.0 110.419 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -53.4 -57.99 8.7 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.112 1.365 . . . . 15.0 112.758 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -68.19 -37.18 80.65 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.613 0.365 . . . . 15.0 111.746 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 140' ' ' MET . 96.3 mtp -74.09 -22.55 59.45 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-O 118.671 -0.681 . . . . 15.0 110.924 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -68.83 -39.51 79.97 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.91 0.484 . . . . 15.0 110.928 170.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 -63.26 -49.54 73.67 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.583 -0.525 . . . . 15.0 109.583 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.97 -42.23 98.9 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 124.654 1.221 . . . . 15.0 111.263 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 130' ' ' VAL . 29.5 tp -72.54 -45.01 61.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.605 0.762 . . . . 15.0 111.325 -175.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -58.5 -37.86 76.46 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.688 0.617 . . . . 15.0 109.972 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.8 t -68.39 -42.27 79.3 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.09 1.356 . . . . 15.0 111.707 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -61.09 -48.31 82.3 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.31 0.644 . . . . 15.0 110.744 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 130' ' ' VAL . 79.1 mt -64.73 -36.6 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.621 1.168 . . . . 15.0 110.167 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -59.79 -57.07 14.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.48 0.712 . . . . 15.0 109.945 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.411 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 49.9 m-80 -73.17 -19.92 61.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.259 -0.882 . . . . 15.0 111.606 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 289' ' ' GLN . 10.3 tpt180 -68.41 -63.15 1.12 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 118.063 0.392 . . . . 15.0 110.286 173.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.58 -43.34 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.197 0.999 . . . . 15.0 109.856 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.594 ' HA ' HG11 ' A' ' 408' ' ' VAL . 73.8 tttt -51.96 -58.9 5.13 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.712 -1.131 . . . . 15.0 111.512 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.0 p -63.23 -33.51 75.64 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.225 0.454 . . . . 15.0 112.225 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 285' ' ' ARG . 18.5 mm-40 -67.73 -39.12 84.29 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.971 -0.381 . . . . 15.0 109.971 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.04 80.01 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.012 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 347' ' ' VAL . 48.3 mm -66.11 -48.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.734 0.814 . . . . 15.0 109.674 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -60.9 -46.97 88.53 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.621 -1.172 . . . . 15.0 110.159 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -63.93 -37.02 94.03 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.142 0.902 . . . . 15.0 112.586 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 10.2 mt -54.47 -60.54 3.21 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.156 0.982 . . . . 15.0 109.649 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 10.9 t -66.02 -38.34 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.625 0.578 . . . . 15.0 110.484 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -64.5 -27.04 68.7 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.511 0.324 . . . . 15.0 111.472 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -100.57 -9.8 21.64 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -139.37 162.47 34.93 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 118.307 0.503 . . . . 15.0 111.484 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -153.62 148.36 26.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.1 tp -162.09 130.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.355 0.662 . . . . 15.0 109.911 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.51 125.86 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.422 -0.584 . . . . 15.0 109.422 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.73 137.07 24.32 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.323 -0.853 . . . . 15.0 110.447 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.69 125.27 13.85 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.022 2.482 . . . . 15.0 112.24 164.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -52.78 -46.67 67.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.757 1.623 . . . . 15.0 113.617 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -63.2 -31.27 72.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.063 0.545 . . . . 15.0 112.23 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 68.2 mt -68.81 -39.52 80.02 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.759 0.424 . . . . 15.0 109.985 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 60.1 mt -60.46 -50.67 79.43 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.001 0 CA-C-N 114.973 -1.012 . . . . 15.0 109.287 175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -35.3 74.68 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.682 1.193 . . . . 15.0 112.217 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 62.8 m -61.83 -52.0 65.93 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.702 0.626 . . . . 15.0 110.258 174.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 345' ' ' VAL . 17.4 mm-40 -68.02 -29.62 68.66 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 116.354 -0.384 . . . . 15.0 111.769 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.466 ' O ' ' HG3' ' A' ' 315' ' ' ARG . 75.3 mt -61.93 -48.98 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.04 -40.48 95.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.584 1.178 . . . . 15.0 111.727 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 96.7 t -62.27 -43.25 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.553 0.533 . . . . 15.0 110.228 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.02 -29.23 65.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.002 0.521 . . . . 15.0 111.713 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 23.3 mtm180 -72.87 -39.3 66.57 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.102 0.561 . . . . 15.0 109.63 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -69.02 -40.88 78.38 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.319 0.648 . . . . 15.0 110.023 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 9.0 tt0 -64.66 -39.27 93.39 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.817 0.698 . . . . 15.0 110.752 176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -69.68 -51.52 33.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.176 0.591 . . . . 15.0 110.781 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.0 -30.71 71.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.057 0.943 . . . . 15.0 111.578 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -58.98 -38.03 78.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.842 0.857 . . . . 15.0 110.693 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 317' ' ' GLN . 55.6 mtt180 -79.93 -43.1 22.73 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -87.5 80.73 7.99 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.452 1.101 . . . . 15.0 109.501 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.56 -36.24 3.37 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.639 -0.71 . . . . 15.0 113.826 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 91.56 45.62 3.96 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -173.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.8 m-20 -70.26 128.26 35.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.236 1.014 . . . . 15.0 111.566 -172.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -82.81 90.72 6.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.878 1.271 . . . . 15.0 109.777 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 64.59 -0.63 0.91 Allowed 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 125.253 1.421 . . . . 15.0 114.045 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 21.7 tm0? -64.35 -15.27 60.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.215 1.006 . . . . 15.0 110.34 175.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 315' ' ' ARG . . . -44.09 -27.67 0.41 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.683 1.993 . . . . 15.0 115.027 175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.95 -27.52 63.48 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.654 0.782 . . . . 15.0 111.828 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -78.87 -17.4 55.65 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.047 0.939 . . . . 15.0 112.04 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 333' ' ' PRO . 76.8 mt -65.79 134.73 95.27 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 119.234 -0.412 . . . . 15.0 110.896 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 332' ' ' LEU . 48.0 Cg_exo -56.98 114.99 2.17 Favored 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 123.756 2.971 . . . . 15.0 114.449 -169.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.415 ' HG3' HD13 ' A' ' 311' ' ' ILE . 48.5 ttt85 -47.45 -50.44 22.91 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.196 1.398 . . . . 15.0 112.83 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -63.19 -20.43 65.41 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.097 0.873 . . . . 15.0 113.14 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' A' ' 333' ' ' PRO . 70.9 mt -71.83 -27.92 63.23 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.88 -0.415 . . . . 15.0 109.88 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.503 ' HA ' HE21 ' A' ' 340' ' ' GLN . 61.1 m-85 -108.86 -22.25 12.28 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.892 0.877 . . . . 15.0 112.141 -174.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.32 -47.62 72.95 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.152 0.581 . . . . 15.0 111.916 -169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -57.15 -56.73 17.98 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.928 0.767 . . . . 15.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.503 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.0 pt20 -65.14 -38.54 90.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.968 0.793 . . . . 15.0 112.171 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -61.37 -62.19 2.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.187 0.595 . . . . 15.0 110.128 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 346' ' ' VAL . 85.7 tttt -51.65 -38.69 55.96 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 124.406 1.066 . . . . 15.0 111.439 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.9 OUTLIER -64.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.05 0.94 . . . . 15.0 109.589 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 58.4 mtt-85 -66.52 -37.15 84.42 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.5 t -76.9 -26.7 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 119.526 -0.273 . . . . 15.0 110.735 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 350' ' ' LEU . 32.5 t -60.77 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 N-CA-C 107.52 -1.289 . . . . 15.0 107.52 175.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 291' ' ' ILE . 18.7 t -61.75 -37.09 77.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.864 0 O-C-N 124.251 0.969 . . . . 15.0 110.346 174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -63.7 -26.89 70.29 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.267 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 84.1 mt -85.84 -36.91 19.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.271 0.629 . . . . 15.0 110.597 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.3 mt -61.96 -51.73 66.91 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.839 0.828 . . . . 15.0 109.591 177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.551 ' HA ' HG12 ' A' ' 354' ' ' VAL . 81.1 mt -65.18 -38.76 91.54 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 113.689 -1.596 . . . . 15.0 110.119 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -57.59 -35.74 74.79 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.57 0.544 . . . . 15.0 112.999 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 12.3 tp10 -80.33 -38.88 29.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.422 0.689 . . . . 15.0 111.591 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.2 p -69.25 -33.37 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.54 -45.92 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.899 0.88 . . . . 15.0 109.602 172.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -56.86 -63.57 1.16 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.06 0.944 . . . . 15.0 110.423 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 34.8 p -59.92 -42.68 94.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.995 0.918 . . . . 15.0 112.564 -176.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -96.03 14.91 22.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.907 0.483 . . . . 15.0 111.76 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 38.9 52.75 1.98 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.55 1.54 . . . . 15.0 113.687 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' A' ' 410' ' ' ALA . 80.3 mt -71.95 164.96 25.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.51 -0.768 . . . . 15.0 112.414 -176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -148.24 151.67 35.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.623 -1.171 . . . . 15.0 109.294 -173.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -90.69 93.01 9.07 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.688 -1.227 . . . . 15.0 107.688 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.94 112.26 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.415 -0.811 . . . . 15.0 111.071 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.499 ' HB3' ' HE2' ' A' ' 368' ' ' LYS . 9.0 mm-40 -50.68 -43.86 57.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.666 1.186 . . . . 15.0 113.182 -174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -66.51 -29.94 70.15 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.207 0.317 . . . . 15.0 110.975 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -77.62 -44.77 27.16 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.096 0.558 . . . . 15.0 110.233 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 371' ' ' ILE . 52.3 t -59.32 -56.3 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 123.922 0.764 . . . . 15.0 109.281 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.499 ' HE2' ' HB3' ' A' ' 364' ' ' GLU . 52.0 mtmt -65.75 -35.28 80.28 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.822 -1.081 . . . . 15.0 111.667 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 373' ' ' GLU . . . -57.85 -46.72 92.05 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 123.511 0.507 . . . . 15.0 112.155 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 6.0 tt -61.29 -45.36 94.79 Favored 'General case' 0 C--O 1.248 1.004 0 C-N-CA 123.797 0.839 . . . . 15.0 109.655 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 367' ' ' VAL . 86.1 mt -56.46 -40.16 65.97 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 123.527 0.731 . . . . 15.0 110.877 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 368' ' ' LYS . 44.9 mt-10 -68.34 -46.35 70.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.288 0.635 . . . . 15.0 111.135 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 369' ' ' GLY . 52.3 mt-10 -54.59 -50.24 68.49 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 123.834 0.709 . . . . 15.0 110.971 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.477 ' HE2' ' HB3' ' A' ' 374' ' ' MET . 28.3 ttp -69.43 -42.94 74.32 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.42 -1.264 . . . . 15.0 111.865 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.668 ' HA ' ' HG3' ' B' ' 287' ' ' PRO . . . -71.48 -25.31 62.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.503 0.721 . . . . 15.0 111.878 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.9 t -60.24 -18.53 49.41 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.237 1.015 . . . . 15.0 112.206 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.34 68.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.167 0.587 . . . . 15.0 111.886 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -88.82 169.48 11.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.399 0.68 . . . . 15.0 111.059 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -56.92 -27.43 60.88 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.738 1.215 . . . . 15.0 112.289 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -151.66 126.64 4.71 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 123.845 0.858 . . . . 15.0 109.496 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 385' ' ' ILE . 72.6 Cg_endo -73.99 -37.85 2.55 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.031 1.82 . . . . 15.0 112.779 176.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -57.26 -48.11 79.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.923 0.889 . . . . 15.0 112.646 -166.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.7 -28.53 69.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.565 0.746 . . . . 15.0 111.091 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 97.6 t -81.37 -37.27 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 123.671 0.789 . . . . 15.0 110.45 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 381' ' ' PRO . 27.0 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 109.157 -0.683 . . . . 15.0 109.157 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.83 -40.7 95.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.663 -1.153 . . . . 15.0 110.851 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -54.86 -52.73 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.767 0.667 . . . . 15.0 110.185 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 395' ' ' MET . 5.6 m-85 -55.21 -58.99 5.41 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.341 1.025 . . . . 15.0 110.515 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.6 p -56.84 -24.33 50.51 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 112.949 0.722 . . . . 15.0 112.949 -175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -94.82 -28.45 15.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.521 0.729 . . . . 15.0 111.597 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -97.24 83.37 3.3 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 107.604 -1.258 . . . . 15.0 107.604 -177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 39.5 ttmt -62.19 -21.81 65.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.452 -0.794 . . . . 15.0 111.348 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.96 -47.45 61.26 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.773 0.829 . . . . 15.0 110.851 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.692 HD22 ' H ' ' B' ' 289' ' ' ARG . 18.4 tp -101.59 -19.22 15.56 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.851 0.461 . . . . 15.0 112.102 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 388' ' ' TYR . 0.0 OUTLIER -72.15 -48.74 41.26 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 109.12 -0.696 . . . . 15.0 109.12 -178.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -53.09 -47.29 68.68 Favored 'General case' 0 C--N 1.359 1.022 0 O-C-N 124.57 1.169 . . . . 15.0 109.736 173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -62.14 -44.42 96.67 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 124.007 0.817 . . . . 15.0 110.722 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 56.7 tpp -68.56 -30.44 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.577 0.751 . . . . 15.0 110.787 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -84.98 -24.47 28.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.85 0.46 . . . . 15.0 110.159 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -76.63 -37.03 57.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.973 0.909 . . . . 15.0 109.462 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 9.5 p -77.44 -32.9 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 123.67 0.606 . . . . 15.0 110.408 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.79 73.74 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.417 0.627 . . . . 15.0 109.999 173.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.2 -36.79 85.21 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 114.556 -1.202 . . . . 15.0 111.045 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 7.3 tp10 -55.48 -51.94 65.3 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.84 0.856 . . . . 15.0 109.133 178.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 93.1 mt-10 -57.34 -54.11 50.55 Favored 'General case' 0 C--O 1.214 -0.763 0 O-C-N 124.587 1.179 . . . . 15.0 110.715 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -59.45 -39.32 83.23 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.678 0.621 . . . . 15.0 112.678 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.11 76.93 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.864 0.865 . . . . 15.0 110.357 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 287' ' ' LYS . 55.1 t -61.83 -43.47 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.35 -0.841 . . . . 15.0 110.298 174.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -65.89 -30.78 71.43 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.048 0.939 . . . . 15.0 111.592 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.451 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -62.99 -33.4 75.33 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.578 0.549 . . . . 15.0 111.378 170.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 67.4 t -79.44 -35.31 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 109.227 -0.657 . . . . 15.0 109.227 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 -35.55 80.91 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.866 0.867 . . . . 15.0 110.927 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.98 67.85 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.587 0.755 . . . . 15.0 111.699 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -100.02 -25.26 14.37 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.379 1.072 . . . . 15.0 111.751 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -91.89 160.59 15.21 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.229 1.011 . . . . 15.0 111.47 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.577 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 86.5 mttt -75.84 88.32 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.706 -0.479 . . . . 15.0 109.706 175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.98 85.65 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 8.9 t -79.33 124.3 28.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.91 -1.041 . . . . 15.0 109.209 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -102.2 138.69 38.81 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.134 0.574 . . . . 15.0 111.443 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.34 159.7 42.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.576 0.751 . . . . 15.0 109.292 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -109.49 148.66 30.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.66 0.784 . . . . 15.0 110.456 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 14.7 t -166.86 175.4 7.77 Favored 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.774 0.671 . . . . 15.0 111.408 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 54.0 p -92.76 160.27 15.04 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.163 0.985 . . . . 15.0 111.362 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.44 ' O ' ' HG2' ' A' ' 428' ' ' MET . 53.9 t80 -53.76 -60.56 3.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.056 0.943 . . . . 15.0 110.54 -176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -59.99 -26.73 66.27 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 124.288 0.992 . . . . 15.0 111.823 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.401 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 8.4 tp10 -72.64 -37.52 67.98 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.803 0.441 . . . . 15.0 110.937 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.49 HD22 HG21 ' A' ' 130' ' ' VAL . 46.8 tp -70.7 -26.65 63.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.572 0.349 . . . . 15.0 110.287 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 424' ' ' PHE . 64.9 mmm -74.29 -15.6 60.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.791 0.436 . . . . 15.0 111.269 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 90.7 m-20 -79.53 37.01 0.33 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.762 0.825 . . . . 15.0 112.139 -178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -93.29 80.44 4.44 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.872 -0.788 . . . . 15.0 108.872 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.76 -37.51 20.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.689 0.796 . . . . 15.0 110.155 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 C-N-CA 123.894 0.878 . . . . 15.0 109.126 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.64 -0.134 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 66.67 -78.82 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.258 1.423 . . . . 0.0 112.204 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -91.24 68.39 5.95 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -94.98 144.34 25.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.456 -171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.16 176.83 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.28 1.032 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 40.7 p -77.93 176.49 9.07 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.944 0.497 . . . . 0.0 111.263 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -146.1 130.75 17.91 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -129.56 179.3 16.85 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -166.63 173.99 42.03 Favored Glycine 0 N--CA 1.469 0.873 0 CA-C-O 119.987 -0.34 . . . . 0.0 112.3 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 75.54 -67.3 2.26 Favored Glycine 0 C--N 1.348 1.218 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . 68.21 18.44 9.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.343 1.457 . . . . 0.0 113.039 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -164.38 77.84 0.35 Allowed 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.196 0.598 . . . . 0.0 109.899 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 80.8 p 49.45 -158.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.753 1.221 . . . . 0.0 113.218 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.524 ' HE2' HG21 ' A' ' 172' ' ' VAL . 55.5 t80 -130.19 -88.2 0.5 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 178.04 -78.98 0.0 OUTLIER 'General case' 0 C--N 1.349 0.562 0 C-N-CA 125.361 1.464 . . . . 0.0 107.525 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 179.5 147.74 0.24 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.917 1.287 . . . . 0.0 108.966 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.89 140.82 35.11 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.18 0.592 . . . . 0.0 109.412 169.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.44 -41.86 90.57 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 60.8 p 53.78 18.04 1.44 Allowed 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.652 1.581 . . . . 0.0 113.649 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.89 78.61 5.32 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.011 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -155.29 -105.45 0.24 Allowed Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.801 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.511 ' HB3' HG11 ' A' ' 186' ' ' VAL . 10.0 tp10 -157.95 158.02 34.17 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.163 0.585 . . . . 0.0 110.268 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 2.9 m95 161.09 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 128.145 2.578 . . . . 0.0 109.147 168.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -158.93 16.09 0.18 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.656 0.782 . . . . 0.0 111.816 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -70.38 -25.99 74.83 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.601 -0.272 . . . . 0.0 112.641 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -104.16 88.42 2.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.792 . . . . 0.0 109.841 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -176.56 -20.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 36.9 tp -74.92 -39.75 61.24 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.148 0.431 . . . . 0.0 111.016 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -93.24 6.45 48.01 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.723 0.809 . . . . 0.0 111.523 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.31 -45.2 72.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.917 1.287 . . . . 0.0 112.571 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -57.77 -27.41 63.04 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.037 0.836 . . . . 0.0 112.554 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.09 -55.9 18.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.745 0.418 . . . . 0.0 110.756 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.87 -6.21 59.34 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.138 0.575 . . . . 0.0 111.915 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.34 -43.41 13.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.094 0.557 . . . . 0.0 109.864 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -58.82 5.29 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -73.73 87.35 0.64 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.18 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -58.23 175.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.386 1.074 . . . . 0.0 112.277 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -65.52 87.58 0.08 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 121.847 0.832 . . . . 0.0 111.407 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.76 -52.34 2.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.168 1.387 . . . . 0.0 107.436 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.6 141.11 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.896 1.278 . . . . 0.0 108.271 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 54.1 m -71.22 133.76 46.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.865 0.466 . . . . 0.0 110.765 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -144.56 114.11 7.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.576 0.75 . . . . 0.0 109.4 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -106.02 2.08 27.03 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.719 0.808 . . . . 0.0 110.772 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -89.44 -17.36 28.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.823 0.849 . . . . 0.0 112.142 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 21.7 t 66.24 19.88 11.07 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.853 1.261 . . . . 0.0 110.412 -172.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 92.8 mt 57.59 -81.34 0.02 OUTLIER 'General case' 0 C--N 1.366 1.29 0 C-N-CA 124.773 1.229 . . . . 0.0 109.742 -166.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -132.67 -63.21 0.79 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 24.9 p -178.8 -55.68 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.403 1.481 . . . . 0.0 107.014 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.97 162.44 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 114.146 -1.388 . . . . 0.0 108.706 169.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 24.2 m -69.19 102.3 1.65 Allowed 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.21 147.08 50.23 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.941 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -111.06 -17.75 13.19 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.256 1.022 . . . . 0.0 110.585 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -66.37 -54.59 22.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.337 0.655 . . . . 0.0 111.09 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 76.33 -29.74 0.18 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.236 1.414 . . . . 0.0 112.191 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -98.6 101.77 13.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 0.0 109.59 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -105.6 140.95 21.68 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 122.969 0.508 . . . . 0.0 109.974 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.32 133.14 53.02 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.104 1.87 . . . . 0.0 110.585 165.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 34.9 mt -79.7 22.27 0.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . . . . . . . . . 10.7 tp -157.84 -87.16 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 63.18 22.35 65.04 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 115.238 0.855 . . . . 0.0 115.238 170.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 98.8 mt -138.9 -17.33 1.08 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.769 0.785 . . . . 0.0 112.256 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.43 -15.25 35.93 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -146.17 -79.74 0.16 Allowed 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.864 0.756 . . . . 0.0 111.324 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -105.06 -57.36 2.04 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.113 0.565 . . . . 0.0 111.16 -174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 139.75 -33.47 2.12 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 119.719 -0.489 . . . . 0.0 113.826 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 64.7 t30 65.49 8.91 5.39 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.283 1.033 . . . . 0.0 111.214 -175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 88.2 mtp -122.71 121.8 27.36 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.464 1.105 . . . . 0.0 108.966 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.668 ' HG3' ' HA ' ' A' ' 375' ' ' ALA . 67.4 Cg_endo -81.18 -175.19 2.53 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 123.381 2.721 . . . . 0.0 114.235 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 48.4 t 66.92 88.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.816 1.246 . . . . 0.0 111.207 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.692 ' H ' HD22 ' A' ' 394' ' ' LEU . 2.7 tpp180 60.48 157.35 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.297 1.839 . . . . 0.0 111.174 -166.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.411 ' HZ2' ' SD ' ' A' ' 374' ' ' MET . 3.1 p-90 94.02 177.46 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 126.435 1.894 . . . . 0.0 109.381 -142.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 293' ' ' PRO . 23.5 tp 86.4 81.68 0.02 OUTLIER 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.657 1.983 . . . . 0.0 111.181 173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -99.89 -15.92 29.86 Favored Glycine 0 CA--C 1.562 3.027 0 CA-C-O 116.929 -2.04 . . . . 0.0 115.081 166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 291' ' ' LEU . 94.7 Cg_exo -52.51 6.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.402 3.361 0 CA-C-N 122.678 3.239 . . . . 0.0 118.282 173.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -73.88 97.59 2.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 120.748 1.613 . . . . 0.0 107.283 166.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.26 -48.25 12.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.652 -165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 68.3 p -119.94 155.85 31.95 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.11 0.564 . . . . 0.0 111.581 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -70.99 113.91 8.51 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -113.24 118.78 35.6 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -70.96 -173.34 14.41 Favored Glycine 0 C--N 1.353 1.512 0 O-C-N 123.28 0.363 . . . . 0.0 112.646 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.96 128.46 36.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.046 0.538 . . . . 0.0 110.355 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.525 HG12 ' N ' ' B' ' 302' ' ' ASP . 2.3 tt -157.47 159.07 2.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 C-N-CA 123.619 0.767 . . . . 0.0 109.947 -168.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.525 ' N ' HG12 ' B' ' 301' ' ' ILE . 10.2 t70 72.56 137.93 0.05 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 125.391 1.477 . . . . 0.0 111.66 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.58 115.44 55.86 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 167.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -22.13 95.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.393 2.878 1 C-N-CA 126.42 4.747 . . . . 0.0 115.446 -164.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.35 79.79 0.54 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.718 0.77 . . . . 0.0 111.293 -174.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.5 160.77 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 124.707 1.203 . . . . 0.0 109.723 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 24.5 m -65.35 99.65 0.42 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 23.8 p -122.84 159.05 28.95 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.642 1.177 . . . . 0.0 108.641 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' B' ' 310' ' ' PRO . 6.7 t -87.63 102.66 3.63 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 122.925 0.49 . . . . 0.0 110.27 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 309' ' ' THR . 18.5 Cg_endo . . . . . 0 C--N 1.385 2.459 0 C-N-CA 122.994 2.463 . . . . 12.53 110.973 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ptm . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.784 0.326 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -137.27 147.93 46.05 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.425 -0.954 . . . . 15.0 108.425 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.75 157.66 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 15.0 109.76 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.8 p -148.6 126.98 12.26 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.476 -0.935 . . . . 15.0 108.476 173.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.2 p -97.48 138.05 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-O 121.248 0.547 . . . . 15.0 110.386 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 43.5 mt-10 -128.89 168.99 15.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.144 1.378 . . . . 15.0 108.55 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 m -132.97 120.95 22.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.1 p -90.23 -51.17 5.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.542 0.737 . . . . 15.0 110.592 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -160.49 93.48 1.02 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.558 0.743 . . . . 15.0 109.518 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 -88.9 0.08 OUTLIER Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.273 -0.876 . . . . 15.0 113.949 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 113' ' ' PRO . 2.6 mm? -72.99 -39.57 65.98 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.777 0.831 . . . . 15.0 110.123 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.24 114.63 7.07 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 124.469 1.105 . . . . 15.0 112.535 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -125.36 125.39 43.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.013 1.325 . . . . 15.0 109.32 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.655 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 40.9 ttm180 -100.93 91.49 4.61 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 15.0 109.685 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -85.23 85.9 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.772 -0.825 . . . . 15.0 108.772 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.7 m -74.46 94.84 2.64 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.582 -1.19 . . . . 15.0 109.984 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.9 mt -88.3 113.94 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.885 0.874 . . . . 15.0 110.171 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 65.2 m -91.81 89.57 7.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.383 0.673 . . . . 15.0 109.482 170.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 70' ' ' LEU . 65.1 mt -71.26 97.61 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.072 -1.084 . . . . 15.0 108.072 170.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.96 176.03 10.01 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.603 0.361 . . . . 15.0 110.227 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.75 63.15 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.424 1.09 . . . . 15.0 113.846 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.25 -21.65 65.36 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.577 0.751 . . . . 15.0 111.63 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.449 ' HB2' HG23 ' A' ' 19' ' ' ILE . 32.3 m -116.5 -27.95 6.59 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.881 0.872 . . . . 15.0 111.623 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.73 -66.5 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.262 0 N-CA-C 108.882 -0.784 . . . . 15.0 108.882 174.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.56 -31.54 72.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.449 -1.251 . . . . 15.0 111.301 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -64.14 -46.46 83.99 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.004 0.522 . . . . 15.0 110.901 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.85 -42.65 73.28 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.124 0.57 . . . . 15.0 111.737 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 92.7 t -58.62 -51.02 76.83 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 O-C-N 123.971 0.794 . . . . 15.0 109.508 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -59.58 -45.14 92.75 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.477 1.111 . . . . 15.0 112.056 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.1 m -67.11 -24.83 65.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.209 0.604 . . . . 15.0 111.241 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.89 -28.01 24.64 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.045 0.538 . . . . 15.0 110.67 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 78.8 mt -68.74 -32.89 72.99 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.727 0.411 . . . . 15.0 111.001 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.8 p -75.12 -29.17 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 122.413 0.285 . . . . 15.0 110.3 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -66.69 -50.46 62.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.249 0.62 . . . . 15.0 109.934 173.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.09 -33.32 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.278 1.031 . . . . 15.0 110.507 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -59.99 -48.31 82.23 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.838 0.455 . . . . 15.0 110.554 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.8 mttt -70.6 -38.6 74.03 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.146 0.579 . . . . 15.0 111.236 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -69.07 -38.88 79.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.415 1.086 . . . . 15.0 111.636 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.2 t -98.8 3.27 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.755 0.822 . . . . 15.0 110.277 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 70.36 15.21 7.4 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.183 1.393 . . . . 15.0 112.53 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 55.5 mt -61.86 -31.29 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.82 1.248 . . . . 15.0 110.698 175.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -60.83 -35.48 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.719 1.208 . . . . 15.0 111.323 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.43 -43.51 86.98 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.799 0.687 . . . . 15.0 111.846 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -75.3 -17.66 60.22 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.598 0.759 . . . . 15.0 111.393 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -73.15 105.83 4.75 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.714 0.805 . . . . 15.0 109.871 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -87.56 -2.75 58.83 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.563 1.145 . . . . 15.0 112.131 -173.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.09 14.72 74.1 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.05 0.218 . . . . 15.0 112.696 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -66.18 -59.31 3.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.054 0.942 . . . . 15.0 110.701 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -93.35 121.68 64.67 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.363 0.665 . . . . 15.0 109.422 -176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.67 158.64 45.16 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 122.837 2.358 . . . . 15.0 112.359 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 12.3 tpt -69.49 -15.45 63.26 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.336 1.054 . . . . 15.0 112.904 -165.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -79.77 -38.67 32.68 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.044 0.538 . . . . 15.0 110.999 173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 56' ' ' GLN . 50.3 mt -81.46 -23.51 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.023 0.529 . . . . 15.0 110.896 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 ' HA ' ' HD1' ' A' ' 58' ' ' TYR . 10.5 m -67.84 -18.57 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 122.103 -0.373 . . . . 15.0 110.692 172.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.89 -43.23 15.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.499 0.719 . . . . 15.0 111.823 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 53' ' ' ILE . 3.6 pt20 -79.32 -16.92 55.56 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.99 0.516 . . . . 15.0 111.998 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -110.05 -71.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.913 0.485 . . . . 15.0 111.182 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 54' ' ' VAL . 70.9 m-85 -71.12 -48.62 51.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.252 0.621 . . . . 15.0 110.626 -171.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.57 8.75 79.32 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.689 -0.687 . . . . 15.0 113.0 -174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.36 -22.6 66.26 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 123.81 0.844 . . . . 15.0 111.381 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 p -82.77 -33.24 27.43 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.962 0.905 . . . . 15.0 111.55 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.9 t -111.03 87.39 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.663 0.785 . . . . 15.0 110.264 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 72.0 mtp85 -135.72 -26.53 1.21 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.773 0.829 . . . . 15.0 109.805 175.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -69.19 -36.82 77.71 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.668 0.787 . . . . 15.0 111.054 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -59.08 -39.36 81.91 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.917 0.887 . . . . 15.0 110.364 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 28' ' ' VAL . 47.6 t -68.66 -38.85 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.868 -1.514 . . . . 15.0 110.327 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 83.4 mt -62.57 -40.89 98.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.082 0.553 . . . . 15.0 111.047 178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.27 -38.11 95.93 Favored Glycine 0 C--N 1.35 1.333 0 O-C-N 123.614 0.571 . . . . 15.0 112.115 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.46 -36.84 79.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.426 1.09 . . . . 15.0 111.057 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 19' ' ' ILE . 37.1 mt -67.15 -48.03 69.24 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.48 0.712 . . . . 15.0 111.087 -178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 51.1 mtm -55.29 -39.15 69.54 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.42 0.629 . . . . 15.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -65.7 -54.63 24.81 Favored 'General case' 0 CA--C 1.55 0.942 0 CA-C-N 114.372 -1.285 . . . . 15.0 110.637 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -84.18 2.41 39.81 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.926 0.713 . . . . 15.0 112.926 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.22 -36.63 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.269 0.628 . . . . 15.0 109.449 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.17 -56.03 7.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.961 -0.563 . . . . 15.0 110.707 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.69 -35.47 59.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.046 0 O-C-N 123.745 0.653 . . . . 15.0 110.446 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.69 -52.93 63.41 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.175 0.99 . . . . 15.0 110.363 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.25 -43.2 87.19 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.091 -0.959 . . . . 15.0 112.441 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 pt -73.47 -31.19 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 112.511 0.559 . . . . 15.0 112.511 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.1 mt -68.9 -52.42 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.825 0.45 . . . . 15.0 110.225 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 82' ' ' GLU . 16.6 ptpt -66.67 -44.66 81.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.554 0.341 . . . . 15.0 111.294 -175.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 35.9 mm-40 -86.34 0.96 52.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.19 0.596 . . . . 15.0 111.823 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 57.6 26.0 12.31 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.376 1.07 . . . . 15.0 112.353 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.6 mt -74.15 111.22 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 108.622 -0.881 . . . . 15.0 108.622 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -90.66 100.19 2.61 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.561 0.744 . . . . 15.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.32 137.63 12.0 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.215 2.61 . . . . 15.0 112.186 -172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.11 110.78 22.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.897 0.879 . . . . 15.0 109.862 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.0 -161.91 49.62 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.841 0.713 . . . . 15.0 113.262 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.8 121.68 74.52 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.747 0.819 . . . . 15.0 110.555 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.13 141.55 63.93 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.037 2.492 . . . . 15.0 112.369 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 m -91.38 103.26 15.92 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.489 0.716 . . . . 15.0 109.791 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -85.67 109.15 18.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.963 -0.755 . . . . 15.0 108.963 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.77 95.17 16.04 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.524 0.73 . . . . 15.0 109.657 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.27 102.69 0.28 Allowed 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.036 2.491 . . . . 15.0 112.002 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.25 -52.61 10.48 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.883 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' HG2' ' HB ' ' A' ' 104' ' ' THR . 11.9 pt-20 -153.11 155.49 36.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.349 0.66 . . . . 15.0 110.949 -177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -146.21 112.94 6.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.238 -0.892 . . . . 15.0 108.775 166.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.7 mttt -93.9 150.28 20.5 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.278 -1.008 . . . . 15.0 108.278 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.83 84.23 0.2 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.414 0.686 . . . . 15.0 110.518 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.44 46.2 49.91 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.247 -0.888 . . . . 15.0 113.38 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 41.5 mt-10 -131.41 -65.09 0.78 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.099 0.559 . . . . 15.0 110.108 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -142.83 151.55 41.25 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.59 0.756 . . . . 15.0 110.326 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -143.61 83.56 1.77 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.551 ' HB ' ' HG2' ' A' ' 96' ' ' GLU . 49.4 m -88.81 124.05 33.79 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.184 -0.916 . . . . 15.0 109.646 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -144.78 137.49 26.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.35 0.66 . . . . 15.0 109.684 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 52.0 m -92.33 107.74 19.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.334 1.054 . . . . 15.0 110.612 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -85.0 89.58 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.681 -0.859 . . . . 15.0 108.681 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -90.71 100.56 13.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.87 0.868 . . . . 15.0 110.298 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -134.31 151.47 51.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 15.0 109.861 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.5 173.52 7.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.909 0.884 . . . . 15.0 109.574 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.26 166.45 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.675 0.79 . . . . 15.0 110.24 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -82.34 119.17 74.26 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.652 0.781 . . . . 15.0 109.574 173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.73 ' HG2' HD11 ' A' ' 300' ' ' ILE . 90.8 Cg_endo -83.0 166.32 14.77 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.469 2.112 . . . . 15.0 113.203 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.64 127.69 33.3 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.291 -0.868 . . . . 15.0 109.391 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.643 ' HA ' HD13 ' A' ' 300' ' ' ILE . 99.9 t -83.18 140.25 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.073 0.949 . . . . 15.0 111.07 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -85.79 88.63 7.58 Favored 'General case' 0 C--O 1.245 0.867 0 C-N-CA 123.347 0.659 . . . . 15.0 109.846 174.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 120' ' ' LEU . 38.4 mt -75.63 116.09 15.98 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.472 -0.936 . . . . 15.0 108.472 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -163.37 151.9 13.95 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.21 1.004 . . . . 15.0 109.364 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 70.78 15.02 73.38 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 120.061 -0.299 . . . . 15.0 113.318 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 117' ' ' LEU . 86.7 mt -63.84 -29.88 71.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.132 0.973 . . . . 15.0 111.182 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -78.99 -19.65 51.09 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.602 0.761 . . . . 15.0 111.59 174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.62 -20.24 28.16 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.858 0.463 . . . . 15.0 111.817 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.426 HG23 ' HA3' ' A' ' 293' ' ' GLY . 59.6 mt -61.15 99.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.64 0.776 . . . . 15.0 110.722 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 416' ' ' LYS . 40.6 mt-10 -84.23 88.01 7.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 15.0 109.907 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.8 t -81.48 101.13 6.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 CA-C-N 115.348 -0.842 . . . . 15.0 109.547 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' HA ' HG23 ' A' ' 418' ' ' THR . 1.6 tm-20 -72.78 94.33 1.77 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE2' HD11 ' A' ' 129' ' ' ILE . 82.9 tttt -94.1 110.83 50.44 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.503 0.721 . . . . 15.0 110.352 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -95.66 93.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.366 1.462 0 C-N-CA 122.827 2.352 . . . . 15.0 112.039 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.539 HD11 ' HE2' ' A' ' 127' ' ' LYS . 15.1 mm -71.11 123.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.737 -0.838 . . . . 15.0 108.737 171.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' A' ' 282' ' ' ILE . 83.9 t -133.36 140.25 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.672 0.789 . . . . 15.0 109.625 -174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -126.0 157.51 37.67 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.863 -1.162 . . . . 15.0 107.863 165.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 38.9 t -82.26 114.08 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.705 -0.85 . . . . 15.0 108.705 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.479 ' O ' HG23 ' A' ' 137' ' ' VAL . 62.2 p -93.08 170.63 9.5 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.139 0.975 . . . . 15.0 109.105 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -58.81 -32.58 69.5 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.225 0.61 . . . . 15.0 111.398 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.67 -45.17 92.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.699 0.8 . . . . 15.0 110.473 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -70.51 -39.42 74.12 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.122 -0.944 . . . . 15.0 111.638 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 133' ' ' THR . 59.7 t -65.95 -55.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.022 0.529 . . . . 15.0 110.124 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.26 -27.64 65.61 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.718 0.636 . . . . 15.0 111.113 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.66 -45.44 95.78 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.806 -0.517 . . . . 15.0 111.806 169.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.5 tpt -62.79 -47.17 84.65 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.921 0.888 . . . . 15.0 110.304 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.04 -41.53 98.22 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 110.824 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.72 -47.4 86.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.146 0.978 . . . . 15.0 110.5 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 26.5 m -56.66 -50.38 72.25 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 124.213 0.945 . . . . 15.0 110.628 177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -57.82 -46.62 84.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.389 1.076 . . . . 15.0 111.291 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -69.55 -29.89 67.57 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.01 -0.541 . . . . 15.0 111.892 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -73.95 -33.1 63.78 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.186 0.194 . . . . 15.0 111.41 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.35 -35.32 73.49 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.225 0.61 . . . . 15.0 110.167 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.474 ' HB3' ' HZ ' ' A' ' 252' ' ' PHE . 30.2 mm-40 -98.62 15.34 25.42 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.08 0.952 . . . . 15.0 111.341 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.91 134.88 47.6 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.135 0.574 . . . . 15.0 111.407 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.2 m -73.44 120.3 18.86 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.437 -0.949 . . . . 15.0 108.437 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.438 ' HB2' ' HG2' ' B' ' 243' ' ' GLN . 11.1 m95 -76.23 136.03 39.69 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.54 -1.281 . . . . 15.0 107.54 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -151.01 121.02 7.14 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.944 0.498 . . . . 15.0 109.849 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.24 128.23 35.11 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.872 0.869 . . . . 15.0 110.732 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.829 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 60.3 pttt -133.06 -178.35 4.93 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.644 1.178 . . . . 15.0 110.604 -178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -149.47 149.0 30.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.44 0.696 . . . . 15.0 109.697 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.78 -39.75 2.26 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-O 119.448 -0.64 . . . . 15.0 114.512 170.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.41 152.8 30.61 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 117.865 0.833 . . . . 15.0 111.667 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.621 HG11 HG22 ' A' ' 202' ' ' ILE . 62.0 t -104.23 114.4 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 167.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -90.13 175.3 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -64.06 -45.47 88.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.012 0.925 . . . . 15.0 113.379 -167.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.22 10.7 27.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.375 0.67 . . . . 15.0 112.364 -166.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -70.49 -168.38 0.24 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.894 0.478 . . . . 15.0 111.523 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.726 ' HG3' ' HB2' ' A' ' 241' ' ' GLU . 10.1 ptm85 -137.61 107.41 6.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.66 0.784 . . . . 15.0 109.62 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 239' ' ' LYS . 46.4 t -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.97 0.908 . . . . 15.0 111.989 -171.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 17.9 m -91.67 122.24 34.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.816 1.246 . . . . 15.0 109.121 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.575 HG21 HG23 ' A' ' 235' ' ' ILE . 5.2 mt -126.92 160.26 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-O 121.168 0.509 . . . . 15.0 111.049 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.24 104.48 12.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 105.861 -1.903 . . . . 15.0 105.861 151.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 54.8 p90 -106.38 121.46 44.29 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.9 p -133.88 102.93 5.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.528 0.731 . . . . 15.0 110.426 -169.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -152.67 -152.31 5.94 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.793 -0.523 . . . . 15.0 111.793 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -150.53 154.93 38.48 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.411 0.684 . . . . 15.0 109.877 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.58 138.68 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.886 0.875 . . . . 15.0 109.928 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.4 t0 64.67 9.22 5.0 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.897 1.279 . . . . 15.0 112.731 170.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.72 38.49 36.8 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.418 -0.355 . . . . 15.0 113.239 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.44 162.88 40.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.285 0.634 . . . . 15.0 109.753 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -65.18 86.01 0.06 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.16 0.984 . . . . 15.0 110.572 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' HB3' ' CE1' ' B' ' 233' ' ' PHE . 48.0 m-85 -113.17 179.99 3.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.067 0.947 . . . . 15.0 109.205 171.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -85.75 -171.65 3.7 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.978 -0.749 . . . . 15.0 108.978 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 75.4 -7.32 25.2 Favored Glycine 0 C--N 1.346 1.138 0 O-C-N 121.953 -0.467 . . . . 15.0 113.816 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -94.98 19.86 51.96 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.139 -0.812 . . . . 15.0 113.713 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.6 tttt -168.64 125.59 1.01 Allowed 'General case' 0 C--N 1.35 0.594 0 CA-C-N 117.576 0.688 . . . . 15.0 111.887 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.1 137.99 11.09 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.442 1.097 . . . . 15.0 108.834 163.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 57.4 m -107.79 143.24 36.63 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.523 1.129 . . . . 15.0 110.185 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 58.39 27.29 15.2 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.681 1.192 . . . . 15.0 112.311 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -76.71 100.87 5.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.117 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 165' ' ' THR . 29.6 t -77.43 135.21 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 170.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.6 tp -141.38 115.17 9.09 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.784 0.834 . . . . 15.0 109.452 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.39 111.03 11.41 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.082 -0.71 . . . . 15.0 109.082 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.458 ' HB3' ' HB2' ' A' ' 199' ' ' GLU . 1.4 mpp? -89.46 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.723 0.809 . . . . 15.0 110.788 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 71.92 15.2 76.09 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-N 115.867 -0.606 . . . . 15.0 112.991 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -154.88 171.53 19.51 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.237 1.015 . . . . 15.0 109.522 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.32 66.77 3.82 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 123.277 0.361 . . . . 15.0 113.588 -174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.94 -2.71 7.12 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.917 0.887 . . . . 15.0 110.565 174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.608 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -163.89 174.46 11.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.938 0.895 . . . . 15.0 109.173 176.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.608 HG22 ' SD ' ' A' ' 194' ' ' MET . 5.6 tt -75.07 133.6 75.29 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 123.674 0.79 . . . . 15.0 111.039 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -58.42 131.48 43.0 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.907 2.405 . . . . 15.0 111.452 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.65 -43.84 1.61 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.104 -0.798 . . . . 15.0 111.104 -173.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -64.46 -50.58 66.95 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 108.767 -0.827 . . . . 15.0 108.767 173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 189' ' ' MET . 7.4 pt-20 -65.61 -35.99 82.44 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.353 -1.294 . . . . 15.0 111.675 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -73.26 -28.36 62.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.819 0.447 . . . . 15.0 111.08 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.24 -43.4 97.24 Favored Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.621 HG22 HG11 ' A' ' 158' ' ' VAL . 73.4 mt -64.42 -47.64 88.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.763 1.225 . . . . 15.0 110.263 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 39.2 mtpt -69.54 -12.31 61.54 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.615 1.166 . . . . 15.0 112.076 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -80.95 7.16 60.22 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.969 -0.35 . . . . 15.0 113.364 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -139.68 -173.12 3.54 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 15.0 109.702 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -113.06 -67.99 0.96 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 114.557 1.317 . . . . 15.0 114.557 -166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.83 -56.8 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 113.891 1.071 . . . . 15.0 113.891 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -125.93 53.04 0.79 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.67 0.628 . . . . 15.0 114.67 -165.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 237' ' ' LEU . 14.0 pt-20 -138.3 130.68 28.96 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.439 0.619 . . . . 15.0 111.69 -174.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -80.88 148.8 29.74 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.593 0.357 . . . . 15.0 111.109 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -160.09 -172.81 3.76 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.95 1.3 . . . . 15.0 109.186 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.3 m -141.99 133.25 26.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.252 0.621 . . . . 15.0 109.674 177.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.52 HG21 ' HA3' ' A' ' 201' ' ' GLY . 23.5 pt -125.67 140.97 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 123.15 0.58 . . . . 15.0 110.209 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.02 101.45 12.93 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.739 1.216 . . . . 15.0 109.099 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 15.7 m -100.34 122.65 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.418 0.687 . . . . 15.0 111.647 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 30.4 m -92.09 97.53 10.98 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.157 -1.053 . . . . 15.0 108.157 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -37.94 142.08 0.47 Allowed Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 125.097 1.359 . . . . 15.0 113.16 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.29 154.38 53.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.384 2.723 . . . . 15.0 114.02 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.95 -16.7 61.08 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.648 0.779 . . . . 15.0 109.997 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -84.61 -14.9 47.37 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.642 1.577 . . . . 15.0 110.336 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -67.14 110.66 3.53 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.473 1.109 . . . . 15.0 109.322 -175.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -70.21 -11.16 60.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.05 0.94 . . . . 15.0 112.205 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.58 99.91 2.16 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.699 -1.223 . . . . 15.0 107.699 167.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -41.11 73.1 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.373 1.069 . . . . 15.0 111.484 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -64.5 -30.84 71.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.831 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -99.32 -23.39 15.19 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.358 1.244 . . . . 15.0 114.358 -171.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -60.53 110.94 1.4 Allowed 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.977 0.808 . . . . 15.0 110.831 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.36 13.51 59.96 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 115.572 -0.74 . . . . 15.0 114.626 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -88.66 141.76 28.25 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.857 0.829 . . . . 15.0 110.703 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -99.16 119.22 37.51 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.487 0.715 . . . . 15.0 109.984 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -116.44 147.09 42.03 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.259 1.024 . . . . 15.0 109.893 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.428 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 25.8 mtpp -121.58 108.05 13.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.686 -0.857 . . . . 15.0 108.686 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 27.7 m-85 -112.37 130.65 55.89 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.96 0.504 . . . . 15.0 110.401 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.47 94.75 5.63 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.575 HG23 HG21 ' A' ' 166' ' ' ILE . 39.0 mm -73.33 102.03 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.146 -0.934 . . . . 15.0 109.182 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.449 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.11 86.07 7.27 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 105.392 -2.077 . . . . 15.0 105.392 176.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 202' ' ' ILE . 11.9 tp -62.01 109.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.115 -1.069 . . . . 15.0 108.115 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -95.96 -64.24 1.07 Allowed 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.176 0.512 . . . . 15.0 110.593 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 93.6 mttt -130.63 160.68 33.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.604 -0.725 . . . . 15.0 111.135 -171.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 8.8 t -130.99 124.6 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.752 -1.944 . . . . 15.0 105.752 166.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.726 ' HB2' ' HG3' ' A' ' 163' ' ' ARG . 52.2 mt-10 -108.85 118.57 37.15 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.098 -1.075 . . . . 15.0 108.098 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.829 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 42.3 tt0 -66.49 138.24 57.38 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.724 0.809 . . . . 15.0 110.492 174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -89.13 74.27 8.05 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.303 -0.999 . . . . 15.0 108.303 167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -69.24 129.79 40.8 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.137 -0.938 . . . . 15.0 110.034 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.54 139.22 75.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 O-C-N 123.968 0.792 . . . . 15.0 110.863 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.84 173.54 12.56 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.371 2.048 . . . . 15.0 111.968 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -79.95 150.59 30.44 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 114.788 -1.096 . . . . 15.0 109.995 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.0 70.71 10.06 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 108.469 -0.937 . . . . 15.0 108.469 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 53.6 m -95.5 126.84 41.07 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.739 -1.119 . . . . 15.0 108.418 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.07 -51.95 60.14 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.763 0.825 . . . . 15.0 111.295 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 255' ' ' ARG . 15.6 mm-40 -62.85 -17.95 62.19 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.038 0.935 . . . . 15.0 112.851 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.474 ' HZ ' ' HB3' ' A' ' 148' ' ' GLN . 84.6 t80 -83.82 -63.28 1.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.582 HG13 HD22 ' A' ' 266' ' ' LEU . 11.5 tt -59.31 -36.27 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.321 1.048 . . . . 15.0 112.497 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -82.85 -18.55 39.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 111.889 0.329 . . . . 15.0 111.889 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 251' ' ' GLU . 7.0 tpp180 -68.72 -23.9 64.41 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.285 0.564 . . . . 15.0 110.358 -174.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' B' ' 277' ' ' LEU . 83.8 m-85 -67.72 -19.34 65.13 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.917 -1.038 . . . . 15.0 111.841 175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 120.63 56.94 0.23 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.324 -0.31 . . . . 15.0 112.324 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 23.6 t -118.09 136.58 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 108.159 -1.052 . . . . 15.0 108.159 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -72.75 -42.75 63.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.61 0.764 . . . . 15.0 110.316 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.83 -61.49 1.7 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.325 1.05 . . . . 15.0 110.82 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.71 -6.55 13.84 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.661 -0.521 . . . . 15.0 114.107 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 96.1 p -78.33 154.81 30.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.489 0.716 . . . . 15.0 110.517 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.8 t -54.95 -49.99 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.014 0.925 . . . . 15.0 111.035 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -61.44 -24.55 66.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.049 0.843 . . . . 15.0 111.723 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.47 -33.34 48.4 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 110.913 -0.875 . . . . 15.0 110.913 175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.582 HD22 HG13 ' A' ' 253' ' ' ILE . 58.3 tp -73.32 -36.64 66.26 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 108.812 -0.81 . . . . 15.0 108.812 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.2 ttt85 -69.31 -38.58 78.31 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.283 0.633 . . . . 15.0 109.734 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.84 87.78 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.526 0.731 . . . . 15.0 110.445 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -63.75 -48.93 75.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.808 -0.633 . . . . 15.0 110.411 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.69 -31.6 51.29 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 C-N-CA 124.237 1.015 . . . . 15.0 109.986 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -64.36 -60.93 2.59 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 117.868 0.303 . . . . 15.0 110.615 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.04 -34.38 76.13 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.912 0.758 . . . . 15.0 111.691 -175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.476 ' HB3' HD13 ' B' ' 278' ' ' LEU . 17.3 m-80 -78.72 -40.63 33.08 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.016 0.526 . . . . 15.0 112.145 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 5.3 mmt -60.82 -45.64 93.68 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.816 -0.439 . . . . 15.0 109.816 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -74.34 -24.38 59.18 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 15.0 111.771 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -62.32 -55.26 29.9 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.713 0.805 . . . . 15.0 109.55 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.664 ' HG3' ' HB2' ' B' ' 283' ' ' ASP . 58.6 tt0 -66.69 -34.41 77.79 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.816 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.556 HD13 ' HD1' ' A' ' 424' ' ' PHE . 31.9 tp -68.5 -48.42 64.48 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.726 0.811 . . . . 15.0 110.564 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -58.91 -43.83 91.16 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.963 0.79 . . . . 15.0 110.254 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.0 t -61.45 -44.54 96.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.751 0.821 . . . . 15.0 110.677 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.22 57.58 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.033 0.933 . . . . 15.0 110.163 -177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' A' ' 130' ' ' VAL . 80.8 mt -62.13 -40.51 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.534 1.133 . . . . 15.0 110.816 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -64.44 -51.65 62.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.905 0.482 . . . . 15.0 110.44 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -73.27 -23.88 60.36 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.003 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -63.79 -59.24 4.8 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.814 0.846 . . . . 15.0 109.729 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 282' ' ' ILE . 81.0 t -60.29 -41.0 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.011 0.924 . . . . 15.0 110.491 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 291' ' ' ILE . 88.1 tttt -58.54 -55.67 32.04 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.783 0.677 . . . . 15.0 110.384 177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 80.5 p -64.01 -34.64 78.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.291 0.636 . . . . 15.0 112.408 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -72.11 -40.44 68.17 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.894 0.477 . . . . 15.0 111.559 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -64.55 -37.23 86.84 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.558 0.536 . . . . 15.0 110.576 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 287' ' ' LYS . 20.1 mm -67.54 -45.35 85.38 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 C-N-CA 124.418 1.087 . . . . 15.0 110.629 176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -58.75 -51.44 69.98 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.828 0.851 . . . . 15.0 109.914 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.426 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -67.64 -29.96 74.36 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 114.757 -1.111 . . . . 15.0 112.745 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.472 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.86 -59.78 4.62 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 177.132 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 41.1 t -56.42 -48.49 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.309 0.381 . . . . 15.0 110.108 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -56.76 -38.89 73.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.765 1.226 . . . . 15.0 112.26 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -94.37 -10.97 30.93 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.585 0.587 . . . . 15.0 112.585 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -117.64 -179.63 3.79 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 122.768 0.427 . . . . 15.0 110.773 -171.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -147.39 131.57 17.38 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.467 0.707 . . . . 15.0 110.154 -176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.73 HD11 ' HG2' ' A' ' 113' ' ' PRO . 9.4 tp -172.09 134.58 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.436 1.094 . . . . 15.0 109.256 168.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.86 151.26 19.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.803 -0.814 . . . . 15.0 108.803 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.405 ' HB ' ' HG3' ' A' ' 342' ' ' LYS . 93.5 t -108.78 125.63 31.25 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 123.547 0.739 . . . . 15.0 110.181 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.48 138.01 65.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.162 2.574 . . . . 15.0 112.282 167.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.87 68.8 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.275 1.43 . . . . 15.0 113.362 -169.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -58.95 -45.09 91.29 Favored 'General case' 0 C--O 1.249 1.061 0 C-N-CA 123.651 0.78 . . . . 15.0 111.277 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' A' ' 310' ' ' GLU . 39.7 mt -60.54 -43.13 97.51 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.121 178.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.419 ' O ' HG13 ' A' ' 311' ' ' ILE . 53.3 mt -61.81 -54.65 31.88 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 O-C-N 124.517 1.136 . . . . 15.0 110.085 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.61 -46.54 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.255 1.022 . . . . 15.0 111.674 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.5 m -56.59 -53.83 53.03 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.998 0.811 . . . . 15.0 111.007 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 306' ' ' LEU . 20.6 mm-40 -67.08 -30.05 69.99 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 115.923 -0.581 . . . . 15.0 111.533 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 307' ' ' ILE . 86.8 mt -63.72 -53.2 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.93 -0.767 . . . . 15.0 108.93 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.68 -41.59 77.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.676 0.79 . . . . 15.0 111.951 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 309' ' ' SER . 98.9 t -62.02 -49.91 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 123.755 0.659 . . . . 15.0 111.072 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 310' ' ' GLU . 69.0 mt -66.06 -31.34 72.16 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.222 0.609 . . . . 15.0 111.384 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 332' ' ' LEU . 75.1 mtm180 -72.36 -42.84 64.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.816 0.447 . . . . 15.0 110.008 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -65.33 -42.35 93.03 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.729 0.412 . . . . 15.0 110.884 176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -63.39 -38.93 93.04 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.924 0.89 . . . . 15.0 110.947 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.46 -47.51 60.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.509 -0.769 . . . . 15.0 110.248 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.42 -32.67 73.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.363 1.065 . . . . 15.0 111.788 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.46 -32.29 62.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.955 0.902 . . . . 15.0 110.999 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -91.96 -36.76 13.25 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.383 0.673 . . . . 15.0 110.305 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -87.76 76.28 8.81 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.115 0.966 . . . . 15.0 109.247 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.3 40.2 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.692 -0.686 . . . . 15.0 113.999 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.74 52.42 5.9 Favored Glycine 0 C--N 1.358 1.789 0 N-CA-C 110.574 -1.01 . . . . 15.0 110.574 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 74.4 m-20 -86.86 121.97 30.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.901 0.881 . . . . 15.0 111.602 -169.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.92 93.32 9.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.59 1.156 . . . . 15.0 108.925 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm 65.14 3.26 2.12 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.481 1.513 . . . . 15.0 114.063 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.798 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 24.8 tm0? -68.89 -16.58 63.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.536 0.735 . . . . 15.0 109.025 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -46.61 -32.12 3.28 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.044 1.738 . . . . 15.0 113.444 168.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -27.64 64.1 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.028 0.931 . . . . 15.0 111.199 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -79.62 -25.64 41.4 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.929 0.891 . . . . 15.0 111.529 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.423 ' HB2' ' HD2' ' A' ' 315' ' ' ARG . 94.3 mt -59.85 136.68 90.29 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 122.988 0.515 . . . . 15.0 110.681 -176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.71 110.8 0.63 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.126 2.551 . . . . 15.0 112.359 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.4 ' HB2' HD13 ' A' ' 311' ' ' ILE . 14.1 ptm180 -53.34 -43.22 67.52 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.601 0.76 . . . . 15.0 111.513 -175.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 1.4 pm0 -63.86 -23.46 67.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.633 1.173 . . . . 15.0 112.775 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.91 -33.67 76.24 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.478 ' HA ' HE21 ' A' ' 340' ' ' GLN . 81.1 m-85 -95.48 -39.09 10.15 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-N 114.961 -1.018 . . . . 15.0 110.264 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 335' ' ' GLU . 34.4 tt0 -60.44 -37.67 81.65 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.044 1.337 . . . . 15.0 113.026 -165.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.23 -41.22 79.09 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.962 0.789 . . . . 15.0 111.546 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' A' ' 337' ' ' PHE . 4.2 pp0? -101.07 -19.38 15.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.626 0.77 . . . . 15.0 111.506 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -66.87 -54.51 21.59 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.173 -0.677 . . . . 15.0 109.173 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.3 tttt -54.24 -36.55 63.66 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 124.51 1.131 . . . . 15.0 110.687 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 347' ' ' VAL . 22.7 ttt180 -69.37 -32.75 72.01 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 123.622 0.576 . . . . 15.0 110.449 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 93.6 mtt180 -68.14 -36.27 79.42 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.878 -0.416 . . . . 15.0 109.878 175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 341' ' ' ALA . 3.6 t -73.08 -31.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-N 116.077 -0.511 . . . . 15.0 109.971 176.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 342' ' ' LYS . 25.6 t -59.39 -47.94 88.87 Favored 'Isoleucine or valine' 0 C--N 1.365 1.239 0 N-CA-C 108.821 -0.807 . . . . 15.0 108.821 173.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 343' ' ' ARG . 49.4 t -58.97 -38.46 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 123.882 0.738 . . . . 15.0 110.386 173.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -57.47 -43.44 94.02 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.233 -0.894 . . . . 15.0 112.732 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 82.7 mt -75.87 -37.24 59.09 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.576 0.751 . . . . 15.0 111.088 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.472 HD13 HD22 ' A' ' 294' ' ' LEU . 95.6 mt -61.73 -56.88 14.87 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.838 0.855 . . . . 15.0 110.395 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.53 -32.27 73.51 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.659 -0.7 . . . . 15.0 111.049 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -62.15 -39.57 97.83 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.589 0.556 . . . . 15.0 112.138 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -67.69 -43.9 79.02 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.378 0.671 . . . . 15.0 110.358 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.46 -40.84 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.083 0.553 . . . . 15.0 110.736 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . . . . . . . . . 63.3 mt -65.55 -45.46 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.541 0.736 . . . . 15.0 110.699 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -63.44 -58.32 7.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.069 0.462 . . . . 15.0 110.169 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 98.9 m -56.68 -42.59 79.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.029 1.331 . . . . 15.0 112.576 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.54 10.13 39.34 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 119.069 -0.491 . . . . 15.0 111.804 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.77 49.23 3.86 Favored 'General case' 0 N--CA 1.505 2.3 0 C-N-CA 125.522 1.529 . . . . 15.0 113.479 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 83.3 mt -78.02 169.79 17.68 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.783 -1.098 . . . . 15.0 112.219 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.56 ' HA ' HD13 ' B' ' 301' ' ' ILE . 60.8 pttt -143.61 161.56 38.18 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 15.0 110.348 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 403' ' ' LEU . . . -97.37 90.58 5.13 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.288 -1.375 . . . . 15.0 107.288 166.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.432 ' HB2' ' HE3' ' A' ' 361' ' ' LYS . 32.2 t70 -56.76 115.65 2.69 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.897 0.748 . . . . 15.0 110.21 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -59.85 -23.3 63.28 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.028 0.931 . . . . 15.0 113.219 -174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -84.04 -24.04 30.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.572 0.349 . . . . 15.0 111.05 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -76.08 -37.83 57.76 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.648 0.779 . . . . 15.0 109.0 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 399' ' ' ARG . 94.7 t -59.48 -53.3 50.18 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 124.274 1.03 . . . . 15.0 108.956 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.438 ' HB3' ' HE3' ' A' ' 368' ' ' LYS . 18.7 mmmt -52.12 -45.5 64.97 Favored 'General case' 0 C--O 1.256 1.437 0 C-N-CA 124.925 1.29 . . . . 15.0 111.79 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -52.81 -60.99 7.26 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.204 -1.362 . . . . 15.0 111.791 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.487 ' HB2' ' SD ' ' A' ' 398' ' ' MET . 81.0 mt -65.7 -31.31 72.24 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.893 0.877 . . . . 15.0 111.768 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 32.6 mt -51.69 -66.13 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 124.093 0.957 . . . . 15.0 109.169 174.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -75.77 -31.03 59.35 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.694 0.621 . . . . 15.0 111.543 -171.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -62.92 -48.36 79.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.103 0.961 . . . . 15.0 110.21 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.0 ttp -79.59 -35.66 39.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.81 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.16 -25.27 66.07 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.635 0.374 . . . . 15.0 111.997 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 29.1 t -58.09 -24.28 57.98 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.653 0.781 . . . . 15.0 112.115 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -75.65 -16.74 60.16 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.266 0.626 . . . . 15.0 111.937 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -83.52 155.84 23.13 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.125 0.57 . . . . 15.0 110.284 175.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -9.06 58.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.488 0.715 . . . . 15.0 111.763 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -152.45 106.62 2.75 Favored Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 107.658 -1.238 . . . . 15.0 107.658 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.45 -42.36 41.54 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.491 2.128 . . . . 15.0 112.945 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -60.8 -46.83 88.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 114.783 -1.099 . . . . 15.0 113.311 -159.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.58 -25.67 65.0 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.794 0.438 . . . . 15.0 111.147 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.02 -32.17 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 109.299 -0.63 . . . . 15.0 109.299 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 78.7 mt -63.31 -48.14 88.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 123.744 0.817 . . . . 15.0 109.611 172.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.73 -36.5 83.2 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.59 -1.187 . . . . 15.0 110.228 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -64.55 -32.28 73.86 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.039 0.535 . . . . 15.0 111.427 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -64.84 -56.76 11.45 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 75.6 p -62.69 -22.61 66.62 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.302 -0.863 . . . . 15.0 112.699 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.68 -22.11 18.95 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.495 0.718 . . . . 15.0 111.455 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -127.86 96.49 4.52 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.46 -0.941 . . . . 15.0 108.46 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 41.2 ttmt -65.19 -7.28 12.02 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.973 1.309 . . . . 15.0 113.09 -171.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -62.93 -42.58 99.85 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 120.997 0.427 . . . . 15.0 110.08 171.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.91 -33.03 24.82 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.024 -0.535 . . . . 15.0 110.69 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.491 ' HB3' ' HA ' ' A' ' 392' ' ' LYS . 15.4 tpt -65.76 -32.03 73.34 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 110.169 -0.308 . . . . 15.0 110.169 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -60.88 -63.43 1.3 Allowed 'General case' 0 C--O 1.209 -1.029 0 N-CA-C 108.147 -1.057 . . . . 15.0 108.147 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 400' ' ' ASN . 56.8 t30 -60.78 -26.26 67.13 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 125.264 1.603 . . . . 15.0 112.182 -167.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.487 ' SD ' ' HB2' ' A' ' 370' ' ' LEU . 48.8 tpp -80.18 -44.83 19.14 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.772 0.829 . . . . 15.0 111.099 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.447 ' HA ' HG22 ' A' ' 367' ' ' VAL . 78.7 mtt180 -63.15 -28.32 69.98 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.756 0.423 . . . . 15.0 110.635 170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 397' ' ' ASN . 26.9 t-20 -81.93 -39.13 24.21 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.687 1.195 . . . . 15.0 111.13 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 6.9 p -64.47 -46.27 93.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.993 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.22 -52.12 64.4 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.848 0.859 . . . . 15.0 111.757 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 362' ' ' ALA . 34.7 tp -66.34 -53.01 41.23 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 114.826 -1.079 . . . . 15.0 111.654 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.16 -26.88 65.09 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 123.608 0.568 . . . . 15.0 111.306 -175.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.76 -60.37 3.95 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 107.921 -1.14 . . . . 15.0 107.921 167.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.98 -35.23 70.9 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.956 0.785 . . . . 15.0 111.962 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -74.01 -43.95 56.21 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.001 0.92 . . . . 15.0 111.008 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.5 t -69.31 -34.53 63.17 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.203 0.601 . . . . 15.0 110.213 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.404 ' HG2' HD12 ' A' ' 412' ' ' LEU . 52.7 mt-10 -70.9 -29.34 65.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.437 0.695 . . . . 15.0 111.137 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.54 -26.57 68.76 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 122.94 0.496 . . . . 15.0 111.157 168.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.3 t -85.38 -34.53 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.125 0.57 . . . . 15.0 109.469 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.404 HD12 ' HG2' ' A' ' 409' ' ' GLU . 95.6 mt -64.31 -36.6 84.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.019 0.927 . . . . 15.0 110.845 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -60.83 -22.0 63.75 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.873 . . . . 15.0 111.828 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -104.83 -21.27 13.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.083 0.953 . . . . 15.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -89.28 156.94 18.42 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.982 0.913 . . . . 15.0 111.544 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 124' ' ' GLU . 97.7 mttt -73.7 87.16 1.69 Allowed 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.366 -0.834 . . . . 15.0 109.286 173.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 57.3 t -81.08 81.1 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 121.955 0.883 . . . . 15.0 108.644 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 126' ' ' GLU . 1.8 t -72.89 89.47 1.4 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.183 -1.371 . . . . 15.0 108.548 175.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.2 136.58 35.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.953 -173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -128.64 160.87 31.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.459 0.704 . . . . 15.0 109.361 168.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 129' ' ' ILE . 41.8 mt-10 -113.29 127.17 56.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.538 -0.912 . . . . 15.0 108.538 176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -155.42 179.3 9.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 122.828 0.451 . . . . 15.0 110.952 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 76.3 p -91.79 166.21 12.87 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.716 0.806 . . . . 15.0 112.278 -174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.556 ' HD1' HD13 ' A' ' 278' ' ' LEU . 72.7 t80 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.116 1.366 . . . . 15.0 110.799 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 429' ' ' ASN . 55.4 m-80 -57.25 -38.28 73.61 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.788 0.68 . . . . 15.0 110.938 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.4 -40.23 67.36 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.649 0.593 . . . . 15.0 111.202 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 130' ' ' VAL . 50.9 tp -64.53 -37.29 87.03 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.755 0.312 . . . . 15.0 110.929 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.2 mmt -84.35 -6.8 59.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.131 0.572 . . . . 15.0 112.071 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 425' ' ' ASN . 13.4 t-20 -84.86 37.3 0.65 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.839 0.856 . . . . 15.0 110.671 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -101.12 35.08 2.32 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.579 0.751 . . . . 15.0 111.721 -173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.88 99.68 7.67 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.8 0.84 . . . . 15.0 108.815 177.485 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -77.73 149.37 34.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.808 0.843 . . . . 0.0 108.941 174.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 65.77 -71.66 0.08 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.473 1.109 . . . . 0.0 110.584 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 37.6 t70 68.97 168.38 0.28 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.029 1.331 . . . . 0.0 111.821 168.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.78 157.12 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 24.5 m -59.04 89.74 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.701 0.8 . . . . 0.0 109.594 171.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 40.3 tp -75.04 88.91 2.41 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.868 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 155.47 114.18 0.48 Allowed Glycine 0 C--N 1.337 0.626 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.346 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -84.64 -2.76 88.66 Favored Glycine 0 C--N 1.353 1.507 0 C-N-CA 122.81 0.243 . . . . 0.0 113.061 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 125.85 -160.79 20.33 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 123.406 0.527 . . . . 0.0 111.845 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -74.21 165.09 25.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.358 0.663 . . . . 0.0 110.885 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -138.98 96.38 3.11 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 20.7 m 66.56 161.71 0.16 Allowed 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.497 1.119 . . . . 0.0 111.07 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' B' ' 235' ' ' GLU . 4.1 t80 -163.61 -55.69 0.04 OUTLIER 'General case' 0 C--N 1.352 0.694 0 O-C-N 121.734 -0.604 . . . . 0.0 110.593 170.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 60.32 72.24 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -165.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.443 ' HA ' ' HD2' ' B' ' 233' ' ' PHE . 0.5 OUTLIER -83.81 136.0 34.31 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.9 -159.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 28.5 m 75.23 -15.4 0.67 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.915 1.286 . . . . 0.0 113.242 165.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 50.78 43.52 28.15 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 124.832 1.253 . . . . 0.0 111.005 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 5.7 m -70.62 90.38 0.75 Allowed 'General case' 0 C--N 1.35 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.235 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.94 69.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.101 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.74 40.88 99.76 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 123.862 0.726 . . . . 0.0 112.084 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.547 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 22.6 mt-10 -80.4 135.8 36.24 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.02 0.528 . . . . 0.0 111.438 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -149.64 177.0 10.16 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 125.312 1.445 . . . . 0.0 108.274 168.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 151' ' ' TRP . 52.8 mt-30 -86.68 156.08 20.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.586 0.754 . . . . 0.0 109.912 176.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -57.31 -73.53 0.44 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.814 . . . . 0.0 113.048 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 66.96 83.11 0.17 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.474 1.11 . . . . 0.0 112.782 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 17.3 m 66.27 -68.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 160.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.644 ' H ' HD23 ' B' ' 247' ' ' LEU . 2.1 pt? -111.99 2.14 16.75 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -165.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.548 ' HG2' ' HG3' ' B' ' 249' ' ' GLU . 62.6 ttm-85 -62.51 -82.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 -167.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.548 ' HG3' ' HG2' ' B' ' 248' ' ' ARG . 43.5 mt-10 -101.84 -81.79 0.48 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.87 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -101.81 -77.42 0.55 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.99 -78.12 0.59 Allowed 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.85 -76.73 0.45 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 168.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -114.23 -85.24 0.6 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 168.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.441 ' HB2' ' HB3' ' B' ' 250' ' ' GLN . 99.2 mtt180 59.04 17.88 5.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.893 1.277 . . . . 0.0 113.453 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -129.33 -73.02 0.14 Allowed Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 62.88 -174.16 0.15 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.254 1.422 . . . . 0.0 111.328 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -82.33 73.55 9.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.692 0.758 . . . . 0.0 109.727 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.76 134.34 41.06 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 175.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -65.4 92.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.21 1.005 . . . . 0.0 110.06 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 35.3 t -129.3 124.54 34.62 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.5 1.12 . . . . 0.0 108.844 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.83 -77.75 0.21 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.156 0.583 . . . . 0.0 110.512 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -111.0 -73.32 0.68 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.614 0.766 . . . . 0.0 109.908 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -108.19 -49.65 3.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.53 0.732 . . . . 0.0 110.106 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 31.6 m 75.78 -49.3 0.61 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.951 1.701 . . . . 0.0 112.678 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 78.9 mt 59.94 -158.73 0.31 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.166 0.987 . . . . 0.0 111.054 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 8.8 t30 76.21 -60.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.238 1.415 . . . . 0.0 111.246 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.6 t -65.95 86.96 0.1 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.677 0.791 . . . . 0.0 110.018 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.89 133.21 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.825 1.25 . . . . 0.0 108.219 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 15.3 t -94.49 45.25 1.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 122.353 1.073 . . . . 0.0 110.559 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . 0.551 ' HG2' ' H ' ' B' ' 271' ' ' ALA . 20.8 tt0 -72.33 -164.05 0.13 Allowed 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.095 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.551 ' H ' ' HG2' ' B' ' 270' ' ' GLU . . . -48.28 -31.34 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 124.264 1.026 . . . . 0.0 113.539 -177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -86.87 29.8 0.79 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.094 0.957 . . . . 0.0 112.119 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.79 8.66 2.28 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.445 0.698 . . . . 0.0 112.432 174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -65.24 -1.94 2.66 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.214 1.006 . . . . 0.0 112.227 173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 276' ' ' PRO . 0.1 OUTLIER -58.02 119.76 37.12 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 162.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 275' ' ' LYS . 3.0 Cg_exo -77.85 170.54 18.81 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.621 2.214 . . . . 0.0 112.913 -175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 256' ' ' PHE . 31.9 tp -85.34 119.07 25.3 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 273' ' ' ASN . 36.3 tp -159.67 135.54 8.63 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.508 0.723 . . . . 0.0 110.14 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -104.49 103.26 2.22 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.67 57.74 0.58 Allowed 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.335 1.454 . . . . 0.0 113.092 -171.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -59.43 -27.76 66.33 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.756 0.822 . . . . 0.0 112.102 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.76 -96.05 0.38 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 118.674 -0.679 . . . . 0.0 109.384 169.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.664 ' HB2' ' HG3' ' A' ' 277' ' ' GLU . 33.1 t70 53.13 -80.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.05 1.34 . . . . 0.0 112.685 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 150.98 -10.55 0.77 Allowed Glycine 0 C--N 1.346 1.117 0 C-N-CA 124.055 0.836 . . . . 0.0 111.483 -175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 8.1 t30 66.18 94.75 0.06 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.917 1.287 . . . . 0.0 109.924 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -109.67 120.76 44.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.168 -171.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.8 -167.26 0.38 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.082 2.521 . . . . 0.0 109.561 160.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 t -79.75 69.8 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.182 0 CA-C-O 122.512 1.149 . . . . 0.0 108.272 171.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -171.88 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -172.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 286' ' ' MET 0.258 3.2 p-90 51.9 172.22 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 127.931 2.492 . . . . 0.0 116.722 164.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 397' ' ' ASN . 95.5 mt 63.06 -155.85 0.33 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.2 1.4 . . . . 0.0 111.559 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 173.58 -67.79 0.11 Allowed Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.29 86.72 0.79 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.599 2.2 . . . . 0.0 111.529 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 121.69 17.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.564 1.146 . . . . 0.0 108.904 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.15 -56.61 4.24 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.578 0.751 . . . . 0.0 109.04 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 28.4 m 75.26 -21.7 0.29 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 159.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -79.32 69.38 5.53 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.911 0.862 . . . . 0.0 110.119 -175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 179.62 26.24 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.529 1.932 . . . . 0.0 109.243 -175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.87 45.98 3.5 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.337 -0.392 . . . . 0.0 112.451 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.66 -36.74 81.28 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.245 1.018 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 361' ' ' LYS . 59.7 mt -55.17 -31.04 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 125.168 1.387 . . . . 0.0 113.158 -172.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -56.23 -38.19 70.73 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.424 1.09 . . . . 0.0 111.925 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -78.85 -57.07 0.82 Allowed Pre-proline 0 CA--C 1.572 1.806 0 CA-C-O 118.025 -0.988 . . . . 0.0 111.682 -168.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -86.32 135.99 4.63 Favored 'Trans proline' 0 C--N 1.402 3.358 0 C-N-CA 122.131 1.888 . . . . 0.0 112.14 172.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.48 121.46 17.82 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.7 89.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.712 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.8 m -151.36 144.35 24.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.831 1.252 . . . . 0.0 108.54 -171.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -77.08 83.35 3.58 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.345 0.593 . . . . 0.0 109.539 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 9.1 t -148.85 135.0 9.97 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 124.046 0.938 . . . . 0.0 109.711 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 C--N 1.377 2.052 0 C-N-CA 122.506 2.137 . . . . 12.53 112.211 179.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 121.149 0.499 . . . . 15.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.6 tt0 -65.08 100.09 0.41 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.868 0.867 . . . . 15.0 110.671 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.584 HG12 HG12 ' A' ' 17' ' ' ILE . 19.3 m -102.66 103.13 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 CA-C-O 121.699 0.762 . . . . 15.0 110.09 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -101.72 100.24 10.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.022 0.529 . . . . 15.0 109.801 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -74.64 110.34 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-O 121.601 0.715 . . . . 15.0 109.527 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -117.23 114.92 24.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.092 0.957 . . . . 15.0 109.429 -174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -73.48 85.24 1.52 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.446 0.698 . . . . 15.0 109.184 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -91.36 -26.34 18.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.872 0.869 . . . . 15.0 112.204 -172.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' A' ' 12' ' ' GLY . 54.3 tp60 -129.17 16.44 6.14 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.02 0.528 . . . . 15.0 111.102 -173.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.1 -72.64 2.58 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.238 -0.345 . . . . 15.0 112.238 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.9 -35.63 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.171 -1.048 . . . . 15.0 108.171 170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 110' ' ' GLU . . . -78.96 132.53 11.59 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 114.709 -1.132 . . . . 15.0 113.033 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -130.92 119.74 22.57 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.304 1.041 . . . . 15.0 109.343 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -83.62 104.14 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.255 1.022 . . . . 15.0 109.458 173.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.5 t -87.44 94.28 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 107.951 -1.129 . . . . 15.0 107.951 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 48.3 m -78.35 100.69 6.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.446 -0.797 . . . . 15.0 108.99 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.584 HG12 HG12 ' A' ' 3' ' ' VAL . 35.2 mt -93.04 122.52 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.125 -0.943 . . . . 15.0 110.072 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 62.7 m -111.95 98.96 7.73 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.092 -1.077 . . . . 15.0 108.092 173.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 70' ' ' LEU . 43.6 mt -87.59 135.21 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 109.159 -0.682 . . . . 15.0 109.159 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.34 137.71 58.05 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 123.983 0.913 . . . . 15.0 111.224 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.15 -42.93 91.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.145 0.978 . . . . 15.0 112.714 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -62.45 -33.39 74.72 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.751 0.821 . . . . 15.0 111.374 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.6 m -74.23 -37.3 63.85 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.235 0.614 . . . . 15.0 110.499 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.526 HG23 HD11 ' A' ' 70' ' ' LEU . 70.3 mt -66.01 -40.28 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.314 0.645 . . . . 15.0 109.749 173.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -67.23 -35.64 80.0 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.235 1.014 . . . . 15.0 110.699 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.2 m -67.9 -38.56 83.13 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.717 0.807 . . . . 15.0 110.692 172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.47 -38.77 84.91 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.157 0.583 . . . . 15.0 111.094 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.493 ' HA ' HG21 ' A' ' 66' ' ' VAL . 97.9 t -65.45 -43.1 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.399 0.68 . . . . 15.0 110.133 175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.6 ttmp? -64.35 -40.02 95.04 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.774 -1.103 . . . . 15.0 110.895 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.0 m -83.77 -5.49 59.21 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.025 0.93 . . . . 15.0 111.202 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.23 -42.84 10.78 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.217 0.607 . . . . 15.0 110.451 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 55' ' ' ALA . 69.8 mt -56.76 -36.15 69.45 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.951 -1.022 . . . . 15.0 112.099 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -58.34 -38.86 71.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 O-C-N 123.763 0.664 . . . . 15.0 111.613 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -73.98 -51.09 17.08 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.229 0.612 . . . . 15.0 109.881 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.45 -34.02 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 114.631 -1.168 . . . . 15.0 111.002 -176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.62 -52.05 29.52 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.502 0.721 . . . . 15.0 110.149 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -59.74 -31.83 70.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.136 0.574 . . . . 15.0 112.228 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.76 -35.97 73.61 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 122.795 0.438 . . . . 15.0 111.099 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' HB ' HG13 ' A' ' 41' ' ' ILE . 6.3 t -107.5 -2.91 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.547 0 C-N-CA 123.939 0.896 . . . . 15.0 110.511 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 64.68 29.71 12.78 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.606 1.563 . . . . 15.0 112.707 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.526 HG13 ' HB ' ' A' ' 39' ' ' VAL . 60.8 mt -66.51 -26.7 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.268 1.027 . . . . 15.0 110.634 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.19 -27.34 69.3 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.237 1.015 . . . . 15.0 111.924 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.24 -27.24 72.85 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 116.113 -0.494 . . . . 15.0 113.288 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.407 ' HD2' ' HA ' ' A' ' 41' ' ' ILE . 93.8 m-85 -80.43 -18.66 48.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.415 0.686 . . . . 15.0 111.264 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -65.64 102.47 0.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.625 0.726 . . . . 15.0 109.76 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -76.7 -23.44 53.13 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.903 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.42 -9.9 69.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.055 -0.521 . . . . 15.0 112.388 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -68.63 -48.15 64.81 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 123.837 0.855 . . . . 15.0 110.421 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -76.22 117.34 63.45 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 53' ' ' ILE . 78.7 Cg_exo -52.56 140.56 54.75 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 123.501 2.8 . . . . 15.0 113.323 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 tpt -70.18 -24.48 63.14 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.718 0.807 . . . . 15.0 110.718 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.401 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 10.4 p30 -71.58 -28.1 63.6 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.611 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.621 HG23 ' HD2' ' A' ' 57' ' ' ARG . 14.7 mt -68.87 -52.82 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.537 0.735 . . . . 15.0 109.747 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.91 -19.36 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.924 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HA ' HD11 ' A' ' 32' ' ' LEU . . . -65.34 -36.59 84.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.253 0.621 . . . . 15.0 111.985 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -115.42 5.43 14.54 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.042 -0.526 . . . . 15.0 112.15 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HD2' HG23 ' A' ' 53' ' ' ILE . 98.0 mtt180 -131.92 -73.28 0.52 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.95 0.5 . . . . 15.0 111.099 -176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -71.65 -24.92 61.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.102 0.561 . . . . 15.0 112.197 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.92 31.59 5.64 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.925 0.774 . . . . 15.0 111.45 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -22.11 64.45 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.859 0.864 . . . . 15.0 111.971 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 p -79.33 -30.0 42.55 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.908 0.883 . . . . 15.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.5 t -72.89 -19.44 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 123.782 0.833 . . . . 15.0 110.731 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 67.9 mtp85 -60.69 -24.58 65.73 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.834 0.854 . . . . 15.0 111.518 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -66.41 -41.28 89.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.319 1.048 . . . . 15.0 110.729 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.43 -34.26 74.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.472 0.709 . . . . 15.0 110.629 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 28' ' ' VAL . 90.3 t -61.84 -39.77 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 115.148 -0.933 . . . . 15.0 110.268 175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 70' ' ' LEU . 85.5 mt -58.22 -38.53 77.01 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.314 0.645 . . . . 15.0 110.577 175.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.4 -41.65 93.32 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.643 0.59 . . . . 15.0 112.701 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.25 -41.89 84.85 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.564 0.746 . . . . 15.0 110.931 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.526 HD11 HG23 ' A' ' 24' ' ' ILE . 97.1 mt -63.38 -51.76 64.51 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.492 0.717 . . . . 15.0 111.483 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.1 mtm -72.21 -34.73 68.59 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.6 0.76 . . . . 15.0 111.924 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -104.08 -58.24 1.91 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.983 0.513 . . . . 15.0 112.072 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -70.61 -49.75 44.4 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.716 0.407 . . . . 15.0 110.187 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 70' ' ' LEU . 38.0 m-80 -65.37 -22.02 66.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.999 -0.438 . . . . 15.0 111.391 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -69.29 -45.62 69.18 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.095 0.558 . . . . 15.0 111.53 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HA ' HG12 ' A' ' 79' ' ' ILE . 11.9 tt -66.51 -37.92 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.868 0.304 . . . . 15.0 110.284 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.82 -38.06 80.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.908 0.483 . . . . 15.0 111.182 173.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.07 75.92 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.53 -0.759 . . . . 15.0 111.6 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 76' ' ' ILE . 27.4 pt -76.77 -23.52 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 112.582 0.586 . . . . 15.0 112.582 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.42 -51.4 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 122.882 0.473 . . . . 15.0 110.141 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -70.23 -37.83 75.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.929 0.492 . . . . 15.0 110.908 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -80.39 -4.78 54.9 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.414 0.686 . . . . 15.0 112.098 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm 62.65 31.66 16.64 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.545 1.138 . . . . 15.0 111.734 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 62.3 mt -95.03 116.24 35.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.0 0.92 . . . . 15.0 108.833 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -100.38 106.35 41.94 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.628 0.771 . . . . 15.0 108.932 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.44 161.45 40.07 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.945 2.43 . . . . 15.0 113.004 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.94 137.12 37.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.433 1.093 . . . . 15.0 109.225 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 78.89 -89.57 1.17 Allowed Glycine 0 C--N 1.342 0.865 0 O-C-N 123.703 0.627 . . . . 15.0 111.861 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -170.0 140.56 1.68 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.358 0.663 . . . . 15.0 111.113 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.645 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 83.1 Cg_endo -82.54 133.5 7.19 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.049 2.5 . . . . 15.0 113.665 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 m -95.61 103.65 15.53 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.778 0.831 . . . . 15.0 108.873 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -79.89 82.44 5.98 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.29 111.83 11.5 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 107.611 -1.255 . . . . 15.0 107.611 173.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.66 -174.11 1.89 Allowed 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.718 2.279 . . . . 15.0 112.185 -174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -168.3 18.01 Favored Glycine 0 C--O 1.241 0.58 0 N-CA-C 111.028 -0.829 . . . . 15.0 111.028 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -80.64 126.64 31.52 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.131 0.573 . . . . 15.0 109.909 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -118.03 98.96 6.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.892 -1.151 . . . . 15.0 107.892 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.655 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 92.9 mttt -82.34 139.76 33.93 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.216 -1.031 . . . . 15.0 108.216 173.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.0 tp -64.49 105.89 1.04 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.8 37.37 Favored Glycine 0 N--CA 1.477 1.373 0 CA-C-O 119.81 -0.439 . . . . 15.0 113.24 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 46.8 mt-10 -118.94 157.12 28.32 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.994 0.918 . . . . 15.0 111.082 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -73.05 137.63 45.45 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.142 0.977 . . . . 15.0 112.609 -166.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -90.07 101.93 14.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.313 0.645 . . . . 15.0 109.999 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 31.4 m -87.77 133.14 33.92 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.831 -0.803 . . . . 15.0 108.831 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -153.09 148.03 26.52 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.247 -1.02 . . . . 15.0 108.247 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 21.3 m -114.25 108.17 16.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.33 0.652 . . . . 15.0 110.604 -171.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -85.18 99.58 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -92.7 117.62 30.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.659 0.784 . . . . 15.0 110.103 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 21.0 p90 -148.21 176.6 10.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.664 -0.865 . . . . 15.0 108.664 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.617 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 39.7 mt-10 -113.72 163.67 14.71 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.026 0.53 . . . . 15.0 109.742 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.0 m -117.45 162.14 15.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.374 0.669 . . . . 15.0 109.953 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -79.66 117.23 66.17 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 109.0 -0.741 . . . . 15.0 109.0 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.63 158.61 16.53 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.432 2.088 . . . . 15.0 112.213 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.3 124.14 25.88 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.19 -1.041 . . . . 15.0 108.19 173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.7 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 52.2 t -92.09 135.58 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 121.031 0.444 . . . . 15.0 111.413 -166.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -83.8 134.11 34.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.218 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 120' ' ' LEU . 98.1 mt -120.5 128.65 53.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.099 -1.074 . . . . 15.0 108.099 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -156.42 144.73 19.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.125 0.57 . . . . 15.0 110.585 -174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.95 11.74 61.34 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.674 -0.693 . . . . 15.0 114.608 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 117' ' ' LEU . 72.6 mt -60.94 -35.73 77.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.81 0.844 . . . . 15.0 111.196 -176.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.18 -18.79 60.1 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.449 0.699 . . . . 15.0 111.989 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.12 -17.68 27.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.975 0.51 . . . . 15.0 111.76 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -65.84 120.66 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.383 0.673 . . . . 15.0 109.976 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 416' ' ' LYS . 45.9 mt-10 -103.74 112.89 26.04 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.657 0.783 . . . . 15.0 109.137 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.97 125.09 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.758 0.823 . . . . 15.0 109.095 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.535 ' HB3' HE22 ' A' ' 289' ' ' GLN . 34.2 tt0 -71.12 134.64 47.16 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 122.933 0.493 . . . . 15.0 110.593 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.61 ' HE2' HD11 ' A' ' 129' ' ' ILE . 87.5 tttt -115.29 92.58 32.6 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 107.94 -1.133 . . . . 15.0 107.94 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.77 94.49 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.266 1.977 . . . . 15.0 111.635 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 127' ' ' LYS . 49.2 mm -69.11 86.63 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.534 -0.913 . . . . 15.0 108.534 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG21 HD22 ' A' ' 427' ' ' LEU . 84.5 t -80.27 108.09 13.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.702 -1.136 . . . . 15.0 109.76 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -92.4 113.14 25.33 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.541 -0.911 . . . . 15.0 108.541 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 424' ' ' PHE . 41.1 t -86.3 78.42 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 N-CA-C 108.584 -0.895 . . . . 15.0 108.584 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.9 p -66.41 175.41 2.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.238 0.615 . . . . 15.0 110.713 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.01 -31.84 61.35 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.873 0.469 . . . . 15.0 111.534 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.66 90.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.968 0.507 . . . . 15.0 111.273 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -72.99 -38.1 66.76 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.982 0.513 . . . . 15.0 110.772 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 74.7 t -65.5 -49.23 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.293 0.637 . . . . 15.0 109.755 177.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.15 -29.99 70.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.551 0.74 . . . . 15.0 110.784 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.12 -49.79 74.74 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.015 0.822 . . . . 15.0 111.718 172.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.455 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 51.6 ttm -62.01 -48.24 81.17 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.666 0.786 . . . . 15.0 111.105 177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 96.1 mt -62.69 -40.71 97.97 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.842 0.857 . . . . 15.0 111.25 -177.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -66.27 -41.39 89.95 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.803 0.841 . . . . 15.0 110.758 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 92.3 m -61.33 -39.82 91.95 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 123.576 0.547 . . . . 15.0 110.433 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.516 HD21 HD11 ' B' ' 277' ' ' LEU . 87.1 mt -58.66 -50.21 74.71 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.059 0.544 . . . . 15.0 109.795 173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 65.9 mtp85 -67.41 -21.99 65.55 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.866 -1.061 . . . . 15.0 112.125 -178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -82.05 -41.28 20.83 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.784 0.434 . . . . 15.0 111.918 175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.3 -34.99 59.07 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.99 0.516 . . . . 15.0 111.2 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -96.99 18.93 13.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.927 0.891 . . . . 15.0 110.514 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ARG . . . -80.29 169.91 17.12 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.589 0.756 . . . . 15.0 111.655 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.1 m -118.23 126.52 52.34 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.331 1.052 . . . . 15.0 108.674 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 241' ' ' GLU . 85.8 m95 -76.94 99.29 5.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.837 0.827 . . . . 15.0 110.064 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -98.16 117.45 32.57 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.028 -1.442 . . . . 15.0 109.524 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -57.48 113.3 1.73 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.574 0.75 . . . . 15.0 109.691 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.77 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 48.7 pttt -124.03 177.87 5.58 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.992 0.917 . . . . 15.0 110.333 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -149.65 149.56 30.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.831 0.852 . . . . 15.0 109.436 -176.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 122.84 -51.15 0.81 Allowed Glycine 0 C--N 1.349 1.26 0 CA-C-O 119.274 -0.737 . . . . 15.0 113.809 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 206' ' ' LYS . . . -154.96 149.93 26.83 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 117.959 0.879 . . . . 15.0 111.998 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 77.2 t -87.91 119.6 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 169.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -87.64 -178.81 6.19 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 118.11 0.414 . . . . 15.0 110.017 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -83.78 -22.89 31.71 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.574 0.953 . . . . 15.0 113.574 -164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -117.15 -3.61 11.5 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.558 0.743 . . . . 15.0 112.144 -167.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.44 175.52 10.59 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.558 0.694 . . . . 15.0 112.612 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 186' ' ' VAL . 60.3 mtt-85 -88.58 144.38 26.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.788 -1.19 . . . . 15.0 107.788 164.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG22 HG13 ' A' ' 240' ' ' VAL . 43.7 t -137.73 113.11 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.665 HG22 ' HD3' ' A' ' 238' ' ' LYS . 55.7 m -76.95 121.13 23.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.706 0.629 . . . . 15.0 110.008 177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.584 HG21 HG23 ' A' ' 235' ' ' ILE . 8.5 mt -126.56 165.05 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.113 0.965 . . . . 15.0 108.99 176.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -113.29 105.85 13.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 104.614 -2.365 . . . . 15.0 104.614 149.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 235' ' ' ILE . 12.1 p90 -104.37 116.42 32.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.56 HG22 ' HG3' ' A' ' 181' ' ' LYS . 73.9 p -125.14 100.1 6.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.472 -0.785 . . . . 15.0 109.959 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -156.52 146.88 14.66 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.64 -0.314 . . . . 15.0 112.789 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -88.34 150.54 23.16 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.626 0.77 . . . . 15.0 109.197 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.24 114.8 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 107.462 -1.31 . . . . 15.0 107.462 174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 p30 54.16 17.21 1.38 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 126.486 1.915 . . . . 15.0 114.129 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.53 -27.47 6.89 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.641 -0.533 . . . . 15.0 113.673 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -102.14 140.11 36.86 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.464 0.632 . . . . 15.0 110.832 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.93 145.3 30.39 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.224 0.61 . . . . 15.0 110.676 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -137.53 166.83 22.94 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 124.874 1.27 . . . . 15.0 108.083 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -67.58 148.57 51.25 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.048 -0.723 . . . . 15.0 109.048 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.57 ' HA3' HG21 ' B' ' 236' ' ' THR . . . 86.22 -44.82 3.38 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 119.582 -0.565 . . . . 15.0 113.141 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.12 -30.07 46.01 Favored Glycine 0 C--N 1.365 2.142 0 C-N-CA 123.367 0.508 . . . . 15.0 112.986 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.56 ' HG3' HG22 ' A' ' 169' ' ' THR . 84.6 tttt -112.66 110.2 20.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.091 -1.078 . . . . 15.0 108.091 165.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -146.6 125.29 12.56 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.4 0.68 . . . . 15.0 110.334 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.2 p -93.17 140.99 28.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.456 1.102 . . . . 15.0 109.883 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 57.26 45.21 20.73 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.325 1.05 . . . . 15.0 111.651 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' B' ' 238' ' ' THR . 87.0 t80 -77.63 96.03 4.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.533 -1.212 . . . . 15.0 108.336 172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 163' ' ' ARG . 6.5 t -92.72 77.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 163' ' ' ARG . 56.8 tp -68.23 107.95 2.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.507 0.723 . . . . 15.0 112.52 -170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.07 88.18 2.99 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.556 -0.905 . . . . 15.0 108.556 166.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.4 ptp -78.54 -177.61 5.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.163 0.985 . . . . 15.0 111.265 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.19 87.62 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 116.127 -0.488 . . . . 15.0 112.71 -174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -124.67 138.99 54.27 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.976 1.31 . . . . 15.0 108.035 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.58 51.6 4.58 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 123.624 0.577 . . . . 15.0 113.317 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -108.99 -28.0 9.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.296 1.038 . . . . 15.0 109.304 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 27.7 tpp -94.59 164.66 12.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.838 1.255 . . . . 15.0 110.319 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 36.2 mm -48.63 123.12 11.27 Favored Pre-proline 0 C--N 1.361 1.094 0 C-N-CA 124.428 1.091 . . . . 15.0 111.028 171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.63 107.59 0.62 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.551 2.167 . . . . 15.0 110.171 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 121.68 -30.6 5.28 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.404 -0.664 . . . . 15.0 112.943 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.503 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 48.6 t80 -60.32 -56.15 24.99 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 117.12 0.46 . . . . 15.0 109.972 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.74 -36.28 83.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.712 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.52 -33.63 74.46 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.64 0.776 . . . . 15.0 110.728 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -60.1 -32.63 76.58 Favored Glycine 0 C--N 1.349 1.289 0 O-C-N 123.756 0.66 . . . . 15.0 113.079 173.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.85 -39.07 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.832 1.253 . . . . 15.0 110.685 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -68.77 -16.58 63.84 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.502 1.121 . . . . 15.0 112.772 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.25 6.01 69.85 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 123.287 0.367 . . . . 15.0 113.073 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -131.91 177.25 7.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.709 1.204 . . . . 15.0 109.954 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 157' ' ' ALA . 63.4 mttp -111.31 -66.12 1.11 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.668 1.359 . . . . 15.0 114.668 -161.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -147.89 -60.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.573 0.953 . . . . 15.0 113.573 -173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -135.73 45.41 1.1 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.425 0.53 . . . . 15.0 114.425 -167.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -116.47 135.2 54.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.787 0.435 . . . . 15.0 110.942 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.85 137.81 38.59 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.908 0.483 . . . . 15.0 110.565 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -158.03 -174.69 4.95 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.751 0.82 . . . . 15.0 109.709 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 88.8 m -138.63 133.67 32.72 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.414 0.686 . . . . 15.0 109.224 177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 pt -117.59 133.57 63.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 109.543 -0.54 . . . . 15.0 109.543 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.19 122.31 37.74 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.467 ' HB ' HG21 ' A' ' 195' ' ' ILE . 16.2 m -114.44 127.06 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 15.0 111.129 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.7 m -87.77 104.28 16.42 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.573 -1.269 . . . . 15.0 107.573 169.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -58.51 145.89 74.8 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.376 0.67 . . . . 15.0 111.347 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.1 154.3 19.24 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.973 2.448 . . . . 15.0 111.917 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -70.36 -14.01 62.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.471 0.708 . . . . 15.0 110.565 171.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.84 -33.51 68.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.99 1.316 . . . . 15.0 110.849 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -66.9 134.04 51.24 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.483 -1.235 . . . . 15.0 110.895 -173.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -81.82 31.79 0.37 Allowed 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 113.659 0.985 . . . . 15.0 113.659 -167.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -130.36 122.91 28.75 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.283 -0.636 . . . . 15.0 109.283 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -24.33 64.16 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.055 0.847 . . . . 15.0 111.142 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.93 -44.76 88.44 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.998 0.519 . . . . 15.0 111.018 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.7 pp -100.89 -27.22 13.43 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 118.368 -0.825 . . . . 15.0 112.277 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -57.0 119.56 6.5 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.652 0.66 . . . . 15.0 111.545 -171.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.16 80.48 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 114.446 0.539 . . . . 15.0 114.446 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -92.46 165.69 12.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 117.338 0.569 . . . . 15.0 109.846 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 215' ' ' VAL . . . -119.18 108.47 14.71 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.804 -0.813 . . . . 15.0 108.804 175.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.77 139.54 35.29 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.343 0.657 . . . . 15.0 110.352 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -109.57 94.67 5.15 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.523 -0.917 . . . . 15.0 108.523 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.504 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 32.9 m-85 -90.69 117.5 29.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.989 -0.55 . . . . 15.0 110.385 -177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.33 93.99 4.12 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 108.577 -0.897 . . . . 15.0 108.577 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 166' ' ' ILE . 39.4 mm -72.4 107.19 3.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 114.698 -1.137 . . . . 15.0 109.628 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -92.56 78.72 4.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.076 -1.824 . . . . 15.0 106.076 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.427 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 12.0 tp -59.86 116.41 4.08 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 114.643 -1.162 . . . . 15.0 108.676 -175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.665 ' HD3' HG22 ' A' ' 165' ' ' THR . 45.4 mtpt -98.78 -68.46 0.8 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.042 0.448 . . . . 15.0 110.232 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -143.08 167.77 21.31 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.995 0.918 . . . . 15.0 109.904 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 164' ' ' VAL . 6.6 t -131.7 119.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.026 -1.101 . . . . 15.0 108.026 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 163' ' ' ARG . 13.9 mp0 -98.72 106.76 19.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.972 -0.751 . . . . 15.0 108.972 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 31.6 tt0 -67.34 139.08 57.21 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 124.07 0.856 . . . . 15.0 110.284 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 10.3 ptp180 -80.23 77.07 6.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.444 -0.947 . . . . 15.0 108.444 168.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -66.19 111.6 3.52 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 114.85 -1.068 . . . . 15.0 109.483 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 24.7 mt -57.95 144.99 73.76 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 124.387 1.075 . . . . 15.0 111.155 -171.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.64 -168.37 0.31 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.785 2.99 . . . . 15.0 113.086 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.48 171.29 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.695 0.798 . . . . 15.0 111.961 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -128.77 12.66 6.31 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.725 1.21 . . . . 15.0 108.027 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 4.9 m -66.37 153.43 42.72 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.654 1.182 . . . . 15.0 110.387 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -51.32 -42.64 61.37 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.252 1.021 . . . . 15.0 112.057 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.16 -23.2 67.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.892 0.877 . . . . 15.0 112.314 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -85.33 -57.22 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.055 0.542 . . . . 15.0 109.864 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 11.6 tt -68.91 -19.79 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.26 0.624 . . . . 15.0 112.161 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -72.91 -15.89 61.57 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.992 -0.442 . . . . 15.0 111.707 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -59.63 -29.49 68.05 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.454 0.645 . . . . 15.0 110.004 171.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.8 15.76 9.21 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.977 -1.011 . . . . 15.0 111.561 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 90.36 -13.8 64.23 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.739 -0.478 . . . . 15.0 113.732 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 266' ' ' LEU . 19.6 t -80.44 80.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.016 -0.735 . . . . 15.0 109.016 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -58.44 -37.46 75.47 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.367 -1.288 . . . . 15.0 112.165 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -69.33 -68.53 0.4 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.353 0.661 . . . . 15.0 110.624 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 140.51 12.71 0.59 Allowed Glycine 0 C--N 1.353 1.489 0 CA-C-O 119.224 -0.764 . . . . 15.0 114.851 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 64.7 m -71.56 120.36 17.03 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.934 0.867 . . . . 15.0 111.157 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 62.3 t -58.74 -50.91 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 123.676 0.791 . . . . 15.0 110.633 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.87 -18.74 63.36 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.617 175.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -78.28 -30.75 49.18 Favored Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.392 -0.683 . . . . 15.0 111.392 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 270' ' ' VAL . 39.7 tp -69.6 -46.69 65.71 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.901 -0.777 . . . . 15.0 108.901 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -63.61 -37.05 85.85 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.598 -0.728 . . . . 15.0 110.499 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -61.52 -49.86 75.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.227 0.611 . . . . 15.0 110.605 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.86 -47.98 83.55 Favored 'General case' 0 C--O 1.253 1.265 0 O-C-N 123.972 0.795 . . . . 15.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 274' ' ' MET . 78.3 t -57.66 -46.26 86.58 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 114.603 -1.181 . . . . 15.0 110.074 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -66.17 -50.8 62.67 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.338 0.496 . . . . 15.0 112.338 -175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -63.04 -36.01 82.15 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 123.238 0.336 . . . . 15.0 111.547 -177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.405 ' HB2' HD11 ' B' ' 278' ' ' LEU . 82.4 m-20 -80.57 -26.36 37.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.962 175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 270' ' ' VAL . 0.0 OUTLIER -64.16 -53.98 40.87 Favored 'General case' 0 C--O 1.195 -1.769 0 N-CA-C 108.885 -0.783 . . . . 15.0 108.885 -178.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -59.91 -26.73 66.14 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 123.777 0.673 . . . . 15.0 111.924 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -71.11 -54.99 9.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.592 0.757 . . . . 15.0 110.491 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.7 -28.03 68.77 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.081 0.943 . . . . 15.0 110.862 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 43.6 tp -78.74 -42.01 29.29 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 114.341 -1.3 . . . . 15.0 109.385 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 32.9 ttpt -56.75 -43.78 81.06 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 124.071 0.857 . . . . 15.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.6 m -63.04 -43.55 98.36 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.213 0.945 . . . . 15.0 111.945 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -60.41 -53.74 53.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.329 0.651 . . . . 15.0 110.999 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 71.4 mt -65.72 -29.11 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.394 1.078 . . . . 15.0 110.609 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 279' ' ' LYS . 13.7 tpt180 -65.31 -53.51 42.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.062 0.545 . . . . 15.0 109.785 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -71.46 -26.68 62.81 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.919 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 4.9 tpt85 -66.49 -60.73 2.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.491 0.716 . . . . 15.0 110.324 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 89.2 t -59.71 -37.02 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.537 0.735 . . . . 15.0 110.386 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.478 ' O ' HG12 ' A' ' 291' ' ' ILE . 83.9 tttt -60.8 -53.96 51.04 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.719 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.4 p -63.1 -37.43 87.17 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.401 0.438 . . . . 15.0 111.524 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 126' ' ' GLU . 54.4 mt-30 -67.74 -38.24 83.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.205 0.602 . . . . 15.0 111.049 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -64.19 -41.98 96.87 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.101 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 287' ' ' LYS . 36.5 mm -63.22 -48.55 87.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.861 0.864 . . . . 15.0 109.863 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -55.69 -51.75 66.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.712 1.205 . . . . 15.0 110.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -69.4 -31.22 71.21 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.092 -0.958 . . . . 15.0 113.453 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.673 HD22 HD13 ' A' ' 350' ' ' LEU . 1.0 OUTLIER -65.59 -55.74 16.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.759 -0.83 . . . . 15.0 108.759 -179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.44 HG11 ' HE ' ' A' ' 343' ' ' ARG . 77.4 t -60.03 -45.65 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.531 -0.759 . . . . 15.0 109.875 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -51.24 -46.13 62.22 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.538 1.135 . . . . 15.0 111.741 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.0 51.27 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.451 -0.795 . . . . 15.0 112.921 -177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -120.01 170.29 9.41 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.287 0.565 . . . . 15.0 112.461 -165.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -148.57 153.34 38.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.479 1.511 . . . . 15.0 108.474 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.4 tp -159.55 143.47 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.437 0.695 . . . . 15.0 110.131 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.46 107.79 3.5 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.492 0.717 . . . . 15.0 109.157 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.9 122.2 59.08 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 123.714 0.806 . . . . 15.0 109.87 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 349' ' ' LEU . 34.2 Cg_endo -66.16 132.55 30.14 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.536 2.157 . . . . 15.0 111.665 171.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.55 70.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.094 0.958 . . . . 15.0 111.913 -172.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -56.72 -46.25 81.39 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 124.053 0.941 . . . . 15.0 111.998 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.4 mt -68.91 -36.52 78.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.653 -0.703 . . . . 15.0 110.735 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.465 ' HA ' HG21 ' A' ' 345' ' ' VAL . 44.8 mt -58.04 -51.24 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.114 -0.698 . . . . 15.0 109.114 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.84 -34.12 75.4 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.366 1.041 . . . . 15.0 112.242 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 38.7 m -58.85 -54.53 46.09 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 123.675 0.61 . . . . 15.0 110.821 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.19 -41.16 99.15 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.701 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.548 HD13 ' HG3' ' A' ' 334' ' ' ARG . 92.3 mt -56.6 -48.72 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.128 0.971 . . . . 15.0 109.294 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.4 -42.3 98.76 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 124.16 0.912 . . . . 15.0 111.402 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.01 -44.83 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 O-C-N 123.621 0.575 . . . . 15.0 110.142 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 341' ' ' ALA . 95.2 mt -71.0 -28.11 64.18 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.55 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 27.1 mtm180 -72.1 -39.22 69.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.24 0.616 . . . . 15.0 109.804 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -68.15 -45.12 74.41 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.002 0.521 . . . . 15.0 110.037 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -56.23 -44.72 79.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.221 0.95 . . . . 15.0 110.96 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.06 -54.5 20.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.602 0.761 . . . . 15.0 111.414 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.49 -30.97 67.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.588 0.755 . . . . 15.0 111.572 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.64 -42.15 91.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.068 0.947 . . . . 15.0 109.758 173.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -82.37 -16.07 50.45 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.137 0.575 . . . . 15.0 111.333 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -120.6 84.93 2.31 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.13 0.972 . . . . 15.0 109.499 -176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.68 -35.33 3.52 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.544 -0.753 . . . . 15.0 114.228 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.32 44.57 7.41 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.853 -1.299 . . . . 15.0 109.853 -169.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 50.6 m-20 -67.25 107.54 2.4 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.018 0.927 . . . . 15.0 110.24 -171.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -53.22 91.52 0.01 OUTLIER 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.084 1.353 . . . . 15.0 112.808 -176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 62.47 12.1 5.14 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.409 1.083 . . . . 15.0 113.14 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 22.6 tm0? -75.58 -8.41 56.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.243 1.017 . . . . 15.0 109.435 174.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -45.63 -42.29 11.21 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.177 1.391 . . . . 15.0 112.188 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 61.3 tp -52.32 -35.12 49.9 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.553 1.141 . . . . 15.0 112.409 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -80.8 -23.38 39.28 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.046 0.939 . . . . 15.0 112.468 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 63.1 mt -57.2 129.16 79.24 Favored Pre-proline 0 CA--C 1.565 1.521 0 C-N-CA 122.983 0.513 . . . . 15.0 111.457 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.02 121.23 7.86 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 124.771 3.647 . . . . 15.0 115.407 -166.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.548 ' HG3' HD13 ' A' ' 311' ' ' ILE . 36.0 ttt85 -45.13 -59.21 2.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.715 1.606 . . . . 15.0 112.966 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 338' ' ' GLU . 0.2 OUTLIER -67.28 -15.81 63.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.988 -1.005 . . . . 15.0 112.736 -171.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.57 -12.91 60.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.813 0.339 . . . . 15.0 111.172 177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.412 ' HB2' HG23 ' A' ' 311' ' ' ILE . 62.7 m-85 -116.28 -35.4 4.34 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.765 0.826 . . . . 15.0 109.749 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 40.6 tt0 -61.88 -29.27 70.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.87 1.268 . . . . 15.0 111.958 -176.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -47.75 -47.49 30.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 15.0 111.323 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.462 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 29.8 pt20 -94.92 -35.32 12.06 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.97 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.43 -56.11 21.3 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.703 0.801 . . . . 15.0 111.623 -170.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.8 tttt -56.11 -39.08 71.66 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.797 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 347' ' ' VAL . 41.9 ttt180 -67.74 -31.8 71.97 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.629 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 90.3 mtt180 -67.33 -42.3 83.8 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 108.728 -0.842 . . . . 15.0 108.728 175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 307' ' ' ILE . 15.0 t -64.96 -34.02 67.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 123.329 0.393 . . . . 15.0 110.188 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 85.1 t -55.69 -51.09 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 109.154 -0.684 . . . . 15.0 109.154 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 343' ' ' ARG . 48.7 t -57.62 -38.26 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 123.371 0.668 . . . . 15.0 111.163 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.449 ' HA2' ' ND1' ' B' ' 298' ' ' HIS . . . -61.15 -45.74 95.93 Favored Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.192 -0.913 . . . . 15.0 112.31 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 303' ' ' PRO . 88.9 mt -75.65 -43.03 49.71 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.732 0.813 . . . . 15.0 110.801 -177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.673 HD13 HD22 ' A' ' 294' ' ' LEU . 98.2 mt -59.0 -59.54 5.31 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.667 0.787 . . . . 15.0 110.701 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.68 -25.64 66.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.962 0.505 . . . . 15.0 111.846 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -65.36 -42.02 96.26 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 123.43 0.456 . . . . 15.0 112.003 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.7 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 9.1 tp10 -66.5 -42.75 86.93 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.043 -0.578 . . . . 15.0 110.289 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 350' ' ' LEU . 94.0 t -58.15 -39.17 71.9 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 122.813 0.445 . . . . 15.0 110.63 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.568 ' HA ' HD12 ' A' ' 360' ' ' LEU . 59.4 mt -61.79 -49.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.327 0.651 . . . . 15.0 110.734 176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -65.27 -60.58 2.83 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 116.445 -0.343 . . . . 15.0 111.292 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 90.4 m -52.65 -44.88 66.42 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.344 1.457 . . . . 15.0 113.012 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.94 16.99 13.01 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 118.95 -0.547 . . . . 15.0 111.763 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 46.25 31.75 1.3 Allowed 'General case' 0 N--CA 1.509 2.48 0 C-N-CA 125.097 1.359 . . . . 15.0 113.146 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 407' ' ' ALA . 96.0 mt -63.17 133.89 55.08 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 123.809 0.844 . . . . 15.0 111.498 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.1 153.33 44.06 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.391 -1.337 . . . . 15.0 107.391 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -66.45 96.85 0.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.73 120.76 7.81 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.182 0.993 . . . . 15.0 111.429 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -49.95 -46.67 52.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.802 1.314 . . . . 15.0 112.325 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.52 -32.44 74.04 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.362 0.665 . . . . 15.0 111.232 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -77.07 -44.56 30.21 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.407 -0.815 . . . . 15.0 110.111 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 371' ' ' ILE . 93.6 t -62.15 -49.6 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.255 -0.884 . . . . 15.0 109.315 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -67.13 -26.18 66.55 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.442 0.697 . . . . 15.0 110.962 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.42 -50.67 65.02 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.529 -0.628 . . . . 15.0 111.529 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 76.4 mt -61.45 -37.69 84.49 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.632 0.773 . . . . 15.0 111.127 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 367' ' ' VAL . 36.7 mm -63.29 -40.88 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.828 0.851 . . . . 15.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.91 -34.87 64.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.942 0.497 . . . . 15.0 111.505 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.42 -44.64 90.56 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.729 0.412 . . . . 15.0 109.911 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.428 ' SD ' ' CD2' ' A' ' 388' ' ' TYR . 43.3 ttp -57.9 -53.8 54.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.235 1.014 . . . . 15.0 111.042 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.68 83.5 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.883 -1.053 . . . . 15.0 111.672 -170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 32.1 t -68.85 -20.89 64.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.696 0.798 . . . . 15.0 111.129 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -76.62 -3.52 38.14 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.197 0.599 . . . . 15.0 111.589 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.64 174.85 5.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.124 0.969 . . . . 15.0 109.519 170.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -68.49 -67.67 0.45 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.94 0.496 . . . . 15.0 109.916 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -92.45 116.52 66.62 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.225 -1.028 . . . . 15.0 108.225 174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.73 -44.22 8.49 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 122.596 2.197 . . . . 15.0 112.966 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -65.08 -34.37 78.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.737 -1.119 . . . . 15.0 112.786 -161.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -65.37 -36.2 83.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.491 0.494 . . . . 15.0 110.675 176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 -39.49 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.094 -0.706 . . . . 15.0 109.094 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 77.9 mt -55.76 -53.93 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.194 0.998 . . . . 15.0 110.262 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -64.63 -53.59 45.16 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.374 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.405 ' HE2' HG21 ' B' ' 288' ' ' VAL . 30.0 t80 -52.76 -45.03 66.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.972 0.909 . . . . 15.0 112.197 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.428 ' CD2' ' SD ' ' A' ' 374' ' ' MET . 5.7 t80 -65.27 -56.75 10.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.161 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 70.8 p -60.51 -39.24 87.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.444 0.698 . . . . 15.0 112.393 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -72.07 -8.23 53.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.758 0.823 . . . . 15.0 111.848 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -110.28 93.32 4.44 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 107.138 -1.43 . . . . 15.0 107.138 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -61.14 -25.97 67.36 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.754 0.422 . . . . 15.0 111.377 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -59.32 -33.22 70.85 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.246 0.618 . . . . 15.0 110.867 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 397' ' ' ASN . 27.9 tp -100.13 -28.81 12.84 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 115.08 -0.964 . . . . 15.0 111.436 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -42.57 66.82 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.327 -0.62 . . . . 15.0 109.327 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.643 ' HA ' ' HE ' ' A' ' 399' ' ' ARG . 19.7 t70 -60.45 -36.1 77.42 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.572 1.149 . . . . 15.0 110.509 174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 394' ' ' LEU . 38.6 t-20 -60.1 -50.43 73.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.358 1.063 . . . . 15.0 109.981 174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 59.7 tpp -63.24 -37.45 87.28 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.079 0.466 . . . . 15.0 111.744 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.643 ' HE ' ' HA ' ' A' ' 396' ' ' ASP . 78.5 mtm180 -65.19 -36.26 83.66 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.758 -0.655 . . . . 15.0 109.967 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 403' ' ' LEU . 0.1 OUTLIER -75.52 -23.99 56.75 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.209 0.943 . . . . 15.0 109.776 -178.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . . . . . . . . . 59.9 t -59.3 -62.21 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.718 -1.216 . . . . 15.0 107.718 169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.0 73.89 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.051 -1.431 . . . . 15.0 111.831 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 400' ' ' ASN . 55.9 tp -75.8 -47.8 24.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.994 0.917 . . . . 15.0 111.765 -172.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -64.11 -44.03 93.49 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -50.37 74.2 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.84 -0.618 . . . . 15.0 110.094 174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.506 ' HG2' HD22 ' A' ' 360' ' ' LEU . 53.1 tt0 -62.62 -34.33 76.81 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.228 1.011 . . . . 15.0 111.448 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.574 ' HA ' HD13 ' A' ' 360' ' ' LEU . . . -66.48 -46.02 77.73 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.523 0.729 . . . . 15.0 110.079 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 287' ' ' LYS . 84.2 t -64.39 -42.44 95.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 115.289 -0.869 . . . . 15.0 110.529 173.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 412' ' ' LEU . 49.1 mt-10 -70.25 -24.17 63.03 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.788 0.835 . . . . 15.0 112.259 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.23 64.14 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.314 0.384 . . . . 15.0 110.879 172.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 294' ' ' LEU . 54.5 t -85.99 -38.29 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 109.119 -0.697 . . . . 15.0 109.119 173.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.8 mt -63.47 -33.01 74.63 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.77 0.828 . . . . 15.0 111.501 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.7 94.07 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.515 0.726 . . . . 15.0 110.214 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -74.65 -37.81 62.65 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.849 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -77.94 167.96 20.67 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.546 1.138 . . . . 15.0 112.995 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 124' ' ' GLU . 93.4 mttt -90.08 87.35 6.85 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.714 -1.13 . . . . 15.0 109.55 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.07 99.06 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.204 -1.036 . . . . 15.0 108.204 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.6 t -84.46 105.62 15.42 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 121.764 0.792 . . . . 15.0 110.688 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 127' ' ' LYS . 34.6 tt0 -86.32 127.55 34.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.301 1.04 . . . . 15.0 111.061 -173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.09 148.63 43.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.484 0.714 . . . . 15.0 109.502 173.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -93.33 147.25 23.09 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.763 -0.458 . . . . 15.0 109.763 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.9 t -159.74 177.71 10.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.034 0.534 . . . . 15.0 110.547 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 70.8 p -95.42 166.8 11.69 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.495 0.718 . . . . 15.0 111.458 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 132' ' ' VAL . 80.0 t80 -67.49 -39.93 85.2 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.43 -0.804 . . . . 15.0 110.94 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -57.43 -45.31 84.81 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.975 0.797 . . . . 15.0 110.524 175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . 0.462 ' HA ' ' ND2' ' A' ' 429' ' ' ASN . 7.5 tp10 -61.53 -41.32 97.15 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.618 0.574 . . . . 15.0 111.928 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 130' ' ' VAL . 48.5 tp -59.9 -34.74 73.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.83 0.452 . . . . 15.0 110.727 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 25.1 mmt -92.75 -4.47 53.05 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.412 0.685 . . . . 15.0 112.323 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 426' ' ' GLU . 97.9 m-20 -75.63 21.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 123.374 0.67 . . . . 15.0 112.734 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -97.58 57.98 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.824 0.821 . . . . 15.0 109.824 -174.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.12 -35.8 64.15 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.71 -1.132 . . . . 15.0 110.551 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 C-N-CA 123.288 0.635 . . . . 15.0 109.569 176.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 66.23 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.68 1.192 . . . . 0.0 111.227 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -161.77 98.66 1.1 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.504 0.721 . . . . 0.0 109.058 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -131.44 125.54 32.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.206 1.002 . . . . 0.0 109.501 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.53 101.07 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.3 m -86.79 140.89 29.27 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.397 0.679 . . . . 0.0 109.76 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 77.1 mt -73.86 92.7 2.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 109.922 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.57 100.53 2.55 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.866 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 128.41 -154.2 19.89 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.81 0.243 . . . . 0.0 112.978 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.85 14.01 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -132.0 120.06 21.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.626 0.771 . . . . 0.0 108.932 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.479 ' O ' ' HD3' ' B' ' 231' ' ' LYS . 6.8 tmtm? 69.28 -12.12 0.44 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 125.091 1.356 . . . . 0.0 111.174 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 44.8 p 57.77 -89.61 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.586 1.554 . . . . 0.0 110.112 -155.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 1.2 t80 175.15 -130.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -165.84 85.01 0.34 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.991 0.814 . . . . 0.0 110.416 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 77.08 -52.66 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.153 1.381 . . . . 0.0 112.273 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.57 HG21 ' HA3' ' A' ' 179' ' ' GLY . 13.2 m 79.27 -16.47 0.67 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.265 1.826 . . . . 0.0 111.884 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 58.63 57.89 3.56 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 124.262 1.025 . . . . 0.0 110.045 -170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.558 ' HA ' ' HE1' ' A' ' 185' ' ' PHE . 41.8 p -71.88 85.53 0.96 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.624 -175.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.62 102.29 11.35 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.066 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -148.75 140.2 8.08 Favored Glycine 0 C--O 1.244 0.762 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -83.13 92.33 7.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 117.576 0.688 . . . . 0.0 109.318 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -115.12 84.69 2.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.808 0.843 . . . . 0.0 109.133 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -97.66 -42.22 7.75 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.134 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -73.32 79.84 0.76 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.774 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' HG3' ' B' ' 248' ' ' ARG . 74.6 mmtt -88.9 125.98 35.18 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 66.0 p -67.29 -2.05 5.46 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -171.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . 0.604 ' H ' HD23 ' B' ' 247' ' ' LEU . 2.0 pt? -111.85 -11.18 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.514 ' HG3' ' HB2' ' B' ' 245' ' ' LYS . 75.0 mtm180 -59.11 -60.98 2.99 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-O 121.727 0.775 . . . . 0.0 111.95 -169.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.76 -21.81 61.69 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.558 -1.655 . . . . 0.0 111.714 -173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -76.22 -48.38 20.56 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.138 0.495 . . . . 0.0 110.447 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.468 ' HA ' ' HA3' ' B' ' 255' ' ' GLY . . . -64.64 -39.72 94.19 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.748 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -70.09 -32.61 70.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.381 0.672 . . . . 0.0 110.806 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -70.5 -66.87 0.55 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.356 0.662 . . . . 0.0 111.942 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -148.74 5.92 0.7 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 111.787 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' B' ' 251' ' ' ALA . . . -83.98 -15.98 68.64 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.475 0.484 . . . . 0.0 112.784 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 55.7 t80 69.93 88.23 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.252 1.421 . . . . 0.0 109.589 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -98.26 120.65 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 55.8 tp -67.81 143.96 55.56 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 172.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.92 123.73 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 123.112 0.565 . . . . 0.0 110.115 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 25.5 t -63.2 -39.78 95.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.603 0.761 . . . . 0.0 110.598 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -162.77 129.18 3.45 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.929 0.892 . . . . 0.0 109.197 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -86.51 -11.57 51.3 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 0.0 110.885 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -64.07 -63.16 1.23 Allowed 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.896 0.878 . . . . 0.0 110.394 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 20.8 m 51.3 71.34 0.45 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.935 1.294 . . . . 0.0 111.909 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 29.0 tp 66.85 10.97 8.0 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 124.772 1.229 . . . . 0.0 111.296 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 56.32 37.04 28.47 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.595 1.158 . . . . 0.0 110.805 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 33.0 t -68.28 96.3 0.65 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.96 -40.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.812 0.845 . . . . 0.0 109.979 177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 19.1 p -95.82 -10.14 29.74 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.306 0.642 . . . . 0.0 110.884 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -144.78 89.19 1.96 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.121 0.968 . . . . 0.0 108.645 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.52 -5.06 14.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.495 1.118 . . . . 0.0 110.985 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.63 -26.73 62.68 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.397 0.679 . . . . 0.0 110.156 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 66.45 33.6 6.73 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.057 1.343 . . . . 0.0 110.981 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -144.48 107.22 4.45 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -149.25 135.61 10.32 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 117.627 -1.178 . . . . 0.0 108.055 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -18.24 -75.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.4 3.263 1 C-N-CA 126.277 4.651 . . . . 0.0 116.798 -175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.516 HD11 HD21 ' A' ' 144' ' ' LEU . 50.8 tp 176.61 -76.72 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 121.45 0.643 . . . . 0.0 110.728 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.629 HD13 ' H ' ' B' ' 278' ' ' LEU . 0.0 OUTLIER -80.38 3.04 22.49 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.105 -161.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.77 59.98 4.41 Favored Glycine 0 C--N 1.349 1.253 0 O-C-N 123.326 0.391 . . . . 0.0 112.253 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -10.86 0.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.218 1.007 . . . . 0.0 111.283 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -75.01 -73.33 0.25 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -88.51 -79.09 0.32 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.59 . . . . 0.0 110.795 -170.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -81.65 -47.61 12.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 53.94 40.38 65.21 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.425 1.078 . . . . 0.0 115.001 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.406 HD21 ' HB2' ' B' ' 287' ' ' PRO . 6.4 t30 -155.1 119.8 4.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.715 0.406 . . . . 0.0 110.3 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 16.3 tpt -84.49 -41.75 0.71 Allowed Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.11 -0.948 . . . . 0.0 112.236 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.406 ' HB2' HD21 ' B' ' 285' ' ' ASN . 40.3 Cg_exo -42.35 130.25 4.86 Favored 'Trans proline' 0 C--N 1.401 3.341 0 C-N-CA 122.924 2.416 . . . . 0.0 114.321 174.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.405 HG21 ' HE2' ' A' ' 387' ' ' PHE . 30.3 m -64.78 -7.32 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -71.7 -46.35 59.03 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 173.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.5 ' HD1' ' H ' ' B' ' 291' ' ' LEU 0.285 0.3 OUTLIER 36.44 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 174.505 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.5 ' H ' ' HD1' ' B' ' 290' ' ' TRP . 83.7 mt -89.28 171.86 9.47 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.094 0.95 . . . . 0.0 113.082 -155.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -143.86 72.86 0.35 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.84 0.35 9.92 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.559 2.839 . . . . 0.0 113.363 -166.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -76.08 80.49 2.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.0 -16.67 63.78 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.613 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 60.2 m -149.93 -77.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.841 0.856 . . . . 0.0 109.274 171.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -177.44 -74.07 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -164.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.449 ' ND1' ' HA2' ' A' ' 348' ' ' GLY . 49.0 m-70 62.55 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.747 1.619 . . . . 0.0 110.686 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.31 -155.44 26.8 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -163.39 139.88 7.06 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 170.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 360' ' ' LEU . 3.8 mp -76.56 -25.42 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.425 1.09 . . . . 0.0 110.396 -175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.98 -60.28 3.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.647 1.179 . . . . 0.0 111.795 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' B' ' 304' ' ' PRO . 20.9 tptm -149.23 -40.36 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' B' ' 303' ' ' LYS . 69.6 Cg_exo -47.78 -30.8 13.67 Favored 'Trans proline' 0 C--N 1.404 3.454 0 C-N-CA 122.295 1.996 . . . . 0.0 113.666 171.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.48 82.42 7.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.39 167.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.159 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 9.4 t -107.5 156.87 18.52 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.275 0.63 . . . . 0.0 109.494 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 46.6 t -86.44 -15.72 39.36 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.922 0.489 . . . . 0.0 111.28 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.1 t -97.32 127.35 38.54 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 123.07 0.548 . . . . 0.0 110.379 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.308 2.672 . . . . 12.53 111.902 176.379 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.608 -0.516 . . . . 15.0 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.3 tt0 -77.87 134.06 38.02 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.783 -0.821 . . . . 15.0 108.783 173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 17' ' ' ILE . 16.7 m -137.87 156.92 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.34 0.656 . . . . 15.0 110.816 -178.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 p -157.87 101.21 1.78 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.181 -0.918 . . . . 15.0 108.959 175.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG23 HG22 ' A' ' 15' ' ' VAL . 4.3 p -79.14 84.88 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 122.223 1.011 . . . . 15.0 110.181 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -76.96 155.61 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.865 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.2 m -127.45 121.11 29.95 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.114 0.566 . . . . 15.0 109.649 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -78.42 -60.86 2.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.379 0.671 . . . . 15.0 110.273 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -158.94 122.41 3.81 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.187 0.595 . . . . 15.0 110.347 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 -89.62 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.481 1.113 . . . . 15.0 114.586 168.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 301' ' ' ASP . 2.0 mm? -86.53 -44.19 12.13 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.811 0.844 . . . . 15.0 109.609 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.4 128.76 41.92 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 124.476 1.11 . . . . 15.0 113.866 -174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -140.29 125.16 18.32 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.559 1.144 . . . . 15.0 110.527 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.48 ' HG3' ' HB3' ' A' ' 106' ' ' SER . 42.3 ttm180 -96.86 84.95 3.67 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.394 1.078 . . . . 15.0 109.271 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG22 HG23 ' A' ' 5' ' ' VAL . 52.4 t -78.74 87.05 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 109.263 -0.643 . . . . 15.0 109.263 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 59.7 m -79.73 109.34 14.04 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.503 -0.772 . . . . 15.0 110.45 -178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 3' ' ' VAL . 61.0 mt -101.29 128.64 53.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.955 0.902 . . . . 15.0 108.887 177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 48.4 m -113.87 101.04 8.89 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.624 0.769 . . . . 15.0 109.123 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 43.2 mt -76.99 121.61 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.218 -0.66 . . . . 15.0 109.218 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -61.32 148.66 40.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.493 0.717 . . . . 15.0 111.862 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.04 99.16 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.157 0.983 . . . . 15.0 112.649 -172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -66.49 -35.92 81.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.92 0.763 . . . . 15.0 109.987 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.4 m -68.61 -33.87 74.78 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.219 -0.9 . . . . 15.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 72.1 mt -67.19 -49.73 70.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.002 0 C-N-CA 123.716 0.806 . . . . 15.0 109.631 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -51.98 -40.71 61.35 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.431 1.092 . . . . 15.0 110.881 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.3 m -81.62 -41.13 21.93 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.976 0.91 . . . . 15.0 111.666 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.71 -36.04 75.58 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 112.531 0.567 . . . . 15.0 112.531 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 63' ' ' ARG . 94.8 t -73.53 -34.84 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 122.979 0.511 . . . . 15.0 109.755 173.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 32' ' ' LEU . 5.0 ttmp? -64.65 -24.84 67.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.299 0.639 . . . . 15.0 111.545 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -57.37 -38.2 73.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.257 0.623 . . . . 15.0 110.236 170.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 18.6 tp10 -82.69 -34.07 27.45 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.353 0.661 . . . . 15.0 111.38 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 29' ' ' LYS . 93.1 mt -67.89 -26.18 65.87 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 122.244 -0.285 . . . . 15.0 111.473 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -84.44 -25.21 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 C-N-CA 122.771 0.429 . . . . 15.0 110.245 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 85.1 m-20 -63.01 -46.67 86.54 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.232 -0.655 . . . . 15.0 109.232 168.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.56 -35.86 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.041 0.937 . . . . 15.0 110.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . . . -58.76 -53.45 58.25 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 123.592 0.558 . . . . 15.0 110.565 175.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -70.9 -36.2 72.64 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.116 0.567 . . . . 15.0 111.645 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -71.03 -47.27 59.54 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.125 1.37 . . . . 15.0 111.741 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.27 8.86 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.401 0 CA-C-O 121.505 0.669 . . . . 15.0 110.201 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 69.29 12.22 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 125.379 1.472 . . . . 15.0 112.818 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 42.0 mt -65.98 -21.04 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 125.054 1.342 . . . . 15.0 111.034 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.03 -42.05 89.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.211 1.004 . . . . 15.0 111.242 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.68 -33.15 75.44 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.717 -0.674 . . . . 15.0 111.784 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -75.02 -29.51 60.86 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.974 0.91 . . . . 15.0 111.074 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -73.77 107.97 6.33 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.842 0.457 . . . . 15.0 109.934 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -90.88 -4.1 56.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.61 0.764 . . . . 15.0 111.173 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.38 37.32 41.84 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.392 0.432 . . . . 15.0 112.74 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -74.61 -59.0 2.93 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.347 0.659 . . . . 15.0 109.775 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.49 129.07 39.86 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.927 -1.138 . . . . 15.0 107.927 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -56.75 146.53 77.06 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.376 2.05 . . . . 15.0 112.568 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.4 tpt -60.13 -34.75 73.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 15.0 111.907 -169.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -60.53 -38.06 83.2 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 56.1 mt -67.38 -55.65 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 O-C-N 124.076 0.86 . . . . 15.0 110.371 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.46 -23.8 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 122.333 0.253 . . . . 15.0 111.597 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.35 -47.63 60.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.38 0.672 . . . . 15.0 111.288 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -79.68 -16.38 55.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.32 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.41 -76.34 0.11 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.748 0.419 . . . . 15.0 110.275 170.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -81.76 -34.11 30.61 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.612 0.765 . . . . 15.0 111.478 -165.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 63' ' ' ARG . . . -82.8 10.37 57.1 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-O 118.624 -1.098 . . . . 15.0 113.58 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.22 -40.04 67.29 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.834 0.854 . . . . 15.0 112.776 -176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.4 p -76.92 -37.21 55.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.608 0.763 . . . . 15.0 111.178 177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 66' ' ' VAL . 49.6 t -60.23 -31.29 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.213 1.005 . . . . 15.0 110.868 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 59' ' ' GLY . 54.0 mtp85 -59.12 -31.04 68.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.888 0.875 . . . . 15.0 112.038 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.5 -33.1 42.43 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.682 0.793 . . . . 15.0 110.466 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -50.41 63.05 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.895 0.478 . . . . 15.0 111.221 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 62' ' ' VAL . 48.4 t -62.23 -21.16 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.819 0.848 . . . . 15.0 111.744 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.507 HD23 HD12 ' A' ' 70' ' ' LEU . 94.4 mt -52.47 -34.69 50.3 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.437 0.695 . . . . 15.0 112.418 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.9 -39.32 95.36 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.452 0.47 . . . . 15.0 112.81 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.67 -41.48 60.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.711 0.805 . . . . 15.0 110.281 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.507 HD12 HD23 ' A' ' 67' ' ' LEU . 83.2 mt -63.99 -37.09 86.14 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.931 0.769 . . . . 15.0 112.083 -174.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 67.1 mtm -63.68 -40.67 97.4 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 110.109 -0.33 . . . . 15.0 110.109 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.4 t -70.93 -37.15 72.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.749 0.82 . . . . 15.0 110.611 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -66.36 -41.36 89.57 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.767 0.827 . . . . 15.0 111.69 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -72.24 -40.17 67.92 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.241 0.616 . . . . 15.0 109.907 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -64.03 -49.09 73.76 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.57 0.748 . . . . 15.0 112.056 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 tt -61.24 -45.16 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 123.838 0.711 . . . . 15.0 111.064 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -66.12 -42.72 88.81 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.782 0.433 . . . . 15.0 110.262 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.62 76.84 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.044 0.84 . . . . 15.0 112.036 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.5 pt -70.93 -26.87 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 112.424 0.528 . . . . 15.0 112.424 -175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 76.5 mt -72.71 -49.01 43.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.281 0.632 . . . . 15.0 110.437 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -81.02 -31.75 34.46 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 112.299 0.481 . . . . 15.0 112.299 -173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -93.53 -3.82 52.15 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.971 0.508 . . . . 15.0 111.403 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 58.58 56.03 4.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.469 1.108 . . . . 15.0 111.826 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mt -107.14 125.93 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 114.248 -1.342 . . . . 15.0 108.598 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -111.58 92.6 17.2 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 123.24 0.616 . . . . 15.0 109.506 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.33 144.56 62.5 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.336 2.691 . . . . 15.0 113.166 -172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.63 119.12 38.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.72 0.808 . . . . 15.0 110.267 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.21 -92.3 1.27 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.514 0.509 . . . . 15.0 112.138 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -148.02 140.68 14.83 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 123.602 0.761 . . . . 15.0 110.248 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.2 Cg_endo -82.81 118.6 2.78 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.38 2.053 . . . . 15.0 112.304 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.7 m -75.77 91.88 2.98 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.396 -0.594 . . . . 15.0 109.396 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -68.6 117.13 9.94 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.696 -0.684 . . . . 15.0 109.37 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.17 91.47 3.83 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 108.148 -1.056 . . . . 15.0 108.148 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 124.13 10.27 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.517 2.145 . . . . 15.0 110.944 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -84.49 -154.91 21.57 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 116.316 -0.402 . . . . 15.0 113.528 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.06 111.4 19.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.54 0.736 . . . . 15.0 110.248 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' OH ' ' HB3' ' A' ' 63' ' ' ARG . 74.0 t80 -76.64 126.62 31.3 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.599 -0.728 . . . . 15.0 110.854 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -143.45 153.31 42.51 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.15 0.58 . . . . 15.0 111.389 -176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD13 ' NH2' ' A' ' 63' ' ' ARG . 54.6 tp -107.36 143.75 35.21 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.007 -1.109 . . . . 15.0 108.007 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.03 -50.45 4.28 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.242 -0.743 . . . . 15.0 111.242 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -90.94 159.67 16.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.584 0.754 . . . . 15.0 109.183 168.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.13 134.21 38.1 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.651 0.78 . . . . 15.0 110.628 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -71.58 102.69 2.8 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.728 0.811 . . . . 15.0 110.51 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 29.5 m -92.22 132.57 36.55 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.942 0.897 . . . . 15.0 109.609 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -152.04 150.21 29.7 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.51 0.724 . . . . 15.0 109.556 176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 14' ' ' ARG . 56.9 m -109.71 122.93 48.58 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.395 0.678 . . . . 15.0 110.291 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.7 t -97.11 95.47 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.113 -1.069 . . . . 15.0 108.113 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -89.6 127.64 35.93 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.032 0.533 . . . . 15.0 110.33 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 42.9 p90 -165.28 156.63 14.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.112 0.565 . . . . 15.0 109.989 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 48.8 mt-10 -86.62 154.9 20.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.837 -1.074 . . . . 15.0 109.879 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -115.69 169.84 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.372 0.669 . . . . 15.0 110.261 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HE1' HD11 ' A' ' 306' ' ' LEU . 57.2 m-85 -83.57 121.33 76.38 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.701 -0.682 . . . . 15.0 110.775 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' HD11 ' A' ' 300' ' ' ILE . 47.9 Cg_endo -84.89 169.91 10.17 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.658 2.239 . . . . 15.0 112.273 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.82 110.42 19.94 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.677 -0.86 . . . . 15.0 108.677 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD13 ' A' ' 300' ' ' ILE . 36.0 t -75.91 117.03 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.903 0.881 . . . . 15.0 110.655 -171.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.63 95.05 10.09 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.722 -0.473 . . . . 15.0 109.722 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.518 ' HB3' HD11 ' A' ' 120' ' ' LEU . 68.1 mt -70.87 139.06 50.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.876 0.87 . . . . 15.0 110.327 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -158.86 154.46 26.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.711 0.804 . . . . 15.0 110.114 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 67.56 19.44 70.95 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.895 -0.593 . . . . 15.0 113.64 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 117' ' ' LEU . 34.2 mt -66.69 -27.45 67.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.211 0.604 . . . . 15.0 110.237 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -78.37 -20.96 50.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.923 0.889 . . . . 15.0 111.21 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.47 -13.38 56.82 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.24 0.616 . . . . 15.0 111.257 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.52 HG23 ' HA3' ' A' ' 293' ' ' GLY . 60.5 mt -68.26 104.65 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.788 0.835 . . . . 15.0 110.28 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.25 105.31 15.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.633 0.773 . . . . 15.0 109.837 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.8 t -106.39 115.72 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.102 0.961 . . . . 15.0 109.257 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.494 ' H ' ' NE2' ' A' ' 289' ' ' GLN . 0.6 OUTLIER -93.26 102.47 14.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.953 -1.129 . . . . 15.0 107.953 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -91.88 108.88 33.26 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.767 0.827 . . . . 15.0 109.743 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -93.61 109.47 0.18 Allowed 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 122.279 1.986 . . . . 15.0 111.959 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.57 89.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' HD11 ' A' ' 282' ' ' ILE . 77.7 t -104.59 142.63 17.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 114.865 -1.062 . . . . 15.0 110.034 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.72 164.36 28.43 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 163.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 271' ' ' ARG . 17.5 t -85.62 78.01 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 109.322 -0.621 . . . . 15.0 109.322 -177.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.9 p -68.66 -179.43 1.4 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.841 0.856 . . . . 15.0 110.797 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -56.13 -46.21 79.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.271 0.628 . . . . 15.0 111.475 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.36 71.08 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.249 0.619 . . . . 15.0 111.897 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -79.99 -39.59 29.7 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.375 0.67 . . . . 15.0 111.341 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 t -66.74 -51.71 53.07 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.48 -40.58 75.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.969 0.908 . . . . 15.0 111.051 174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.03 -45.48 96.02 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.97 0.794 . . . . 15.0 112.945 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.93 -46.15 86.03 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.207 0.603 . . . . 15.0 110.395 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 99.1 mt -60.94 -39.17 88.45 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.792 0.837 . . . . 15.0 110.519 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.02 -44.04 93.78 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.253 1.021 . . . . 15.0 110.787 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.6 m -61.46 -46.26 90.83 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.609 0.568 . . . . 15.0 110.799 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.56 -47.44 82.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.693 0.797 . . . . 15.0 110.148 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HB3' ' HB3' ' A' ' 245' ' ' LEU . 70.6 mtp180 -71.88 -24.79 61.73 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.988 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -73.66 -35.11 65.19 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 122.895 0.478 . . . . 15.0 110.676 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -81.62 -27.43 34.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.924 0.49 . . . . 15.0 111.435 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -96.84 10.72 38.13 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.303 0.641 . . . . 15.0 111.13 175.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -67.12 125.56 26.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.702 . . . . 15.0 112.419 -173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 55.8 m -70.58 119.4 14.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.748 0.819 . . . . 15.0 109.295 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 243' ' ' ARG . 45.9 m95 -80.92 93.55 6.33 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.769 -0.826 . . . . 15.0 108.769 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -85.25 106.21 16.5 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.241 -0.89 . . . . 15.0 109.142 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.13 103.03 0.56 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.728 -0.471 . . . . 15.0 109.728 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 57.1 pttt -117.93 177.56 4.74 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.275 -0.875 . . . . 15.0 111.504 -171.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -146.35 150.5 35.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.656 1.183 . . . . 15.0 109.204 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 120.78 -48.38 0.95 Allowed Glycine 0 C--N 1.343 0.967 0 CA-C-O 119.61 -0.55 . . . . 15.0 113.792 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.81 132.67 11.5 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.379 0.59 . . . . 15.0 111.577 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.38 138.98 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.449 -0.945 . . . . 15.0 108.449 166.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.23 176.83 5.12 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.325 0.583 . . . . 15.0 109.997 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HA ' ' HE3' ' A' ' 203' ' ' LYS . . . -76.86 -21.67 54.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.325 -0.852 . . . . 15.0 113.196 -170.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.02 20.08 6.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.273 0.629 . . . . 15.0 111.129 -174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -77.46 -171.15 2.02 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.912 0.863 . . . . 15.0 112.286 -177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.465 ' HG3' HH11 ' A' ' 163' ' ' ARG . 25.4 ttm-85 -118.52 157.08 27.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.049 -1.432 . . . . 15.0 107.916 164.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.618 HG21 HG21 ' A' ' 202' ' ' ILE . 13.6 m -143.43 177.38 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.873 1.269 . . . . 15.0 109.501 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.8 m -138.23 123.8 19.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.005 -1.109 . . . . 15.0 108.005 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.494 HD13 HG23 ' A' ' 235' ' ' ILE . 10.9 mt -126.49 162.66 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.653 0.781 . . . . 15.0 110.613 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -117.2 106.08 12.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 104.962 -2.236 . . . . 15.0 104.962 150.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 42.4 p90 -94.4 134.09 37.28 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.282 -1.007 . . . . 15.0 108.282 -177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.4 p -142.32 96.33 2.94 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.2 0.6 . . . . 15.0 110.209 -168.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -166.74 -179.53 39.97 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 120.995 -0.621 . . . . 15.0 114.45 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.6 m -111.84 140.43 46.49 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.15 0.98 . . . . 15.0 111.148 -175.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.07 128.49 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.766 0.826 . . . . 15.0 109.12 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 29.2 t70 65.15 17.4 11.02 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.735 0.814 . . . . 15.0 111.086 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.1 31.44 64.11 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.995 -0.548 . . . . 15.0 112.942 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -146.08 148.9 33.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.787 0.835 . . . . 15.0 109.611 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.0 86.1 1.3 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.286 0.634 . . . . 15.0 111.607 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -90.76 165.72 13.51 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.197 -0.668 . . . . 15.0 109.197 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 159.08 33.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.359 -0.978 . . . . 15.0 108.359 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 74.75 15.82 80.58 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.597 -0.335 . . . . 15.0 112.315 -172.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.605 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -79.11 -19.69 71.76 Favored Glycine 0 C--N 1.352 1.464 0 C-N-CA 123.308 0.48 . . . . 15.0 112.284 175.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 87.1 tttt -145.86 138.24 25.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.884 0.474 . . . . 15.0 111.683 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.403 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -149.45 125.25 10.49 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.439 1.095 . . . . 15.0 108.139 164.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -86.38 140.31 30.14 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.3 0.64 . . . . 15.0 109.453 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 186' ' ' VAL . 30.3 m-20 57.14 46.43 18.98 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.345 1.058 . . . . 15.0 110.138 -175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -72.98 94.68 1.89 Allowed 'General case' 0 C--O 1.242 0.69 0 CA-C-N 113.825 -1.534 . . . . 15.0 108.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 240' ' ' GLY . 39.5 t -94.37 81.69 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.155 -0.93 . . . . 15.0 109.724 -173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.3 147.38 26.09 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.563 0.745 . . . . 15.0 111.357 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.71 121.19 44.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.833 -1.173 . . . . 15.0 107.833 167.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -87.54 167.55 13.85 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.516 0.726 . . . . 15.0 110.443 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 103.79 -47.98 1.05 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.052 -0.819 . . . . 15.0 111.052 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -100.56 145.52 28.23 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.182 -0.673 . . . . 15.0 109.182 171.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.84 79.12 1.15 Allowed Glycine 0 C--N 1.35 1.347 0 O-C-N 123.525 0.516 . . . . 15.0 114.379 -172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 58.7 mtt-85 -105.43 15.48 27.11 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.751 0.82 . . . . 15.0 110.099 171.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.401 ' HG3' ' HB3' ' A' ' 198' ' ' PHE . 41.8 tpp -173.05 163.75 4.79 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.166 0.986 . . . . 15.0 110.039 -170.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.3 mt -51.36 125.77 27.01 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.063 1.345 . . . . 15.0 111.427 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -60.24 112.66 1.38 Allowed 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.648 2.232 . . . . 15.0 110.093 165.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.58 -38.91 2.41 Favored Glycine 0 N--CA 1.467 0.715 0 N-CA-C 111.485 -0.646 . . . . 15.0 111.485 -171.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.401 ' HB3' ' HG3' ' A' ' 194' ' ' MET . 25.3 t80 -69.77 -50.25 45.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.822 -0.807 . . . . 15.0 108.822 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 202' ' ' ILE . 4.9 pt-20 -63.23 -36.59 84.15 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.82 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.45 -34.98 75.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.598 0.759 . . . . 15.0 111.41 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -57.53 -36.1 76.05 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.746 0.654 . . . . 15.0 112.418 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.618 HG21 HG21 ' A' ' 164' ' ' VAL . 44.3 mt -72.56 -48.88 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 124.374 1.07 . . . . 15.0 109.918 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 160' ' ' ALA . 40.9 mtpt -58.93 -26.75 64.65 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.722 1.209 . . . . 15.0 112.557 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.24 17.08 8.14 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-O 119.601 -0.555 . . . . 15.0 114.35 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -138.78 -171.2 3.02 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.904 0.881 . . . . 15.0 110.073 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -114.12 -67.43 1.0 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.387 1.254 . . . . 15.0 114.387 -163.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -151.22 -62.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.509 1.3 . . . . 15.0 114.509 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -126.09 54.88 0.75 Allowed Glycine 0 N--CA 1.47 0.927 0 CA-C-N 115.292 -0.867 . . . . 15.0 112.53 -163.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.09 139.42 45.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.26 0.624 . . . . 15.0 111.089 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -94.0 143.53 26.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.435 0.694 . . . . 15.0 110.053 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -157.54 -178.97 7.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.932 1.293 . . . . 15.0 108.947 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.3 m -141.57 113.17 7.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 109.778 -0.453 . . . . 15.0 109.778 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.64 141.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.051 0.453 . . . . 15.0 111.537 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -86.76 110.34 19.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.982 -1.008 . . . . 15.0 109.129 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.0 118.39 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.558 0.694 . . . . 15.0 110.939 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.2 m -84.41 106.64 16.16 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.248 -1.389 . . . . 15.0 107.248 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -47.0 144.42 3.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 O-C-N 123.966 0.791 . . . . 15.0 110.904 172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.0 131.56 27.49 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.563 2.176 . . . . 15.0 112.567 -170.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -68.21 -13.28 62.12 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.861 0.864 . . . . 15.0 111.206 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -71.46 -33.77 69.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.268 1.027 . . . . 15.0 109.656 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -73.52 135.46 44.0 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.917 -1.038 . . . . 15.0 110.447 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -88.41 -2.28 58.51 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.976 0.91 . . . . 15.0 112.898 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.26 99.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -61.92 -40.81 96.76 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.642 0.777 . . . . 15.0 111.971 -168.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.25 -4.72 54.34 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 112.309 0.485 . . . . 15.0 112.309 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.27 -32.51 6.72 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 118.919 -0.562 . . . . 15.0 112.262 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.73 123.64 18.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 120.866 0.365 . . . . 15.0 110.837 -171.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 79.51 5.75 89.18 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.476 -0.624 . . . . 15.0 114.365 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.3 mmtt -76.23 120.09 21.03 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 117.732 0.766 . . . . 15.0 110.204 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.18 92.45 6.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.594 0.711 . . . . 15.0 109.663 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.37 150.0 25.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.75 -1.113 . . . . 15.0 110.245 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -124.26 95.68 4.64 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.665 -0.865 . . . . 15.0 108.665 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.605 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 71.7 m-85 -102.41 124.3 47.73 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.23 0.612 . . . . 15.0 110.537 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -77.74 94.34 4.44 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 108.239 -1.023 . . . . 15.0 108.239 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 166' ' ' ILE . 47.2 mm -72.75 106.09 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.74 -1.118 . . . . 15.0 109.006 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.6 OUTLIER -89.12 77.82 7.5 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.223 -1.769 . . . . 15.0 106.223 175.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 207' ' ' ALA . 53.3 tp -66.36 101.21 0.71 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 108.432 -0.951 . . . . 15.0 108.432 -177.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -83.4 -59.59 2.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.115 -0.948 . . . . 15.0 110.204 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -134.79 168.1 19.67 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.398 -0.819 . . . . 15.0 110.977 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.83 144.57 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.966 -1.124 . . . . 15.0 107.966 171.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.35 107.2 9.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.458 -0.941 . . . . 15.0 108.458 170.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.8 tt0 -62.54 132.73 53.41 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.309 0.643 . . . . 15.0 109.937 175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.494 ' HB3' ' CZ3' ' A' ' 151' ' ' TRP . 0.6 OUTLIER -80.83 66.52 6.39 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.775 0.798 . . . . 15.0 109.05 169.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -65.83 108.19 2.06 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.789 -1.096 . . . . 15.0 108.554 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 145' ' ' ARG . 19.8 mt -56.4 136.53 76.16 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 124.214 0.947 . . . . 15.0 109.442 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.4 Cg_endo -72.15 178.85 5.51 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.311 2.007 . . . . 15.0 111.572 -175.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.35 174.58 3.21 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.284 0.634 . . . . 15.0 111.761 -173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 263' ' ' VAL . 17.7 tp -116.02 27.74 9.07 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.117 0.96 . . . . 15.0 108.433 170.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 91.4 m -62.22 160.84 12.23 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.009 -1.45 . . . . 15.0 109.994 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -44.48 -48.41 10.07 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.63 1.172 . . . . 15.0 111.681 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -57.09 -19.05 17.23 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.451 1.501 . . . . 15.0 113.276 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -102.74 -57.22 2.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.363 0.665 . . . . 15.0 110.031 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 266' ' ' LEU . 18.8 tt -59.31 -39.53 79.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.56 0.744 . . . . 15.0 112.374 -170.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 20.3 ptmt -96.52 0.58 50.37 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 119.671 -0.204 . . . . 15.0 111.443 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.34 -24.9 66.59 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.75 -0.833 . . . . 15.0 108.75 172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.415 ' HB3' HD22 ' B' ' 277' ' ' LEU . 72.9 m-85 -77.16 13.75 1.06 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.111 1.365 . . . . 15.0 111.92 171.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.447 ' HA3' ' HE3' ' B' ' 275' ' ' LYS . . . 79.12 7.01 88.73 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-O 119.32 -0.711 . . . . 15.0 113.863 173.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 269' ' ' GLU . 46.2 t -75.03 135.88 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.876 0.871 . . . . 15.0 110.39 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -75.94 -37.8 58.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.968 0.507 . . . . 15.0 110.754 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -83.44 133.47 34.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.8 0.333 . . . . 15.0 110.637 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -86.8 -17.68 59.41 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.634 -0.712 . . . . 15.0 113.681 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.4 m -73.66 148.11 43.08 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 122.839 0.456 . . . . 15.0 110.278 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.418 HG13 HD21 ' A' ' 248' ' ' LEU . 41.6 t -55.22 -47.11 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 124.367 1.042 . . . . 15.0 111.124 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.76 -28.35 34.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.161 -1.382 . . . . 15.0 112.508 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.63 -36.24 62.28 Favored Glycine 0 C--N 1.354 1.565 0 O-C-N 123.461 0.476 . . . . 15.0 112.526 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.51 HD22 HG13 ' A' ' 253' ' ' ILE . 56.5 tp -73.85 -39.26 64.12 Favored 'General case' 0 C--O 1.211 -0.963 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HG2' HD11 ' A' ' 141' ' ' LEU . 61.6 mtp85 -68.22 -29.03 67.78 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.761 0.663 . . . . 15.0 111.156 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 272' ' ' LYS . . . -74.7 -41.26 60.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.103 0.561 . . . . 15.0 109.759 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 258' ' ' VAL . 11.7 tp10 -66.15 -39.96 90.21 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.194 0.934 . . . . 15.0 110.374 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 38.8 t -65.98 -42.55 91.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 C-N-CA 123.984 0.914 . . . . 15.0 109.651 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.469 ' HD2' ' HB ' ' A' ' 132' ' ' VAL . 16.3 tpt180 -55.96 -58.82 6.29 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.045 0.538 . . . . 15.0 110.396 177.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 268' ' ' ALA . 13.5 ptmm? -67.77 -38.21 83.11 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.742 0.645 . . . . 15.0 112.742 -174.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.51 HD22 ' HG ' ' B' ' 277' ' ' LEU . 96.9 m-20 -77.18 -37.03 54.48 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.209 0.459 . . . . 15.0 111.691 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 95.0 mtp -68.33 -36.2 78.92 Favored 'General case' 0 C--O 1.212 -0.882 0 CA-C-O 118.456 -0.783 . . . . 15.0 109.5 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 48.2 mt-10 -68.48 -32.28 72.16 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.211 0.605 . . . . 15.0 111.525 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.542 ' HG3' ' HB2' ' B' ' 285' ' ' ASN . 14.1 tpt180 -59.41 -50.52 73.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.653 1.181 . . . . 15.0 109.629 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.524 ' HA ' ' ND2' ' B' ' 285' ' ' ASN . 1.3 mp0 -76.56 -23.18 53.55 Favored 'General case' 0 CA--C 1.562 1.433 0 C-N-CA 123.483 0.713 . . . . 15.0 112.619 174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.568 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.5 tp -67.18 -60.42 2.62 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.129 0.971 . . . . 15.0 111.945 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.67 -35.61 63.72 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.372 1.045 . . . . 15.0 110.26 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 46.6 t -62.85 -55.73 23.7 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.503 1.521 . . . . 15.0 111.739 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.582 ' HB3' HD21 ' A' ' 427' ' ' LEU . . . -73.0 -23.14 60.6 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 112.397 0.517 . . . . 15.0 112.397 -177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 130' ' ' VAL . 56.0 mt -72.57 -36.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 108.938 -0.764 . . . . 15.0 108.938 170.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 283' ' ' ARG . 13.6 tpt180 -65.43 -38.37 89.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.142 -0.688 . . . . 15.0 109.142 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -60.99 -46.92 88.79 Favored 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.023 0.827 . . . . 15.0 110.222 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -53.07 -61.47 2.28 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.677 0.791 . . . . 15.0 111.814 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.44 -48.16 89.55 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.202 1.001 . . . . 15.0 110.344 -174.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -64.64 -45.1 88.25 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 115.369 -0.832 . . . . 15.0 110.904 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 95.7 p -65.06 -40.18 94.34 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.852 0.296 . . . . 15.0 111.284 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 126' ' ' GLU . 11.8 mt-30 -68.14 -38.89 82.67 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.457 0.473 . . . . 15.0 110.985 175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.32 96.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.675 0.39 . . . . 15.0 112.02 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 294' ' ' LEU . 29.0 mm -74.84 -42.23 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.492 1.117 . . . . 15.0 110.161 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -63.34 -43.13 98.61 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 115.71 -0.677 . . . . 15.0 109.478 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.52 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -65.71 -38.47 94.54 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.294 0.997 . . . . 15.0 112.777 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 291' ' ' ILE . 17.0 mt -54.85 -58.31 8.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.836 0.855 . . . . 15.0 110.006 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.433 HG11 ' HD3' ' A' ' 343' ' ' ARG . 52.8 t -65.46 -42.55 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.499 0.499 . . . . 15.0 110.708 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -61.49 -34.53 75.64 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.298 0.639 . . . . 15.0 111.557 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -99.54 0.77 43.0 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.065 0.546 . . . . 15.0 112.471 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -139.53 147.65 41.53 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.565 0.62 . . . . 15.0 112.084 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.59 137.19 33.5 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 115' ' ' VAL . 4.9 tp -134.37 147.16 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.566 0.746 . . . . 15.0 109.36 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . 0.464 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.5 m-20 -61.23 90.55 0.02 OUTLIER 'General case' 0 C--N 1.346 0.456 0 C-N-CA 123.356 0.662 . . . . 15.0 109.795 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 46.6 t -83.94 116.49 65.04 Favored Pre-proline 0 C--O 1.243 0.762 0 CA-C-N 115.172 -0.922 . . . . 15.0 109.064 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.57 125.5 19.21 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.446 2.097 . . . . 15.0 111.993 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.6 -37.94 68.77 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.561 1.145 . . . . 15.0 111.642 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.6 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.039 0.935 . . . . 15.0 111.594 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.465 HD11 ' HE1' ' A' ' 112' ' ' TYR . 96.8 mt -61.58 -44.12 97.6 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.691 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 32.7 mt -65.34 -46.84 89.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 O-C-N 123.903 0.752 . . . . 15.0 109.73 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.39 -48.33 65.71 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.417 1.087 . . . . 15.0 110.963 175.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 313' ' ' VAL . 50.3 m -56.61 -55.77 29.71 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 124.514 1.134 . . . . 15.0 111.353 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -68.01 -31.33 70.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.138 0.575 . . . . 15.0 111.726 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.594 HD13 ' HG3' ' A' ' 334' ' ' ARG . 66.1 mt -61.68 -50.97 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.941 -0.763 . . . . 15.0 108.941 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 12.2 t70 -57.39 -44.3 84.36 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.41 1.068 . . . . 15.0 110.526 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 309' ' ' SER . 86.1 t -58.66 -47.8 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.48 0.712 . . . . 15.0 110.874 176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.19 -29.57 69.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.127 0.571 . . . . 15.0 111.913 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 30.2 mtm-85 -75.09 -38.22 61.31 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.993 -0.373 . . . . 15.0 109.993 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 25.3 mtm180 -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 109.981 -0.377 . . . . 15.0 109.981 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -67.52 -37.64 83.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.772 0.829 . . . . 15.0 110.832 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.77 54.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.94 0.496 . . . . 15.0 110.736 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -62.68 -30.95 71.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 15.0 111.156 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 324' ' ' GLY . 50.9 tt0 -63.42 -34.05 76.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.677 0.791 . . . . 15.0 110.47 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -83.16 -28.33 29.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.9 0.48 . . . . 15.0 110.101 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -99.02 76.3 2.1 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.293 -0.632 . . . . 15.0 109.293 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 87.08 -23.4 11.16 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 115.067 0.787 . . . . 15.0 115.067 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 320' ' ' GLN . . . 82.38 47.29 6.11 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 110.491 -1.044 . . . . 15.0 110.491 -172.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 76.7 m-20 -67.9 113.55 5.71 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.988 0.915 . . . . 15.0 110.728 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -69.9 94.87 0.87 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.944 0.898 . . . . 15.0 110.737 -175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm 70.97 1.83 3.96 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.194 1.398 . . . . 15.0 113.435 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.663 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 20.3 tm0? -63.98 -17.71 63.57 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.57 0.748 . . . . 15.0 109.595 171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -38.13 -41.86 0.62 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.055 1.742 . . . . 15.0 113.69 168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.428 ' HA ' HH21 ' A' ' 315' ' ' ARG . 48.6 tp -53.79 -34.82 60.31 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.483 1.113 . . . . 15.0 112.101 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -69.14 -34.34 74.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.262 1.025 . . . . 15.0 112.242 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.23 123.4 54.71 Favored Pre-proline 0 N--CA 1.492 1.65 0 CA-C-O 118.784 -0.627 . . . . 15.0 111.02 -171.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -49.41 121.53 7.21 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.773 2.982 . . . . 15.0 114.344 -173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.594 ' HG3' HD13 ' A' ' 311' ' ' ILE . 40.1 ttt180 -55.92 -36.83 68.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.4 1.08 . . . . 15.0 111.687 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -73.75 4.05 5.68 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.234 0.828 . . . . 15.0 113.234 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 98.1 mt -96.31 -16.56 21.26 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.842 0.457 . . . . 15.0 110.963 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.44 ' HB2' HG23 ' A' ' 311' ' ' ILE . 72.5 m-85 -120.1 -11.98 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.966 0.906 . . . . 15.0 111.517 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -57.97 -51.04 71.31 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.365 1.066 . . . . 15.0 110.792 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.68 -52.19 47.61 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-N 114.93 -1.032 . . . . 15.0 111.334 -176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 337' ' ' PHE . 24.9 pt20 -67.76 -36.44 80.52 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.281 0.475 . . . . 15.0 112.281 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.419 ' O ' HG23 ' A' ' 345' ' ' VAL . . . -65.09 -57.41 8.69 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 109.427 -0.583 . . . . 15.0 109.427 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 346' ' ' VAL . 88.5 tttt -56.72 -33.62 66.69 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 124.308 1.005 . . . . 15.0 110.751 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.487 ' O ' HG23 ' A' ' 347' ' ' VAL . 11.8 mmt180 -55.79 -51.87 65.95 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.359 0.663 . . . . 15.0 109.749 171.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -67.49 -29.43 68.86 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.576 0.548 . . . . 15.0 111.603 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 341' ' ' ALA . 15.4 t -78.25 -38.2 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 O-C-N 123.137 0.273 . . . . 15.0 110.771 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 342' ' ' LYS . 56.0 t -58.42 -46.97 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 108.333 -0.988 . . . . 15.0 108.333 174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 343' ' ' ARG . 88.2 t -56.93 -44.23 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 124.013 0.821 . . . . 15.0 111.111 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -67.32 -30.7 75.67 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 116.398 -0.365 . . . . 15.0 113.631 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.25 -39.42 25.33 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.238 0.615 . . . . 15.0 110.788 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 89.2 mt -66.09 -56.18 12.79 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.286 0.635 . . . . 15.0 109.287 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.7 mt -61.97 -34.53 76.31 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 123.999 0.812 . . . . 15.0 110.745 176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . 0.521 ' HA2' HD12 ' A' ' 355' ' ' ILE . . . -62.14 -36.52 93.08 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 123.666 0.604 . . . . 15.0 112.476 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.2 tp10 -71.78 -43.36 65.83 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 119.593 -0.241 . . . . 15.0 110.673 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 350' ' ' LEU . 58.3 t -56.49 -37.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.009 0.524 . . . . 15.0 109.956 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.521 HD12 ' HA2' ' A' ' 352' ' ' GLY . 62.2 mt -58.43 -62.87 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 114.575 -1.193 . . . . 15.0 110.136 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -57.1 -53.98 51.98 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 123.474 0.483 . . . . 15.0 111.175 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 97.1 m -48.77 -52.98 20.95 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.034 1.333 . . . . 15.0 112.545 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -98.65 17.97 17.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.734 0.414 . . . . 15.0 111.677 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 42.04 38.24 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 125.719 1.608 . . . . 15.0 114.34 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 355' ' ' ILE . 85.7 mt -68.65 164.14 22.22 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.954 0.902 . . . . 15.0 112.773 -177.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.627 ' HA ' HD13 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -153.86 149.34 27.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.097 0.959 . . . . 15.0 110.148 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.405 ' H ' HG21 ' B' ' 301' ' ' ILE . . . -66.82 101.34 0.81 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.166 -0.679 . . . . 15.0 109.166 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -70.22 101.27 1.84 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.438 -0.801 . . . . 15.0 110.361 -170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.09 -22.73 67.06 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.876 0.87 . . . . 15.0 112.874 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -77.58 -25.7 50.19 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.6 0.36 . . . . 15.0 110.24 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -79.21 -38.81 34.8 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.39 0.676 . . . . 15.0 109.231 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 371' ' ' ILE . 57.3 t -55.93 -57.42 8.33 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 108.305 -0.998 . . . . 15.0 108.305 172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -59.87 -36.01 76.01 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 124.244 0.965 . . . . 15.0 112.101 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.79 -49.68 64.85 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.629 0.58 . . . . 15.0 112.041 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.13 -35.38 80.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.897 0.879 . . . . 15.0 111.542 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 367' ' ' VAL . 49.5 mm -59.96 -48.72 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.241 0.616 . . . . 15.0 109.866 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -36.81 75.61 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 118.485 -0.769 . . . . 15.0 112.259 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -62.0 -41.6 98.23 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 118.702 0.683 . . . . 15.0 110.405 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.518 ' SD ' HG13 ' B' ' 288' ' ' VAL . 38.5 ttp -68.07 -41.04 82.53 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.953 -1.021 . . . . 15.0 111.591 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -82.28 -20.99 36.39 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.492 0.717 . . . . 15.0 112.458 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 22.9 t -60.19 -24.57 64.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.439 1.096 . . . . 15.0 111.166 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.681 ' HB1' ' SD ' ' B' ' 286' ' ' MET . . . -73.77 -19.34 60.8 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.882 -1.054 . . . . 15.0 112.72 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -103.86 154.55 19.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.808 0.443 . . . . 15.0 111.022 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -64.24 -39.57 94.24 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.73 -1.123 . . . . 15.0 110.194 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -122.4 106.29 35.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.669 -0.863 . . . . 15.0 108.669 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -61.02 -35.28 88.21 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.839 2.36 . . . . 15.0 113.313 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -54.08 -49.88 68.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.876 0.87 . . . . 15.0 112.585 -168.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.76 -26.06 66.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.203 0.601 . . . . 15.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.13 -38.89 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 108.745 -0.835 . . . . 15.0 108.745 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.73 -48.25 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.548 0.739 . . . . 15.0 110.059 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -57.51 -56.85 16.51 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 123.823 0.702 . . . . 15.0 110.75 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -50.91 -45.45 60.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.858 1.263 . . . . 15.0 111.579 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.481 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 62.2 t80 -67.73 -49.12 64.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.215 -0.902 . . . . 15.0 111.695 -173.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 51.2 p -66.34 -24.03 66.45 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.72 0.408 . . . . 15.0 111.79 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -85.34 -13.54 49.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.44 0.696 . . . . 15.0 111.038 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -107.71 69.29 0.74 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 105.212 -2.144 . . . . 15.0 105.212 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -69.18 -16.95 63.74 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 113.252 -1.795 . . . . 15.0 112.712 -159.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -57.84 -37.85 74.59 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.246 0.618 . . . . 15.0 110.328 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.45 HD11 ' NH1' ' B' ' 289' ' ' ARG . 8.4 mp -85.41 -34.93 21.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.116 0.967 . . . . 15.0 111.028 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.0 tpt -64.31 -47.27 80.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.552 0.341 . . . . 15.0 110.854 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.99 -45.3 94.24 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.353 0.661 . . . . 15.0 110.399 172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 401' ' ' VAL . 50.2 t-20 -55.4 -40.78 71.85 Favored 'General case' 0 C--O 1.212 -0.875 0 O-C-N 124.303 1.002 . . . . 15.0 110.051 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.481 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 60.7 tpp -68.44 -35.5 77.69 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.454 0.702 . . . . 15.0 111.971 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.416 ' HA ' HG22 ' A' ' 367' ' ' VAL . 55.6 mtp180 -67.26 -39.54 86.11 Favored 'General case' 0 C--O 1.249 1.061 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.09 -29.34 68.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.61 -1.177 . . . . 15.0 110.902 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 397' ' ' ASN . 88.8 t -63.43 -55.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.64 -0.874 . . . . 15.0 108.64 176.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -52.47 -46.65 66.63 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 124.477 1.111 . . . . 15.0 111.618 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 17.8 tp -61.4 -54.14 47.47 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 114.973 -1.012 . . . . 15.0 111.658 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.05 -34.85 77.01 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.792 0.683 . . . . 15.0 111.025 -175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -61.57 -57.07 13.52 Favored 'General case' 0 C--O 1.217 -0.657 0 O-C-N 124.029 0.831 . . . . 15.0 109.597 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -59.46 -40.53 87.17 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.814 0.696 . . . . 15.0 111.488 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.03 86.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.652 0.781 . . . . 15.0 111.455 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 24.8 t -70.66 -38.51 73.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.472 0.709 . . . . 15.0 110.579 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -69.69 -30.55 68.23 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.203 0.601 . . . . 15.0 111.535 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -65.71 -22.96 66.66 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.511 0.507 . . . . 15.0 111.196 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.82 -32.62 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.103 0.561 . . . . 15.0 109.49 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 93.2 mt -67.67 -30.27 69.76 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.807 0.843 . . . . 15.0 111.296 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.54 67.85 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.496 0.718 . . . . 15.0 110.604 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -94.78 -27.92 15.54 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.325 1.05 . . . . 15.0 111.146 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.491 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -85.24 158.08 20.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.994 0.917 . . . . 15.0 111.87 -171.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.27 80.14 3.78 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.087 0.955 . . . . 15.0 111.293 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.41 84.58 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.688 -0.687 . . . . 15.0 109.56 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 126' ' ' GLU . 4.4 t -78.87 99.02 6.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 122.073 0.94 . . . . 15.0 110.017 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -86.82 130.71 34.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.538 -1.21 . . . . 15.0 110.342 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 13.2 pttm -145.41 141.26 28.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.657 -0.497 . . . . 15.0 109.657 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.57 135.59 33.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.535 0.734 . . . . 15.0 110.315 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.493 HG23 HG22 ' A' ' 130' ' ' VAL . 5.8 t -164.2 177.61 8.23 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.991 0.916 . . . . 15.0 110.174 -170.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 38.3 p -103.71 175.19 5.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.084 0.954 . . . . 15.0 111.981 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.437 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 7.8 t80 -65.42 -18.19 65.12 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.805 1.242 . . . . 15.0 111.318 -174.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -54.94 -39.95 69.41 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.312 1.045 . . . . 15.0 110.885 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.63 -43.53 68.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.528 1.131 . . . . 15.0 111.34 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.582 HD21 ' HB3' ' A' ' 281' ' ' ALA . 23.2 tp -73.28 -44.03 59.95 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.936 -1.029 . . . . 15.0 111.868 -171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 78.1 mmm -82.16 -28.38 32.15 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.155 0.428 . . . . 15.0 112.155 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -81.09 34.06 0.35 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.0 0.52 . . . . 15.0 111.471 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -114.56 88.1 2.79 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.159 0.983 . . . . 15.0 108.857 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.98 71.99 10.17 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.738 -1.208 . . . . 15.0 107.738 170.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.342 -1.299 . . . . 15.0 108.608 -174.057 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -90.43 172.88 8.42 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.604 0.762 . . . . 0.0 111.228 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.55 64.85 1.25 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.874 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -128.15 104.99 8.07 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.778 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.48 123.01 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.742 0.817 . . . . 0.0 109.624 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 14.9 p -68.79 135.23 50.87 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.085 0.554 . . . . 0.0 109.959 170.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -151.04 135.05 16.65 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -159.5 -140.9 3.0 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 172.66 141.12 3.34 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.88 -0.4 . . . . 0.0 112.694 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -76.27 118.12 5.22 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.45 1.03 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.512 0.725 . . . . 0.0 111.583 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -85.26 117.92 24.49 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.39 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 75.0 p -119.42 -168.29 1.55 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.431 1.092 . . . . 0.0 110.31 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -58.92 102.29 0.12 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.467 0.707 . . . . 0.0 109.844 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.85 -77.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.658 1.183 . . . . 0.0 113.149 -168.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -113.42 125.8 54.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.777 0.431 . . . . 0.0 110.166 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 5.6 m -93.21 96.29 9.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -67.2 84.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.157 0.583 . . . . 0.0 110.336 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 25.2 m -98.62 137.98 36.47 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.422 1.089 . . . . 0.0 109.714 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.41 46.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.718 0.807 . . . . 0.0 109.393 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 186' ' ' VAL . . . -164.02 114.83 0.62 Allowed Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -80.61 -10.27 59.74 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.296 0.638 . . . . 0.0 110.658 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -119.05 -171.63 2.14 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 109.931 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.87 -79.18 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.337 1.455 . . . . 0.0 111.7 171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.58 -17.94 60.71 Favored Glycine 0 C--N 1.352 1.435 0 O-C-N 123.643 0.59 . . . . 0.0 114.314 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -70.43 78.29 0.56 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.173 0.989 . . . . 0.0 109.786 175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.5 p -110.64 108.23 18.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.628 0.771 . . . . 0.0 111.371 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.98 -16.66 59.95 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.203 0.601 . . . . 0.0 110.862 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -50.25 -33.84 21.08 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.715 1.206 . . . . 0.0 110.774 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.43 -51.23 69.59 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.729 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' B' ' 253' ' ' ALA . 1.0 OUTLIER -71.54 -18.0 62.28 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.65 -45.75 64.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.206 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.96 -20.03 39.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.025 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' B' ' 250' ' ' GLN . . . -89.06 16.85 6.46 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.453 0.701 . . . . 0.0 111.301 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.46 48.52 8.29 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.215 1.806 . . . . 0.0 113.273 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -61.49 102.63 0.45 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 114.924 -1.035 . . . . 0.0 113.256 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 41.8 t80 73.37 96.86 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.138 1.375 . . . . 0.0 109.818 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -116.31 -163.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.973 0.909 . . . . 0.0 111.917 -174.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.41 ' O ' HG22 ' B' ' 259' ' ' VAL . 1.2 pp -56.97 165.82 1.17 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.777 1.231 . . . . 0.0 112.814 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . 0.41 HG22 ' O ' ' B' ' 258' ' ' LEU . 3.1 m 61.97 7.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 126.683 1.993 . . . . 0.0 112.678 -174.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 78.7 p -149.34 -7.46 0.35 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 109.566 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -62.47 -44.04 97.36 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.469 1.108 . . . . 0.0 111.45 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.69 59.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.798 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -63.96 -32.67 74.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.064 0.546 . . . . 0.0 111.024 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 22.8 t 59.91 28.92 18.5 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.43 1.092 . . . . 0.0 111.609 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 2.7 tt 66.1 86.48 0.13 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 125.059 1.344 . . . . 0.0 108.505 -167.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -92.92 -48.94 6.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.713 0.805 . . . . 0.0 109.826 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 47.0 t 62.91 14.42 7.45 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.303 1.041 . . . . 0.0 112.087 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 6.6 m 48.57 13.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 126.769 2.028 . . . . 0.0 114.211 -169.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' B' ' 273' ' ' GLN . 39.2 p -124.66 53.79 1.44 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.951 1.301 . . . . 0.0 107.978 -176.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 64.59 -86.42 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.878 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -112.88 -64.82 1.25 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -138.34 -21.77 1.04 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.468 0.707 . . . . 0.0 111.276 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . 0.581 ' HB2' ' HB ' ' B' ' 269' ' ' THR . 17.9 tm0? 66.2 172.94 0.24 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.502 1.521 . . . . 0.0 110.494 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.81 95.75 0.38 Allowed 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.796 -0.565 . . . . 0.0 109.949 175.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.447 ' HE3' ' HA3' ' A' ' 257' ' ' GLY . 0.0 OUTLIER -63.83 150.19 91.65 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.816 0.846 . . . . 0.0 110.383 174.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.717 ' HB3' ' HB3' ' B' ' 286' ' ' MET . 55.4 Cg_endo -66.24 2.28 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 123.384 2.723 . . . . 0.0 115.622 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 273' ' ' ASN . 60.1 mt 67.5 -73.11 0.08 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.914 1.286 . . . . 0.0 110.747 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.551 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.6 pt? -83.19 -56.5 3.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.735 0.414 . . . . 0.0 110.121 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 51.78 -99.64 0.04 OUTLIER Glycine 0 C--N 1.354 1.567 0 N-CA-C 114.717 0.647 . . . . 0.0 114.717 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.96 -12.13 34.79 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.982 1.313 . . . . 0.0 112.295 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' B' ' 278' ' ' LEU . 24.6 t80 -61.69 -30.4 70.72 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.2 1.0 . . . . 0.0 110.597 173.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 277' ' ' GLU . . . -115.08 -59.72 1.98 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.122 0.569 . . . . 0.0 109.839 171.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -161.02 -58.27 0.05 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.339 0.656 . . . . 0.0 111.291 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 113.37 73.49 0.62 Allowed Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.698 0.239 . . . . 0.0 113.698 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 276' ' ' ARG . 11.0 m-80 -75.71 -37.51 59.37 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.668 0.787 . . . . 0.0 111.139 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.717 ' HB3' ' HB3' ' B' ' 276' ' ' PRO . 17.0 tpt -56.11 -50.95 84.44 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.666 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.15 13.13 0.68 Allowed 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.306 2.004 . . . . 0.0 113.985 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.518 HG13 ' SD ' ' A' ' 374' ' ' MET . 26.7 t 63.86 60.4 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 172.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.45 ' NH1' HD11 ' A' ' 394' ' ' LEU . 9.6 mmt180 -140.54 -35.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.305 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.49 ' HB2' HD23 ' B' ' 291' ' ' LEU . 0.6 OUTLIER 48.65 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 126.024 1.73 . . . . 0.0 115.225 170.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.497 ' HB3' ' OG ' ' A' ' 280' ' ' SER . 1.9 pt? -52.28 -35.71 50.91 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.391 1.076 . . . . 0.0 113.018 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . 0.417 ' H ' ' HE3' ' B' ' 290' ' ' TRP . . . 62.42 62.82 5.22 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.145 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' B' ' 291' ' ' LEU . 64.6 Cg_endo -88.14 69.87 3.0 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.059 2.506 . . . . 0.0 110.953 -173.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . 0.588 ' HE3' ' HA ' ' B' ' 296' ' ' THR . 58.4 tptt -99.23 101.13 12.35 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.875 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.44 -4.2 32.2 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.06 0.544 . . . . 0.0 110.574 170.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.588 ' HA ' ' HE3' ' B' ' 294' ' ' LYS . 7.1 m 75.94 -76.41 0.06 Allowed 'General case' 0 C--N 1.355 0.829 0 C-N-CA 125.747 1.619 . . . . 0.0 111.635 164.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -69.58 114.86 8.2 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.245 0.341 . . . . 0.0 111.223 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -145.05 95.8 2.74 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.179 0.991 . . . . 0.0 108.913 171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.85 49.7 1.01 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.826 -0.17 . . . . 0.0 112.682 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -163.13 161.42 25.13 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.433 0.693 . . . . 0.0 109.165 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.627 HD13 ' HA ' ' A' ' 361' ' ' LYS . 70.3 mt 72.25 158.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.599 1.16 . . . . 0.0 112.261 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 26.9 t0 84.9 -48.04 0.09 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.102 1.761 . . . . 0.0 109.145 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -161.57 88.55 1.55 Allowed Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.071 0.948 . . . . 0.0 108.641 161.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.69 89.22 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.636 2.224 . . . . 0.0 110.156 172.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -74.52 81.5 1.97 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.742 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -166.48 138.05 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.691 1.196 . . . . 0.0 108.819 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 20.1 p -79.18 91.88 5.01 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 50.6 t -90.39 -83.07 0.26 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.63 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 10.5 m 39.32 75.49 0.57 Allowed Pre-proline 0 CA--C 1.573 1.848 0 C-N-CA 126.006 1.722 . . . . 0.0 113.884 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 123.358 2.705 . . . . 12.53 112.135 -179.127 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.6 -0.518 . . . . 15.0 109.6 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 8.7 tt0 -75.32 105.74 6.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.972 0.509 . . . . 15.0 109.898 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.458 HG12 HG12 ' A' ' 17' ' ' ILE . 21.7 m -122.99 155.7 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.765 0.826 . . . . 15.0 111.173 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.6 p -158.08 121.13 3.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 15.0 109.454 175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -96.54 133.83 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 15.0 109.865 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.73 119.99 30.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.882 0.873 . . . . 15.0 108.95 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 m -75.22 85.23 2.42 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 109.077 -0.712 . . . . 15.0 109.077 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.9 p -78.61 -61.1 2.12 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.795 0.838 . . . . 15.0 111.321 -171.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -118.12 49.94 1.21 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.961 0.886 . . . . 15.0 108.913 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.97 -83.57 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.886 -1.052 . . . . 15.0 112.81 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.97 -37.19 67.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.748 0.819 . . . . 15.0 108.96 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.48 121.61 10.06 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 124.05 0.844 . . . . 15.0 112.011 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -124.66 120.12 30.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.96 0.904 . . . . 15.0 110.08 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -87.24 98.32 11.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.198 0.999 . . . . 15.0 110.112 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.61 97.27 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.413 -0.588 . . . . 15.0 109.413 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 66.1 m -70.71 117.58 12.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.071 0.949 . . . . 15.0 110.2 173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 3' ' ' VAL . 52.7 mt -116.31 141.68 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.673 0.789 . . . . 15.0 109.22 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 2' ' ' GLN . 88.1 m -121.89 116.78 25.0 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.016 0.926 . . . . 15.0 109.314 175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 103' ' ' PHE . 71.3 mt -85.49 134.35 27.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 124.478 1.111 . . . . 15.0 108.488 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.92 149.87 49.53 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.814 0.696 . . . . 15.0 111.371 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.563 1.145 . . . . 15.0 112.416 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -75.54 -31.48 60.1 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.36 -0.836 . . . . 15.0 111.211 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.2 m -70.75 -27.32 63.86 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.385 0.674 . . . . 15.0 111.478 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 28' ' ' VAL . 75.4 mt -66.8 -51.03 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.931 -0.766 . . . . 15.0 108.931 171.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -62.2 -32.56 73.23 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.011 0.82 . . . . 15.0 111.199 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.0 m -64.22 -49.03 73.57 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 115.68 -0.691 . . . . 15.0 109.33 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.77 78.83 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.835 0.854 . . . . 15.0 112.346 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.429 HG22 HG21 ' A' ' 66' ' ' VAL . 85.5 t -63.83 -47.31 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 109.13 -0.693 . . . . 15.0 109.13 177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -68.02 -34.11 75.87 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.356 -0.838 . . . . 15.0 111.409 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 64.6 m -67.84 -26.45 66.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.639 0.776 . . . . 15.0 110.369 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.9 tp10 -82.64 -40.38 20.84 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.48 0.488 . . . . 15.0 110.161 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.2 mt -70.01 -28.54 65.59 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.641 0.776 . . . . 15.0 112.622 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.4 -26.9 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 110.038 -0.356 . . . . 15.0 110.038 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -69.34 -52.45 27.09 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 172.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 31' ' ' GLU . 66.9 t -59.77 -33.04 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.43 1.092 . . . . 15.0 111.11 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.38 -48.13 83.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.245 0.618 . . . . 15.0 110.698 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.13 -19.61 33.89 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.892 0.477 . . . . 15.0 111.885 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -76.24 -44.26 38.28 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.613 0.765 . . . . 15.0 110.277 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.13 -0.07 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 CA-C-N 115.458 -0.792 . . . . 15.0 109.766 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 64.1 35.15 10.61 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.965 1.306 . . . . 15.0 111.567 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt -90.44 -9.44 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 C-N-CA 123.953 0.901 . . . . 15.0 110.248 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -62.39 -28.77 70.01 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.096 0.958 . . . . 15.0 112.282 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.48 -19.82 73.09 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-N 116.427 -0.351 . . . . 15.0 112.639 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.65 -17.36 41.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.481 0.713 . . . . 15.0 110.373 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.0 ttt85 -66.43 106.06 1.64 Allowed 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.853 -0.795 . . . . 15.0 108.853 170.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -74.12 -23.13 59.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.232 1.013 . . . . 15.0 111.591 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.58 2.89 90.06 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 115.792 -0.64 . . . . 15.0 112.249 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -69.11 -50.41 48.36 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.071 0.948 . . . . 15.0 109.532 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.65 126.49 59.66 Favored Pre-proline 0 C--O 1.248 0.98 0 CA-C-N 114.74 -1.118 . . . . 15.0 108.912 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.02 144.4 87.48 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.818 2.345 . . . . 15.0 112.718 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 50.5 tpp -67.86 -32.87 73.68 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.044 -0.98 . . . . 15.0 111.616 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -65.1 -37.45 87.53 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.052 0.541 . . . . 15.0 111.907 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -76.32 -43.57 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.047 0.539 . . . . 15.0 110.624 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 m -72.84 -27.48 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 112.028 0.381 . . . . 15.0 112.028 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.75 -61.48 2.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.097 0.559 . . . . 15.0 110.793 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 3.1 pt20 -59.26 -30.62 68.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.841 -0.618 . . . . 15.0 112.393 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' A' ' 56' ' ' GLN . 99.6 mtt180 -97.91 8.63 44.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.659 0.614 . . . . 15.0 112.659 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -122.7 -6.29 8.59 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.007 0.923 . . . . 15.0 109.888 163.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.24 -9.25 80.72 Favored Glycine 0 C--N 1.348 1.22 0 O-C-N 123.472 0.482 . . . . 15.0 113.555 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.18 -24.26 58.41 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.53 1.132 . . . . 15.0 112.376 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -79.46 -50.02 11.42 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.729 0.812 . . . . 15.0 110.694 175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 66' ' ' VAL . 7.2 p -85.58 95.94 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 CA-C-O 122.116 0.96 . . . . 15.0 110.134 -175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -115.27 -79.03 0.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.906 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -65.91 -21.18 66.43 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.103 0.961 . . . . 15.0 111.121 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.55 -50.9 70.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.1 0.96 . . . . 15.0 108.819 177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 62' ' ' VAL . 67.0 t -66.34 -48.17 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 114.738 -1.119 . . . . 15.0 110.26 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' MET . 90.5 mt -58.97 -54.68 44.43 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.756 0.66 . . . . 15.0 111.04 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.05 -45.3 96.18 Favored Glycine 0 C--N 1.342 0.9 0 O-C-N 123.957 0.785 . . . . 15.0 112.48 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.19 -43.32 95.99 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.738 0.815 . . . . 15.0 111.591 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.411 HD13 HD13 ' A' ' 19' ' ' ILE . 67.2 mt -70.54 -46.52 63.42 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 68.7 mtm -61.67 -32.84 73.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 122.862 0.465 . . . . 15.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.8 t -74.62 -48.24 27.55 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.915 0.886 . . . . 15.0 110.657 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -68.73 -34.37 75.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.919 0.488 . . . . 15.0 111.71 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -74.9 -29.27 60.94 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.805 0.442 . . . . 15.0 110.55 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -66.28 -55.85 14.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.1 0.56 . . . . 15.0 110.813 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 tt -64.53 -38.4 82.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 O-C-N 123.482 0.489 . . . . 15.0 110.376 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.91 -38.7 91.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.768 0.827 . . . . 15.0 110.718 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.21 -52.92 51.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 15.0 111.251 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.86 -25.18 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.152 0.427 . . . . 15.0 112.152 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.1 mt -71.17 -52.17 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.383 0.673 . . . . 15.0 110.815 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -73.67 -34.56 64.97 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.787 0.435 . . . . 15.0 111.238 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -86.51 -9.59 55.86 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.602 0.761 . . . . 15.0 111.605 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 61.74 39.08 14.52 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.481 1.113 . . . . 15.0 111.671 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' HE2' ' A' ' 109' ' ' PHE . 63.6 mt -90.17 134.25 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.264 -0.88 . . . . 15.0 109.14 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.48 93.01 3.02 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.344 1.058 . . . . 15.0 108.209 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.96 173.12 14.98 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.827 2.351 . . . . 15.0 113.86 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.13 166.94 31.21 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.738 1.215 . . . . 15.0 109.554 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.35 -119.3 7.76 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.703 0.627 . . . . 15.0 112.101 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -147.29 138.76 13.4 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.437 0.695 . . . . 15.0 109.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.7 108.07 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.797 2.332 . . . . 15.0 111.466 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' A' ' 108' ' ' GLU . 30.2 m -86.44 98.71 11.17 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.846 -0.427 . . . . 15.0 109.846 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -73.06 115.16 12.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.659 -0.701 . . . . 15.0 110.099 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 106' ' ' SER . 39.6 t -106.99 92.17 7.31 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.787 1.235 . . . . 15.0 108.965 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.23 101.19 0.69 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.416 2.077 . . . . 15.0 111.028 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 105' ' ' TYR . . . -60.5 -70.26 1.06 Allowed Glycine 0 C--N 1.353 1.52 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -165.7 130.64 2.4 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 123.443 0.697 . . . . 15.0 110.396 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.81 135.87 42.62 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.878 0.871 . . . . 15.0 109.365 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -132.7 150.21 52.19 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.743 0.817 . . . . 15.0 110.447 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.2 tp -90.37 117.57 29.19 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.028 0.931 . . . . 15.0 109.327 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.75 -23.02 14.55 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.135 -0.484 . . . . 15.0 113.121 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -101.52 179.3 4.39 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.995 0.918 . . . . 15.0 109.815 174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.86 165.99 24.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.12 0.968 . . . . 15.0 112.064 -173.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' HD2' HD12 ' A' ' 19' ' ' ILE . 13.3 t80 -115.75 109.49 17.76 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.893 0.877 . . . . 15.0 109.63 176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.2 m -94.94 134.86 37.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.186 0.594 . . . . 15.0 109.533 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 33.9 p90 -156.27 -176.78 6.15 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.06 0.944 . . . . 15.0 109.045 175.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.522 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . 31.3 m -140.07 163.33 32.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.87 0.868 . . . . 15.0 109.765 174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.86 106.09 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 91' ' ' THR . 37.3 mt-10 -90.31 95.57 10.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.639 0.776 . . . . 15.0 109.617 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 84' ' ' ILE . 42.7 p90 -120.25 148.24 43.94 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.055 -0.721 . . . . 15.0 109.055 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.4 176.03 8.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.997 0.519 . . . . 15.0 110.303 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.38 153.79 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.315 0.646 . . . . 15.0 110.767 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -83.73 113.39 46.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 169.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' HD11 ' A' ' 300' ' ' ILE . 91.0 Cg_endo -80.52 164.04 21.37 Favored 'Trans proline' 0 C--N 1.371 1.723 0 C-N-CA 122.554 2.169 . . . . 15.0 112.667 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -74.16 116.25 14.59 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.121 -0.696 . . . . 15.0 109.121 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 300' ' ' ILE . 61.5 t -80.1 108.52 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.813 0.845 . . . . 15.0 110.7 -170.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -68.27 106.36 2.43 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.91 0.884 . . . . 15.0 110.963 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.4 mt -106.95 127.23 53.26 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.255 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -159.54 160.95 35.11 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.508 1.523 . . . . 15.0 108.469 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 68.48 22.1 74.76 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 112.467 -0.253 . . . . 15.0 112.467 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 117' ' ' LEU . 85.8 mt -68.44 -28.38 67.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.557 0.743 . . . . 15.0 110.79 -177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -79.79 -16.96 54.5 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.086 0.954 . . . . 15.0 110.765 174.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -86.49 -15.53 39.81 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.394 0.678 . . . . 15.0 111.401 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -66.26 127.18 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.664 0.786 . . . . 15.0 109.213 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -125.22 100.58 6.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.812 0.845 . . . . 15.0 109.739 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -96.17 139.29 19.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.368 1.067 . . . . 15.0 109.522 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -89.94 140.13 29.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.627 ' HE2' HD11 ' A' ' 129' ' ' ILE . 81.1 tttt -126.52 94.37 40.63 Favored Pre-proline 0 C--O 1.248 0.981 0 C-N-CA 124.89 1.276 . . . . 15.0 108.651 -173.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -85.74 95.22 0.59 Allowed 'Trans proline' 0 C--N 1.366 1.449 0 C-N-CA 122.412 2.075 . . . . 15.0 111.038 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.627 HD11 ' HE2' ' A' ' 127' ' ' LYS . 36.8 mm -70.98 101.07 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.335 -0.987 . . . . 15.0 108.335 170.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.8 t -126.84 147.82 31.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-N 114.276 -1.329 . . . . 15.0 109.43 -172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -142.81 164.57 29.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.742 0.817 . . . . 15.0 109.306 166.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.11 79.3 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 108.771 -0.826 . . . . 15.0 108.771 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.9 p -67.8 172.25 5.58 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.454 0.702 . . . . 15.0 109.94 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.12 -25.79 67.93 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.62 0.368 . . . . 15.0 111.857 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.96 92.79 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.077 0.465 . . . . 15.0 110.431 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -74.77 -36.49 62.56 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.177 -0.92 . . . . 15.0 111.182 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.51 -51.36 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 109.439 -0.578 . . . . 15.0 109.439 178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.01 -39.81 93.52 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.977 0.511 . . . . 15.0 111.039 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -63.34 -43.28 98.62 Favored Glycine 0 C--N 1.348 1.233 0 O-C-N 124.026 0.828 . . . . 15.0 112.59 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.6 tpt -70.0 -41.0 74.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.336 0.654 . . . . 15.0 110.696 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.64 -45.07 94.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.284 0.634 . . . . 15.0 110.046 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.15 -45.73 86.9 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.062 0.851 . . . . 15.0 110.668 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 79.1 m -62.66 -50.27 71.87 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.56 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.88 -28.07 66.37 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 117.75 0.25 . . . . 15.0 111.044 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.1 mtp85 -74.65 -32.51 62.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.516 0.326 . . . . 15.0 111.241 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.15 -24.2 57.9 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.473 0.309 . . . . 15.0 110.618 171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.532 ' HG2' ' H ' ' B' ' 262' ' ' ALA . 36.8 tt0 -86.65 -17.55 33.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.76 1.224 . . . . 15.0 110.432 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' B' ' 258' ' ' LEU . 24.8 mm-40 -115.63 23.87 12.0 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.008 0.923 . . . . 15.0 111.359 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.75 171.67 13.72 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.322 0.582 . . . . 15.0 112.329 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.9 m -132.42 134.9 45.67 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.064 0.946 . . . . 15.0 109.338 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -77.13 127.53 32.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.124 0.569 . . . . 15.0 110.924 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -133.61 112.78 11.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.133 1.373 . . . . 15.0 108.264 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -54.81 113.26 1.25 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.347 0.659 . . . . 15.0 109.967 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 47.7 pttt -116.71 171.75 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.586 0.754 . . . . 15.0 110.529 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -101.3 116.73 33.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.235 0.614 . . . . 15.0 111.259 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 207' ' ' ALA . . . 58.26 48.3 84.35 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 117.839 1.896 . . . . 15.0 117.839 157.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.09 88.25 1.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.627 0.713 . . . . 15.0 111.36 173.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.613 HG11 HG22 ' A' ' 202' ' ' ILE . 40.9 t -79.62 96.89 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.096 -0.705 . . . . 15.0 109.096 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -78.87 -169.65 1.86 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.321 1.049 . . . . 15.0 109.609 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.84 -28.03 30.43 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.568 0.951 . . . . 15.0 113.568 -168.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.91 16.63 11.76 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.599 0.76 . . . . 15.0 112.295 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -80.11 -179.17 6.9 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.878 0.847 . . . . 15.0 111.998 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -104.01 139.11 39.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.569 -1.271 . . . . 15.0 107.569 164.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.88 133.81 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.859 -0.793 . . . . 15.0 108.859 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' HD3' ' A' ' 238' ' ' LYS . 26.0 m -105.8 126.19 51.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.371 -0.974 . . . . 15.0 108.371 175.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 235' ' ' ILE . 14.4 mt -127.69 160.3 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.045 0.938 . . . . 15.0 109.951 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -112.55 105.36 13.55 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 104.945 -2.243 . . . . 15.0 104.945 151.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 29.8 p90 -99.59 123.65 44.05 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.051 -1.092 . . . . 15.0 108.051 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 69.3 p -127.41 111.99 14.48 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.72 -0.844 . . . . 15.0 108.72 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -169.83 -168.94 32.44 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.473 -0.87 . . . . 15.0 114.522 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m -133.28 135.14 44.72 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.872 0.869 . . . . 15.0 109.648 -176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 231' ' ' ALA . 38.6 t -89.15 119.04 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.836 -0.801 . . . . 15.0 108.836 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.481 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 27.0 t70 67.58 7.49 5.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.921 0.889 . . . . 15.0 111.733 -176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.47 -0.97 57.01 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.171 -0.468 . . . . 15.0 113.578 -176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -125.19 153.65 42.76 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.77 0.828 . . . . 15.0 109.198 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.34 123.12 37.55 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.03 0.443 . . . . 15.0 111.195 -177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.81 -157.38 0.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.038 1.335 . . . . 15.0 108.195 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 12.7 tp10 -72.7 146.56 46.4 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 169.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.474 ' HA2' HG23 ' B' ' 236' ' ' THR . . . 69.25 20.9 75.5 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 120.099 -0.279 . . . . 15.0 113.238 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -80.43 -22.86 61.69 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 112.171 -0.371 . . . . 15.0 112.171 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.78 136.62 7.18 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.515 0.726 . . . . 15.0 110.205 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -156.75 131.66 8.97 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.604 0.762 . . . . 15.0 109.38 171.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.1 p -86.51 145.09 26.94 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.04 0.837 . . . . 15.0 109.462 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 55.31 36.93 28.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.481 1.112 . . . . 15.0 111.625 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -62.38 103.08 0.36 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.658 -1.156 . . . . 15.0 109.535 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' B' ' 242' ' ' TRP . 76.6 t -89.51 110.43 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.044 -0.98 . . . . 15.0 109.616 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 66.8 tp -110.88 106.58 15.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.309 1.044 . . . . 15.0 110.533 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.7 87.39 5.23 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 107.533 -1.284 . . . . 15.0 107.533 164.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.0 ptp -71.06 173.61 7.35 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.113 -0.949 . . . . 15.0 111.362 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.18 -10.91 59.61 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.592 -0.731 . . . . 15.0 112.516 -172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -120.26 153.76 35.9 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 124.537 1.135 . . . . 15.0 108.036 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.78 54.42 4.66 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 123.341 0.401 . . . . 15.0 113.676 -176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -96.09 -12.04 25.42 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.051 0.941 . . . . 15.0 110.564 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.602 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -135.47 175.19 9.82 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.265 1.026 . . . . 15.0 108.886 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.602 HG22 ' SD ' ' A' ' 194' ' ' MET . 2.9 tt -70.66 129.06 90.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 122.761 0.424 . . . . 15.0 109.995 170.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.47 129.45 34.81 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.673 2.249 . . . . 15.0 110.994 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 115.3 -36.86 3.71 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.858 -0.497 . . . . 15.0 111.858 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -65.68 -53.02 46.91 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -61.81 -36.98 82.71 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 15.0 111.024 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.74 -31.91 70.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.63 0.772 . . . . 15.0 110.89 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -63.79 -30.76 78.63 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.85 0.719 . . . . 15.0 112.027 173.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.613 HG22 HG11 ' A' ' 158' ' ' VAL . 68.3 mt -76.34 -39.32 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.167 0.987 . . . . 15.0 110.46 175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 -12.2 61.41 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.874 1.27 . . . . 15.0 113.069 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.27 -6.26 88.93 Favored Glycine 0 CA--C 1.539 1.538 0 O-C-N 123.298 0.374 . . . . 15.0 112.758 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -125.47 175.41 7.53 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.706 1.202 . . . . 15.0 109.62 -172.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -110.72 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.28 1.585 . . . . 15.0 115.28 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.482 ' HB2' ' HA2' ' A' ' 156' ' ' GLY . . . -146.55 -61.34 0.3 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 115.774 1.768 . . . . 15.0 115.774 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 237' ' ' LEU . . . -129.22 53.79 0.8 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 113.624 0.21 . . . . 15.0 113.624 -163.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -135.01 127.43 30.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.761 0.824 . . . . 15.0 111.105 -170.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -82.78 126.76 32.77 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.1 -0.375 . . . . 15.0 110.007 174.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -140.19 178.73 7.08 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 124.236 1.014 . . . . 15.0 109.851 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 89.6 m -128.74 127.18 41.55 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.155 0.582 . . . . 15.0 109.666 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 34.8 pt -120.78 152.31 23.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 C-N-CA 123.59 0.756 . . . . 15.0 109.567 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -109.47 109.18 19.93 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.377 -0.971 . . . . 15.0 108.377 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 13.8 m -101.26 110.3 27.81 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.933 0.873 . . . . 15.0 110.456 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 37.5 m -86.74 94.49 9.53 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.59 -1.186 . . . . 15.0 108.144 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 195' ' ' ILE . 94.2 m-85 -44.26 143.06 2.04 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.908 1.283 . . . . 15.0 111.879 174.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 8.0 Cg_endo -81.44 169.25 15.75 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.897 2.398 . . . . 15.0 111.765 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -74.61 -4.96 40.24 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.579 169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 33.2 mt-10 -88.01 -15.22 36.99 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.983 1.313 . . . . 15.0 110.095 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.513 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.7 OUTLIER -72.91 126.32 29.66 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.507 -0.77 . . . . 15.0 110.114 -175.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -67.72 -19.39 65.14 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.328 1.051 . . . . 15.0 112.268 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 226' ' ' LEU . . . -68.06 98.57 0.78 Allowed 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 171.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -59.47 -44.7 92.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.343 1.057 . . . . 15.0 112.004 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -73.58 -21.12 60.44 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.47 -0.786 . . . . 15.0 111.35 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.477 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 40.8 mt -122.88 15.21 10.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.77 1.026 . . . . 15.0 113.77 -170.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.78 31.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.176 -1.046 . . . . 15.0 108.176 166.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.46 -5.78 49.19 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.4 -0.667 . . . . 15.0 114.277 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 73.7 mmtt -77.42 164.36 25.54 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 117.711 0.756 . . . . 15.0 111.105 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -124.8 106.37 9.99 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.91 0.884 . . . . 15.0 109.016 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 172' ' ' VAL . . . -93.45 133.23 36.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.659 0.784 . . . . 15.0 111.372 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -107.09 95.71 5.91 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.374 -0.973 . . . . 15.0 108.374 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -103.42 125.62 50.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.916 0.486 . . . . 15.0 110.857 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.5 89.35 3.26 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.81 -1.181 . . . . 15.0 107.81 168.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.473 HG23 HD13 ' A' ' 166' ' ' ILE . 47.5 mm -70.46 104.89 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 114.367 -1.288 . . . . 15.0 109.736 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -87.07 85.1 7.21 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 106.273 -1.751 . . . . 15.0 106.273 175.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.421 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 18.9 tp -62.11 104.16 0.45 Allowed 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.291 -1.003 . . . . 15.0 108.291 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.451 ' HD3' HG22 ' A' ' 165' ' ' THR . 37.1 mtpt -87.65 -66.09 0.95 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 -175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -137.79 162.99 32.49 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.511 0.672 . . . . 15.0 111.853 -173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.1 139.03 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 170.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -133.75 109.61 9.25 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.495 -0.928 . . . . 15.0 108.495 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.491 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 40.6 tt0 -72.9 136.22 45.23 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.994 1.317 . . . . 15.0 111.067 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -78.53 78.22 4.99 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.186 -1.042 . . . . 15.0 108.186 165.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -68.05 124.02 22.25 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 114.994 -1.003 . . . . 15.0 109.282 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 26.0 mt -59.66 146.52 80.44 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.57 1.148 . . . . 15.0 111.098 -174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.58 -170.54 0.84 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.146 2.564 . . . . 15.0 112.262 -176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.6 166.82 22.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.575 0.702 . . . . 15.0 110.468 172.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.64 28.45 4.59 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 107.807 -1.183 . . . . 15.0 107.807 167.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 12.1 m -67.22 156.74 35.53 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.397 -1.274 . . . . 15.0 109.201 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 254' ' ' LYS . . . -46.28 -52.02 13.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.229 1.012 . . . . 15.0 112.53 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -53.74 -30.46 44.33 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.44 0.696 . . . . 15.0 112.729 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -79.87 -76.35 0.22 Allowed 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 108.134 -1.061 . . . . 15.0 108.134 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.554 HD11 ' HB2' ' A' ' 266' ' ' LEU . 12.5 tt -53.48 -40.41 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 124.544 1.138 . . . . 15.0 113.772 -165.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 250' ' ' ALA . 18.3 ptmt -76.4 -33.71 58.86 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.815 0.341 . . . . 15.0 111.532 -175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -77.55 -13.41 59.92 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.51 0.671 . . . . 15.0 110.415 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . 0.47 ' HE2' ' HA ' ' B' ' 260' ' ' SER . 75.0 m-85 -92.54 24.47 3.48 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 114.833 -1.076 . . . . 15.0 110.993 170.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.22 12.88 32.55 Favored Glycine 0 C--N 1.358 1.775 0 N-CA-C 115.233 0.853 . . . . 15.0 115.233 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 254' ' ' LYS . 57.9 t -112.3 87.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.182 0.593 . . . . 15.0 109.505 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -40.74 -53.31 2.84 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 125.359 1.464 . . . . 15.0 113.208 -171.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -97.65 112.61 24.41 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.822 -1.177 . . . . 15.0 107.822 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.22 48.9 4.13 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 114.372 0.509 . . . . 15.0 114.372 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 68.5 p -91.29 141.05 29.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 15.0 109.286 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.99 -49.62 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 124.024 0.828 . . . . 15.0 110.181 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.08 -26.97 65.1 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.293 0.637 . . . . 15.0 111.592 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -76.22 -32.08 53.15 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 110.914 -0.874 . . . . 15.0 110.914 177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.554 ' HB2' HD11 ' A' ' 253' ' ' ILE . 68.0 tp -72.76 -36.83 67.77 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 108.937 -0.764 . . . . 15.0 108.937 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 61.9 mtp85 -64.29 -42.48 96.37 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.562 0.745 . . . . 15.0 110.999 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.5 -37.76 80.36 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.457 -0.792 . . . . 15.0 110.669 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -64.59 -44.11 91.68 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.787 -0.642 . . . . 15.0 110.317 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.44 -43.12 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.504 -0.771 . . . . 15.0 109.607 177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -53.45 -59.21 4.88 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.324 0.65 . . . . 15.0 110.787 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -67.17 -40.65 86.63 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -67.56 -45.04 76.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 120.682 0.277 . . . . 15.0 110.522 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . . . . . . . . . 1.7 mmt -74.54 -21.28 59.6 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 118.273 -0.87 . . . . 15.0 111.881 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.603 ' HA ' ' HB3' ' A' ' 278' ' ' LEU . 63.5 mt-10 -80.66 -24.23 39.1 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 118.985 0.811 . . . . 15.0 111.985 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -70.86 -42.06 70.6 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.668 -0.864 . . . . 15.0 108.668 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.31 -46.32 90.8 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 114.502 -1.226 . . . . 15.0 110.369 169.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.603 ' HB3' ' HA ' ' A' ' 275' ' ' GLU . 53.9 tp -62.96 -44.54 95.77 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.38 1.072 . . . . 15.0 112.526 -174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -66.99 -33.83 76.42 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.905 -0.405 . . . . 15.0 109.905 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.8 t -66.88 -38.9 87.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.933 0.493 . . . . 15.0 109.684 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -58.2 -54.72 43.76 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.506 0.722 . . . . 15.0 110.754 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 69.4 mt -65.23 -37.66 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 124.176 0.923 . . . . 15.0 110.628 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.442 HH22 ' CD ' ' A' ' 409' ' ' GLU . 20.8 tpt180 -70.04 -44.77 68.53 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.667 0.27 . . . . 15.0 111.382 -174.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -72.62 -30.72 64.57 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.138 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -61.78 -55.33 31.23 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.915 0.886 . . . . 15.0 110.087 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.11 -42.79 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.811 0.845 . . . . 15.0 111.078 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.48 -50.67 73.02 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.516 0.51 . . . . 15.0 110.104 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.0 p -65.79 -40.16 91.68 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.538 0.524 . . . . 15.0 111.682 -175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -76.08 -32.67 59.37 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.72 0.408 . . . . 15.0 111.773 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.75 80.91 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.142 -0.318 . . . . 15.0 110.142 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.515 HD12 HG13 ' A' ' 347' ' ' VAL . 26.2 mm -66.31 -39.94 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.119 -0.946 . . . . 15.0 110.602 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.6 -51.63 67.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.319 0.648 . . . . 15.0 109.512 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -70.77 -33.58 66.45 Favored Glycine 0 C--N 1.345 1.036 0 O-C-N 124.314 1.009 . . . . 15.0 113.47 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -66.92 -51.02 60.44 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.314 -0.624 . . . . 15.0 109.314 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.83 -43.03 97.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.232 0.957 . . . . 15.0 109.692 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -57.84 -35.88 71.53 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.919 0.887 . . . . 15.0 111.357 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -88.41 -20.61 25.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.346 0.659 . . . . 15.0 111.802 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -148.9 116.16 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 117.995 0.361 . . . . 15.0 111.324 -169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -108.28 145.37 34.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.399 0.68 . . . . 15.0 109.835 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.488 HD11 ' HG2' ' A' ' 113' ' ' PRO . 7.4 tp -135.72 130.98 50.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.494 -0.928 . . . . 15.0 108.494 175.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -75.6 110.42 9.98 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.347 0.594 . . . . 15.0 109.664 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 92.4 t -76.47 145.66 76.07 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 114.392 -1.276 . . . . 15.0 110.534 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.04 128.96 23.59 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.668 2.245 . . . . 15.0 112.038 164.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -56.79 -36.12 69.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.774 1.23 . . . . 15.0 113.109 -171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.27 -30.07 65.85 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.077 0.551 . . . . 15.0 112.103 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.25 -43.9 73.03 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.231 0.539 . . . . 15.0 109.737 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 311' ' ' ILE . 58.3 mt -58.7 -46.06 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 114.658 -1.155 . . . . 15.0 109.35 174.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' ILE . 12.6 t70 -61.91 -40.78 96.65 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.83 1.331 . . . . 15.0 111.032 -177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 313' ' ' VAL . 53.4 m -60.99 -46.52 90.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.462 -0.79 . . . . 15.0 110.043 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -64.31 -33.88 76.84 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 116.008 -0.542 . . . . 15.0 112.16 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 308' ' ' ASP . 97.7 mt -60.0 -47.99 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 108.436 -0.95 . . . . 15.0 108.436 175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.55 -47.87 83.85 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 124.374 1.046 . . . . 15.0 111.15 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 309' ' ' SER . 98.6 t -57.58 -43.24 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.934 0.771 . . . . 15.0 110.595 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 93.1 mt -71.39 -34.55 70.5 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.453 0.701 . . . . 15.0 112.636 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 26.3 mtm180 -67.94 -42.17 81.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.903 0.481 . . . . 15.0 109.869 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -75.72 -27.85 58.34 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.982 0.801 . . . . 15.0 111.204 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.67 -44.36 74.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.658 0.783 . . . . 15.0 109.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.83 -49.09 74.2 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.125 -0.943 . . . . 15.0 109.667 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' A' ' 325' ' ' ASN . . . -59.22 -36.52 75.57 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.274 1.03 . . . . 15.0 111.908 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -63.43 -28.43 69.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.954 0.902 . . . . 15.0 110.268 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -87.9 -39.91 14.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.012 0.525 . . . . 15.0 110.49 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -94.3 84.54 4.41 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.78 0.832 . . . . 15.0 109.492 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 92.85 -40.95 2.77 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.495 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 94.98 40.05 4.42 Favored Glycine 0 N--CA 1.473 1.127 0 N-CA-C 110.952 -0.859 . . . . 15.0 110.952 -171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.722 ' HB3' ' HB1' ' A' ' 319' ' ' ALA . 24.1 t-20 -66.62 126.67 29.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.902 0.881 . . . . 15.0 111.106 -176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -87.91 89.02 7.83 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.321 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm 66.47 -4.8 0.67 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 164.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.401 ' HB3' HD21 ' A' ' 325' ' ' ASN . 24.8 tm0? -72.77 -14.57 61.56 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.748 -0.834 . . . . 15.0 108.748 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -60.44 -5.07 1.03 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.314 1.445 . . . . 15.0 112.926 169.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.2 tp -48.78 -32.47 8.68 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.81 1.244 . . . . 15.0 111.412 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -80.86 -10.81 59.68 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.33 1.052 . . . . 15.0 112.31 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 37.3 mt -61.69 145.3 92.02 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 122.873 0.469 . . . . 15.0 111.072 177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -57.01 113.04 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.982 3.121 . . . . 15.0 114.375 -170.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 50.9 ttm-85 -44.92 -60.41 2.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.095 1.358 . . . . 15.0 112.707 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -22.6 62.22 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.267 1.027 . . . . 15.0 112.495 -175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.43 -35.29 78.96 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.647 ' HA ' HE21 ' A' ' 340' ' ' GLN . 88.7 m-85 -105.49 -21.36 13.23 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.126 -0.943 . . . . 15.0 112.177 -175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -69.79 -36.42 75.69 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.649 0.78 . . . . 15.0 112.598 -170.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.1 -56.49 14.5 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.41 0.684 . . . . 15.0 110.47 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 337' ' ' PHE . 22.5 pt20 -65.45 -34.89 79.34 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.64 -0.709 . . . . 15.0 111.57 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -58.94 -59.12 5.97 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.642 0.777 . . . . 15.0 110.558 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.485 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.7 tttt -49.65 -46.88 50.14 Favored 'General case' 0 C--N 1.356 0.869 0 O-C-N 124.33 1.019 . . . . 15.0 109.688 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 347' ' ' VAL . 38.3 ttt180 -61.98 -35.22 77.83 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.674 1.233 . . . . 15.0 111.222 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -67.01 -40.66 87.33 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.361 0.413 . . . . 15.0 110.179 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 3.5 t -72.41 -31.79 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 116.198 -0.455 . . . . 15.0 109.931 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 342' ' ' LYS . 42.8 t -59.91 -43.46 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.601 0.76 . . . . 15.0 109.381 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.515 HG13 HD12 ' A' ' 291' ' ' ILE . 91.1 t -48.79 -49.83 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 123.799 0.687 . . . . 15.0 110.273 171.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' B' ' 297' ' ' TYR . . . -68.14 -34.25 80.56 Favored Glycine 0 C--N 1.345 1.031 0 CA-C-N 114.693 -1.14 . . . . 15.0 113.823 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.415 ' HB2' HG21 ' A' ' 300' ' ' ILE . 38.0 mt -77.84 -39.14 44.49 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.576 0.688 . . . . 15.0 110.73 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 294' ' ' LEU . 85.5 mt -61.99 -55.1 32.83 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.268 -0.641 . . . . 15.0 109.268 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 291' ' ' ILE . 68.4 mt -62.61 -35.87 80.93 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.443 -0.799 . . . . 15.0 111.206 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.7 -40.72 98.85 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.759 0.662 . . . . 15.0 111.945 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.55 -43.0 95.33 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.999 -0.601 . . . . 15.0 110.701 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 350' ' ' LEU . 90.2 t -60.72 -39.0 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 122.975 0.51 . . . . 15.0 110.494 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.686 HG21 HD13 ' B' ' 301' ' ' ILE . 54.6 mt -62.77 -43.96 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.433 0.693 . . . . 15.0 110.496 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -64.16 -49.62 71.38 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 123.613 0.571 . . . . 15.0 110.138 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 59.0 m -57.56 -37.45 73.14 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.418 1.087 . . . . 15.0 112.035 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -104.59 10.22 35.03 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 118.539 -0.743 . . . . 15.0 111.986 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 33.28 65.72 0.25 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 125.954 1.702 . . . . 15.0 113.874 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.38 159.62 17.24 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.568 0.699 . . . . 15.0 112.187 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.07 141.72 24.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 114.28 -1.327 . . . . 15.0 108.642 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -63.39 111.54 2.34 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.942 0.497 . . . . 15.0 110.158 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.434 ' HB2' ' NE2' ' A' ' 406' ' ' GLN . 14.1 t70 -79.22 112.54 16.55 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.302 0.641 . . . . 15.0 111.255 -169.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -57.33 -29.46 63.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.894 1.278 . . . . 15.0 114.106 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -75.5 -31.03 60.03 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.751 -0.463 . . . . 15.0 109.751 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -76.6 -34.85 58.37 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.132 -0.692 . . . . 15.0 109.132 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 371' ' ' ILE . 25.1 t -55.57 -56.91 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.575 -1.193 . . . . 15.0 108.885 171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -51.67 -49.01 63.19 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.989 0.916 . . . . 15.0 112.228 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -55.43 -60.6 8.55 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.317 1.011 . . . . 15.0 113.032 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.66 -43.08 98.05 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.047 0.939 . . . . 15.0 109.953 -176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 367' ' ' VAL . 35.7 mt -50.29 -62.51 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.344 0 O-C-N 124.187 0.929 . . . . 15.0 110.006 177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.737 ' HG2' HD11 ' A' ' 385' ' ' ILE . 45.4 mt-10 -70.52 -31.81 69.03 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.9 0.75 . . . . 15.0 112.373 -169.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.06 -42.82 88.95 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 123.178 0.299 . . . . 15.0 111.722 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 45.1 ttp -77.64 -27.44 51.03 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.267 0.556 . . . . 15.0 110.259 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 372' ' ' GLU . . . -72.28 -25.82 61.74 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.383 1.073 . . . . 15.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 42.6 t -64.65 -1.05 1.64 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.447 1.099 . . . . 15.0 112.766 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' B' ' 286' ' ' MET . . . -67.46 -32.75 73.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.128 0.571 . . . . 15.0 110.485 168.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.86 168.81 10.41 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.705 0.802 . . . . 15.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.6 -42.75 81.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.722 0.809 . . . . 15.0 110.418 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -116.52 112.62 41.07 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.943 0.897 . . . . 15.0 109.533 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.05 -28.81 49.0 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.664 2.243 . . . . 15.0 113.44 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 385' ' ' ILE . 34.1 mmtp -67.43 -29.13 68.53 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.852 0.686 . . . . 15.0 112.852 -168.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -75.36 -16.0 60.42 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.109 0.164 . . . . 15.0 110.897 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.98 -34.41 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.104 -0.702 . . . . 15.0 109.104 172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.737 HD11 ' HG2' ' A' ' 372' ' ' GLU . 1.9 mp -56.75 -44.45 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 108.504 -0.925 . . . . 15.0 108.504 167.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -62.16 -47.16 85.78 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 115.532 -0.758 . . . . 15.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -61.63 -26.91 68.29 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.366 0.667 . . . . 15.0 111.335 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.538 ' HB3' ' SD ' ' A' ' 395' ' ' MET . 6.2 m-85 -66.82 -61.02 2.17 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.781 -0.822 . . . . 15.0 108.781 170.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.5 p -66.76 -9.07 32.94 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.04 -8.58 15.82 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.712 0.805 . . . . 15.0 111.405 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -128.88 98.0 4.82 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.273 -1.01 . . . . 15.0 108.273 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -65.43 -20.42 66.36 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.675 0.79 . . . . 15.0 111.662 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.67 -33.99 73.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.273 1.029 . . . . 15.0 109.657 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -45.01 60.11 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.069 -0.968 . . . . 15.0 109.049 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 388' ' ' TYR . 95.8 mmm -64.43 -31.35 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.519 -0.764 . . . . 15.0 111.622 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -59.49 -63.05 1.44 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.128 0.892 . . . . 15.0 108.772 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.519 ' HA ' ' HB2' ' A' ' 400' ' ' ASN . 60.7 t30 -72.72 -13.76 61.41 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.468 -176.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.443 ' HB2' ' HE1' ' A' ' 388' ' ' TYR . 27.5 tpp -65.4 -48.53 72.53 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.777 0.322 . . . . 15.0 110.563 167.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -66.52 -36.35 82.47 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.648 -0.705 . . . . 15.0 110.076 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 397' ' ' ASN . 0.9 OUTLIER -60.76 -60.14 4.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.203 0.601 . . . . 15.0 111.141 179.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 405' ' ' GLU . 91.5 t -61.65 -47.4 93.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.707 0 CA-C-O 118.764 -0.636 . . . . 15.0 110.823 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -45.19 86.09 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.373 0.606 . . . . 15.0 111.671 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.404 HD11 HD11 ' B' ' 301' ' ' ILE . 38.6 tp -72.25 -35.29 68.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.022 -0.99 . . . . 15.0 111.346 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -37.58 86.54 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.775 0.672 . . . . 15.0 109.676 174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 48.5 mt-10 -61.8 -48.14 81.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.119 0.568 . . . . 15.0 109.682 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 363' ' ' ASP . 91.0 mt-30 -61.71 -47.4 85.44 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.59 0.556 . . . . 15.0 111.747 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -68.65 -34.64 76.06 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.024 0.93 . . . . 15.0 111.57 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 32.0 t -76.85 -46.6 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.472 0.709 . . . . 15.0 109.816 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.442 ' CD ' HH22 ' A' ' 283' ' ' ARG . 52.7 mt-10 -66.94 -24.47 66.08 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.002 0.521 . . . . 15.0 112.144 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -67.41 -27.33 66.98 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.48 0.488 . . . . 15.0 110.735 171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 48.0 t -84.71 -35.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.437 -0.579 . . . . 15.0 109.437 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 409' ' ' GLU . 92.0 mt -65.44 -35.11 79.93 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.676 0.79 . . . . 15.0 111.279 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.07 -17.17 61.98 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.3 0.64 . . . . 15.0 111.515 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -108.37 -26.95 10.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.96 1.304 . . . . 15.0 111.534 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -98.63 152.21 19.86 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.088 0.955 . . . . 15.0 111.055 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.74 133.79 48.86 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.255 0.622 . . . . 15.0 109.429 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.79 91.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 12.9 t -76.48 140.53 41.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.103 -0.703 . . . . 15.0 109.103 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.49 143.58 51.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.786 0.434 . . . . 15.0 111.533 -168.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -135.45 154.12 51.54 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.156 0.582 . . . . 15.0 109.63 165.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.25 119.9 39.93 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.838 -0.801 . . . . 15.0 108.838 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.7 t -152.68 177.78 10.31 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 120.738 0.304 . . . . 15.0 111.592 -173.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 37.1 p -83.76 163.87 19.92 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.363 1.065 . . . . 15.0 112.113 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.482 ' HD1' HD13 ' A' ' 278' ' ' LEU . 58.3 t80 -66.74 -40.46 88.33 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.42 1.088 . . . . 15.0 111.51 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -55.22 -41.56 72.21 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.982 0.913 . . . . 15.0 109.866 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.46 -48.73 74.05 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.641 -0.708 . . . . 15.0 111.568 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 15.4 tp -80.36 -17.4 52.06 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 116.158 -0.474 . . . . 15.0 111.278 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.66 -22.38 58.92 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.928 0.491 . . . . 15.0 111.363 175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -80.77 41.59 0.58 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.506 0.722 . . . . 15.0 111.616 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -106.1 61.81 0.65 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.537 0.735 . . . . 15.0 109.774 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -79.74 -46.99 16.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 CA-C-N 114.904 -1.044 . . . . 15.0 108.358 -179.034 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.691 -0.114 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.72 144.79 47.94 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.233 0.613 . . . . 0.0 110.275 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -97.38 125.27 41.9 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.394 0.677 . . . . 0.0 109.68 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.41 -31.41 71.58 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.126 0.489 . . . . 0.0 109.988 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.22 121.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.371 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 20.4 m -109.97 138.9 45.7 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.005 0.922 . . . . 0.0 109.556 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 31.1 tp 65.1 -85.53 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.062 1.345 . . . . 0.0 111.335 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.05 68.77 1.52 Allowed Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -76.18 169.37 54.85 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.471 0.558 . . . . 0.0 113.004 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -91.6 -165.24 39.42 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 113.909 0.324 . . . . 0.0 113.909 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -121.16 -177.08 3.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 109.726 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 70.72 113.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.99 1.316 . . . . 0.0 110.114 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -148.33 106.52 3.74 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.341 -0.361 . . . . 0.0 111.213 -168.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 178' ' ' GLU . 28.7 t80 -103.18 65.13 0.85 Allowed 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.01 82.29 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.957 -175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -88.22 88.9 7.78 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.043 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . 0.474 HG23 ' HA2' ' A' ' 179' ' ' GLY . 32.4 m -66.85 -16.18 64.12 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 161.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.35 25.13 2.86 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 125.98 1.712 . . . . 0.0 110.736 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 34.6 p -60.02 112.94 2.07 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.488 169.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -74.31 4.36 5.92 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.507 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 62.96 -120.32 20.85 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 61.48 -80.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.793 1.237 . . . . 0.0 109.808 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.478 ' HA ' HG21 ' A' ' 186' ' ' VAL . 14.4 m95 54.8 118.65 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.01 1.724 . . . . 0.0 113.75 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -54.71 139.4 39.19 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.18 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -49.36 -45.7 36.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 124.614 1.196 . . . . 0.0 112.722 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? 51.3 11.05 0.1 Allowed 'General case' 0 N--CA 1.509 2.522 0 C-N-CA 126.801 2.041 . . . . 0.0 114.816 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.1 p -143.37 150.92 39.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.037 0.935 . . . . 0.0 109.662 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -26.76 66.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.127 0.571 . . . . 0.0 111.179 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -64.56 -43.45 93.86 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.406 0.682 . . . . 0.0 111.481 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -79.17 -14.34 59.15 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.047 0.539 . . . . 0.0 111.421 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -101.6 3.65 40.14 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.6 1.16 . . . . 0.0 111.139 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.43 -76.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.043 0.937 . . . . 0.0 113.142 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -102.13 -79.03 0.53 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 175.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -116.54 -74.62 0.6 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 168.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 50.0 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.559 1.143 . . . . 0.0 111.489 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 52.99 -98.42 0.03 OUTLIER Glycine 0 C--N 1.359 1.821 0 O-C-N 124.001 0.813 . . . . 0.0 112.738 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -136.13 153.43 51.29 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.453 1.101 . . . . 0.0 108.398 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.18 93.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.371 0.605 . . . . 0.0 109.519 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 148' ' ' GLN . 24.5 tp -121.02 100.29 6.98 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.764 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.75 118.33 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . 0.47 ' HA ' ' HE2' ' A' ' 256' ' ' PHE . 42.5 t 71.2 -64.17 0.39 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.268 1.427 . . . . 0.0 111.341 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . 0.469 ' HB2' ' NE2' ' A' ' 147' ' ' GLN . 3.1 p-10 -152.21 162.45 41.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.674 0.79 . . . . 0.0 109.532 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . 0.532 ' H ' ' HG2' ' A' ' 147' ' ' GLN . . . -106.39 -6.36 18.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.61 48.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 120.794 0.331 . . . . 0.0 110.194 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 89.9 p -147.69 170.26 17.92 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.91 0.884 . . . . 0.0 109.623 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 30.3 tp -78.46 -7.58 57.58 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.56 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 74.57 160.31 0.23 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.09 1.756 . . . . 0.0 111.978 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 35.7 m -51.77 -41.89 61.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.708 1.203 . . . . 0.0 111.688 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.73 131.99 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 25.1 m -78.83 76.1 5.33 Favored 'General case' 0 C--O 1.245 0.818 0 C-N-CA 123.636 0.775 . . . . 0.0 109.623 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -163.78 123.72 2.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.186 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -89.56 -17.66 28.1 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.201 1.0 . . . . 0.0 110.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -93.62 11.7 27.93 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.337 1.055 . . . . 0.0 111.213 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -91.48 131.53 36.87 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 122.614 0.366 . . . . 0.0 110.344 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -64.86 100.28 0.4 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 166.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -159.93 173.66 4.68 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.52 131.69 41.87 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 121.385 1.39 . . . . 0.0 110.05 163.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 9.0 tt -44.94 -51.45 9.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.118 1.367 . . . . 0.0 111.462 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.596 HD23 ' H ' ' B' ' 278' ' ' LEU . 2.5 pt? -81.06 178.21 8.56 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.024 -174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -89.7 -162.94 38.84 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.635 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.94 -34.19 44.7 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.381 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . 0.563 ' HE2' ' HB2' ' B' ' 278' ' ' LEU . 49.8 m-85 60.03 -80.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.078 1.351 . . . . 0.0 113.368 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -96.66 -66.89 0.88 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.071 0.549 . . . . 0.0 112.245 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -150.9 -25.01 0.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -65.04 88.15 0.09 OUTLIER Glycine 0 C--N 1.346 1.121 0 O-C-N 123.712 0.632 . . . . 0.0 113.685 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.81 102.53 7.25 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.137 0.575 . . . . 0.0 109.989 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.412 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 1.3 tmt? -59.12 -44.43 98.6 Favored Pre-proline 0 CA--C 1.564 1.511 0 C-N-CA 123.755 0.822 . . . . 0.0 110.458 171.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 16.9 Cg_exo -70.01 110.31 2.58 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 121.7 1.6 . . . . 0.0 110.124 163.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.93 82.54 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.836 1.303 . . . . 0.0 112.418 -171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -115.91 21.79 13.53 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.417 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.627 ' HE3' ' H ' ' B' ' 291' ' ' LEU . 19.3 m95 82.61 169.75 0.11 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.627 ' H ' ' HE3' ' B' ' 290' ' ' TRP . 0.0 OUTLIER -143.0 158.27 43.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 111.817 -2.447 . . . . 0.0 108.707 178.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 52.52 62.63 5.62 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-O 119.307 -0.719 . . . . 0.0 114.261 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.87 -164.2 0.18 Allowed 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.145 2.563 . . . . 0.0 115.521 -162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.51 113.09 0.45 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 126.663 1.985 . . . . 0.0 114.458 -173.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.0 10.24 4.58 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 124.604 1.162 . . . . 0.0 108.879 163.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 96.6 m -82.41 85.51 6.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.58 1.152 . . . . 0.0 110.726 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.515 ' HB2' ' HA3' ' A' ' 348' ' ' GLY . 30.6 m-85 -126.47 59.95 1.34 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 122.245 1.021 . . . . 0.0 108.458 173.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -105.58 13.5 29.87 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.334 -171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 81.45 16.2 74.31 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-O 119.725 -0.486 . . . . 0.0 113.002 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 5.2 t30 60.34 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.577 1.551 . . . . 0.0 110.987 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 355' ' ' ILE . 31.2 pt -98.55 14.04 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 122.63 0.372 . . . . 0.0 110.917 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.46 91.44 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.135 0.974 . . . . 0.0 110.584 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -163.53 142.13 6.25 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -48.96 141.64 21.51 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.732 2.288 . . . . 0.0 112.482 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.65 50.92 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.087 0.955 . . . . 0.0 112.561 -172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -68.93 172.72 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.583 0.753 . . . . 0.0 110.601 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 4.9 t -62.73 92.85 0.05 Allowed 'General case' 0 CA--C 1.557 1.246 0 CA-C-O 122.053 0.93 . . . . 0.0 110.819 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 38.5 t -79.04 79.52 5.44 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.879 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 m -120.65 84.33 36.77 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.624 1.17 . . . . 0.0 108.782 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 C--N 1.381 2.244 0 C-N-CA 123.359 2.706 . . . . 12.53 112.473 -176.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HG3' HG13 ' A' ' 3' ' ' VAL . 22.7 ptm . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -76.33 96.95 4.1 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.613 -0.514 . . . . 15.0 109.613 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 1' ' ' MET . 12.7 m -136.45 158.91 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.375 1.07 . . . . 15.0 109.785 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.609 ' HB2' ' HB ' ' A' ' 16' ' ' THR . 10.9 m -138.61 85.16 2.06 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.26 125.76 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.013 -0.54 . . . . 15.0 109.957 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -125.03 100.74 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.787 0.835 . . . . 15.0 109.28 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' HG2' ' A' ' 13' ' ' ARG . 50.0 m -75.94 79.18 2.82 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.167 -1.049 . . . . 15.0 108.167 173.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.6 p -71.27 -47.46 56.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.561 -168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -132.29 39.28 3.41 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.258 0.551 . . . . 15.0 109.602 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.92 -74.15 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.543 -0.753 . . . . 15.0 112.513 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.0 mp -67.6 -53.6 26.73 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.351 1.06 . . . . 15.0 109.318 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.62 118.65 11.0 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.3 1.0 . . . . 15.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.588 HH11 HG11 ' A' ' 111' ' ' VAL . 58.5 mtt85 -131.28 120.96 23.93 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 15.0 110.468 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.7 ttm180 -92.91 101.23 13.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.741 0.816 . . . . 15.0 109.538 171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.58 89.8 2.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' A' ' 4' ' ' SER . 29.7 m -76.26 90.59 3.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.947 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.94 134.58 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.723 0.809 . . . . 15.0 109.702 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.7 m -116.15 111.69 20.6 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.412 -0.958 . . . . 15.0 108.412 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 70' ' ' LEU . 29.1 mt -76.71 125.49 36.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 123.704 0.802 . . . . 15.0 108.905 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.42 135.56 57.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.624 0.769 . . . . 15.0 110.741 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.35 -35.86 74.65 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.375 1.07 . . . . 15.0 112.035 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.92 -38.18 88.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.135 -0.939 . . . . 15.0 110.994 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -77.29 -27.51 53.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.506 0.722 . . . . 15.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 28' ' ' VAL . 81.4 mt -64.14 -51.65 66.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.094 0 N-CA-C 107.656 -1.238 . . . . 15.0 107.656 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.83 -44.43 82.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.065 0.946 . . . . 15.0 111.971 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 49.7 m -65.86 -49.55 67.73 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.118 0.886 . . . . 15.0 110.604 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.4 -35.38 70.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.289 0.636 . . . . 15.0 112.274 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.527 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 69.9 t -64.48 -49.81 78.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -59.18 -37.43 77.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.617 0.767 . . . . 15.0 111.42 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.3 m -69.31 -30.06 68.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.646 -0.706 . . . . 15.0 110.771 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' HG23 ' A' ' 35' ' ' VAL . 15.0 tp10 -81.69 -27.83 33.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.088 0.555 . . . . 15.0 110.929 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 93.7 mt -70.23 -36.63 74.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.577 0.751 . . . . 15.0 111.606 -177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HE3' ' A' ' 37' ' ' LYS . 7.2 p -71.23 -27.47 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 O-C-N 123.912 0.758 . . . . 15.0 110.094 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 31' ' ' GLU . 66.7 m-20 -66.63 -44.8 81.04 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.038 0.535 . . . . 15.0 109.742 173.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 31' ' ' GLU . 47.0 t -65.31 -40.62 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.313 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.88 -42.57 97.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.614 0.766 . . . . 15.0 110.91 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.598 ' HE3' HG22 ' A' ' 33' ' ' VAL . 97.2 mttt -69.3 -43.53 73.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.885 0.474 . . . . 15.0 110.734 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.6 -47.39 85.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.846 0.858 . . . . 15.0 111.746 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.6 -5.3 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.521 0 C-N-CA 123.474 0.71 . . . . 15.0 110.388 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 37' ' ' LYS . 23.9 mmt180 75.47 10.15 3.55 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.911 1.684 . . . . 15.0 113.001 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.79 -22.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 124.707 1.203 . . . . 15.0 111.342 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -56.76 -40.61 76.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.108 0.963 . . . . 15.0 111.331 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.14 -32.91 55.48 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 115.83 -0.623 . . . . 15.0 112.246 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -75.4 -20.77 58.73 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.346 0.658 . . . . 15.0 111.157 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.2 ttp85 -78.11 102.44 7.5 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.423 -1.325 . . . . 15.0 107.423 171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.48 14.12 5.94 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.109 0.781 . . . . 15.0 113.109 -167.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.81 -8.68 78.92 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.89 -0.394 . . . . 15.0 113.752 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.25 -39.74 86.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.534 0.734 . . . . 15.0 110.252 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.23 102.56 44.22 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.569 -0.9 . . . . 15.0 108.569 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' A' ' 53' ' ' ILE . 25.4 Cg_endo -62.55 166.07 14.24 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.854 2.37 . . . . 15.0 113.136 176.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.512 ' HA ' HG22 ' A' ' 54' ' ' VAL . 49.5 tpp -65.2 -25.98 67.94 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.474 1.109 . . . . 15.0 112.547 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -70.14 -35.18 73.88 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.568 0.347 . . . . 15.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.438 HD12 ' HD2' ' A' ' 50' ' ' PRO . 45.7 mt -73.55 -44.31 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 122.905 0.482 . . . . 15.0 110.046 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 51' ' ' MET . 17.5 m -70.22 -18.45 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 122.445 -0.159 . . . . 15.0 111.393 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.49 -44.71 77.84 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.934 0.494 . . . . 15.0 111.528 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -90.18 1.31 56.57 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.678 0.791 . . . . 15.0 112.134 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -116.0 -70.67 0.78 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.161 0.584 . . . . 15.0 110.108 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -73.73 -34.71 64.91 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.429 0.692 . . . . 15.0 110.255 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.81 -12.26 80.16 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.357 -0.838 . . . . 15.0 113.609 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.9 67.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.953 0.901 . . . . 15.0 111.988 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.1 m -80.11 -26.52 39.45 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.684 0.794 . . . . 15.0 112.167 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -109.28 5.15 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 122.951 0.5 . . . . 15.0 111.563 -172.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 18.6 mmt180 -54.34 -45.49 72.71 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.274 0.63 . . . . 15.0 111.465 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -53.98 -44.94 71.24 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.311 1.444 . . . . 15.0 111.615 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.76 -35.47 38.65 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.954 -1.021 . . . . 15.0 112.505 -169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 48.7 t -66.48 -27.44 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 122.562 0.345 . . . . 15.0 110.101 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 63' ' ' ARG . 87.2 mt -54.0 -33.44 57.12 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.226 0.61 . . . . 15.0 111.29 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.72 99.29 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.455 0.472 . . . . 15.0 113.023 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -68.38 -38.24 81.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.654 0.782 . . . . 15.0 110.552 174.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 19' ' ' ILE . 76.7 mt -67.7 -42.01 82.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.379 0.671 . . . . 15.0 111.086 -176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.8 mtm -64.56 -37.28 87.02 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.124 0.57 . . . . 15.0 110.464 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.1 t -62.22 -55.75 25.47 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.639 0.775 . . . . 15.0 110.206 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -91.24 32.09 1.07 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.462 0.705 . . . . 15.0 111.71 -177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -125.66 -40.08 2.1 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.603 -0.888 . . . . 15.0 108.603 163.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -64.15 -51.61 63.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.459 0.704 . . . . 15.0 111.116 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.6 tt -64.96 -32.65 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 O-C-N 124.089 0.868 . . . . 15.0 110.848 -175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.26 -51.71 54.8 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.491 0.716 . . . . 15.0 109.833 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.36 -52.23 66.48 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.608 1.192 . . . . 15.0 111.942 -174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.6 pt -63.76 -31.57 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 112.686 0.625 . . . . 15.0 112.686 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -76.4 -47.39 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.65 0.38 . . . . 15.0 111.024 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -72.63 -31.32 65.05 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 111.751 0.278 . . . . 15.0 111.751 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -89.03 -6.87 56.85 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.055 0.542 . . . . 15.0 111.625 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm 63.41 65.45 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.694 1.197 . . . . 15.0 111.494 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -116.05 132.85 64.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 CA-C-N 113.624 -1.625 . . . . 15.0 107.602 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -107.87 87.57 3.81 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.39 163.5 38.87 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.921 2.414 . . . . 15.0 113.285 -171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.7 155.9 30.75 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.021 0.928 . . . . 15.0 109.811 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.572 ' HA2' ' HG ' ' A' ' 306' ' ' LEU . . . 84.33 -104.83 2.75 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.662 -0.699 . . . . 15.0 112.997 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.85 125.51 3.72 Favored Pre-proline 0 C--O 1.244 0.766 0 C-N-CA 123.61 0.764 . . . . 15.0 109.406 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 73.4 Cg_endo -76.37 107.23 2.41 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 121.762 1.641 . . . . 15.0 110.678 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.4 m -83.56 90.52 7.26 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.116 0.566 . . . . 15.0 109.855 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -72.0 106.97 4.48 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.169 0.588 . . . . 15.0 109.521 176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.68 92.25 4.07 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 107.979 -1.119 . . . . 15.0 107.979 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.56 122.14 10.15 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.726 2.284 . . . . 15.0 111.638 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.64 50.57 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.946 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 96' ' ' GLU . 6.9 pt-20 -62.14 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.461 1.104 . . . . 15.0 111.762 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.0 111.86 7.6 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 123.052 0.541 . . . . 15.0 110.514 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 101' ' ' GLU . 40.0 pttt -99.06 116.68 31.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.028 0.931 . . . . 15.0 108.499 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.83 122.86 18.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.21 1.004 . . . . 15.0 110.697 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.27 -18.31 30.7 Favored Glycine 0 N--CA 1.472 1.07 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.951 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' HB2' ' HG3' ' A' ' 98' ' ' LYS . 34.7 mt-10 -123.23 -169.26 1.9 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.165 0.986 . . . . 15.0 109.827 173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.56 169.02 18.62 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.656 1.182 . . . . 15.0 112.805 -166.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -119.21 100.99 7.67 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.431 0.692 . . . . 15.0 110.314 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.8 m -84.46 144.17 28.92 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.953 0.901 . . . . 15.0 109.458 170.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -162.2 142.04 9.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.745 0.818 . . . . 15.0 109.801 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 51.8 m -105.06 108.44 19.96 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.473 1.109 . . . . 15.0 110.705 -174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.67 104.21 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 109.463 -0.569 . . . . 15.0 109.463 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.41 101.16 12.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.665 0.786 . . . . 15.0 110.107 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.556 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 26.4 p90 -129.8 153.52 48.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.879 0.871 . . . . 15.0 108.761 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -94.04 176.34 6.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.197 0.599 . . . . 15.0 109.605 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG11 HH11 ' A' ' 13' ' ' ARG . 29.6 m -133.38 158.73 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.707 0.803 . . . . 15.0 110.293 -177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 74.5 m-85 -70.89 114.49 27.41 Favored Pre-proline 0 C--O 1.247 0.957 0 N-CA-C 108.244 -1.021 . . . . 15.0 108.244 167.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 112' ' ' TYR . 3.8 Cg_exo -77.84 158.85 31.33 Favored 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 121.971 1.781 . . . . 15.0 111.248 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -68.32 101.55 1.23 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 168.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.628 ' HA ' HD13 ' A' ' 300' ' ' ILE . 53.5 t -72.82 122.45 25.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.454 -0.794 . . . . 15.0 110.049 -172.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -82.79 99.99 10.03 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.655 0.782 . . . . 15.0 109.957 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 120' ' ' LEU . 76.2 mt -88.07 134.68 33.69 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.537 -0.542 . . . . 15.0 109.537 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.42 161.11 24.15 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.466 1.107 . . . . 15.0 109.277 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 123' ' ' ILE . . . 67.12 14.22 63.38 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.431 -0.649 . . . . 15.0 113.796 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 117' ' ' LEU . 78.3 mt -67.2 -24.86 65.89 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 117.541 0.671 . . . . 15.0 111.586 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.37 -25.18 29.32 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.297 0.639 . . . . 15.0 110.197 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.7 -26.54 54.83 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.381 0.673 . . . . 15.0 110.606 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' GLY . 77.8 mt -59.77 117.82 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.244 1.018 . . . . 15.0 109.426 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 416' ' ' LYS . 82.3 mt-10 -107.36 106.32 16.69 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.678 -0.86 . . . . 15.0 108.678 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.64 138.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.688 0.795 . . . . 15.0 108.946 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.601 ' HB3' HE22 ' A' ' 289' ' ' GLN . 44.5 tt0 -103.7 114.79 29.31 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.178 0.513 . . . . 15.0 110.556 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -99.52 113.16 64.74 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.679 1.191 . . . . 15.0 109.205 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 282' ' ' ILE . 10.5 Cg_endo -90.72 109.83 0.35 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.739 2.293 . . . . 15.0 112.072 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 45.0 mm -67.17 97.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.762 -0.829 . . . . 15.0 108.762 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.508 ' HB ' HD11 ' A' ' 282' ' ' ILE . 21.7 t -118.97 142.59 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.262 -0.881 . . . . 15.0 109.273 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -133.73 161.37 34.89 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 107.662 -1.236 . . . . 15.0 107.662 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.49 HG23 ' HG2' ' A' ' 275' ' ' GLU . 38.9 t -81.76 82.13 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 107.341 -1.355 . . . . 15.0 107.341 171.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.1 p -62.95 162.55 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.086 -0.507 . . . . 15.0 109.697 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.96 -23.96 67.54 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.438 0.563 . . . . 15.0 111.51 177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.43 94.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.582 0.753 . . . . 15.0 110.009 169.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.411 ' HA ' ' ND2' ' A' ' 425' ' ' ASN . 68.5 m-20 -70.06 -33.38 71.86 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 116.053 -0.521 . . . . 15.0 111.652 176.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.6 t -68.31 -53.07 31.24 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 109.338 -0.615 . . . . 15.0 109.338 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -63.53 -36.27 83.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.893 0.477 . . . . 15.0 111.644 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.5 -42.78 99.67 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.446 0.466 . . . . 15.0 111.962 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 5.8 tpt -67.65 -41.64 83.5 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.697 0.799 . . . . 15.0 110.529 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 88.5 mt -62.96 -43.94 97.41 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.729 0.643 . . . . 15.0 109.599 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.51 -50.55 67.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.176 0.99 . . . . 15.0 110.501 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 33.3 m -59.05 -49.18 78.87 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.179 0.924 . . . . 15.0 111.095 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.58 -41.14 85.04 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.839 0.855 . . . . 15.0 110.585 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -68.12 -35.5 78.23 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.479 -0.782 . . . . 15.0 111.276 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.418 ' HG2' HD21 ' A' ' 245' ' ' LEU . 93.2 mttt -76.07 -27.79 57.37 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.611 0.364 . . . . 15.0 111.798 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -74.87 -39.47 61.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.322 0.649 . . . . 15.0 110.175 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -104.04 35.22 2.74 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.86 0.864 . . . . 15.0 110.173 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 140.86 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.136 0.574 . . . . 15.0 111.401 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.8 m -78.6 126.02 30.16 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.735 0.814 . . . . 15.0 109.548 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -77.08 141.09 40.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.472 -0.566 . . . . 15.0 109.472 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -150.43 118.08 6.16 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.713 0.633 . . . . 15.0 109.976 -170.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.28 103.69 0.2 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.97 0.908 . . . . 15.0 109.819 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.754 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 51.6 pttt -110.08 -178.85 3.63 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.84 0.856 . . . . 15.0 111.256 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -159.97 146.92 16.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.842 1.257 . . . . 15.0 108.404 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 124.09 -49.59 0.89 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-O 119.012 -0.882 . . . . 15.0 115.151 174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.87 121.82 5.5 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.745 1.273 . . . . 15.0 112.058 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 202' ' ' ILE . 60.0 t -75.26 139.18 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 109.353 -0.61 . . . . 15.0 109.353 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.54 -169.15 1.55 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.652 1.181 . . . . 15.0 109.561 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -88.0 -26.24 22.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.384 0.673 . . . . 15.0 112.691 -171.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 11.47 11.39 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.171 0.589 . . . . 15.0 112.106 -169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -69.41 177.71 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.638 0.977 . . . . 15.0 113.638 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -114.01 99.3 7.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.022 1.329 . . . . 15.0 108.427 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 202' ' ' ILE . 57.4 t -106.45 128.14 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.947 0.499 . . . . 15.0 111.989 -172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.628 HG22 ' HD3' ' A' ' 238' ' ' LYS . 19.8 m -89.98 130.0 36.24 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.111 1.364 . . . . 15.0 110.259 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.539 HD13 HG23 ' A' ' 235' ' ' ILE . 7.7 mt -135.49 163.43 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.203 0 C-N-CA 124.623 1.169 . . . . 15.0 109.45 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 166' ' ' ILE . 49.7 m-20 -116.6 109.01 16.67 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 105.067 -2.197 . . . . 15.0 105.067 151.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 182' ' ' ALA . 39.0 p90 -99.73 123.55 44.1 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.913 -0.773 . . . . 15.0 108.913 -176.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 181' ' ' LYS . 21.3 p -134.32 91.24 2.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.536 0.734 . . . . 15.0 111.299 -172.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 233' ' ' PHE . . . -148.27 -130.35 1.95 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.828 -0.509 . . . . 15.0 111.828 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.3 m -153.81 177.97 10.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.139 0.975 . . . . 15.0 110.127 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.91 127.47 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.595 -1.261 . . . . 15.0 107.595 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 229' ' ' LYS . 2.2 p30 55.62 13.94 1.12 Allowed 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.941 1.696 . . . . 15.0 114.01 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.17 -28.22 16.08 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 122.836 0.255 . . . . 15.0 112.618 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -83.38 127.11 33.41 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 122.768 0.427 . . . . 15.0 110.263 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -73.83 98.63 3.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.43 0.692 . . . . 15.0 109.495 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -132.43 -173.58 3.21 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.028 -0.987 . . . . 15.0 108.66 -175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 151.22 39.45 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.637 -0.875 . . . . 15.0 108.637 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 86.88 -0.13 86.15 Favored Glycine 0 N--CA 1.465 0.577 0 CA-C-O 120.026 -0.319 . . . . 15.0 113.37 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.44 -6.87 83.21 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-O 119.624 -0.542 . . . . 15.0 113.607 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.406 ' HG3' HG22 ' A' ' 169' ' ' THR . 85.7 tttt -150.57 134.22 16.56 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 117.74 0.77 . . . . 15.0 110.212 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.434 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . . . -159.75 127.79 4.85 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.41 0.684 . . . . 15.0 109.713 169.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 41.6 p -98.85 145.64 26.78 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 123.989 0.916 . . . . 15.0 110.156 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 54.24 44.1 29.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.296 1.438 . . . . 15.0 111.771 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -74.46 98.58 3.34 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.731 -1.122 . . . . 15.0 108.147 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' B' ' 242' ' ' TRP . 3.2 t -112.43 98.51 7.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 120.945 0.402 . . . . 15.0 110.456 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 39.4 tp -94.78 120.67 35.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.45 1.1 . . . . 15.0 110.599 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.62 ' HB3' HH21 ' A' ' 193' ' ' ARG . . . -79.02 89.14 4.77 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.467 -1.309 . . . . 15.0 107.467 162.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.7 ptp -63.4 167.01 5.79 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.474 1.11 . . . . 15.0 111.947 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 90.79 -35.83 3.77 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.223 -0.751 . . . . 15.0 111.223 -167.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -85.24 140.79 30.59 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 124.351 1.06 . . . . 15.0 109.881 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.91 70.42 3.06 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.523 0.515 . . . . 15.0 112.504 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.62 HH21 ' HB3' ' A' ' 188' ' ' ALA . 83.7 mtm180 -119.34 15.37 13.02 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.072 0.949 . . . . 15.0 109.967 174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . . . . . . . . . 34.3 tpp -166.51 163.28 17.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.512 1.525 . . . . 15.0 108.518 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 198' ' ' PHE . 43.4 mt -47.75 123.24 9.46 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.18 1.392 . . . . 15.0 111.309 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.48 111.05 1.03 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 121.897 1.732 . . . . 15.0 109.617 166.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 123.56 -34.4 3.64 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-O 119.682 -0.51 . . . . 15.0 112.616 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.2 t80 -59.76 -44.62 93.77 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 117.611 0.706 . . . . 15.0 109.617 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -62.37 -35.75 80.12 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.912 -1.04 . . . . 15.0 111.423 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 5.0 m-20 -67.25 -30.83 70.84 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.344 0.658 . . . . 15.0 111.96 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -58.67 -33.09 71.01 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 123.769 0.668 . . . . 15.0 112.198 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.511 HG22 HG11 ' A' ' 158' ' ' VAL . 50.9 mt -80.98 -41.77 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.395 1.078 . . . . 15.0 110.223 176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 47.9 mtpt -63.32 -22.77 67.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.15 0.98 . . . . 15.0 112.319 -172.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -89.73 37.39 3.35 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.027 -0.318 . . . . 15.0 112.662 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -150.19 -172.88 4.28 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.711 1.205 . . . . 15.0 109.949 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -113.38 -67.03 1.03 Allowed 'General case' 0 C--N 1.361 1.093 0 N-CA-C 114.403 1.26 . . . . 15.0 114.403 -165.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -149.36 -53.14 0.16 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.121 0.785 . . . . 15.0 113.121 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -150.31 46.94 0.62 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 115.191 0.836 . . . . 15.0 115.191 -162.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -92.62 -169.78 2.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.239 0.616 . . . . 15.0 110.95 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -134.47 128.84 34.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.414 0.686 . . . . 15.0 109.637 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.36 -177.49 6.58 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.264 1.025 . . . . 15.0 110.393 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 55.3 m -145.18 121.79 11.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.41 0.684 . . . . 15.0 109.272 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 25.5 pt -116.92 139.75 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.924 0.489 . . . . 15.0 111.413 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -86.86 95.82 10.0 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.234 1.014 . . . . 15.0 108.999 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 198' ' ' PHE . 13.6 m -89.57 114.42 27.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.769 0.795 . . . . 15.0 110.665 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 18.5 m -86.17 97.25 10.24 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 114.609 -1.178 . . . . 15.0 108.324 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.488 ' HE1' ' HB2' ' A' ' 231' ' ' ALA . 91.8 m-85 -48.29 141.16 9.09 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.854 0.862 . . . . 15.0 111.971 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 217' ' ' PHE . 6.2 Cg_exo -78.57 158.63 28.73 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.841 2.361 . . . . 15.0 112.972 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -72.88 -13.8 61.35 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.584 -0.734 . . . . 15.0 110.437 168.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -68.92 -34.68 75.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.486 1.115 . . . . 15.0 109.537 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -65.81 126.79 29.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.202 -1.363 . . . . 15.0 109.383 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -82.67 8.31 12.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.69 0.796 . . . . 15.0 112.087 -170.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -86.4 118.4 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 122.93 0.492 . . . . 15.0 110.054 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 227' ' ' LYS . 33.6 tt0 -60.64 -37.99 83.34 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.561 0.538 . . . . 15.0 109.551 169.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' B' ' 231' ' ' LYS . 6.8 p30 -68.94 -15.94 63.62 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.904 0.882 . . . . 15.0 112.658 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.505 HD21 ' CE1' ' B' ' 233' ' ' PHE . 79.0 mt -117.12 -30.52 5.63 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 118.072 -0.966 . . . . 15.0 113.575 -175.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -55.06 109.82 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.9 0.773 . . . . 15.0 111.606 -175.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 82.98 20.43 61.08 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.751 -0.659 . . . . 15.0 114.644 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 173' ' ' ASP . 70.6 mmtt -87.98 153.46 21.27 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.083 0.553 . . . . 15.0 110.08 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -119.78 94.84 4.54 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.105 -0.702 . . . . 15.0 109.105 176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB2' ' HE1' ' A' ' 217' ' ' PHE . . . -90.32 139.42 30.68 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.728 -0.669 . . . . 15.0 110.885 -177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -116.19 108.87 16.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.946 -1.131 . . . . 15.0 107.946 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 170' ' ' GLY . 36.5 m-85 -111.31 132.85 54.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.377 0.671 . . . . 15.0 109.708 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -74.42 95.04 2.65 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.795 -1.187 . . . . 15.0 107.795 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 166' ' ' ILE . 46.7 mm -70.31 100.67 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.683 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.34 76.99 7.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 105.758 -1.941 . . . . 15.0 105.758 175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 202' ' ' ILE . 14.6 tp -61.66 115.51 4.01 Favored 'General case' 0 C--N 1.348 0.537 0 CA-C-N 114.174 -1.376 . . . . 15.0 108.079 -172.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.628 ' HD3' HG22 ' A' ' 165' ' ' THR . 55.5 mtpt -94.17 -73.32 0.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.753 0.311 . . . . 15.0 110.96 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.66 169.74 17.02 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.537 0.735 . . . . 15.0 110.009 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 158' ' ' VAL . 18.4 t -131.69 137.48 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 107.702 -1.221 . . . . 15.0 107.702 170.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -105.78 113.9 27.73 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.465 -0.939 . . . . 15.0 108.465 166.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.754 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 35.0 tt0 -66.7 138.23 57.26 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.077 -0.965 . . . . 15.0 109.483 171.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -81.7 75.93 8.63 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 107.665 -1.235 . . . . 15.0 107.665 165.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.82 116.72 5.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.638 -1.165 . . . . 15.0 109.214 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 146' ' ' LYS . 55.6 mt -61.01 135.18 93.12 Favored Pre-proline 0 CA--C 1.541 0.612 0 O-C-N 123.899 0.749 . . . . 15.0 110.277 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.7 -169.0 0.34 Allowed 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.101 2.534 . . . . 15.0 113.361 -168.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.81 168.38 13.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.107 -0.951 . . . . 15.0 111.663 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 28.1 tp -123.69 8.44 8.85 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.023 -0.99 . . . . 15.0 108.583 170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 27.6 m -53.47 147.66 10.46 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.988 1.315 . . . . 15.0 111.278 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -46.42 -49.07 18.59 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.483 1.113 . . . . 15.0 111.647 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.44 -21.66 65.54 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.312 1.008 . . . . 15.0 112.542 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -80.79 -59.15 2.78 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.53 -0.544 . . . . 15.0 109.53 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.86 -29.54 47.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.938 -173.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . 0.546 ' HA ' ' HB ' ' A' ' 258' ' ' VAL . 19.2 ptmt -79.67 -8.6 59.32 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.986 0.365 . . . . 15.0 111.986 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -69.44 -9.37 53.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.045 0.538 . . . . 15.0 111.289 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -89.37 12.48 16.14 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.15 0.98 . . . . 15.0 110.931 172.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 86.97 22.72 44.37 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.699 -0.501 . . . . 15.0 113.102 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 254' ' ' LYS . 34.2 t -83.77 148.92 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.681 0.792 . . . . 15.0 109.733 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -55.8 -48.34 75.54 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.424 1.09 . . . . 15.0 111.997 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -145.72 -165.89 2.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.245 0.618 . . . . 15.0 109.803 -173.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -97.65 26.62 22.41 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 114.835 0.694 . . . . 15.0 114.835 -175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 69.3 p -77.49 118.48 19.96 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.452 0.626 . . . . 15.0 110.698 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 88.1 t -56.57 -43.7 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 123.814 0.846 . . . . 15.0 110.244 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -56.05 -28.8 59.01 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.538 1.149 . . . . 15.0 111.657 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -71.68 -36.27 62.09 Favored Glycine 0 C--N 1.361 1.934 0 N-CA-C 111.471 -0.652 . . . . 15.0 111.471 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 270' ' ' VAL . 61.4 tp -74.39 -35.54 63.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.347 -0.612 . . . . 15.0 109.347 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.5 mtp85 -74.54 -31.63 62.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.656 0.782 . . . . 15.0 110.42 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.87 65.18 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.207 0.603 . . . . 15.0 110.039 173.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -69.25 -42.17 75.96 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.677 0.611 . . . . 15.0 110.086 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 266' ' ' LEU . 55.1 t -60.0 -44.1 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.79 0.836 . . . . 15.0 109.571 172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -53.41 -65.75 0.51 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.904 0.882 . . . . 15.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -64.0 -41.71 97.4 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 -173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -78.43 -52.22 8.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.24 0.216 . . . . 15.0 111.305 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.481 ' SD ' HD13 ' B' ' 278' ' ' LEU . 21.6 ttt -73.24 -27.43 61.59 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 119.012 -0.518 . . . . 15.0 110.91 -170.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 132' ' ' VAL . 61.8 mt-10 -78.74 -29.39 45.23 Favored 'General case' 0 C--N 1.367 1.356 0 CA-C-N 118.55 0.614 . . . . 15.0 111.846 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -66.58 -40.48 88.95 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.378 0.608 . . . . 15.0 109.414 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.32 -41.46 89.61 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.074 -1.421 . . . . 15.0 110.148 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.551 ' HB2' ' HE2' ' A' ' 424' ' ' PHE . 47.8 tp -60.27 -41.49 93.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.372 1.069 . . . . 15.0 112.282 178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -56.98 -45.09 83.18 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.562 0.539 . . . . 15.0 109.684 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 38.1 t -64.99 -41.25 95.57 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 124.111 0.882 . . . . 15.0 110.811 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -59.67 -51.69 68.72 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.23 0.612 . . . . 15.0 111.75 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.508 HD11 ' HB ' ' A' ' 130' ' ' VAL . 70.3 mt -66.78 -35.98 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.927 0.891 . . . . 15.0 110.441 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 405' ' ' GLU . 19.5 tpt180 -65.09 -44.02 90.23 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.89 0.476 . . . . 15.0 110.057 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 287' ' ' LYS . 90.7 m-20 -80.17 -23.18 41.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.053 0.941 . . . . 15.0 111.023 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -63.78 -60.17 3.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.99 0.916 . . . . 15.0 109.601 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 82.5 t -59.46 -39.81 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.218 1.007 . . . . 15.0 110.748 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 284' ' ' ASN . 84.9 tttt -55.54 -59.15 5.23 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.735 0.814 . . . . 15.0 110.655 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.7 p -62.59 -36.75 83.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.179 0.592 . . . . 15.0 112.12 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.601 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.8 mt-30 -74.62 -34.67 62.84 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.692 0.397 . . . . 15.0 111.938 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.13 -42.57 84.21 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.61 0.364 . . . . 15.0 110.372 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.473 HD12 HG13 ' A' ' 347' ' ' VAL . 24.0 mm -63.91 -41.66 93.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 124.417 1.087 . . . . 15.0 110.39 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -57.42 -56.05 26.92 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.891 0.876 . . . . 15.0 110.057 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 123' ' ' ILE . . . -62.84 -33.63 87.55 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 124.522 1.139 . . . . 15.0 112.882 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.09 -66.34 0.5 Allowed 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.835 0.854 . . . . 15.0 109.863 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.25 -43.76 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 O-C-N 123.64 0.587 . . . . 15.0 110.077 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -57.81 -41.92 83.2 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.189 0.996 . . . . 15.0 112.295 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -96.01 -4.38 43.27 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.651 0.611 . . . . 15.0 112.651 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -134.74 112.28 10.63 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.059 0.39 . . . . 15.0 110.634 -170.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -95.41 138.73 32.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.341 0.656 . . . . 15.0 109.743 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 115' ' ' VAL . 5.9 tp -144.89 139.4 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.836 0.855 . . . . 15.0 109.162 175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.38 114.66 13.01 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.32 -0.993 . . . . 15.0 108.32 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.32 125.01 47.05 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.01 0.924 . . . . 15.0 110.866 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 116.94 3.65 Favored 'Trans proline' 0 C--N 1.386 2.504 0 C-N-CA 123.011 2.474 . . . . 15.0 112.238 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.8 72.1 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.48 1.512 . . . . 15.0 112.533 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.22 68.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.984 0.914 . . . . 15.0 112.183 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.572 ' HG ' ' HA2' ' A' ' 88' ' ' GLY . 27.8 mt -69.15 -34.06 74.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.286 0.635 . . . . 15.0 111.549 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 311' ' ' ILE . 48.2 mt -61.29 -56.21 19.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.4 -44.54 34.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.075 1.35 . . . . 15.0 111.515 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 313' ' ' VAL . 56.4 m -55.33 -61.41 2.35 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 124.278 0.986 . . . . 15.0 110.778 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -52.53 -46.77 66.88 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.28 0.988 . . . . 15.0 111.948 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.665 HD13 ' HG3' ' A' ' 334' ' ' ARG . 90.7 mt -54.04 -59.47 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 15.0 110.074 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.508 ' HA ' ' HE ' ' A' ' 315' ' ' ARG . 25.2 t0 -64.05 -37.06 86.06 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.313 1.008 . . . . 15.0 111.646 -171.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 309' ' ' SER . 94.6 t -60.48 -47.62 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 123.37 0.419 . . . . 15.0 110.293 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.05 -29.57 69.95 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.658 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 64.1 mtm180 -68.86 -44.7 72.81 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.44 0.462 . . . . 15.0 109.933 177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 92.1 mtt180 -63.68 -44.15 94.57 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.478 0.486 . . . . 15.0 110.21 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.53 -41.18 93.89 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.1 0.875 . . . . 15.0 111.245 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.95 15.23 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.555 -0.748 . . . . 15.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.773 ' HB1' ' HB2' ' A' ' 325' ' ' ASN . . . -59.97 -33.84 72.49 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.529 1.131 . . . . 15.0 112.165 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -52.74 -40.22 62.88 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.189 0.93 . . . . 15.0 110.495 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -89.93 -64.61 1.11 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.449 -0.796 . . . . 15.0 109.373 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -69.36 99.72 1.25 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.415 1.086 . . . . 15.0 110.222 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 93.4 -36.67 3.63 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.833 -0.622 . . . . 15.0 113.516 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 85.71 36.22 10.7 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 117.084 0.442 . . . . 15.0 112.233 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.773 ' HB2' ' HB1' ' A' ' 319' ' ' ALA . 82.1 m-20 -79.86 108.56 13.53 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.406 0.682 . . . . 15.0 110.581 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.79 88.18 2.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.874 0.87 . . . . 15.0 111.099 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt 62.22 11.19 4.26 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.612 1.165 . . . . 15.0 113.016 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 26.1 tm0? -72.46 -12.56 61.15 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.772 1.229 . . . . 15.0 108.439 167.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.421 ' HA ' ' HG ' ' A' ' 332' ' ' LEU . . . -49.97 -16.41 0.28 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.298 2.239 . . . . 15.0 115.388 173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.418 HD12 ' NH2' ' A' ' 315' ' ' ARG . 25.5 tp -54.73 -27.52 41.49 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.417 0.687 . . . . 15.0 111.039 173.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.6 -26.79 45.48 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.412 1.085 . . . . 15.0 112.371 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 319' ' ' ALA . 31.8 mt -55.98 138.07 72.44 Favored Pre-proline 0 N--CA 1.491 1.612 0 C-N-CA 123.103 0.561 . . . . 15.0 112.265 -170.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . 0.457 ' HG2' HD12 ' A' ' 336' ' ' LEU . 13.2 Cg_endo -55.83 108.62 0.34 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.709 2.94 . . . . 15.0 113.743 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.665 ' HG3' HD13 ' A' ' 311' ' ' ILE . 23.0 ttt180 -44.69 -54.78 5.86 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.26 1.824 . . . . 15.0 112.98 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -59.59 -23.97 63.38 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 124.294 0.996 . . . . 15.0 113.465 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . 0.457 HD12 ' HG2' ' A' ' 333' ' ' PRO . 29.1 mt -67.63 -33.07 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.099 0.476 . . . . 15.0 110.522 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.444 ' HB2' HG23 ' A' ' 311' ' ' ILE . 81.7 m-85 -98.5 -31.5 11.95 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.923 0.889 . . . . 15.0 110.409 -174.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 341' ' ' ALA . 42.1 tt0 -65.75 -30.06 70.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.131 0.972 . . . . 15.0 111.351 -177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.03 -42.29 62.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 15.0 111.344 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 24.4 pt20 -94.83 -33.94 12.66 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 119.24 -0.41 . . . . 15.0 111.145 173.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 338' ' ' GLU . . . -62.65 -59.74 4.5 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.834 0.854 . . . . 15.0 111.531 -171.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 346' ' ' VAL . 86.3 tttt -55.29 -38.81 69.11 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 115.132 -0.94 . . . . 15.0 110.06 176.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.538 ' O ' HG23 ' A' ' 347' ' ' VAL . 56.6 ttt180 -67.59 -29.93 69.4 Favored 'General case' 0 C--O 1.214 -0.799 0 O-C-N 124.248 0.967 . . . . 15.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 340' ' ' GLN . 75.1 mtt180 -68.76 -39.93 80.02 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.192 -0.67 . . . . 15.0 109.192 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' B' ' 297' ' ' TYR . 40.5 t -62.79 -42.53 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.315 0 CA-C-N 115.087 -0.96 . . . . 15.0 110.191 174.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 342' ' ' LYS . 84.0 t -57.95 -48.5 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.895 0.878 . . . . 15.0 109.999 176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 343' ' ' ARG . 72.5 t -60.81 -42.71 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.989 0.916 . . . . 15.0 110.506 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' B' ' 297' ' ' TYR . . . -68.45 -26.62 74.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 116.016 -0.538 . . . . 15.0 112.875 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 57.3 mt -76.27 -45.04 34.5 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.594 0.758 . . . . 15.0 110.845 175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 346' ' ' VAL . 87.7 mt -70.69 -55.52 8.52 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.618 0.767 . . . . 15.0 110.329 -176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 354' ' ' VAL . 62.1 mt -61.98 -33.74 74.87 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.225 -0.898 . . . . 15.0 110.338 173.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.74 -35.88 92.45 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 123.38 0.425 . . . . 15.0 112.837 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 11.4 tp10 -78.52 -39.12 38.94 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.023 0.529 . . . . 15.0 111.386 -178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 351' ' ' LEU . 9.4 p -69.44 -34.71 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-N 118.212 0.46 . . . . 15.0 110.14 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 407' ' ' ALA . 16.7 mt -62.09 -46.71 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.685 0.794 . . . . 15.0 110.102 171.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.07 -53.55 55.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.936 0.895 . . . . 15.0 109.342 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.6 m -54.48 -47.27 73.2 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.618 1.167 . . . . 15.0 111.497 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -93.26 14.35 18.5 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.566 0.746 . . . . 15.0 112.832 -175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 44.32 32.8 0.75 Allowed 'General case' 0 N--CA 1.51 2.55 0 C-N-CA 125.385 1.474 . . . . 15.0 113.97 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.406 ' HB2' HG23 ' A' ' 355' ' ' ILE . 88.9 mt -68.01 157.56 34.85 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.814 0.816 . . . . 15.0 112.559 -176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 302' ' ' ASP . 0.0 OUTLIER -150.87 164.12 37.05 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.237 -1.347 . . . . 15.0 109.143 177.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -65.45 98.78 0.37 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.413 -0.958 . . . . 15.0 108.413 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -66.06 107.24 1.84 Allowed 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.303 1.002 . . . . 15.0 110.273 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -56.78 -35.51 68.78 Favored 'General case' 0 C--O 1.215 -0.713 0 O-C-N 124.553 1.158 . . . . 15.0 112.041 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.8 -33.72 76.51 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.746 0.653 . . . . 15.0 111.247 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -74.73 -42.01 59.09 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.206 -0.664 . . . . 15.0 109.206 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 24.8 t -63.49 -35.56 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.341 -0.845 . . . . 15.0 110.052 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.47 -51.79 67.22 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.424 0.69 . . . . 15.0 109.891 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.46 -54.82 22.49 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.491 1.12 . . . . 15.0 112.971 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.11 -60.4 3.38 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.133 0.973 . . . . 15.0 111.173 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 62.7 mt -55.88 -54.14 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 124.225 0.953 . . . . 15.0 111.621 -175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.39 -47.19 67.99 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 123.546 0.528 . . . . 15.0 111.95 -170.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.68 -38.17 86.24 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.4 0.438 . . . . 15.0 110.741 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.487 ' SD ' ' CH2' ' B' ' 290' ' ' TRP . 38.2 ttp -67.93 -39.29 83.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.684 0.794 . . . . 15.0 111.156 174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.615 ' HA ' ' HD2' ' A' ' 378' ' ' TYR . . . -70.67 -30.66 67.32 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.367 0.667 . . . . 15.0 111.323 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -61.11 -23.0 65.18 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.02 0.928 . . . . 15.0 111.745 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.83 58.85 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.71 0.804 . . . . 15.0 112.247 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.615 ' HD2' ' HA ' ' A' ' 375' ' ' ALA . 62.0 m-85 -96.47 179.02 5.16 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.312 0.645 . . . . 15.0 110.539 174.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.66 -62.2 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.518 0.727 . . . . 15.0 109.639 -174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 383' ' ' GLU . 17.4 t70 -119.81 112.16 35.38 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 107.76 -1.2 . . . . 15.0 107.76 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.36 -50.48 12.75 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.921 2.414 . . . . 15.0 113.542 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 386' ' ' GLU . 32.5 mmtp -64.89 -36.73 85.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.531 -0.758 . . . . 15.0 112.528 -164.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . 0.41 ' HG2' ' HB3' ' A' ' 380' ' ' ASP . 10.7 pt-20 -73.97 -23.13 59.43 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.231 0.332 . . . . 15.0 111.447 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 388' ' ' TYR . 93.1 t -74.72 -35.44 37.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 108.264 -1.013 . . . . 15.0 108.264 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 66.0 mt -65.45 -39.63 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.954 0.901 . . . . 15.0 110.214 174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 382' ' ' LYS . 52.2 mt-10 -62.39 -57.04 12.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.061 0.545 . . . . 15.0 109.995 174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -50.84 -38.5 49.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.31 1.444 . . . . 15.0 111.195 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.458 ' OH ' ' HB2' ' A' ' 398' ' ' MET . 7.0 t80 -66.9 -55.05 16.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 395' ' ' MET . 52.0 p -66.63 -25.65 66.69 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.257 0.623 . . . . 15.0 112.091 -176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.23 -26.28 60.15 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.162 0.585 . . . . 15.0 110.421 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -98.64 76.73 2.24 Favored 'General case' 0 C--N 1.35 0.624 0 N-CA-C 107.242 -1.392 . . . . 15.0 107.242 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -58.03 -24.52 58.69 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.081 0.952 . . . . 15.0 112.47 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.72 -42.96 99.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.679 0.792 . . . . 15.0 110.932 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 23.1 tp -89.71 -31.16 17.59 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.098 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.401 ' HG3' ' HA ' ' A' ' 389' ' ' SER . 0.0 OUTLIER -61.84 -40.66 96.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.843 -0.799 . . . . 15.0 108.843 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.67 -51.11 71.32 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 114.457 -1.247 . . . . 15.0 109.848 171.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 401' ' ' VAL . 53.8 t30 -51.26 -43.26 61.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.534 1.146 . . . . 15.0 111.468 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.458 ' HB2' ' OH ' ' A' ' 388' ' ' TYR . 61.1 tpp -64.74 -38.56 91.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 123.375 0.422 . . . . 15.0 111.839 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -69.34 -31.37 69.77 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.198 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -71.16 -31.24 67.43 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.726 0.81 . . . . 15.0 110.542 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' B' ' 291' ' ' LEU . 46.2 t -58.21 -59.83 3.03 Favored 'Isoleucine or valine' 0 C--N 1.36 1.025 0 N-CA-C 108.515 -0.92 . . . . 15.0 108.515 172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -53.34 -44.21 68.31 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 124.387 1.055 . . . . 15.0 112.177 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.443 HD21 HD11 ' B' ' 301' ' ' ILE . 31.3 tp -66.97 -51.88 49.67 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.393 -1.276 . . . . 15.0 111.568 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -27.89 67.1 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 119.141 -0.456 . . . . 15.0 111.675 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 401' ' ' VAL . 44.8 mt-10 -61.73 -55.96 24.73 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 109.091 -0.707 . . . . 15.0 109.091 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -64.08 -35.97 82.49 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.502 0.501 . . . . 15.0 111.929 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' A' ' 355' ' ' ILE . . . -64.37 -51.15 64.72 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 15.0 111.213 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.76 -42.57 95.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.528 0.731 . . . . 15.0 110.3 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -61.79 -32.14 72.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.529 0.731 . . . . 15.0 111.986 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.78 -26.37 68.61 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.479 0.487 . . . . 15.0 111.329 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 59.9 t -88.25 -35.68 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 123.207 0.603 . . . . 15.0 109.946 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.04 -41.14 99.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.535 0.734 . . . . 15.0 111.093 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -59.97 -22.01 61.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.968 0.907 . . . . 15.0 111.954 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.47 -27.61 13.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.19 0.996 . . . . 15.0 111.038 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -87.83 155.55 19.83 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.162 0.985 . . . . 15.0 111.964 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 124' ' ' GLU . 64.7 mttt -75.66 83.83 2.67 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.039 -0.726 . . . . 15.0 109.039 175.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.8 86.8 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.675 -0.861 . . . . 15.0 108.675 176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.5 t -70.42 140.94 52.15 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.881 -0.785 . . . . 15.0 108.881 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -125.75 111.55 15.03 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.554 . . . . 15.0 109.503 -169.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -123.6 152.25 42.11 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.921 -0.77 . . . . 15.0 108.921 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -96.62 150.8 20.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.579 0.352 . . . . 15.0 110.192 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.466 HG23 HG22 ' A' ' 130' ' ' VAL . 9.0 t -166.55 161.77 16.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.519 0.728 . . . . 15.0 110.804 175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 44.6 p -84.13 162.1 20.39 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.813 0.845 . . . . 15.0 111.162 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.551 ' HE2' ' HB2' ' A' ' 278' ' ' LEU . 2.3 t80 -66.43 -43.41 85.72 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.496 0.718 . . . . 15.0 109.912 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 136' ' ' ASP . 42.9 m-80 -58.01 -42.1 84.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.186 0.304 . . . . 15.0 110.504 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.07 -35.11 79.66 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.573 0.546 . . . . 15.0 110.783 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 23.0 tp -70.06 -24.27 63.22 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.69 0.796 . . . . 15.0 110.799 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 97.7 mmm -84.67 -31.69 24.02 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.957 0.503 . . . . 15.0 110.191 173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -76.18 25.33 0.13 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.595 0.758 . . . . 15.0 112.143 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -86.89 71.34 10.31 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-O 121.967 0.889 . . . . 15.0 109.932 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -94.85 -18.0 21.58 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.772 -1.104 . . . . 15.0 110.0 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 124.172 0.989 . . . . 15.0 109.33 177.081 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.31 99.42 0.93 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.511 0.724 . . . . 0.0 109.471 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.66 81.72 2.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.516 0.727 . . . . 0.0 110.384 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.09 -173.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.758 1.223 . . . . 0.0 112.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -88.64 136.33 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 35.6 p -79.08 76.48 5.59 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.085 0.945 . . . . 0.0 108.805 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 8.0 tt -167.57 -45.41 0.02 OUTLIER 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 -173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 72.2 -82.49 0.55 Allowed Glycine 0 C--N 1.355 1.592 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.672 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -165.5 -133.64 1.54 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.31 3.49 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -156.33 164.08 38.73 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 109.946 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 225' ' ' ASN . 0.0 OUTLIER -128.05 138.73 52.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 23.5 m -62.79 143.01 57.95 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.58 0.752 . . . . 0.0 110.675 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.505 ' CE1' HD21 ' A' ' 226' ' ' LEU . 34.1 t80 -60.13 151.79 26.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.908 0.883 . . . . 0.0 110.84 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . . . -88.3 37.19 0.81 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.966 0.507 . . . . 0.0 111.996 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 64.86 124.37 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.138 1.375 . . . . 0.0 111.506 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 32.4 m -55.01 119.85 6.05 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 123.002 0.521 . . . . 0.0 109.786 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.72 53.2 1.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.687 0.756 . . . . 0.0 110.027 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 3.9 t -75.05 90.29 2.47 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.839 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -61.08 134.65 57.28 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.538 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.04 73.77 0.4 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -128.92 97.82 4.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.902 0.881 . . . . 0.0 109.116 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . 0.652 ' HB3' HG11 ' A' ' 186' ' ' VAL . 0.4 OUTLIER -160.45 159.35 30.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.706 0.402 . . . . 0.0 110.894 175.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.543 ' HA ' ' OH ' ' B' ' 256' ' ' TYR . 4.7 pp0? -84.32 6.79 21.63 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.24 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -82.48 60.01 4.88 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.287 0.367 . . . . 0.0 112.809 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? 70.44 123.86 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.801 1.641 . . . . 0.0 112.939 171.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 45.6 p -70.85 -55.15 9.11 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.281 1.032 . . . . 0.0 112.156 -172.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -6.54 35.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -71.03 -83.97 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -102.83 -88.94 0.39 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.477 0.58 . . . . 0.0 111.243 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.741 ' HB2' HH12 ' B' ' 254' ' ' ARG . 23.2 pt20 -111.58 -5.83 14.47 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.68 -17.89 62.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -78.63 -34.67 46.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 0.0 110.682 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -54.6 -35.53 63.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.939 0.895 . . . . 0.0 112.513 -175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.741 HH12 ' HB2' ' B' ' 250' ' ' GLN . 0.0 OUTLIER -164.56 149.79 10.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.519 0.728 . . . . 0.0 110.629 176.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 127.68 172.74 13.3 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.606 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . 0.543 ' OH ' ' HA ' ' B' ' 243' ' ' GLN . 30.7 m-85 66.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.146 1.378 . . . . 0.0 112.414 171.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.62 -22.59 62.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.754 0.822 . . . . 0.0 111.369 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' B' ' 254' ' ' ARG . 74.8 mt -63.39 104.26 0.6 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.549 . . . . 0.0 110.403 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -78.6 155.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.672 0.789 . . . . 0.0 110.146 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.0 p -80.35 -87.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.288 0.635 . . . . 0.0 112.04 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -76.46 -37.79 56.4 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.448 0.699 . . . . 0.0 111.161 -171.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -69.25 -4.91 19.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.407 0.683 . . . . 0.0 112.758 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -78.29 -1.85 35.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.006 0.922 . . . . 0.0 111.745 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.1 t -151.55 -79.65 0.11 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.932 0.893 . . . . 0.0 109.861 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.93 114.94 26.9 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.184 0.994 . . . . 0.0 108.76 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -70.71 82.74 0.62 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.214 0.606 . . . . 0.0 109.885 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 91.8 p -68.38 -30.72 69.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.97 0.908 . . . . 0.0 112.822 -171.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.34 71.51 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 CA-C-O 121.869 0.842 . . . . 0.0 110.346 -170.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 26.6 m -112.09 95.18 5.32 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 124.219 1.008 . . . . 0.0 109.1 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.86 99.41 7.52 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.966 0.889 . . . . 0.0 110.926 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . 0.426 ' HB1' ' HD1' ' A' ' 378' ' ' TYR . . . -85.76 -43.49 13.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.306 176.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -95.97 17.28 15.73 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.353 0.661 . . . . 0.0 110.781 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 79.46 -44.25 0.31 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 126.004 1.722 . . . . 0.0 111.825 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -63.94 115.92 5.34 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 171.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 45.3 mttm -68.28 122.85 85.84 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 116.862 -1.542 . . . . 0.0 108.44 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -30.69 82.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.154 1 C-N-CA 125.663 4.242 . . . . 0.0 115.622 -165.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -80.07 84.58 5.77 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.481 HD13 ' SD ' ' A' ' 274' ' ' MET . 30.4 mt 69.74 18.15 7.55 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.759 1.224 . . . . 0.0 111.429 -176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . -78.02 -7.01 87.65 Favored Glycine 0 C--N 1.359 1.818 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.392 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . 0.464 ' HG ' ' HA3' ' B' ' 284' ' ' GLY . 1.4 tt -140.08 50.73 1.72 Allowed 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -89.53 -18.87 25.81 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -135.14 -85.83 0.39 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.176 0.59 . . . . 0.0 109.428 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -89.09 -44.04 10.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.417 0.687 . . . . 0.0 110.42 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . 0.464 ' HA3' ' HG ' ' B' ' 280' ' ' LEU . . . 88.01 80.71 1.25 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.735 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.93 3.85 54.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 122.867 0.467 . . . . 0.0 109.915 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.426 ' HB3' ' HD3' ' B' ' 287' ' ' PRO . 15.4 tpt -78.88 -50.61 1.44 Allowed Pre-proline 0 CA--C 1.568 1.642 0 CA-C-O 118.276 -0.869 . . . . 0.0 112.308 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' B' ' 286' ' ' MET . 15.3 Cg_exo -71.34 137.2 30.49 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 122.064 1.843 . . . . 0.0 111.552 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 290' ' ' TRP . 33.6 t -71.49 81.25 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.437 0.695 . . . . 0.0 110.884 -173.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -170.61 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.349 0.554 0 C-N-CA 124.728 1.211 . . . . 0.0 108.75 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.487 ' CH2' ' SD ' ' A' ' 374' ' ' MET . 1.9 p90 41.34 -176.18 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.754 0 C-N-CA 126.604 1.962 . . . . 0.0 115.643 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 401' ' ' VAL . 3.9 mm? 43.7 -90.1 0.01 OUTLIER 'General case' 0 C--N 1.365 1.27 0 C-N-CA 125.851 1.66 . . . . 0.0 112.714 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . 104.81 -91.69 0.8 Allowed Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.968 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 82.5 1.65 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.799 2.332 . . . . 0.0 112.461 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 159.84 20.56 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 167.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -94.64 -69.34 0.76 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m 48.86 -106.98 0.2 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.718 1.607 . . . . 0.0 110.871 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . 0.509 ' HE1' HD13 ' A' ' 306' ' ' LEU . 65.2 t80 67.53 -56.19 0.46 Allowed 'General case' 0 C--N 1.376 1.752 0 C-N-CA 124.617 1.167 . . . . 0.0 111.139 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.18 78.22 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.603 1.161 . . . . 0.0 111.473 166.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -86.88 -179.46 48.92 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.044 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 56.53 5.66 0.22 Allowed 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 126.202 1.801 . . . . 0.0 114.932 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 355' ' ' ILE . 38.9 pt -80.07 -26.81 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.463 0.705 . . . . 0.0 109.892 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 361' ' ' LYS . 5.4 p-10 -76.4 88.85 3.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.362 1.077 . . . . 0.0 109.896 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -50.92 -43.96 85.02 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 113.284 -1.78 . . . . 0.0 113.199 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -40.03 -39.48 2.38 Favored 'Trans proline' 0 C--N 1.405 3.533 0 C-N-CA 123.45 2.767 . . . . 0.0 115.012 172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -72.57 95.59 1.85 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -67.98 107.83 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.624 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 10.0 t -78.62 161.37 27.01 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.321 0.388 . . . . 0.0 110.154 176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 45.1 t -80.0 -48.44 13.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.137 0.575 . . . . 0.0 110.08 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 85.9 m 64.83 121.18 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.296 0 C-N-CA 125.169 1.388 . . . . 0.0 111.43 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.381 2.254 0 C-N-CA 123.29 2.66 . . . . 12.53 112.114 178.315 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.761 -0.459 . . . . 15.0 109.761 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -69.34 110.5 4.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.27 0.628 . . . . 15.0 109.71 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 17' ' ' ILE . 31.5 m -122.15 142.41 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 15.0 109.731 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -152.39 101.69 2.69 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.331 0.652 . . . . 15.0 110.126 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.31 127.85 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.304 0.573 . . . . 15.0 110.227 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 14' ' ' ARG . 45.2 mt-10 -119.53 87.68 2.79 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.939 -0.763 . . . . 15.0 108.939 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.1 m -63.81 94.04 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.45 -0.795 . . . . 15.0 109.978 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.8 p -74.15 -51.08 16.68 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.325 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -141.86 82.63 1.81 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.315 0.646 . . . . 15.0 109.719 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.1 -86.87 0.02 OUTLIER Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.213 -0.903 . . . . 15.0 113.976 171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' HG22 ' A' ' 111' ' ' VAL . 6.5 mp -72.34 -47.98 45.39 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.128 0.971 . . . . 15.0 109.401 176.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.28 93.34 0.06 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 124.073 0.858 . . . . 15.0 112.937 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -113.84 137.1 52.12 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.391 1.076 . . . . 15.0 111.034 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.678 ' HB3' ' HB2' ' A' ' 6' ' ' GLU . 37.6 ttm180 -102.54 91.5 4.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.53 1.132 . . . . 15.0 109.598 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.52 86.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.837 -0.801 . . . . 15.0 108.837 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.1 m -78.95 114.55 17.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.572 -1.195 . . . . 15.0 109.711 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 3' ' ' VAL . 56.1 mt -115.35 134.66 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 109.373 -0.602 . . . . 15.0 109.373 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.3 m -116.78 111.74 20.17 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.447 -0.946 . . . . 15.0 108.447 171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.94 146.33 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 109.418 -0.586 . . . . 15.0 109.418 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.09 134.74 55.49 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.403 1.081 . . . . 15.0 111.191 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.11 -43.69 41.66 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.479 1.512 . . . . 15.0 113.132 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -65.71 -43.78 88.09 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.267 1.027 . . . . 15.0 111.819 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -66.79 -34.12 77.12 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 15.0 111.246 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 28' ' ' VAL . 89.6 mt -64.98 -57.35 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.556 1.143 . . . . 15.0 109.619 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.62 -28.91 69.71 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.191 0.932 . . . . 15.0 111.626 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.3 m -71.07 -48.07 54.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.082 0.553 . . . . 15.0 110.6 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.87 85.04 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.953 0.501 . . . . 15.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 63.1 t -67.19 -50.18 65.72 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 CA-C-N 115.885 -0.598 . . . . 15.0 109.777 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 29' ' ' LYS . 4.5 ttmp? -64.4 -37.26 86.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.621 0.769 . . . . 15.0 112.124 -173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 44.4 m -73.18 -18.91 61.21 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.159 -0.928 . . . . 15.0 110.559 176.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.61 -26.44 23.06 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.726 0.81 . . . . 15.0 110.458 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 28' ' ' VAL . 89.7 mt -70.04 -40.08 75.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.931 0.893 . . . . 15.0 110.87 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 10.9 p -70.09 -26.53 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.779 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -64.67 -35.91 82.57 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 122.946 0.498 . . . . 15.0 110.925 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.05 -43.08 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.06 0.544 . . . . 15.0 109.603 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.43 75.76 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.123 -0.944 . . . . 15.0 111.967 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 33' ' ' VAL . 89.3 mttt -66.94 -46.32 75.12 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.067 0.547 . . . . 15.0 110.445 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -63.45 -50.03 71.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.308 1.043 . . . . 15.0 111.604 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -81.3 -8.75 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.621 0.768 . . . . 15.0 110.542 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 40' ' ' ARG . 16.0 mmt180 68.24 23.42 7.81 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.166 1.386 . . . . 15.0 113.136 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.3 mt -65.26 -20.9 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 C-N-CA 123.887 0.875 . . . . 15.0 109.741 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.02 -35.87 81.72 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.837 0.855 . . . . 15.0 111.298 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.66 -28.98 71.55 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 112.231 -0.347 . . . . 15.0 112.231 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -83.41 -21.31 33.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.703 0.801 . . . . 15.0 110.563 174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -81.22 113.59 19.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.511 0.724 . . . . 15.0 109.65 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -77.68 -16.31 58.58 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.788 0.835 . . . . 15.0 111.136 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.93 28.29 60.97 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.757 0.661 . . . . 15.0 112.473 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -85.89 -51.93 6.07 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.366 0.666 . . . . 15.0 109.313 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.7 t -72.14 131.47 85.25 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.577 -0.725 . . . . 15.0 109.269 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.21 145.96 62.77 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.115 2.543 . . . . 15.0 112.883 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.1 tpp -66.2 -46.55 76.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.643 0.777 . . . . 15.0 110.59 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -55.21 -35.56 65.01 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.794 1.035 . . . . 15.0 113.794 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.82 -57.18 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.128 0.971 . . . . 15.0 110.466 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 m -78.34 -22.92 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.049 -174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.5 -54.84 12.25 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.306 0.643 . . . . 15.0 111.461 -174.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -64.85 -28.24 69.42 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.362 0.665 . . . . 15.0 111.932 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -80.94 -66.71 0.85 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.492 0.717 . . . . 15.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -74.81 -22.23 58.85 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.213 0.605 . . . . 15.0 111.611 -173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.46 13.48 63.75 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.465 -0.63 . . . . 15.0 113.468 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.11 -26.99 68.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.91 0.884 . . . . 15.0 111.494 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 p -74.01 -39.78 63.38 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.377 1.071 . . . . 15.0 111.742 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 t -81.74 -7.85 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 123.631 0.772 . . . . 15.0 111.365 -172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 97' ' ' TYR . 12.9 mmm180 -56.03 -33.44 64.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.063 0.545 . . . . 15.0 110.678 174.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -61.12 -44.69 96.95 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.964 1.305 . . . . 15.0 111.122 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.012 0.925 . . . . 15.0 111.013 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -82.65 -5.15 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.33 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.51 -55.35 35.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.644 -0.66 . . . . 15.0 110.579 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.46 -28.98 74.17 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.003 -0.999 . . . . 15.0 112.663 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.78 -56.63 17.48 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.924 0.89 . . . . 15.0 110.677 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.57 -43.06 97.71 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.14 -0.936 . . . . 15.0 111.342 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' HB3' ' A' ' 92' ' ' TYR . 70.5 mtm -65.67 -55.02 19.72 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.165 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 76' ' ' ILE . 48.9 m -66.12 -44.32 84.6 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.689 0.625 . . . . 15.0 112.689 -173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -70.05 -30.46 67.73 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 112.021 0.378 . . . . 15.0 112.021 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -88.99 -16.82 30.77 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.824 0.45 . . . . 15.0 111.042 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.56 -59.72 2.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.769 0.428 . . . . 15.0 110.253 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 72' ' ' SER . 6.4 tt -56.89 -37.05 52.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 124.017 0.823 . . . . 15.0 109.76 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.48 -53.05 62.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.911 0.885 . . . . 15.0 111.757 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.01 -43.89 94.27 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 115.456 -0.793 . . . . 15.0 112.017 -174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.6 pt -66.72 -29.15 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.6 mt -71.19 -54.52 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.177 0.591 . . . . 15.0 110.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -69.0 -34.65 75.63 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.884 -0.598 . . . . 15.0 111.574 -175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -90.36 -1.85 57.94 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.243 0.617 . . . . 15.0 111.749 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 64.81 12.57 7.82 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 124.677 1.191 . . . . 15.0 112.678 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.18 134.99 29.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.962 0.905 . . . . 15.0 109.095 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -120.65 99.91 47.14 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.068 -0.716 . . . . 15.0 109.068 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.89 158.37 57.63 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.32 2.68 . . . . 15.0 112.985 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.98 39.26 0.88 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.948 0.899 . . . . 15.0 111.573 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.01 -72.48 2.59 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.839 -0.618 . . . . 15.0 112.112 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.3 110.06 35.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.08 0.952 . . . . 15.0 111.416 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 56.4 Cg_endo -97.48 120.66 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.477 2.785 . . . . 15.0 112.906 172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.3 m -84.26 98.12 9.8 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.81 0.444 . . . . 15.0 110.309 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.484 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 83.9 m-85 -76.1 113.51 13.71 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.552 0.741 . . . . 15.0 109.651 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.0 t -109.33 90.43 8.34 Favored Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 108.736 -0.838 . . . . 15.0 108.736 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.22 100.63 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.843 2.362 . . . . 15.0 111.777 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -59.19 -35.72 85.61 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.671 0.607 . . . . 15.0 113.061 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -166.14 142.45 5.0 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.463 0.705 . . . . 15.0 110.606 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' HE2' ' HB3' ' A' ' 63' ' ' ARG . 91.7 t80 -137.29 137.07 38.59 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.406 -1.331 . . . . 15.0 107.406 164.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 82.5 mttt -141.59 151.81 43.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.402 0.681 . . . . 15.0 109.762 -175.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.72 112.04 3.04 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.039 0.936 . . . . 15.0 109.892 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.4 -5.53 50.41 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 114.73 0.652 . . . . 15.0 114.73 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 28.4 mt-10 -114.3 -174.27 2.45 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.943 0.897 . . . . 15.0 110.039 -172.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -74.58 155.7 37.59 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.523 0.729 . . . . 15.0 112.558 -165.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -128.09 99.01 5.31 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.161 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.5 m -92.14 136.57 33.07 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.749 -0.834 . . . . 15.0 108.749 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -151.0 115.4 5.11 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.397 0.618 . . . . 15.0 110.229 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.5 m -81.47 97.97 8.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.876 1.271 . . . . 15.0 110.784 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.5 t -83.98 95.04 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.4 116.1 27.35 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 15.0 110.614 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.584 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 51.2 p90 -155.04 161.32 41.37 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.837 0.855 . . . . 15.0 109.104 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -87.9 149.14 24.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.534 0.334 . . . . 15.0 110.21 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 11' ' ' LEU . 23.7 m -101.51 157.39 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.358 0.663 . . . . 15.0 109.525 174.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -84.78 111.81 38.03 Favored Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 123.163 0.585 . . . . 15.0 110.193 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.16 148.22 13.17 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 15.0 111.887 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.11 140.94 45.6 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.215 171.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 300' ' ' ILE . 20.0 t -99.43 116.42 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.564 0.746 . . . . 15.0 109.759 -175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -90.53 98.54 11.83 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.909 -0.774 . . . . 15.0 108.909 170.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD13 HD11 ' A' ' 120' ' ' LEU . 42.4 mt -74.61 141.95 44.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.792 0.837 . . . . 15.0 110.205 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.11 111.44 22.12 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.872 0.869 . . . . 15.0 110.326 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 48.46 70.54 0.74 Allowed Glycine 0 C--N 1.358 1.752 0 C-N-CA 124.403 1.001 . . . . 15.0 115.585 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 117' ' ' LEU . 65.9 mt -64.3 -12.94 46.68 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.761 0.425 . . . . 15.0 111.682 177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 416' ' ' LYS . 8.0 mp0 -68.32 -32.31 72.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.213 1.005 . . . . 15.0 110.619 175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.99 -22.35 66.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.05 0.54 . . . . 15.0 112.037 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 56.4 mt -66.7 107.53 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.066 0.946 . . . . 15.0 109.245 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.67 102.84 14.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.615 -0.513 . . . . 15.0 109.615 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.53 132.96 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.061 0.944 . . . . 15.0 109.168 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HB3' HE22 ' A' ' 289' ' ' GLN . 3.3 tm-20 -93.85 130.98 39.69 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.006 -0.738 . . . . 15.0 109.006 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HA ' HG22 ' A' ' 286' ' ' VAL . 82.0 tttt -119.14 103.73 47.18 Favored Pre-proline 0 C--O 1.247 0.963 0 C-N-CA 124.015 0.926 . . . . 15.0 109.133 -176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.16 107.09 0.84 Allowed 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 121.885 1.723 . . . . 15.0 111.273 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.62 88.26 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.276 -1.009 . . . . 15.0 108.276 167.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' A' ' 282' ' ' ILE . 39.1 t -100.04 138.7 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 114.558 -1.201 . . . . 15.0 109.428 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.605 ' HA ' HD21 ' A' ' 278' ' ' LEU . 7.8 pt-20 -125.86 148.92 49.03 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.087 -0.708 . . . . 15.0 109.087 163.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' A' ' 274' ' ' MET . 38.8 t -84.32 90.95 2.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.761 -1.2 . . . . 15.0 107.761 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.0 p -69.9 169.59 12.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.156 0.583 . . . . 15.0 110.344 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.59 -21.98 66.02 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 116.537 -0.302 . . . . 15.0 111.579 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.29 -46.24 74.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.238 0.615 . . . . 15.0 109.896 172.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.04 -38.59 91.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.061 0.544 . . . . 15.0 111.02 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.36 -44.87 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.391 0.677 . . . . 15.0 110.529 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.06 -32.75 74.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.596 0.358 . . . . 15.0 110.749 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -61.44 -45.39 96.5 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 124.006 0.816 . . . . 15.0 111.937 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 53.5 ttm -63.83 -48.21 77.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.932 0.493 . . . . 15.0 111.396 177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.6 -41.56 94.99 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.549 0.74 . . . . 15.0 110.794 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.47 -51.66 66.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.082 1.353 . . . . 15.0 110.424 174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 52.5 m -62.64 -36.86 84.18 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.294 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 140' ' ' MET . 95.5 mt -63.58 -44.5 93.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 15.0 110.046 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -71.61 -31.24 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.849 0.46 . . . . 15.0 111.364 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -79.74 -23.8 42.04 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.274 0.472 . . . . 15.0 112.274 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.436 HE21 ' NE2' ' A' ' 148' ' ' GLN . 22.8 tt0 -80.66 -44.66 18.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.148 0.579 . . . . 15.0 109.567 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.436 ' NE2' HE21 ' A' ' 147' ' ' GLN . 73.7 mm-40 -87.28 14.0 8.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.865 0.866 . . . . 15.0 110.984 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . . . -72.0 157.2 38.26 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.585 0.754 . . . . 15.0 111.564 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.3 m -120.05 127.97 53.07 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.694 -0.854 . . . . 15.0 108.694 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -74.73 124.98 27.76 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.112 0.482 . . . . 15.0 109.947 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -130.29 114.35 15.52 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.005 1.322 . . . . 15.0 108.322 -171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 241' ' ' GLU . 32.4 tt0 -58.54 128.4 36.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 15.0 111.202 -178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 64.8 pttt -139.53 -179.16 5.74 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.343 1.057 . . . . 15.0 110.851 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.33 138.56 20.34 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.35 -0.841 . . . . 15.0 109.117 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.746 ' H ' ' HB2' ' A' ' 207' ' ' ALA . . . 106.4 -6.54 39.12 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.118 -0.824 . . . . 15.0 114.53 169.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -154.79 132.92 11.69 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.926 0.863 . . . . 15.0 112.018 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.459 HG11 HG22 ' A' ' 202' ' ' ILE . 59.5 t -109.91 133.87 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 108.087 -1.079 . . . . 15.0 108.087 164.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.85 -174.68 2.59 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.119 0.967 . . . . 15.0 108.653 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -79.24 -20.58 47.84 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.598 0.592 . . . . 15.0 112.598 -173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -123.78 15.01 9.38 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.678 0.622 . . . . 15.0 112.678 -169.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -80.79 176.46 9.79 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.738 1.014 . . . . 15.0 113.738 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.466 ' NH2' ' HB3' ' B' ' 241' ' ' GLU . 10.9 ttt85 -111.76 100.69 9.14 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.804 1.642 . . . . 15.0 108.611 177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 240' ' ' VAL . 60.8 t -104.38 129.47 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.972 0.509 . . . . 15.0 110.822 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 46.7 m -98.48 121.15 40.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.791 0.837 . . . . 15.0 109.304 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 237' ' ' LEU . 41.2 pt -135.41 153.08 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.52 0.728 . . . . 15.0 111.162 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.3 106.2 15.93 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.142 -1.429 . . . . 15.0 107.142 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 181' ' ' LYS . 40.0 p90 -107.3 131.41 54.24 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.35 -0.611 . . . . 15.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.521 HG22 ' HG3' ' A' ' 181' ' ' LYS . 67.4 p -130.29 123.96 31.27 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.151 -1.055 . . . . 15.0 108.151 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 232' ' ' LYS . . . -172.68 -172.84 38.75 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.225 -0.512 . . . . 15.0 113.908 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.1 m -128.5 136.17 50.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.197 0.999 . . . . 15.0 109.526 -174.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.96 130.1 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 108.646 -0.872 . . . . 15.0 108.646 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.3 t70 68.51 6.94 5.71 Favored 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 124.217 1.007 . . . . 15.0 111.655 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.21 -17.21 26.82 Favored Glycine 0 C--N 1.355 1.603 0 CA-C-O 119.394 -0.67 . . . . 15.0 113.964 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -127.63 162.02 27.5 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 117.689 0.745 . . . . 15.0 110.438 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -72.88 128.18 34.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.233 1.013 . . . . 15.0 111.722 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -137.53 -179.22 5.61 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.743 1.217 . . . . 15.0 109.285 175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.62 155.4 31.46 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.316 -0.994 . . . . 15.0 108.316 174.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.91 -7.91 40.08 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 121.127 -0.558 . . . . 15.0 113.143 -175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.445 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -71.89 -17.82 77.16 Favored Glycine 0 C--N 1.362 2.007 0 C-N-CA 123.102 0.382 . . . . 15.0 112.24 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.2 tttt -140.41 137.83 34.29 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.674 0.79 . . . . 15.0 109.837 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 168' ' ' PHE . . . -155.87 118.87 4.25 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.647 0.779 . . . . 15.0 109.025 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.4 p -81.23 139.42 35.51 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.756 0.822 . . . . 15.0 109.967 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 60.3 24.88 14.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.77 1.228 . . . . 15.0 112.244 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -55.81 103.72 0.11 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 124.661 1.185 . . . . 15.0 110.511 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 163' ' ' ARG . 42.1 t -82.53 99.29 5.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 114.841 -1.072 . . . . 15.0 109.531 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 199' ' ' GLU . 60.3 tp -91.91 94.38 9.27 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.566 -1.197 . . . . 15.0 109.516 172.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.38 88.68 3.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.157 -1.423 . . . . 15.0 107.157 164.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 21.3 ptp -74.74 -179.43 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.166 0.986 . . . . 15.0 111.588 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 83.02 8.83 85.16 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 116.093 -0.503 . . . . 15.0 112.591 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -150.34 143.9 25.17 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.678 1.191 . . . . 15.0 107.877 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.03 66.59 3.57 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.335 0.397 . . . . 15.0 114.026 -171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.499 ' HB3' ' HA ' ' B' ' 239' ' ' ALA . 99.0 mtt180 -105.45 2.89 29.0 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.761 0.824 . . . . 15.0 110.562 173.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.63 ' SD ' HG22 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -149.0 164.53 34.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.57 0.748 . . . . 15.0 109.5 -177.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.63 HG22 ' SD ' ' A' ' 194' ' ' MET . 1.3 tt -62.85 127.06 90.03 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.597 0.759 . . . . 15.0 111.039 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.92 123.03 12.36 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.739 2.293 . . . . 15.0 111.241 171.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 120.82 -36.89 3.19 Favored Glycine 0 N--CA 1.469 0.86 0 N-CA-C 111.55 -0.62 . . . . 15.0 111.55 -172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.584 ' HB2' HG23 ' A' ' 195' ' ' ILE . 69.9 t80 -68.0 -49.57 60.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.094 0.558 . . . . 15.0 109.884 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.421 ' HB3' HD21 ' A' ' 187' ' ' LEU . 8.5 pt-20 -67.37 -35.25 78.96 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.786 -0.643 . . . . 15.0 110.818 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 203' ' ' LYS . 9.8 m-20 -69.77 -27.62 65.08 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.693 0.797 . . . . 15.0 110.6 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -59.93 -41.24 97.72 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-N 115.989 -0.55 . . . . 15.0 112.163 169.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.517 HD11 HD13 ' A' ' 166' ' ' ILE . 69.8 mt -72.24 -39.04 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 124.081 0.952 . . . . 15.0 111.11 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 200' ' ' ASP . 44.3 mtpt -72.8 -8.3 54.81 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.028 0.931 . . . . 15.0 112.922 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -88.53 -1.98 80.03 Favored Glycine 0 N--CA 1.471 0.995 0 O-C-N 122.944 0.152 . . . . 15.0 113.02 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -127.32 176.02 7.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.433 1.093 . . . . 15.0 109.477 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -107.4 -64.85 1.15 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.033 1.494 . . . . 15.0 115.033 -164.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.746 ' HB2' ' H ' ' A' ' 156' ' ' GLY . . . -148.21 -60.93 0.25 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 114.456 1.28 . . . . 15.0 114.456 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.39 52.28 0.82 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.155 -0.475 . . . . 15.0 113.083 -164.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.41 125.57 32.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 15.0 110.294 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.98 146.25 33.5 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.062 0.458 . . . . 15.0 110.7 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -156.86 -179.11 7.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.667 1.187 . . . . 15.0 109.324 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 76.6 m -133.37 128.3 35.33 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.907 -0.775 . . . . 15.0 108.907 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.466 HG21 ' HA3' ' A' ' 201' ' ' GLY . 30.8 pt -113.77 138.2 44.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.832 0 CA-C-O 121.226 0.536 . . . . 15.0 110.05 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -93.03 102.72 15.06 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.048 -1.464 . . . . 15.0 107.048 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 195' ' ' ILE . 27.1 m -90.81 150.96 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.904 -0.776 . . . . 15.0 108.904 172.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.9 m -124.34 104.46 8.8 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.507 ' HA ' HD12 ' A' ' 195' ' ' ILE . 98.2 m-85 -48.45 134.78 12.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.678 1.191 . . . . 15.0 111.607 176.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 221' ' ' TYR . 5.8 Cg_exo -77.98 164.67 27.16 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.299 2.666 . . . . 15.0 112.723 -171.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -74.46 -11.71 60.3 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.925 -1.034 . . . . 15.0 110.679 168.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -69.22 -34.45 74.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.352 1.061 . . . . 15.0 109.574 173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.665 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 1.6 t80 -69.73 116.43 10.12 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.885 -1.507 . . . . 15.0 108.889 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -83.46 3.6 31.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.766 0.827 . . . . 15.0 112.584 -168.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . . . -73.27 125.57 28.09 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.859 0.464 . . . . 15.0 110.213 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.17 -42.71 99.53 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.613 1.165 . . . . 15.0 112.036 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.89 -26.21 34.34 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.813 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 223' ' ' ALA . 22.8 mt -88.66 -26.02 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 113.411 0.893 . . . . 15.0 113.411 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 99.05 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 CA-C-O 121.505 0.669 . . . . 15.0 111.879 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.37 36.3 14.9 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.714 -0.675 . . . . 15.0 113.764 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.07 146.66 26.52 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.983 0.513 . . . . 15.0 111.524 171.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.61 121.9 45.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.006 0.522 . . . . 15.0 110.255 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.17 141.51 48.42 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.967 0.907 . . . . 15.0 110.622 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.413 ' O ' ' HA3' ' A' ' 170' ' ' GLY . 28.3 mtpp -104.65 116.02 31.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.388 -0.967 . . . . 15.0 108.388 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.445 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 28.8 m-85 -118.97 120.54 37.56 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.915 0.486 . . . . 15.0 110.257 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -78.41 89.12 4.4 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 108.341 -0.985 . . . . 15.0 108.341 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 22.9 mm -72.72 102.94 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 114.961 -1.018 . . . . 15.0 109.769 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.7 OUTLIER -83.66 86.51 7.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.704 -1.591 . . . . 15.0 106.704 172.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.613 ' HA ' HG22 ' A' ' 166' ' ' ILE . 16.6 tp -63.64 122.91 17.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.162 -1.051 . . . . 15.0 108.162 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -115.44 -63.9 1.39 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.9 0.48 . . . . 15.0 110.527 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -130.46 159.96 35.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.6 0.76 . . . . 15.0 110.383 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 164' ' ' VAL . 12.0 t -132.77 144.25 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 105.989 -1.856 . . . . 15.0 105.989 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 153' ' ' GLU . 27.3 mt-10 -134.07 116.48 15.51 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 -177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.566 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 36.4 tt0 -74.41 134.25 42.41 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.406 1.082 . . . . 15.0 110.809 -177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -73.5 89.1 1.66 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.438 -1.319 . . . . 15.0 107.438 165.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -63.54 103.99 0.59 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.115 -0.698 . . . . 15.0 109.115 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 35.9 mt -74.06 113.95 28.31 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 114.986 -1.006 . . . . 15.0 108.982 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 149' ' ' ALA . 97.7 Cg_endo -72.38 157.51 53.12 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.7 1.6 . . . . 15.0 110.44 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.66 167.91 17.78 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.448 -0.796 . . . . 15.0 109.364 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 263' ' ' VAL . 17.4 tp -85.0 62.48 7.54 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-O 122.135 0.969 . . . . 15.0 108.723 177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 19.4 m -65.35 157.95 27.82 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.118 -1.401 . . . . 15.0 109.621 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -49.25 -50.61 37.94 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.482 0.713 . . . . 15.0 111.355 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -62.56 -27.81 69.43 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.217 1.007 . . . . 15.0 112.75 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.437 ' HD2' HD12 ' A' ' 248' ' ' LEU . 52.2 t80 -83.35 -49.01 9.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.071 0.548 . . . . 15.0 110.263 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.69 HG21 ' HA2' ' A' ' 261' ' ' GLY . 17.1 tt -67.43 -26.58 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 122.704 0.402 . . . . 15.0 110.672 177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.77 -23.53 66.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.117 0.567 . . . . 15.0 111.461 173.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -68.91 -20.08 64.22 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.002 0.521 . . . . 15.0 110.61 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -97.51 7.54 46.3 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.714 0.806 . . . . 15.0 111.011 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 102.26 -37.23 3.78 Favored Glycine 0 C--N 1.353 1.526 0 O-C-N 123.271 0.357 . . . . 15.0 113.382 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 253' ' ' ILE . 44.7 t -57.69 119.0 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.42 1.088 . . . . 15.0 111.484 -172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -56.07 -45.95 79.13 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.099 1.359 . . . . 15.0 113.367 -170.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -120.5 -174.45 2.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.599 0.759 . . . . 15.0 110.364 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 253' ' ' ILE . . . -93.06 25.16 21.35 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 118.909 -0.94 . . . . 15.0 115.316 -171.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.3 m -72.41 107.34 4.93 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.348 1.074 . . . . 15.0 109.791 174.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . 0.604 HG22 HD23 ' A' ' 248' ' ' LEU . 46.2 t -64.3 -46.06 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.63 0.772 . . . . 15.0 110.923 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -14.51 60.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.105 0.562 . . . . 15.0 111.459 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -72.66 -38.97 56.84 Favored Glycine 0 C--N 1.361 1.946 0 N-CA-C 110.975 -0.85 . . . . 15.0 110.975 169.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 48.7 tp -71.74 -36.84 70.57 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 109.445 -0.576 . . . . 15.0 109.445 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -66.97 -36.64 82.65 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 122.959 0.504 . . . . 15.0 110.747 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.81 -40.88 75.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.323 0.649 . . . . 15.0 110.812 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -57.74 -59.75 4.74 Favored 'General case' 0 C--O 1.26 1.644 0 C-N-CA 123.929 0.891 . . . . 15.0 110.457 175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . . . . . . . . . 69.5 t -48.93 -49.62 15.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.902 1.281 . . . . 15.0 110.463 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -60.73 -47.39 86.49 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.897 0.748 . . . . 15.0 112.348 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -68.02 -33.78 75.25 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 118.412 0.551 . . . . 15.0 110.911 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.48 ' HB3' HD23 ' B' ' 278' ' ' LEU . 56.4 m-80 -69.87 -38.28 76.37 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.053 0.454 . . . . 15.0 110.477 171.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 132' ' ' VAL . 1.4 mmt -67.6 -33.54 75.2 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 123.612 0.765 . . . . 15.0 111.424 -173.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -71.52 -32.2 67.91 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.775 0.672 . . . . 15.0 111.125 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 373' ' ' GLU . 15.3 tpp180 -65.84 -50.59 64.03 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.392 0.677 . . . . 15.0 109.897 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -61.94 -38.75 89.62 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.81 0.694 . . . . 15.0 110.828 174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.605 HD21 ' HA ' ' A' ' 131' ' ' GLU . 54.9 tp -61.16 -57.57 11.92 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.011 0.924 . . . . 15.0 111.011 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' ARG . 40.4 ttpt -58.4 -43.54 88.62 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 124.168 0.918 . . . . 15.0 110.742 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 29.4 t -66.78 -37.08 83.87 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.137 0.898 . . . . 15.0 111.038 -178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -73.96 -43.2 59.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.868 0.467 . . . . 15.0 110.949 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' A' ' 130' ' ' VAL . 82.0 mt -62.14 -38.84 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.627 0.771 . . . . 15.0 109.594 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.44 HH21 ' NH2' ' A' ' 366' ' ' ARG . 17.4 tpt180 -60.65 -57.2 13.72 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 115.335 -0.848 . . . . 15.0 109.279 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.11 -29.65 70.53 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.405 1.082 . . . . 15.0 111.618 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 285' ' ' ARG . 6.1 tpt85 -62.64 -66.27 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.081 0.952 . . . . 15.0 110.035 175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 127' ' ' LYS . 91.9 t -54.21 -39.68 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.383 1.073 . . . . 15.0 110.626 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.489 ' CE ' ' HG3' ' A' ' 404' ' ' GLU . 60.6 tttm -69.21 -44.33 72.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.511 -1.222 . . . . 15.0 111.922 -176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 87.3 p -68.17 -34.49 76.41 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.121 0.263 . . . . 15.0 110.84 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.616 HE22 ' HB3' ' A' ' 126' ' ' GLU . 43.8 mt-30 -67.73 -37.63 82.45 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 123.689 0.618 . . . . 15.0 111.064 174.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 412' ' ' LEU . . . -63.77 -43.19 97.12 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.003 0.521 . . . . 15.0 111.209 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 287' ' ' LYS . 33.0 mm -65.18 -47.98 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.817 0.847 . . . . 15.0 110.721 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -59.03 -51.16 71.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.334 -0.848 . . . . 15.0 110.324 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -64.91 -33.88 88.41 Favored Glycine 0 C--N 1.345 1.068 0 O-C-N 124.371 1.044 . . . . 15.0 113.255 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.585 HD22 HD13 ' A' ' 350' ' ' LEU . 0.6 OUTLIER -61.49 -59.57 5.04 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.541 0.736 . . . . 15.0 109.326 178.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 346' ' ' VAL . 48.5 t -62.75 -43.02 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 123.648 0.592 . . . . 15.0 110.849 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -54.11 -44.49 71.33 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.06 0.944 . . . . 15.0 111.068 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.89 46.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.575 -0.739 . . . . 15.0 112.555 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -140.88 102.98 4.4 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.628 0.649 . . . . 15.0 110.925 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -94.6 152.35 18.59 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.79 0.836 . . . . 15.0 109.745 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.575 HG12 HG22 ' A' ' 115' ' ' VAL . 6.6 tp -149.67 148.83 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.25 0.62 . . . . 15.0 109.981 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.34 116.38 6.6 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.268 1.027 . . . . 15.0 109.089 170.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.485 HG21 HG22 ' A' ' 346' ' ' VAL . 71.5 t -105.78 129.86 23.97 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.121 0.969 . . . . 15.0 110.154 -173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.42 119.43 6.52 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.487 2.125 . . . . 15.0 111.298 171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' A' ' 307' ' ' ILE . . . -59.55 -24.89 64.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.404 1.082 . . . . 15.0 112.368 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -56.61 -48.07 78.25 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.647 0.779 . . . . 15.0 110.946 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 71.3 mt -68.34 -38.5 81.55 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.581 -0.736 . . . . 15.0 111.439 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 311' ' ' ILE . 59.0 mt -56.72 -57.37 9.67 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 123.995 0.81 . . . . 15.0 108.866 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.03 -42.26 76.25 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.514 1.133 . . . . 15.0 112.352 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 313' ' ' VAL . 70.5 m -55.12 -53.68 52.78 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.589 0.556 . . . . 15.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.92 -32.34 73.53 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.692 -0.685 . . . . 15.0 112.067 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.9 mt -61.44 -49.91 82.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 109.032 -0.729 . . . . 15.0 109.032 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.24 -39.29 92.51 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.76 0.663 . . . . 15.0 111.191 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 309' ' ' SER . 87.3 t -58.77 -46.77 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 123.723 0.64 . . . . 15.0 109.839 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.435 HD21 ' NH1' ' A' ' 344' ' ' ARG . 88.7 mt -68.83 -29.6 67.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.073 0.549 . . . . 15.0 112.448 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 311' ' ' ILE . 25.1 mtm180 -72.36 -40.78 67.08 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.698 0.399 . . . . 15.0 110.044 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -72.78 -36.73 67.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.018 0.527 . . . . 15.0 110.547 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -68.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.97 0.908 . . . . 15.0 110.758 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.77 -46.51 62.8 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.588 -0.733 . . . . 15.0 109.635 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.07 -32.65 69.98 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.238 0.961 . . . . 15.0 111.745 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -52.09 -32.18 33.81 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.212 1.005 . . . . 15.0 111.228 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -101.6 -34.85 9.34 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.55 0.74 . . . . 15.0 110.849 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -107.27 97.87 7.58 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.13 0.972 . . . . 15.0 109.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 91.18 -56.39 3.23 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.487 -0.324 . . . . 15.0 113.322 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 87.38 55.36 2.35 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 110.848 -0.901 . . . . 15.0 110.848 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 328' ' ' GLN . 89.5 m-20 -111.17 121.17 44.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.518 0.727 . . . . 15.0 111.692 -168.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -81.05 103.03 10.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.697 1.199 . . . . 15.0 110.107 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 71.02 -13.56 0.5 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.234 1.414 . . . . 15.0 114.173 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 325' ' ' ASN . 1.4 tm0? -65.46 -24.84 67.27 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.03 0.832 . . . . 15.0 109.036 169.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . . . . . . . . . . . -58.16 -18.36 25.03 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.937 1.295 . . . . 15.0 113.049 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 58.6 tp -50.45 -37.27 37.33 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.435 1.094 . . . . 15.0 111.308 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -75.34 -15.56 60.47 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.376 1.07 . . . . 15.0 112.508 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.52 132.58 88.48 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-O 119.143 -0.456 . . . . 15.0 110.288 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.74 109.59 0.27 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.279 3.32 . . . . 15.0 114.103 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.85 -46.82 60.37 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.457 1.503 . . . . 15.0 113.074 -167.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.59 -21.06 66.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.688 0.795 . . . . 15.0 112.708 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 88.7 mt -67.0 -30.58 70.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.387 0.613 . . . . 15.0 110.224 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.5 ' HB2' HG23 ' A' ' 311' ' ' ILE . 64.5 m-85 -101.25 -33.71 9.95 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.218 -0.901 . . . . 15.0 110.766 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -70.76 -39.07 73.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.993 0.917 . . . . 15.0 111.084 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 30.7 tt0 -50.37 -43.88 54.54 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.284 0.99 . . . . 15.0 111.358 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 344' ' ' ARG . 23.1 pt20 -92.58 -33.63 14.35 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.032 -0.985 . . . . 15.0 111.675 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . -63.77 -61.74 2.1 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.373 0.669 . . . . 15.0 110.095 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.536 ' O ' HG23 ' A' ' 346' ' ' VAL . 84.7 tttt -53.15 -40.88 64.61 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 124.637 1.211 . . . . 15.0 110.213 177.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -56.59 -42.73 79.21 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.145 0.978 . . . . 15.0 110.135 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.435 ' NH1' HD21 ' A' ' 314' ' ' LEU . 88.0 mtt180 -68.54 -35.8 77.95 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.419 0.449 . . . . 15.0 110.642 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.53 -35.0 64.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 123.429 0.456 . . . . 15.0 110.351 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 342' ' ' LYS . 59.9 t -63.19 -49.74 81.96 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 108.478 -0.934 . . . . 15.0 108.478 175.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 343' ' ' ARG . 86.2 t -50.73 -43.72 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.063 0.945 . . . . 15.0 110.814 174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -66.48 -42.01 93.94 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.324 -0.853 . . . . 15.0 113.524 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.6 -45.11 76.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.118 0.567 . . . . 15.0 110.511 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.585 HD13 HD22 ' A' ' 294' ' ' LEU . 80.1 mt -62.4 -55.51 27.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.791 0.836 . . . . 15.0 109.995 -179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 62.3 mt -63.36 -34.16 77.11 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.61 0.764 . . . . 15.0 111.625 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -64.84 -36.21 92.82 Favored Glycine 0 C--N 1.347 1.157 0 O-C-N 123.799 0.687 . . . . 15.0 111.82 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -69.91 -46.1 66.13 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.322 -0.439 . . . . 15.0 111.08 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 350' ' ' LEU . 98.5 t -55.79 -40.02 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.33 0.652 . . . . 15.0 109.919 176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.424 ' CG2' HD11 ' B' ' 301' ' ' ILE . 9.4 mt -60.12 -54.0 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.799 1.24 . . . . 15.0 110.677 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -63.59 -50.21 70.32 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 123.648 0.593 . . . . 15.0 110.504 -175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 43.5 m -57.43 -37.8 73.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.784 1.233 . . . . 15.0 111.724 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -101.53 14.59 31.51 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 119.116 -0.469 . . . . 15.0 112.084 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 42.03 39.17 1.25 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.11 1.764 . . . . 15.0 114.148 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 86.8 mt -68.16 159.89 30.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.68 0.792 . . . . 15.0 112.723 -176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' B' ' 301' ' ' ILE . 0.0 OUTLIER -156.46 145.55 20.41 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.064 0.945 . . . . 15.0 109.837 176.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 403' ' ' LEU . . . -62.68 106.62 0.82 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 177.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' B' ' 305' ' ' ALA . 30.7 t70 -71.98 108.25 5.13 Favored 'General case' 0 C--N 1.349 0.564 0 O-C-N 123.435 0.459 . . . . 15.0 109.821 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.405 ' H ' ' HB3' ' B' ' 305' ' ' ALA . 53.8 mm-40 -62.8 -23.46 67.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.297 0.639 . . . . 15.0 111.913 -175.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -73.38 -31.24 63.8 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.536 0.734 . . . . 15.0 110.623 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.44 ' NH2' HH21 ' A' ' 283' ' ' ARG . 47.6 ttt180 -76.64 -40.92 47.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.58 0.752 . . . . 15.0 109.691 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 399' ' ' ARG . 58.0 t -55.93 -49.05 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 124.128 0.892 . . . . 15.0 108.762 173.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -52.45 -52.0 56.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.627 -1.17 . . . . 15.0 111.334 173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -51.31 -53.97 25.73 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 124.51 1.131 . . . . 15.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 96.7 mt -54.06 -52.93 59.34 Favored 'General case' 0 C--O 1.252 1.202 0 C-N-CA 124.466 1.106 . . . . 15.0 111.703 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.05 -45.32 83.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 CA-C-N 115.093 -0.958 . . . . 15.0 110.97 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . 0.541 ' HG2' HD11 ' A' ' 385' ' ' ILE . 49.6 mt-10 -74.68 -34.78 62.73 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.586 0.754 . . . . 15.0 111.687 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.401 ' HB3' ' NH2' ' A' ' 276' ' ' ARG . 43.2 mt-10 -60.46 -44.24 96.05 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.488 0.661 . . . . 15.0 109.942 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.0 ttp -71.03 -38.26 72.58 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 114.737 -1.119 . . . . 15.0 111.093 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 381' ' ' PRO . . . -74.85 -22.38 58.72 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.234 1.013 . . . . 15.0 111.33 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 39.9 t -59.71 -20.03 53.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.456 1.103 . . . . 15.0 112.05 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . 0.459 ' HB3' ' HG3' ' B' ' 287' ' ' PRO . . . -70.5 -18.02 62.96 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.293 0.637 . . . . 15.0 112.178 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -94.75 171.92 8.48 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.449 -0.575 . . . . 15.0 109.449 169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -75.91 -18.28 59.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.215 0.606 . . . . 15.0 110.652 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.02 117.04 11.57 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.689 0.396 . . . . 15.0 110.081 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.555 ' HA ' ' HB1' ' A' ' 375' ' ' ALA . 4.1 Cg_exo -77.97 -32.87 2.37 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.866 2.378 . . . . 15.0 113.008 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -58.41 -48.73 79.73 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.832 0.853 . . . . 15.0 112.357 -165.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.89 -16.38 62.68 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.524 0.73 . . . . 15.0 111.905 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.43 ' O ' ' HD1' ' A' ' 388' ' ' TYR . 51.6 t -83.6 -39.51 15.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 109.171 -0.678 . . . . 15.0 109.171 177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 372' ' ' GLU . 34.0 mt -63.84 -38.39 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.06 -34.88 73.76 Favored 'General case' 0 C--N 1.351 0.649 0 CA-C-N 114.713 -1.13 . . . . 15.0 110.904 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.66 -41.81 86.96 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.077 0.551 . . . . 15.0 110.156 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . 0.512 ' HD2' ' HA ' ' A' ' 395' ' ' MET . 17.4 m-85 -62.52 -53.8 49.41 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.607 0.567 . . . . 15.0 110.322 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 77.6 p -64.48 -20.07 65.96 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.123 0.416 . . . . 15.0 112.123 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.18 -9.72 25.26 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.599 0.76 . . . . 15.0 111.592 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -134.15 83.82 2.07 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.71 -1.218 . . . . 15.0 107.71 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 395' ' ' MET . 36.7 ttmt -72.71 -1.53 16.76 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.913 -1.039 . . . . 15.0 111.863 -171.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.04 -51.05 27.57 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.781 -0.451 . . . . 15.0 109.781 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.687 HD11 ' HZ3' ' B' ' 290' ' ' TRP . 44.9 tp -80.17 -26.99 39.06 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.463 -0.335 . . . . 15.0 110.528 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . 0.512 ' HA ' ' HD2' ' A' ' 388' ' ' TYR . 0.3 OUTLIER -64.64 -47.53 78.17 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 176.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.58 -47.54 76.29 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.177 0.923 . . . . 15.0 110.001 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.442 ' O ' HG23 ' A' ' 401' ' ' VAL . 52.2 t30 -54.57 -56.85 14.66 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.08 0.863 . . . . 15.0 111.236 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . 0.425 ' HB2' ' HE2' ' A' ' 388' ' ' TYR . 5.0 tpt -68.02 -31.95 71.99 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.419 0.687 . . . . 15.0 111.389 -174.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.439 ' HG3' HG21 ' A' ' 367' ' ' VAL . 41.3 ttt180 -68.8 -43.75 75.0 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.999 0.92 . . . . 15.0 110.116 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 404' ' ' GLU . 0.9 OUTLIER -71.3 -24.78 62.2 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.049 -1.432 . . . . 15.0 110.029 179.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 397' ' ' ASN . 52.0 t -69.39 -44.16 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 123.886 0.742 . . . . 15.0 110.544 172.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -55.83 -47.59 76.97 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.229 1.014 . . . . 15.0 110.3 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.528 HD21 HD12 ' B' ' 301' ' ' ILE . 19.3 tp -71.78 -28.98 63.98 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 113.62 -1.627 . . . . 15.0 111.999 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 400' ' ' ASN . 10.9 tp10 -66.13 -50.15 64.99 Favored 'General case' 0 C--O 1.247 0.958 0 C-N-CA 124.093 0.957 . . . . 15.0 109.35 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -55.03 -56.58 18.18 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 114.083 -1.417 . . . . 15.0 109.829 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -56.14 -43.61 78.42 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.292 0.995 . . . . 15.0 111.989 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.94 86.7 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 123.82 0.7 . . . . 15.0 111.242 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' HG3' ' A' ' 287' ' ' LYS . 60.4 t -74.84 -32.91 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.372 -0.831 . . . . 15.0 111.786 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.62 -28.55 66.02 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.619 0.768 . . . . 15.0 110.984 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.84 -26.64 68.42 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 123.796 0.685 . . . . 15.0 111.025 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 t -82.78 -40.02 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 108.879 -0.786 . . . . 15.0 108.879 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 290' ' ' ALA . 96.7 mt -63.9 -31.51 72.72 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.498 1.119 . . . . 15.0 111.813 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.47 66.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.925 0.89 . . . . 15.0 111.187 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -101.44 -36.34 8.86 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.291 1.037 . . . . 15.0 110.206 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -79.53 146.99 32.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 15.0 111.408 -170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 121' ' ' GLU . 95.0 mttt -67.97 82.35 0.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.506 0.722 . . . . 15.0 110.561 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.37 91.03 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.548 -0.908 . . . . 15.0 108.548 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 9.2 t -73.79 157.24 36.79 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -146.83 137.63 23.9 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.179 0.192 . . . . 15.0 110.976 -165.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -149.57 156.14 41.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.89 0.476 . . . . 15.0 109.865 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.28 142.89 27.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.613 0.765 . . . . 15.0 110.16 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 13.6 t -163.91 176.88 9.02 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 123.094 0.558 . . . . 15.0 111.732 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 50.2 p -96.39 166.24 11.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.146 0.978 . . . . 15.0 111.512 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -65.98 -28.66 69.06 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.85 0.86 . . . . 15.0 111.886 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.99 -45.87 82.67 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.553 0.533 . . . . 15.0 110.185 174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.21 -50.81 72.6 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.297 0.639 . . . . 15.0 111.05 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . . . . . . . . . 59.5 tp -51.33 -44.12 61.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.707 1.203 . . . . 15.0 112.231 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 24.4 mmt -86.6 -34.67 19.79 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.52 0.563 . . . . 15.0 112.52 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -82.58 51.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.547 0.739 . . . . 15.0 111.647 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.8 84.52 2.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.966 0.906 . . . . 15.0 109.104 175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -99.4 -26.96 13.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.646 0.779 . . . . 15.0 110.862 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.125 0.57 . . . . 15.0 109.543 178.531 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.34 -53.35 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.04 0.936 . . . . 0.0 110.084 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -149.46 97.37 2.63 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.001 0.52 . . . . 0.0 110.448 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 64.5 -82.78 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.009 1.323 . . . . 0.0 111.759 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 12.5 p -150.69 149.98 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.645 0.778 . . . . 0.0 109.466 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 9.0 t -129.76 162.82 27.56 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.178 0.991 . . . . 0.0 109.262 177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 87.6 mt 60.23 -160.25 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.332 1.053 . . . . 0.0 112.42 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 98.25 -31.09 8.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . -136.11 158.63 24.01 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.89 78.38 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.674 0.279 . . . . 0.0 112.747 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -108.59 158.56 17.47 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.434 0.694 . . . . 0.0 110.882 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? 70.29 32.09 2.93 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.247 1.419 . . . . 0.0 110.639 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 11.9 t -64.77 157.6 27.12 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.432 0.693 . . . . 0.0 111.412 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 226' ' ' LEU . 18.9 t80 -59.36 -68.17 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.997 0.919 . . . . 0.0 109.622 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . 179.03 -73.58 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.739 1.216 . . . . 0.0 108.227 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 174.67 -29.01 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.471 1.908 . . . . 0.0 107.075 -174.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 66.61 47.28 1.64 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.776 1.63 . . . . 0.0 109.717 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 194' ' ' MET . . . 72.43 -71.5 0.13 Allowed 'General case' 0 C--N 1.354 0.766 0 CA-C-N 113.343 -1.753 . . . . 0.0 112.128 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . . . . . . . . . 75.3 p 51.61 104.55 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.848 1.659 . . . . 0.0 112.44 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 193' ' ' ARG . . . -77.74 10.94 2.36 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.79 41.37 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.466 ' HB3' ' NH2' ' A' ' 163' ' ' ARG . 80.3 mm-40 73.08 -31.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.37 1.468 . . . . 0.0 113.33 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -84.61 59.64 5.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 162.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 62.66 87.05 0.11 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.239 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -72.53 -46.8 30.56 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 165.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -154.91 125.27 6.82 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 61.5 m 68.22 130.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.584 1.154 . . . . 0.0 110.58 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.34 -33.72 76.63 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.843 -0.536 . . . . 0.0 110.75 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . . . . . . . . . 52.1 mtt-85 -73.45 -6.24 45.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.843 0.457 . . . . 0.0 112.207 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.03 -28.65 69.94 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.686 0.794 . . . . 0.0 111.102 171.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -44.71 -81.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.064 1.746 . . . . 0.0 114.441 -166.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . . . . . . . . . . . -111.76 -81.77 0.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -165.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -99.43 -24.23 14.86 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 122.156 -0.34 . . . . 0.0 110.733 -168.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -76.99 -24.07 52.23 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.893 0.746 . . . . 0.0 111.971 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 42.3 ttm105 65.38 15.42 10.01 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 124.006 0.923 . . . . 0.0 112.758 163.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 143.88 -42.49 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -167.7 -59.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.437 0.695 . . . . 0.0 109.889 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 64.85 -102.14 0.09 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.559 1.544 . . . . 0.0 111.798 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 58.39 170.06 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.36 1.064 . . . . 0.0 111.938 -166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.69 -26.15 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.157 0.583 . . . . 0.0 110.029 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 27.5 p -54.94 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.379 1.071 . . . . 0.0 111.228 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -166.54 159.18 14.1 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.686 0.794 . . . . 0.0 109.867 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -87.41 22.07 2.28 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.83 1.252 . . . . 0.0 112.939 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -57.65 -44.84 85.94 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 47.9 t -77.22 -68.8 0.58 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . 0.647 ' H ' HD23 ' B' ' 265' ' ' LEU . 1.6 pt? -96.86 106.28 18.57 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -70.12 -53.56 16.81 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.94 0.496 . . . . 0.0 112.281 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 12.9 t 51.47 41.68 28.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.406 1.082 . . . . 0.0 111.778 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 18.9 m -87.79 1.89 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.605 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 8.1 m 61.75 90.45 0.07 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.171 1.388 . . . . 0.0 110.297 -172.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -58.32 -38.48 77.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.714 1.206 . . . . 0.0 112.112 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -66.78 -29.63 69.63 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.182 0.993 . . . . 0.0 112.32 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -97.39 31.25 2.57 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.237 1.015 . . . . 0.0 109.516 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . 0.446 ' HG3' ' HD3' ' B' ' 276' ' ' PRO . 6.5 tp-100 70.5 122.83 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.365 1.466 . . . . 0.0 109.499 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.12 -65.23 0.66 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.022 0.826 . . . . 0.0 111.324 -169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -154.17 98.71 2.55 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.446 ' HD3' ' HG3' ' B' ' 273' ' ' GLN . 87.7 Cg_endo -77.68 153.96 30.39 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 122.503 2.136 . . . . 0.0 110.282 165.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.629 ' HG ' ' H ' ' B' ' 278' ' ' LEU . 0.5 OUTLIER -122.85 -75.34 0.6 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.996 -179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.629 ' H ' ' HG ' ' B' ' 277' ' ' LEU . 2.9 tm? 59.08 -79.92 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.834 1.253 . . . . 0.0 110.922 -175.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.99 -173.78 33.94 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.8 40.06 1.03 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.651 0.78 . . . . 0.0 109.937 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -89.35 -164.02 1.08 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.264 1.026 . . . . 0.0 110.847 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -78.16 -65.37 0.98 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.165 0.586 . . . . 0.0 112.44 -168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -76.6 -41.76 44.98 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.377 0.671 . . . . 0.0 111.153 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . -71.01 82.25 0.43 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.518 -0.764 . . . . 0.0 114.626 -169.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' B' ' 290' ' ' TRP . 30.7 t30 -115.12 -72.22 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 174.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . . . . . . . . . 7.5 mtp -179.06 161.51 1.01 Allowed Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 126.318 1.847 . . . . 0.0 108.074 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 377' ' ' ALA . 19.3 Cg_endo -59.32 155.22 41.93 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 122.279 1.986 . . . . 0.0 112.726 166.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 5.0 m 54.42 108.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 126.947 2.099 . . . . 0.0 112.749 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 73.51 154.7 0.15 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.75 1.62 . . . . 0.0 109.515 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.687 ' HZ3' HD11 ' A' ' 394' ' ' LEU . 0.0 OUTLIER 97.7 -178.66 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 126.258 1.823 . . . . 0.0 112.195 -141.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . . . . . . . . . 32.4 tp 59.1 92.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.663 1.585 . . . . 0.0 112.584 168.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -138.87 56.36 0.65 Allowed Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.934 -0.926 . . . . 0.0 114.156 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -94.06 41.23 0.2 Allowed 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.951 2.434 . . . . 0.0 110.073 173.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -87.3 81.31 7.95 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.512 -163.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . 0.635 HG22 ' H ' ' B' ' 298' ' ' HIS . 22.5 m 59.55 -110.35 0.47 Allowed 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 113.242 -1.799 . . . . 0.0 113.216 165.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 88.8 t80 59.46 19.13 7.51 Favored 'General case' 0 CA--C 1.579 2.081 0 CA-C-O 122.797 1.284 . . . . 0.0 110.253 -165.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . 0.635 ' H ' HG22 ' B' ' 296' ' ' THR . 7.1 m-70 -88.65 12.24 15.28 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.742 1.217 . . . . 0.0 110.901 -177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.01 -2.53 52.9 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.4 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -60.48 -28.0 68.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.884 0.874 . . . . 0.0 111.132 171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.772 HG22 ' H ' ' B' ' 303' ' ' LYS . 43.7 mt -87.57 -81.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.642 0.777 . . . . 0.0 110.079 177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . . . . . . . . . 36.7 t70 57.82 14.11 2.37 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.804 1.242 . . . . 0.0 112.645 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . 0.772 ' H ' HG22 ' B' ' 301' ' ' ILE . 60.6 tttp -77.64 123.53 86.61 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.128 0.971 . . . . 0.0 110.832 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.88 99.3 1.06 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.304 2.003 . . . . 0.0 110.825 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 361' ' ' LYS . . . -65.24 94.02 0.15 Allowed 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.129 0.572 . . . . 0.0 110.748 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 14.9 p -73.02 152.21 7.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.24 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 3.1 t -57.13 133.01 54.64 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.88 0.872 . . . . 0.0 109.631 170.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 87.4 m -69.57 88.13 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' B' ' 310' ' ' PRO . 7.6 t -136.59 136.24 21.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.699 0.8 . . . . 0.0 109.354 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 309' ' ' THR . 5.2 Cg_exo . . . . . 0 C--N 1.379 2.177 0 C-N-CA 122.853 2.369 . . . . 12.53 111.48 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 121.211 0.529 . . . . 15.0 109.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -75.86 86.2 2.82 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG12 HG12 ' A' ' 17' ' ' ILE . 27.5 m -120.22 135.83 59.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.495 1.118 . . . . 15.0 109.267 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 p -147.2 129.35 15.58 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.363 0.665 . . . . 15.0 109.344 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -114.22 101.92 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 CA-C-O 121.692 0.758 . . . . 15.0 111.191 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.48 163.86 16.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.195 0.998 . . . . 15.0 110.21 173.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.7 m -115.33 107.46 15.26 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.404 -0.961 . . . . 15.0 108.404 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.5 p -80.68 -49.25 11.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.434 0.694 . . . . 15.0 110.885 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -154.59 71.51 0.82 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.9 -87.43 0.08 OUTLIER Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.655 -0.702 . . . . 15.0 113.663 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.2 -39.08 86.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.367 0.667 . . . . 15.0 109.487 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 101.38 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.436 1.085 . . . . 15.0 112.272 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -118.85 120.71 38.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.843 1.257 . . . . 15.0 109.841 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -100.4 100.32 11.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.984 1.314 . . . . 15.0 110.565 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -86.73 89.29 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 169.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 106' ' ' SER . 27.9 m -73.35 104.31 4.32 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.53 0.732 . . . . 15.0 109.679 174.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG21 ' HB3' ' A' ' 74' ' ' ASN . 24.9 mt -100.23 154.31 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.018 0.927 . . . . 15.0 108.74 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 86.0 m -132.33 116.76 17.28 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.534 0.734 . . . . 15.0 109.358 174.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 103' ' ' PHE . 83.3 mt -66.28 125.3 23.23 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 108.744 -0.835 . . . . 15.0 108.744 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.98 149.9 46.33 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.964 0.79 . . . . 15.0 111.359 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.78 -40.49 79.96 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.26 1.024 . . . . 15.0 111.711 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -65.23 -28.57 69.46 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.048 -0.978 . . . . 15.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -80.54 -28.57 37.29 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.361 0.664 . . . . 15.0 110.959 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.36 -11.79 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 123.758 0.823 . . . . 15.0 110.299 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -95.26 -64.39 1.07 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.588 0.755 . . . . 15.0 110.379 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.3 m -72.02 -34.99 69.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.246 0.832 . . . . 15.0 113.246 -163.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.69 69.31 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.545 0.157 . . . . 15.0 110.753 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.541 HG22 HG21 ' A' ' 66' ' ' VAL . 45.2 t -69.44 -40.18 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 121.488 0.661 . . . . 15.0 110.009 174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -60.84 -47.72 85.07 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.527 1.131 . . . . 15.0 110.109 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 m -76.45 -12.16 60.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.901 -1.045 . . . . 15.0 111.064 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 12.4 tp10 -82.37 -34.81 28.25 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.098 0.559 . . . . 15.0 109.958 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.0 mt -73.1 -28.31 62.21 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.538 0.735 . . . . 15.0 112.389 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG22 ' HE3' ' A' ' 37' ' ' LYS . 12.7 p -75.65 -23.95 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 110.09 -0.337 . . . . 15.0 110.09 174.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -65.5 -45.44 83.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.208 -0.664 . . . . 15.0 109.208 169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' GLU . 25.7 t -65.31 -38.43 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.16 -0.927 . . . . 15.0 110.017 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.13 90.56 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.604 -0.726 . . . . 15.0 111.286 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.446 ' HE3' HG22 ' A' ' 33' ' ' VAL . 99.3 mttt -71.49 -34.4 70.11 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.465 0.306 . . . . 15.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -66.41 -50.31 63.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.249 1.02 . . . . 15.0 110.952 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.57 0.81 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.529 0.732 . . . . 15.0 110.095 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 73.77 4.79 4.76 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.021 1.728 . . . . 15.0 112.413 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -54.94 -33.11 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 125.535 1.534 . . . . 15.0 111.883 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -55.41 -36.47 66.49 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.008 0.923 . . . . 15.0 112.045 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.4 59.7 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.731 -0.668 . . . . 15.0 113.834 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -99.65 -30.99 11.8 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.335 0.567 . . . . 15.0 111.093 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -70.85 125.61 27.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.342 0.657 . . . . 15.0 109.371 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -65.09 -32.11 73.65 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.055 0.942 . . . . 15.0 111.173 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.44 23.12 63.42 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-N 115.177 -0.919 . . . . 15.0 112.049 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -72.14 -47.73 48.83 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.617 0.767 . . . . 15.0 109.825 176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.04 129.82 77.32 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 115.088 -0.96 . . . . 15.0 108.874 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.06 117.85 3.97 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.247 2.632 . . . . 15.0 112.48 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 58.6 tpp -55.9 -42.11 75.51 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.265 1.026 . . . . 15.0 111.139 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -68.53 -35.62 77.7 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.202 0.601 . . . . 15.0 112.516 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mt -71.27 -26.68 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.377 0.671 . . . . 15.0 110.82 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG12 ' NH1' ' A' ' 57' ' ' ARG . 28.9 m -97.74 -11.93 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 122.283 -0.261 . . . . 15.0 111.126 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.63 -34.5 65.04 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.793 0.437 . . . . 15.0 111.14 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -66.62 -24.9 66.38 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.876 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' NH1' HG12 ' A' ' 54' ' ' VAL . 82.1 mtt180 -85.57 -64.91 1.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.269 1.028 . . . . 15.0 110.172 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.46 -31.65 72.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.254 1.022 . . . . 15.0 111.919 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.45 -11.71 84.12 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-O 119.137 -0.813 . . . . 15.0 114.385 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.93 -25.53 65.52 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.298 0.639 . . . . 15.0 112.087 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.7 p -81.1 -51.31 8.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.796 0.438 . . . . 15.0 110.425 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.33 90.59 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-O 122.401 1.096 . . . . 15.0 111.136 -177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.24 -31.1 5.42 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.183 -0.917 . . . . 15.0 110.104 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -62.8 -41.04 99.11 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.928 0.891 . . . . 15.0 111.86 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.83 -37.72 82.28 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.747 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 28' ' ' VAL . 57.5 t -65.71 -56.28 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.681 0.793 . . . . 15.0 110.046 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.03 -45.1 78.48 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.739 0.816 . . . . 15.0 110.656 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.83 -32.88 66.68 Favored Glycine 0 N--CA 1.477 1.372 0 O-C-N 123.396 0.435 . . . . 15.0 113.313 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.34 -56.68 4.42 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.882 0.873 . . . . 15.0 110.724 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.79 -41.44 95.82 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.374 0.67 . . . . 15.0 111.827 -171.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 70.5 mtm -60.69 -39.39 88.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.099 0.559 . . . . 15.0 111.089 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.3 t -69.94 -45.08 68.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.744 0.818 . . . . 15.0 111.131 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.51 ' HA ' HG22 ' A' ' 76' ' ' ILE . 44.7 mtm180 -78.24 -44.36 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.229 -0.441 . . . . 15.0 111.811 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.575 ' HB3' HG21 ' A' ' 17' ' ' ILE . 16.8 m-80 -56.37 -31.07 63.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.043 0.537 . . . . 15.0 110.94 173.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.49 -54.69 8.54 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.813 0.696 . . . . 15.0 111.551 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 73' ' ' ARG . 14.3 tt -66.51 -42.61 90.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 123.181 0.301 . . . . 15.0 111.063 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -64.47 -32.1 73.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.882 0.473 . . . . 15.0 111.308 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 123.412 0.445 . . . . 15.0 110.342 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 84' ' ' ILE . 35.8 pt -67.12 -22.86 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 112.32 0.489 . . . . 15.0 112.32 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -69.34 -49.47 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.031 0.533 . . . . 15.0 110.186 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -73.89 -27.11 60.89 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.411 0.148 . . . . 15.0 111.357 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -87.5 -10.38 51.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.299 0.64 . . . . 15.0 111.083 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm 60.58 31.71 20.28 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.536 1.134 . . . . 15.0 111.335 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 72.6 mt -92.13 124.84 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 C-N-CA 124.292 1.037 . . . . 15.0 109.687 175.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -113.34 104.88 55.57 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.052 0.541 . . . . 15.0 109.549 177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.03 178.84 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 124.315 3.343 . . . . 15.0 115.545 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.03 141.46 21.59 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.661 1.184 . . . . 15.0 109.561 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HB1' ' A' ' 305' ' ' ALA . . . 75.86 -91.07 0.88 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.68 0.613 . . . . 15.0 112.836 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . . . -161.87 136.86 5.41 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.025 0.93 . . . . 15.0 110.182 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 109' ' ' PHE . 2.0 Cg_endo -82.75 121.37 3.27 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.167 2.578 . . . . 15.0 112.268 175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.5 m -82.22 93.69 7.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.905 0.882 . . . . 15.0 109.553 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -73.05 95.09 1.98 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.308 -0.997 . . . . 15.0 108.308 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.9 t -90.13 105.7 12.23 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.45 -0.944 . . . . 15.0 108.45 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.85 123.72 11.37 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.592 2.195 . . . . 15.0 111.421 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -66.7 -61.17 5.51 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.229 -0.748 . . . . 15.0 111.229 173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -172.09 145.85 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.869 0.868 . . . . 15.0 109.58 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -124.0 116.73 23.31 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.406 0.682 . . . . 15.0 110.325 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 101' ' ' GLU . 91.3 mttt -114.2 150.73 33.82 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.629 0.772 . . . . 15.0 109.424 173.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.34 91.86 2.74 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.649 0.78 . . . . 15.0 108.898 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 121.49 -50.59 0.83 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.838 -0.619 . . . . 15.0 112.377 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 98' ' ' LYS . 49.2 mt-10 -76.16 149.65 37.28 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.207 0.504 . . . . 15.0 110.819 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.32 137.67 57.0 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.863 1.665 . . . . 15.0 112.848 -169.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 24.6 t80 -93.58 98.08 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.762 0.825 . . . . 15.0 110.301 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.5 m -80.05 140.95 36.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.245 0.618 . . . . 15.0 109.6 171.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HE1' HG13 ' A' ' 19' ' ' ILE . 21.2 p90 -156.24 124.94 5.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.209 1.004 . . . . 15.0 109.979 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 61.0 m -86.64 102.74 14.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.667 1.187 . . . . 15.0 110.541 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.41 92.1 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.955 -0.758 . . . . 15.0 108.955 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -89.3 111.37 22.18 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.653 0.781 . . . . 15.0 109.937 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 90' ' ' PRO . 31.7 p90 -131.83 -174.79 3.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.617 -0.883 . . . . 15.0 108.617 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 303' ' ' PRO . 49.8 mt-10 -129.41 169.0 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.698 0.799 . . . . 15.0 109.292 172.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.35 158.71 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.759 0.824 . . . . 15.0 111.056 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -73.44 115.61 43.06 Favored Pre-proline 0 N--CA 1.479 1.02 0 N-CA-C 108.889 -0.782 . . . . 15.0 108.889 169.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HD3' ' HD3' ' A' ' 303' ' ' PRO . 84.1 Cg_endo -75.31 160.22 39.37 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.54 2.16 . . . . 15.0 113.013 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.96 129.12 37.25 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.473 -1.306 . . . . 15.0 107.473 168.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 353' ' ' GLU . 59.7 t -103.27 141.11 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.829 0.851 . . . . 15.0 112.002 -166.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -85.01 108.79 17.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 15.0 111.215 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 120' ' ' LEU . 85.4 mt -88.43 98.92 11.89 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.867 -0.79 . . . . 15.0 108.867 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -142.7 137.48 29.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.869 0.868 . . . . 15.0 109.97 -172.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.28 17.79 79.72 Favored Glycine 0 C--N 1.342 0.915 0 O-C-N 123.038 0.211 . . . . 15.0 113.369 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.457 HD23 HD21 ' A' ' 298' ' ' ASN . 81.2 mt -64.98 -22.98 67.09 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.542 0.737 . . . . 15.0 111.337 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -82.16 -25.02 34.71 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.912 0.885 . . . . 15.0 110.65 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.82 -13.78 60.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.91 0.484 . . . . 15.0 111.728 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 29.1 mt -73.57 89.68 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.744 0.817 . . . . 15.0 109.6 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.32 97.29 10.33 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.896 -0.779 . . . . 15.0 108.896 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.87 115.2 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.315 0.646 . . . . 15.0 109.382 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.454 ' HB3' HE22 ' A' ' 289' ' ' GLN . 2.6 tm-20 -80.72 102.31 9.83 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.088 -1.079 . . . . 15.0 108.088 176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 419' ' ' GLU . 78.0 tttt -93.98 108.38 34.83 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.758 0.823 . . . . 15.0 109.707 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.53 118.73 0.67 Allowed 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 122.279 1.986 . . . . 15.0 112.2 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 421' ' ' GLU . 45.3 mm -72.0 82.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.881 -1.155 . . . . 15.0 107.881 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' A' ' 427' ' ' LEU . 41.1 t -80.02 118.28 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.802 -1.09 . . . . 15.0 108.113 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -115.8 152.52 33.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.239 0.616 . . . . 15.0 109.926 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG23 HD22 ' A' ' 278' ' ' LEU . 15.9 t -95.45 94.48 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.031 -1.1 . . . . 15.0 108.031 173.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.0 p -70.64 172.93 7.79 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.184 0.594 . . . . 15.0 109.895 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -52.72 -42.18 64.62 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.663 0.785 . . . . 15.0 111.116 173.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.39 90.89 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.302 -1.317 . . . . 15.0 111.485 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -77.32 -28.74 53.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.765 0.426 . . . . 15.0 111.629 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 133' ' ' THR . 97.5 t -68.5 -57.72 8.12 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 -19.97 61.88 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.573 0.545 . . . . 15.0 111.831 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.86 -43.54 73.62 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.152 -0.779 . . . . 15.0 111.152 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.8 -43.16 94.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.163 0.585 . . . . 15.0 110.566 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD11 ' HG2' ' A' ' 267' ' ' ARG . 93.5 mt -61.72 -47.23 86.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.336 0.654 . . . . 15.0 110.277 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -57.93 -47.43 82.88 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.344 1.057 . . . . 15.0 110.713 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 87.5 m -62.0 -51.82 66.48 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.863 0.727 . . . . 15.0 111.756 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.03 -30.66 69.94 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.352 0.261 . . . . 15.0 111.022 -175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.42 HH21 ' HB3' ' A' ' 245' ' ' LEU . 65.7 mtp85 -72.7 -30.53 64.29 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.131 -0.486 . . . . 15.0 111.006 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 149' ' ' ALA . 92.7 mttt -77.15 -23.77 51.63 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.752 0.421 . . . . 15.0 111.833 173.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -76.19 -38.9 55.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.145 0.578 . . . . 15.0 110.159 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -101.57 27.78 6.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.741 0.816 . . . . 15.0 110.775 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . . . -79.75 156.92 27.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.63 0.772 . . . . 15.0 112.387 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 30.3 m -90.75 121.44 32.63 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.043 -0.98 . . . . 15.0 108.978 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -77.74 99.35 5.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.813 0.816 . . . . 15.0 109.452 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -96.97 115.95 28.33 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.153 -1.385 . . . . 15.0 108.782 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -67.64 117.31 9.4 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.566 -0.901 . . . . 15.0 108.566 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.675 ' HD3' ' HB2' ' A' ' 242' ' ' GLU . 54.4 pttt -126.81 -176.23 3.64 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.846 0.858 . . . . 15.0 112.46 -167.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 207' ' ' ALA . 19.6 t70 -151.58 145.13 24.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.231 1.412 . . . . 15.0 108.552 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 121.99 -39.27 2.36 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.717 0.647 . . . . 15.0 114.717 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -157.03 148.56 22.32 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.799 0.8 . . . . 15.0 110.954 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.679 ' HB ' ' HA ' ' A' ' 203' ' ' LYS . 63.4 t -100.4 123.68 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 108.899 -0.778 . . . . 15.0 108.899 168.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.16 175.2 6.38 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 118.165 0.439 . . . . 15.0 110.257 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.22 -15.8 59.96 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.392 1.256 . . . . 15.0 114.392 -161.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -128.31 6.58 5.84 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.349 0.66 . . . . 15.0 111.816 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -79.87 162.86 24.78 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.264 0.554 . . . . 15.0 112.033 -173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 188' ' ' ALA . 37.5 ttm180 -89.76 108.18 19.54 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.598 -0.728 . . . . 15.0 109.502 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.62 HG11 HG21 ' A' ' 202' ' ' ILE . 99.1 t -100.67 146.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 124.415 1.086 . . . . 15.0 110.114 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 239' ' ' LYS . 56.8 m -120.31 123.43 43.11 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.973 0.909 . . . . 15.0 108.581 173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 237' ' ' LEU . 45.1 pt -137.07 159.5 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.525 0.73 . . . . 15.0 111.261 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.92 108.74 18.2 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.365 -1.717 . . . . 15.0 106.365 162.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.458 ' HB2' HD13 ' A' ' 235' ' ' ILE . 23.3 p90 -112.14 125.34 54.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.058 0.845 . . . . 15.0 110.765 -177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.486 HG22 ' HG3' ' A' ' 181' ' ' LYS . 32.8 p -134.79 104.37 5.99 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 114.856 -1.065 . . . . 15.0 110.534 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.95 -179.1 32.59 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 117.634 0.197 . . . . 15.0 112.643 176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.1 m -103.24 129.32 50.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.409 1.084 . . . . 15.0 109.663 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 33.2 t -93.38 112.45 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.827 0.851 . . . . 15.0 108.885 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 229' ' ' LYS . 32.8 t70 63.69 27.87 14.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.254 1.022 . . . . 15.0 110.787 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.1 11.04 73.72 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.128 -0.942 . . . . 15.0 113.52 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -138.15 133.86 33.86 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.358 0.579 . . . . 15.0 110.304 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -84.76 101.3 12.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.549 0.739 . . . . 15.0 110.398 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.489 ' HB3' ' HB2' ' B' ' 233' ' ' PHE . 76.4 m-85 -86.43 -176.62 5.94 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.504 0.722 . . . . 15.0 110.181 172.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.541 ' HB3' ' HB3' ' B' ' 233' ' ' PHE . 10.7 tp10 -56.03 147.31 20.24 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 163.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.18 -32.98 2.24 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-N 118.981 0.81 . . . . 15.0 112.324 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.486 ' HA2' ' HE1' ' A' ' 233' ' ' PHE . . . -52.52 -28.57 29.34 Favored Glycine 0 C--N 1.37 2.432 0 C-N-CA 123.673 0.654 . . . . 15.0 112.463 169.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' HG3' HG22 ' A' ' 169' ' ' THR . 87.7 tttt -127.69 118.8 24.5 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.824 -1.176 . . . . 15.0 107.824 164.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -148.39 120.15 8.1 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.235 0.614 . . . . 15.0 109.832 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.3 p -100.34 143.61 30.33 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.562 0.745 . . . . 15.0 110.105 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 186' ' ' VAL . 17.6 m-20 59.83 32.68 21.42 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.884 1.274 . . . . 15.0 111.521 177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.97 94.93 0.04 OUTLIER 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.332 1.053 . . . . 15.0 109.691 175.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 240' ' ' GLY . 71.6 t -80.81 89.27 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 114.625 -1.17 . . . . 15.0 109.654 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.2 tp -93.29 98.17 11.08 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.37 1.068 . . . . 15.0 110.408 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' ARG . . . -75.24 85.3 2.43 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.12 -1.437 . . . . 15.0 107.12 164.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.477 ' SD ' ' HD2' ' A' ' 203' ' ' LYS . 15.3 ptp -69.03 -178.15 1.19 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.361 1.064 . . . . 15.0 113.195 -168.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 84.35 12.64 75.47 Favored Glycine 0 C--N 1.351 1.417 0 CA-C-N 115.005 -0.998 . . . . 15.0 111.481 -168.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -113.98 130.99 56.49 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.794 0.838 . . . . 15.0 108.822 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.06 36.88 3.13 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.682 0.614 . . . . 15.0 114.116 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -91.71 -46.08 8.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.818 0.847 . . . . 15.0 109.052 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' MET . . . . . 0.544 ' HB2' HG21 ' B' ' 238' ' ' THR . 43.8 tpp -77.59 163.17 26.5 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.459 -1.246 . . . . 15.0 109.083 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 49.0 mt -49.07 121.82 11.03 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.153 1.381 . . . . 15.0 110.693 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.17 115.25 2.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.038 1.826 . . . . 15.0 108.514 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.79 -39.01 2.36 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 111.81 -0.516 . . . . 15.0 111.81 -170.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -58.31 -49.67 76.36 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 117.292 0.546 . . . . 15.0 110.534 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.47 -37.39 86.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.662 -0.699 . . . . 15.0 110.836 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.47 -29.58 68.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.595 0.758 . . . . 15.0 111.305 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.431 ' HA3' HG21 ' A' ' 213' ' ' ILE . . . -64.48 -37.55 94.59 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.681 0.613 . . . . 15.0 112.082 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.62 HG21 HG11 ' A' ' 164' ' ' VAL . 77.0 mt -68.52 -41.83 83.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.024 0.93 . . . . 15.0 110.353 174.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.679 ' HA ' ' HB ' ' A' ' 158' ' ' VAL . 42.3 mtpt -68.39 -17.93 64.34 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.276 1.03 . . . . 15.0 113.279 -175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -78.76 5.19 58.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 120.103 -0.276 . . . . 15.0 113.192 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -130.53 -175.89 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.799 1.239 . . . . 15.0 109.818 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -113.66 -68.68 0.91 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.525 1.676 . . . . 15.0 115.525 -162.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 237' ' ' LEU . . . -149.77 -59.64 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 113.94 1.089 . . . . 15.0 113.94 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.29 54.03 0.78 Allowed Glycine 0 N--CA 1.474 1.182 0 N-CA-C 114.09 0.396 . . . . 15.0 114.09 -167.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 237' ' ' LEU . 15.4 pt-20 -132.92 138.66 47.03 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.672 0.736 . . . . 15.0 111.867 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.42 143.23 29.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.35 0.66 . . . . 15.0 109.859 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.448 ' HZ ' ' HA ' ' A' ' 202' ' ' ILE . 30.8 p90 -160.51 -177.94 6.55 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.372 1.069 . . . . 15.0 109.502 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.3 m -131.93 146.84 52.35 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.999 -0.741 . . . . 15.0 108.999 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.431 HG21 ' HA3' ' A' ' 201' ' ' GLY . 34.0 pt -128.88 140.52 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 122.828 0.451 . . . . 15.0 110.875 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -89.97 96.89 10.89 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.155 0.982 . . . . 15.0 109.027 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 21.3 m -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.493 0.717 . . . . 15.0 110.68 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 57.3 m -138.22 110.41 7.35 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.602 1.161 . . . . 15.0 107.878 167.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' A' ' 218' ' ' PRO . 61.5 m-85 -46.45 143.05 4.12 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.519 1.528 . . . . 15.0 112.247 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' A' ' 220' ' ' GLU . 33.3 Cg_endo -84.68 167.65 11.41 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.851 2.367 . . . . 15.0 112.756 -171.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -79.79 0.23 31.69 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.514 -0.766 . . . . 15.0 110.117 168.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.444 ' H ' ' HB2' ' A' ' 218' ' ' PRO . 37.7 mt-10 -76.37 -27.5 56.42 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.083 0.953 . . . . 15.0 109.054 172.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.439 ' HB2' ' HD2' ' A' ' 218' ' ' PRO . 0.6 OUTLIER -74.76 125.73 29.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.296 1.038 . . . . 15.0 109.724 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -99.41 16.04 24.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.881 0.873 . . . . 15.0 111.726 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -98.74 111.79 24.06 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.45 -1.315 . . . . 15.0 107.45 168.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -57.67 -42.9 84.52 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.864 0.865 . . . . 15.0 112.073 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -66.06 -14.41 61.67 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.584 -1.189 . . . . 15.0 112.826 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' B' ' 233' ' ' PHE . 49.8 mt -114.74 -32.77 5.71 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 15.0 112.246 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -69.59 138.65 53.35 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 117.685 0.22 . . . . 15.0 110.495 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 71.01 1.72 42.31 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-O 119.328 -0.707 . . . . 15.0 114.435 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 173' ' ' ASP . 69.6 mmtt -80.93 143.93 32.26 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.936 0.868 . . . . 15.0 110.092 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -106.56 130.84 54.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.942 0.497 . . . . 15.0 110.037 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -128.19 158.17 38.82 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.714 0.805 . . . . 15.0 110.713 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -128.12 96.27 4.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.854 -0.795 . . . . 15.0 108.854 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.486 ' HE1' ' HA2' ' A' ' 180' ' ' GLY . 65.2 m-85 -93.48 128.4 39.55 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.346 0.658 . . . . 15.0 110.786 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.36 91.03 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.511 0.724 . . . . 15.0 109.064 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.458 HD13 ' HB2' ' A' ' 168' ' ' PHE . 13.9 mm -75.48 101.31 2.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.82 0 C-N-CA 124.576 1.151 . . . . 15.0 110.209 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -82.05 88.29 6.43 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.298 -1.371 . . . . 15.0 107.298 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.641 ' HA ' HG22 ' A' ' 166' ' ' ILE . 46.4 tp -68.1 119.86 13.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.609 -0.886 . . . . 15.0 108.609 179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -109.52 -58.22 2.07 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.537 0.735 . . . . 15.0 110.062 -171.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 165' ' ' THR . 96.4 mttt -134.5 160.82 36.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.894 -1.048 . . . . 15.0 110.467 -173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 6.8 t -142.24 142.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 106.37 -1.715 . . . . 15.0 106.37 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.52 107.42 8.86 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.99 -0.744 . . . . 15.0 108.99 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.675 ' HB2' ' HD3' ' A' ' 154' ' ' LYS . 34.4 tt0 -65.81 132.01 47.68 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.515 1.126 . . . . 15.0 109.537 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -80.88 67.77 6.9 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.077 -1.083 . . . . 15.0 108.077 167.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.02 133.88 52.64 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.288 -0.869 . . . . 15.0 109.607 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.42 ' HB3' HH21 ' A' ' 145' ' ' ARG . 78.3 mt -50.89 128.93 28.41 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.72 1.263 . . . . 15.0 109.78 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.58 -167.58 0.42 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.01 2.473 . . . . 15.0 111.659 -170.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -60.03 153.81 20.64 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.574 0.702 . . . . 15.0 111.074 173.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 20.9 tp -122.74 10.99 9.69 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.365 1.066 . . . . 15.0 108.206 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 253' ' ' ILE . 39.5 m -51.42 139.92 18.68 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 125.349 1.46 . . . . 15.0 110.553 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -45.49 -48.2 14.06 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 124.863 1.352 . . . . 15.0 112.815 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -72.4 -19.22 61.64 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.99 0.806 . . . . 15.0 112.902 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -84.16 -54.7 4.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.197 0.599 . . . . 15.0 110.137 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.562 HG23 ' HA3' ' A' ' 261' ' ' GLY . 4.6 tt -65.49 -29.59 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.364 0 C-N-CA 123.045 0.538 . . . . 15.0 111.535 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -77.61 -16.18 58.75 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 122.095 -0.378 . . . . 15.0 111.874 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -68.1 -19.63 64.86 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 123.111 0.564 . . . . 15.0 110.624 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -73.13 -11.51 60.56 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.837 0.855 . . . . 15.0 111.992 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.536 ' HA3' ' HB2' ' B' ' 275' ' ' LYS . . . 119.48 47.46 0.37 Allowed Glycine 0 C--N 1.354 1.551 0 CA-C-O 120.333 -0.148 . . . . 15.0 112.923 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.06 152.52 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.089 0.956 . . . . 15.0 108.435 176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -75.15 -47.16 29.84 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.562 0.745 . . . . 15.0 110.121 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -124.02 113.82 18.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.165 -1.05 . . . . 15.0 108.165 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.562 ' HA3' HG23 ' A' ' 253' ' ' ILE . . . -75.67 71.63 1.85 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.404 -0.362 . . . . 15.0 112.222 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 39.1 m -95.93 139.62 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.513 -1.291 . . . . 15.0 107.513 172.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.02 -46.56 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.247 0.619 . . . . 15.0 110.197 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.42 -34.47 66.8 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.386 1.075 . . . . 15.0 111.179 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -81.07 -22.1 61.7 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 115.497 -0.774 . . . . 15.0 111.414 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 253' ' ' ILE . 63.3 tp -77.79 -40.08 41.88 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 108.302 -0.999 . . . . 15.0 108.302 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.449 ' HG2' HD11 ' A' ' 141' ' ' LEU . 77.1 mtt85 -64.7 -37.22 86.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.396 -0.365 . . . . 15.0 110.903 175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.3 -37.98 71.78 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.546 0.739 . . . . 15.0 111.26 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HG3' HD22 ' B' ' 277' ' ' LEU . 44.9 tp10 -64.68 -54.44 31.62 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.939 0.896 . . . . 15.0 109.806 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' VAL . . . . . 0.547 HG13 ' SD ' ' A' ' 274' ' ' MET . 53.3 t -56.44 -39.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.739 1.216 . . . . 15.0 110.545 174.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -60.34 -60.01 4.5 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.899 0.48 . . . . 15.0 110.61 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -66.01 -37.22 85.36 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.463 0.477 . . . . 15.0 111.261 -172.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -73.15 -47.21 45.82 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.631 0.372 . . . . 15.0 110.821 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' MET . . . . . 0.547 ' SD ' HG13 ' A' ' 270' ' ' VAL . 82.8 mtp -84.23 -13.29 53.04 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-O 117.881 -1.057 . . . . 15.0 112.97 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.1 -32.26 50.5 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.289 0.95 . . . . 15.0 109.964 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -69.15 -46.25 68.03 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.639 -0.709 . . . . 15.0 109.141 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLU . . . . . 0.564 ' HG3' ' HB3' ' B' ' 283' ' ' ASP . 41.9 tt0 -64.77 -35.46 81.15 Favored 'General case' 0 CA--C 1.551 0.996 0 O-C-N 124.199 0.937 . . . . 15.0 110.737 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.561 HD22 HG23 ' A' ' 132' ' ' VAL . 62.2 tp -62.69 -60.36 3.62 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.826 0.851 . . . . 15.0 110.68 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -62.03 -32.03 72.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.917 0.761 . . . . 15.0 110.635 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.449 ' OG ' ' HB3' ' B' ' 291' ' ' LEU . 22.0 t -64.9 -44.17 90.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.07 0.948 . . . . 15.0 110.611 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 427' ' ' LEU . . . -75.6 -30.71 59.68 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.8 -0.637 . . . . 15.0 112.106 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 81.0 mt -69.88 -35.57 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.657 -0.868 . . . . 15.0 108.657 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.768 HH21 ' HB3' ' A' ' 405' ' ' GLU . 30.1 tpt180 -65.15 -44.78 87.48 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.56 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' B' ' 291' ' ' LEU . 91.7 m-20 -66.49 -32.28 73.54 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.658 0.783 . . . . 15.0 111.433 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ARG . . . . . . . . . . . . . 6.2 tpt85 -64.12 -59.41 4.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.828 0.851 . . . . 15.0 110.436 176.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.3 -40.53 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.711 0.804 . . . . 15.0 110.471 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.482 ' O ' HG12 ' A' ' 291' ' ' ILE . 87.8 tttt -61.03 -53.02 62.31 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.519 0.728 . . . . 15.0 110.737 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 79.3 p -62.16 -42.34 99.17 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.786 0.434 . . . . 15.0 111.663 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . 0.454 HE22 ' HB3' ' A' ' 126' ' ' GLU . 52.3 mt-30 -62.93 -43.73 98.01 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.194 0.598 . . . . 15.0 110.958 176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.534 ' O ' ' HB2' ' A' ' 294' ' ' LEU . . . -60.95 -50.18 74.43 Favored 'General case' 0 C--O 1.219 -0.513 0 O-C-N 124.125 0.89 . . . . 15.0 111.157 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 287' ' ' LYS . 40.1 mm -58.82 -53.29 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.544 1.138 . . . . 15.0 110.589 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -60.16 -51.75 68.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.147 -0.933 . . . . 15.0 110.93 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . -63.8 -34.1 89.03 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.123 0.889 . . . . 15.0 113.071 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 411' ' ' VAL . 2.4 tt -61.5 -61.99 2.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.005 0.922 . . . . 15.0 109.044 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG21 HG22 ' A' ' 347' ' ' VAL . 44.5 t -60.95 -39.59 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.547 -0.751 . . . . 15.0 110.607 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -59.9 -37.12 78.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.012 0.925 . . . . 15.0 111.56 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -87.34 -5.67 58.8 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.258 0.623 . . . . 15.0 112.329 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.457 HD21 HD23 ' A' ' 120' ' ' LEU . 7.7 m-80 -123.22 165.39 16.99 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.263 0.625 . . . . 15.0 112.177 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -139.65 126.55 20.84 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.418 1.087 . . . . 15.0 109.087 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 115' ' ' VAL . 8.6 tp -161.71 143.11 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.454 0.702 . . . . 15.0 110.297 168.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.0 156.21 17.58 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.139 0.976 . . . . 15.0 110.08 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.455 HG21 ' HB ' ' A' ' 345' ' ' VAL . 59.2 t -118.86 140.12 28.15 Favored Pre-proline 0 C--O 1.241 0.651 0 CA-C-N 114.294 -1.321 . . . . 15.0 109.123 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' GLU . 11.1 Cg_endo -55.7 130.82 42.51 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.635 2.223 . . . . 15.0 110.986 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ALA . . . . . . . . . . . . . . . -54.33 -26.48 29.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.891 1.276 . . . . 15.0 112.406 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.495 ' HB1' ' HA3' ' A' ' 88' ' ' GLY . . . -60.56 -48.93 79.6 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.895 0.878 . . . . 15.0 111.425 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 62.1 mt -69.35 -37.32 77.6 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.885 -0.598 . . . . 15.0 110.713 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 311' ' ' ILE . 55.4 mt -60.87 -49.18 85.69 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 CA-C-N 115.247 -0.888 . . . . 15.0 108.881 176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.47 -37.49 81.21 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.544 1.138 . . . . 15.0 111.618 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 313' ' ' VAL . 47.0 m -57.87 -54.11 50.62 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.983 0.802 . . . . 15.0 110.434 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.572 ' HG3' HG22 ' A' ' 345' ' ' VAL . 14.6 mm-40 -63.83 -40.59 96.97 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.598 -0.728 . . . . 15.0 111.994 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 337' ' ' PHE . 97.4 mt -56.62 -49.41 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.185 0.994 . . . . 15.0 108.734 177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 316' ' ' ARG . 29.7 t70 -62.74 -44.68 95.58 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 124.522 1.139 . . . . 15.0 111.006 -175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 309' ' ' SER . 91.9 t -60.05 -43.85 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 123.693 0.62 . . . . 15.0 110.794 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.31 -29.96 69.68 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.314 0.645 . . . . 15.0 111.162 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ARG . . . . . 0.436 ' HE ' ' HA ' ' A' ' 312' ' ' ASP . 37.3 mtm180 -75.27 -32.74 61.13 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.611 0.764 . . . . 15.0 110.567 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 312' ' ' ASP . 94.1 mtt180 -66.49 -50.94 61.61 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.281 0.632 . . . . 15.0 109.474 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -62.33 -35.15 78.19 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.62 -1.173 . . . . 15.0 110.935 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -70.21 -49.38 50.83 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.855 -0.611 . . . . 15.0 110.933 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.12 70.66 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.527 0.731 . . . . 15.0 111.12 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.64 -44.49 96.33 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.703 1.201 . . . . 15.0 109.673 172.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -79.1 -19.81 50.27 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.416 0.687 . . . . 15.0 110.738 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -84.91 0.14 52.16 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.274 1.029 . . . . 15.0 110.83 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . 119.05 13.67 6.38 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-O 119.87 -0.406 . . . . 15.0 112.761 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 67.93 34.93 83.46 Favored Glycine 0 C--N 1.357 1.699 0 CA-C-N 116.877 0.339 . . . . 15.0 112.39 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -66.49 136.09 55.17 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.492 0.717 . . . . 15.0 111.272 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -59.29 87.96 0.01 OUTLIER 'General case' 0 C--N 1.358 0.975 0 C-N-CA 125.405 1.482 . . . . 15.0 112.697 -175.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm 56.3 24.48 8.31 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.65 -1.159 . . . . 15.0 112.759 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -73.98 -3.4 28.96 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.74 0.816 . . . . 15.0 109.476 171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 315' ' ' ARG . . . -41.05 -57.95 1.88 Allowed 'General case' 0 C--N 1.356 0.878 0 C-N-CA 125.797 1.639 . . . . 15.0 111.939 168.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.59 -31.51 64.33 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.02 0.928 . . . . 15.0 112.279 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -76.26 -29.79 57.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.263 0.625 . . . . 15.0 111.08 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.37 133.81 85.08 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.997 -0.525 . . . . 15.0 110.135 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.88 108.82 0.25 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.994 3.129 . . . . 15.0 114.479 -167.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -46.75 -49.36 19.78 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.498 1.519 . . . . 15.0 113.197 -172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.96 -27.22 69.25 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.821 0.7 . . . . 15.0 112.495 -174.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' LEU . . . . . . . . . . . . . 57.9 mt -65.86 -22.29 66.52 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 120.962 0.41 . . . . 15.0 110.599 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 311' ' ' ILE . 66.1 m-85 -106.19 -30.35 9.27 Favored 'General case' 0 C--O 1.212 -0.888 0 C-N-CA 123.776 0.831 . . . . 15.0 110.798 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -70.99 -40.87 71.63 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.615 0.766 . . . . 15.0 111.402 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 343' ' ' ARG . 32.3 tt0 -55.06 -43.17 73.59 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.159 0.912 . . . . 15.0 110.982 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -87.48 -28.87 21.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.321 -0.854 . . . . 15.0 111.897 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -66.06 -59.6 3.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.924 0.49 . . . . 15.0 110.259 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 346' ' ' VAL . 87.0 tttt -53.47 -40.29 65.19 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.28 0.987 . . . . 15.0 110.22 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -58.0 -42.19 84.64 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.227 1.011 . . . . 15.0 110.027 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -65.37 -44.14 88.54 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.547 0.739 . . . . 15.0 110.5 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.572 HG22 ' HG3' ' A' ' 310' ' ' GLU . 2.4 t -70.25 -34.16 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.519 0.512 . . . . 15.0 110.205 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 342' ' ' LYS . 24.3 t -58.82 -45.54 91.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 108.795 -0.817 . . . . 15.0 108.795 177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.648 HG22 HG21 ' A' ' 295' ' ' VAL . 10.0 t -57.52 -46.32 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 O-C-N 123.482 0.489 . . . . 15.0 110.05 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -64.97 -26.69 71.5 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.686 -0.688 . . . . 15.0 113.986 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 61.8 mt -84.15 -39.62 19.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.489 0.716 . . . . 15.0 110.755 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 294' ' ' LEU . 85.4 mt -63.41 -49.17 74.81 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.842 0.857 . . . . 15.0 110.132 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.486 ' HA ' HG12 ' A' ' 354' ' ' VAL . 79.4 mt -68.97 -36.89 78.4 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 114.246 -1.343 . . . . 15.0 110.63 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.06 79.48 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.363 0.414 . . . . 15.0 112.448 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 115' ' ' VAL . 10.7 tp10 -77.67 -48.69 16.15 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 122.755 0.422 . . . . 15.0 111.468 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 351' ' ' LEU . 8.9 p -61.64 -30.61 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 120.932 0.396 . . . . 15.0 109.977 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ILE . . . . . 0.581 HG21 HD13 ' B' ' 301' ' ' ILE . 26.0 mt -58.93 -59.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 115.393 -0.822 . . . . 15.0 109.809 169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.564 0.54 . . . . 15.0 111.052 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -45.37 79.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.359 1.064 . . . . 15.0 111.387 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -96.18 20.19 10.67 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.334 0.654 . . . . 15.0 111.577 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 41.94 42.62 2.35 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.753 1.621 . . . . 15.0 114.054 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 410' ' ' ALA . 89.3 mt -81.16 157.85 25.14 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 122.316 1.055 . . . . 15.0 112.924 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 176.1 12.85 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 125.661 1.584 . . . . 15.0 107.977 173.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ALA . . . . . . . . . . . . . . . -68.6 107.82 3.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.424 -0.954 . . . . 15.0 108.424 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -78.48 110.69 13.78 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.306 0.643 . . . . 15.0 110.603 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.03 -32.84 71.27 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.867 0.867 . . . . 15.0 112.476 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -66.18 -36.09 82.16 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.584 0.354 . . . . 15.0 110.768 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -71.61 -47.35 55.21 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 109.687 -0.486 . . . . 15.0 109.687 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.99 -49.34 72.22 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 O-C-N 124.375 1.047 . . . . 15.0 109.673 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -68.07 -33.51 74.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.26 1.024 . . . . 15.0 111.011 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -64.66 -41.45 97.73 Favored Glycine 0 C--N 1.352 1.461 0 CA-C-O 121.538 0.521 . . . . 15.0 112.093 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . . . . . . . . . 89.1 mt -71.31 -29.68 65.32 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.797 -0.702 . . . . 15.0 111.005 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ILE . . . . . . . . . . . . . 70.6 mt -66.72 -34.09 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.545 0.738 . . . . 15.0 110.168 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.86 -43.38 83.74 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.043 0.537 . . . . 15.0 110.745 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -62.16 -39.68 93.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.933 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.553 ' HB2' ' HH2' ' B' ' 290' ' ' TRP . 34.4 ttp -64.58 -45.6 86.33 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.984 0.914 . . . . 15.0 111.316 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 381' ' ' PRO . . . -61.22 -52.95 62.63 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.65 -1.159 . . . . 15.0 110.719 -175.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.2 t -64.22 -26.55 68.56 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.449 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ALA . . . . . . . . . . . . . . . -72.3 -17.73 61.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.333 0.653 . . . . 15.0 111.925 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -113.53 175.72 5.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.18 0.592 . . . . 15.0 110.52 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -67.21 -55.46 13.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 114.583 -1.19 . . . . 15.0 110.001 -170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -120.07 121.81 29.33 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-N 115.506 -0.77 . . . . 15.0 109.3 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.529 ' HB3' ' HB1' ' A' ' 375' ' ' ALA . 77.8 Cg_exo -51.06 -58.45 1.65 Allowed 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 123.349 2.699 . . . . 15.0 114.111 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -52.72 -54.02 39.57 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-N 114.118 -1.401 . . . . 15.0 113.304 -160.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -65.97 -28.85 69.21 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.128 -0.942 . . . . 15.0 111.655 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . . . . . . . . . 57.3 t -76.58 -41.55 34.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.5 -41.97 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.951 0.782 . . . . 15.0 110.149 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.07 -50.75 63.03 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.138 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -51.43 -37.36 48.13 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 124.427 1.091 . . . . 15.0 111.327 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -70.82 -61.29 1.82 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.143 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 39.0 p -60.28 -30.96 69.8 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 15.0 112.305 -172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.272 0.629 . . . . 15.0 110.914 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.89 83.07 7.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.179 -1.415 . . . . 15.0 107.179 173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -56.35 -33.38 65.6 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.829 1.251 . . . . 15.0 111.628 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -56.58 -37.82 71.13 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.903 -1.044 . . . . 15.0 110.863 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' NH2' ' B' ' 289' ' ' ARG . 25.1 tp -91.74 -30.44 16.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.91 0.884 . . . . 15.0 111.291 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' MET . . . . . . . . . . . . . 16.4 tpt -66.95 -52.24 45.32 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.477 0.711 . . . . 15.0 110.488 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.16 -44.68 94.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.657 0.783 . . . . 15.0 110.196 173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 401' ' ' VAL . 26.4 t-20 -52.82 -45.72 67.42 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.433 1.083 . . . . 15.0 111.19 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' MET . . . . . . . . . . . . . 8.0 tpt -64.32 -38.71 92.0 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.021 0.826 . . . . 15.0 111.509 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 36.7 mtp-105 -67.9 -34.55 76.86 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.257 -0.883 . . . . 15.0 109.801 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.59 -32.35 69.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.344 0.658 . . . . 15.0 110.625 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 397' ' ' ASN . 96.5 t -67.23 -52.95 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.042 0.537 . . . . 15.0 109.649 175.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -57.72 -41.44 81.79 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.063 0.945 . . . . 15.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.716 HD11 HD11 ' B' ' 301' ' ' ILE . 42.5 tp -63.18 -47.31 83.17 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.387 -1.279 . . . . 15.0 111.31 175.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 408' ' ' VAL . 10.9 tp10 -56.76 -44.5 81.84 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.333 1.053 . . . . 15.0 109.841 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.768 ' HB3' HH21 ' A' ' 283' ' ' ARG . 53.5 mt-10 -64.53 -48.96 73.13 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.273 -1.331 . . . . 15.0 111.52 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -67.76 -31.95 72.2 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.642 0.589 . . . . 15.0 110.944 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 351' ' ' LEU . . . -61.96 -49.85 74.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.344 0.658 . . . . 15.0 110.162 174.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 404' ' ' GLU . 81.7 t -58.02 -49.29 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 124.091 0.869 . . . . 15.0 110.855 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . 0.412 ' HG2' HD12 ' A' ' 412' ' ' LEU . 48.0 mt-10 -69.97 -22.57 63.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.581 0.586 . . . . 15.0 112.581 -174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 360' ' ' LEU . . . -65.21 -30.45 71.35 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.565 HG21 HD11 ' A' ' 294' ' ' LEU . 60.3 t -83.52 -35.89 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.098 0.559 . . . . 15.0 109.517 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 415' ' ' ALA . 73.3 mt -64.46 -33.76 76.64 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.426 0.69 . . . . 15.0 111.475 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ALA . . . . . . . . . . . . . . . -63.32 -21.79 66.48 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.659 0.784 . . . . 15.0 111.805 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -103.27 -16.87 15.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.424 1.09 . . . . 15.0 111.26 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 412' ' ' LEU . . . -88.3 173.82 8.54 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.893 0.877 . . . . 15.0 111.002 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -103.92 81.89 1.92 Allowed 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.864 0.866 . . . . 15.0 109.07 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.22 89.4 2.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 108.706 -0.85 . . . . 15.0 108.706 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' THR . . . . . . . . . . . . . 13.7 t -73.55 162.12 29.6 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.815 -0.809 . . . . 15.0 108.815 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 127' ' ' LYS . 39.8 tt0 -147.74 132.6 18.04 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 110.231 -0.285 . . . . 15.0 110.231 -172.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -134.76 143.73 47.3 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 109.545 -0.539 . . . . 15.0 109.545 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' A' ' 129' ' ' ILE . 38.6 mt-10 -87.94 134.77 33.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.541 0.736 . . . . 15.0 109.949 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.2 t -156.28 166.48 33.31 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.506 0.722 . . . . 15.0 110.704 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' THR . . . . . . . . . . . . . 46.4 p -88.35 177.1 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.66 0.784 . . . . 15.0 111.253 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.09 -17.1 64.73 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.144 0.978 . . . . 15.0 111.641 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -58.25 -36.14 72.77 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.002 0.921 . . . . 15.0 110.678 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -53.36 -50.13 65.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.1 0.96 . . . . 15.0 111.672 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' LEU . . . . . 0.599 ' HB2' HG11 ' A' ' 130' ' ' VAL . 41.0 tp -65.17 -49.03 71.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.285 -0.871 . . . . 15.0 111.41 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' MET . . . . . . . . . . . . . 79.2 mmm -80.01 -32.51 39.63 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.393 -0.821 . . . . 15.0 112.361 -168.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -82.43 38.95 0.57 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.304 0.641 . . . . 15.0 111.139 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -128.35 79.96 1.94 Allowed 'General case' 0 C--N 1.352 0.704 0 C-N-CA 124.241 1.016 . . . . 15.0 108.495 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -71.89 -24.87 61.73 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.918 -1.037 . . . . 15.0 110.178 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.355 0 C-N-CA 124.409 1.084 . . . . 15.0 108.296 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.15 178.62 7.43 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.458 0.703 . . . . 0.0 110.63 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . 59.16 70.46 0.65 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.072 0.949 . . . . 0.0 110.034 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.22 136.33 52.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.176 0.99 . . . . 0.0 110.876 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.17 102.36 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.347 0.659 . . . . 0.0 109.803 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 32.1 m -125.03 84.76 2.32 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . . . . . . . . . 89.4 mt -87.63 95.08 9.92 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.918 0.887 . . . . 0.0 109.555 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . -71.19 156.26 52.99 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.229 -0.442 . . . . 0.0 112.283 174.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 176.43 151.13 8.64 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 117.056 0.428 . . . . 0.0 113.198 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLY . . . . . . . . . . . . . . . -148.54 175.08 27.99 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.54 49.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.879 0.871 . . . . 0.0 110.935 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -102.69 103.28 13.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.644 0.778 . . . . 0.0 109.157 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' THR . . . . . . . . . . . . . 14.1 t -141.27 -177.96 5.38 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.119 0.968 . . . . 0.0 109.1 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PHE . . . . . 0.611 ' HA ' HD11 ' A' ' 226' ' ' LEU . 11.3 t80 -61.0 142.44 56.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.103 0.961 . . . . 0.0 109.827 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' ALA . . . . . . . . . . . . . . . -79.2 74.07 5.77 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.953 0.901 . . . . 0.0 111.11 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 28.76 82.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 127.161 2.185 . . . . 0.0 114.844 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' THR . . . . . . . . . . . . . 6.7 m 65.44 10.28 6.45 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 123.952 0.901 . . . . 0.0 112.641 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . 72.99 -62.09 0.48 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.208 1.803 . . . . 0.0 112.571 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 194' ' ' MET . 15.2 t -163.89 -167.28 1.33 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.064 0.545 . . . . 0.0 110.51 -167.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . 64.3 -139.77 0.28 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.081 1.353 . . . . 0.0 111.766 170.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 186' ' ' VAL . . . 87.95 -62.63 3.89 Favored Glycine 0 C--N 1.351 1.388 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -173.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 65.73 10.6 6.92 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.115 0.966 . . . . 0.0 112.65 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -83.28 49.96 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.673 0.749 . . . . 0.0 110.205 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' B' ' 248' ' ' ARG . 30.8 tt0 -147.04 6.0 0.87 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.314 1.046 . . . . 0.0 109.189 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.58 179.85 50.36 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-N 116.39 -0.368 . . . . 0.0 113.038 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 12.2 mptt 68.05 -69.24 0.15 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 125.688 1.595 . . . . 0.0 110.681 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.425 HG21 ' N ' ' B' ' 251' ' ' ALA . 14.7 t -94.23 -160.57 0.78 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.889 1.276 . . . . 0.0 109.675 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.56 -79.52 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ARG . . . . . 0.661 ' HA ' ' HG3' ' B' ' 243' ' ' GLN . 3.4 ptp180 -107.4 -90.53 0.43 Allowed 'General case' 0 CA--C 1.562 1.412 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.587 ' H ' ' HG3' ' B' ' 248' ' ' ARG . 37.0 mt-10 -109.02 4.7 23.48 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.814 1.245 . . . . 0.0 110.477 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp60 -67.61 3.43 1.39 Allowed 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 124.644 1.178 . . . . 0.0 113.514 -166.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ALA . . . . . 0.425 ' N ' HG21 ' B' ' 246' ' ' THR . . . -62.2 -29.27 70.26 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.677 1.191 . . . . 0.0 112.255 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.82 -21.66 65.2 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.904 0.482 . . . . 0.0 110.892 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -86.91 21.19 2.35 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.56 164.99 2.36 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.839 0.856 . . . . 0.0 112.074 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 102.69 -58.98 0.56 Allowed Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -107.67 28.36 8.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.141 0.976 . . . . 0.0 111.508 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.72 167.65 13.67 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.124 0.57 . . . . 0.0 110.134 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . . . . . . . . . 9.4 mp 71.7 -67.11 0.27 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 125.55 1.54 . . . . 0.0 111.433 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' VAL . . . . . . . . . . . . . 34.0 m 44.51 38.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 C-N-CA 126.284 1.833 . . . . 0.0 113.423 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' SER . . . . . . . . . . . . . 44.7 t -70.42 169.97 12.9 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.531 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.72 13.04 7.25 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 125.103 1.361 . . . . 0.0 112.37 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ALA . . . . . . . . . . . . . . . -72.17 -32.74 67.12 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.293 1.037 . . . . 0.0 110.712 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' ALA . . . . . . . . . . . . . . . -106.26 21.05 18.01 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.787 0.835 . . . . 0.0 110.273 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' SER . . . . . . . . . . . . . 36.1 m 60.57 55.7 3.3 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.96 1.304 . . . . 0.0 111.993 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 138.79 16.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.795 0.838 . . . . 0.0 109.097 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -91.6 138.0 31.91 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.387 0.675 . . . . 0.0 110.315 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 43.3 p -81.64 79.16 8.28 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.667 0.787 . . . . 0.0 110.106 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 12.5 p -138.24 -0.88 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 C-N-CA 123.649 0.78 . . . . 0.0 110.726 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' THR . . . . . . . . . . . . . 9.8 t 48.41 39.2 12.17 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.606 1.962 . . . . 0.0 112.853 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -77.39 144.72 37.7 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.034 175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -110.08 -66.42 1.07 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -137.73 -45.13 0.53 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.98 146.7 52.52 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.366 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -39.39 -61.04 0.84 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.978 1.711 . . . . 0.0 113.033 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' LYS . . . . . 0.536 ' HB2' ' HA3' ' A' ' 257' ' ' GLY . 89.3 mttt -140.88 157.21 67.96 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.003 0.921 . . . . 0.0 108.771 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' PRO . . . . . 0.41 ' HB2' ' ND2' ' B' ' 285' ' ' ASN . 92.4 Cg_endo -73.22 -5.94 18.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.272 1.981 . . . . 0.0 113.177 174.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . 0.664 HD22 ' HG3' ' A' ' 269' ' ' GLU . 33.2 tp 78.04 -68.7 0.15 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.297 1.439 . . . . 0.0 111.222 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' LEU . . . . . 0.495 ' HG ' ' H ' ' B' ' 279' ' ' GLY . 0.9 OUTLIER -108.17 -64.6 1.2 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.981 0.512 . . . . 0.0 111.596 -174.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' GLY . . . . . 0.495 ' H ' ' HG ' ' B' ' 278' ' ' LEU . . . 140.63 -153.06 23.41 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 118.276 0.489 . . . . 0.0 113.337 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 tt -80.86 55.09 2.32 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.198 1.399 . . . . 0.0 108.825 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -71.46 -49.29 42.95 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 123.187 0.595 . . . . 0.0 110.608 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' ALA . . . . . . . . . . . . . . . -126.45 -24.83 3.56 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.597 0.759 . . . . 0.0 111.093 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ASP . . . . . 0.564 ' HB3' ' HG3' ' A' ' 277' ' ' GLU . 17.0 t70 -151.01 -62.61 0.19 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.888 0.475 . . . . 0.0 110.02 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' GLY . . . . . . . . . . . . . . . 156.99 35.42 0.02 OUTLIER Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.206 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' B' ' 276' ' ' PRO . 1.4 m-80 60.74 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 125.685 1.594 . . . . 0.0 110.926 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' MET . . . . . 0.405 ' H ' ' HB2' ' B' ' 285' ' ' ASN . 0.1 OUTLIER -166.45 85.18 0.91 Allowed Pre-proline 0 C--O 1.246 0.906 0 C-N-CA 125.164 1.385 . . . . 0.0 107.664 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -97.3 151.22 0.97 Allowed 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.526 2.151 . . . . 0.0 113.311 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' VAL . . . . . . . . . . . . . 23.8 m -73.3 -12.67 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.154 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' ARG . . . . . 0.552 ' NH2' HD22 ' A' ' 394' ' ' LEU . 0.0 OUTLIER -76.89 -15.58 59.64 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.078 0.951 . . . . 0.0 111.574 173.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' TRP . . . . . 0.553 ' HH2' ' HB2' ' A' ' 374' ' ' MET . 63.8 m95 72.43 167.96 0.31 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.744 1.618 . . . . 0.0 115.173 168.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 284' ' ' ASN . 2.3 pt? -63.83 -48.08 78.24 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.036 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.1 77.65 0.25 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.32 95.02 0.31 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.115 2.543 . . . . 0.0 110.984 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 66.53 166.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.794 1.237 . . . . 0.0 110.105 -166.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' ALA . . . . . . . . . . . . . . . -141.85 -57.2 0.47 Allowed 'General case' 0 N--CA 1.479 0.981 0 O-C-N 121.678 -0.639 . . . . 0.0 111.45 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 296' ' ' THR . . . . . . . . . . . . . 66.9 p -108.46 -93.26 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.743 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 297' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -176.85 -75.54 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.742 0.817 . . . . 0.0 109.06 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 298' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 73.19 -45.75 0.63 Allowed 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.291 1.836 . . . . 0.0 112.216 -175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' GLY . . . . . . . . . . . . . . . 102.56 26.09 7.4 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.6 -0.555 . . . . 0.0 112.216 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 300' ' ' ASN . . . . . . . . . . . . . 52.1 t30 51.87 75.95 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.123 1.369 . . . . 0.0 110.933 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 403' ' ' LEU . 2.7 pp -80.1 -22.08 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.927 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' ASP . . . . . 0.493 ' N ' HD12 ' B' ' 301' ' ' ILE . 4.3 t70 -63.85 -84.15 0.02 OUTLIER 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.432 1.093 . . . . 0.0 109.943 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt 46.55 81.98 0.24 Allowed Pre-proline 0 C--N 1.366 1.314 0 C-N-CA 124.573 1.149 . . . . 0.0 111.177 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -32.9 100.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 125.28 3.986 . . . . 0.0 115.015 -159.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' ALA . . . . . . . . . . . . . . . -143.02 161.09 39.06 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.202 1.001 . . . . 0.0 110.654 -171.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 10.4 p -93.0 160.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.886 0.874 . . . . 0.0 109.736 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 70.7 m -62.46 122.61 16.17 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.579 0.752 . . . . 0.0 110.106 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -68.39 -37.31 80.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.462 0.705 . . . . 0.0 111.813 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.4 m -128.68 88.8 51.08 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--N 1.373 1.847 0 C-N-CA 123.153 2.569 . . . . 12.53 111.403 177.041 . . . . . . . . 0 0 . 1 stop_ save_